
<html lang="en"     class="pb-page"  data-request-id="067e3584-c559-4e0d-a4f6-3d470d857ea2"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2017.60.issue-24;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.7b01347;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Novel Antitubercular 6-Dialkylaminopyrimidine Carboxamides from Phenotypic Whole-Cell High Throughput Screening of a SoftFocus Library: Structure–Activity Relationship and Target Identification Studies" /></meta><meta name="dc.Creator" content="Colin R.  Wilson" /></meta><meta name="dc.Creator" content="Richard K.  Gessner" /></meta><meta name="dc.Creator" content="Atica  Moosa" /></meta><meta name="dc.Creator" content="Ronnett  Seldon" /></meta><meta name="dc.Creator" content="Digby F.  Warner" /></meta><meta name="dc.Creator" content="Valerie  Mizrahi" /></meta><meta name="dc.Creator" content="Candice  Soares de Melo" /></meta><meta name="dc.Creator" content="Sandile B.  Simelane" /></meta><meta name="dc.Creator" content="Aloysius  Nchinda" /></meta><meta name="dc.Creator" content="Efrem  Abay" /></meta><meta name="dc.Creator" content="Dale  Taylor" /></meta><meta name="dc.Creator" content="Mathew  Njoroge" /></meta><meta name="dc.Creator" content="Christel  Brunschwig" /></meta><meta name="dc.Creator" content="Nina  Lawrence" /></meta><meta name="dc.Creator" content="Helena I. M.  Boshoff" /></meta><meta name="dc.Creator" content="Clifton E.  Barry, III" /></meta><meta name="dc.Creator" content="Frederick A.  Sirgel" /></meta><meta name="dc.Creator" content="Paul  van Helden" /></meta><meta name="dc.Creator" content="C. John  Harris" /></meta><meta name="dc.Creator" content="Richard  Gordon" /></meta><meta name="dc.Creator" content="Sonja  Ghidelli-Disse" /></meta><meta name="dc.Creator" content="Hannah  Pflaumer" /></meta><meta name="dc.Creator" content="Markus  Boesche" /></meta><meta name="dc.Creator" content="Gerard  Drewes" /></meta><meta name="dc.Creator" content="Olalla  Sanz" /></meta><meta name="dc.Creator" content="Gracia  Santos" /></meta><meta name="dc.Creator" content="Maria José  Rebollo-Lopez" /></meta><meta name="dc.Creator" content="Beatriz  Urones" /></meta><meta name="dc.Creator" content="Carolyn  Selenski" /></meta><meta name="dc.Creator" content="Maria Jose  Lafuente-Monasterio" /></meta><meta name="dc.Creator" content="Matthew  Axtman" /></meta><meta name="dc.Creator" content="Joël  Lelièvre" /></meta><meta name="dc.Creator" content="Lluis  Ballell" /></meta><meta name="dc.Creator" content="Rudolf  Mueller" /></meta><meta name="dc.Creator" content="Leslie J.  Street" /></meta><meta name="dc.Creator" content="Sandeep R.  Ghorpade" /></meta><meta name="dc.Creator" content="Kelly  Chibale" /></meta><meta name="dc.Description" content="A BioFocus DPI SoftFocus library of ∼35 000 compounds was screened against Mycobacterium tuberculosis (Mtb) in order to identify novel hits with antitubercular activity. The hits were evaluated in ..." /></meta><meta name="Description" content="A BioFocus DPI SoftFocus library of ∼35 000 compounds was screened against Mycobacterium tuberculosis (Mtb) in order to identify novel hits with antitubercular activity. The hits were evaluated in ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 7, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b01347" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01347" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b01347" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01347" /></link>
        
    
    

<title>Novel Antitubercular 6-Dialkylaminopyrimidine Carboxamides from Phenotypic Whole-Cell High Throughput Screening of a SoftFocus Library: Structure–Activity Relationship and Target Identification Studies | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b01347" /></meta><meta property="og:title" content="Novel Antitubercular 6-Dialkylaminopyrimidine Carboxamides from Phenotypic Whole-Cell High Throughput Screening of a SoftFocus Library: Structure–Activity Relationship and Target Identification Studies" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/large/jm-2017-01347e_0017.jpeg" /></meta><meta property="og:description" content="A BioFocus DPI SoftFocus library of ∼35 000 compounds was screened against Mycobacterium tuberculosis (Mtb) in order to identify novel hits with antitubercular activity. The hits were evaluated in biology triage assays to exclude compounds suggested to function via frequently encountered promiscuous mechanisms of action including inhibition of the QcrB subunit of the cytochrome bc1 complex, disruption of cell–wall homeostasis, and DNA damage. Among the hits that passed this screening cascade, a 6-dialkylaminopyrimidine carboxamide series was prioritized for hit to lead optimization. Compounds from this series were active against clinical Mtb strains, while no cross-resistance to conventional antituberculosis drugs was observed. This suggested a novel mechanism of action, which was confirmed by chemoproteomic analysis leading to the identification of BCG_3193 and BCG_3827 as putative targets of the series with unknown function. Initial structure–activity relationship studies have resulted in compounds with moderate to potent antitubercular activity and improved physicochemical properties." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b01347"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b01347">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b01347&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b01347&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b01347&amp;href=/doi/10.1021/acs.jmedchem.7b01347" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 24</span><span class="cit-fg-pageRange">, 10118-10134</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/24" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b01331" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b01348" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Novel Antitubercular 6-Dialkylaminopyrimidine Carboxamides from Phenotypic Whole-Cell High Throughput Screening of a SoftFocus Library: Structure–Activity Relationship and Target Identification Studies</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Colin+R.++Wilson">Colin R. Wilson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Richard+K.++Gessner">Richard K. Gessner</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Atica++Moosa">Atica Moosa</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ronnett++Seldon">Ronnett Seldon</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Digby+F.++Warner">Digby F. Warner</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Valerie++Mizrahi">Valerie Mizrahi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0003-4824-9115" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Candice++Soares+de+Melo">Candice Soares de Melo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sandile+B.++Simelane">Sandile B. Simelane</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Aloysius++Nchinda">Aloysius Nchinda</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Efrem++Abay">Efrem Abay</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dale++Taylor">Dale Taylor</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mathew++Njoroge">Mathew Njoroge</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christel++Brunschwig">Christel Brunschwig</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nina++Lawrence">Nina Lawrence</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Helena+I.+M.++Boshoff">Helena I. M. Boshoff</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Clifton+E.++Barry%2C++III">Clifton E. Barry, III</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Frederick+A.++Sirgel">Frederick A. Sirgel</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul++van+Helden">Paul van Helden</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=C.+John++Harris">C. John Harris</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∇</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Richard++Gordon">Richard Gordon</a></span><span class="author-xref-symbol author-aff-symbol"><sup>○</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sonja++Ghidelli-Disse">Sonja Ghidelli-Disse</a></span><span class="author-xref-symbol author-aff-symbol"><sup>◆</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hannah++Pflaumer">Hannah Pflaumer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>◆</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Markus++Boesche">Markus Boesche</a></span><span class="author-xref-symbol author-aff-symbol"><sup>◆</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gerard++Drewes">Gerard Drewes</a></span><span class="author-xref-symbol author-aff-symbol"><sup>◆</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Olalla++Sanz">Olalla Sanz</a></span><span class="author-xref-symbol author-aff-symbol"><sup>¶</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gracia++Santos">Gracia Santos</a></span><span class="author-xref-symbol author-aff-symbol"><sup>¶</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maria+Jos%C3%A9++Rebollo-Lopez">Maria José Rebollo-Lopez</a></span><span class="author-xref-symbol author-aff-symbol"><sup>¶</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Beatriz++Urones">Beatriz Urones</a></span><span class="author-xref-symbol author-aff-symbol"><sup>¶</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Carolyn++Selenski">Carolyn Selenski</a></span><span class="author-xref-symbol author-aff-symbol"><sup>¶</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maria+Jose++Lafuente-Monasterio">Maria Jose Lafuente-Monasterio</a></span><span class="author-xref-symbol author-aff-symbol"><sup>¶</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matthew++Axtman">Matthew Axtman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>¶</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jo%C3%ABl++Leli%C3%A8vre">Joël Lelièvre</a></span><span class="author-xref-symbol author-aff-symbol"><sup>¶</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lluis++Ballell">Lluis Ballell</a></span><span class="author-xref-symbol author-aff-symbol"><sup>¶</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rudolf++Mueller">Rudolf Mueller</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Leslie+J.++Street">Leslie J. Street</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sandeep+R.++Ghorpade">Sandeep R. Ghorpade</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-9311-1572" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kelly++Chibale">Kelly Chibale</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∞</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-1327-4727" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Department of Chemistry, Drug Discovery and Development Centre (H3D), University of Cape Town, Rondebosch 7701, South Africa</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Medicine, Division of Clinical Pharmacology, Drug Discovery and Development Centre (H3D), University of Cape Town, Observatory, 7925, South Africa</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">SAMRC/NHLS/UCT Molecular Mycobacteriology Research Unit, Department of Pathology, University of Cape Town, Rondebosch 7701, South Africa</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Rondebosch 7701, South Africa</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">⊥</span> <span class="aff-text">Tuberculosis Research Section, Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, United States</span></div><div class="aff-info" id="aff6"><span class="aff-symbol">#</span> <span class="aff-text">DST/NRF Centre of Excellence for Biomedical TB Research, SA MRC Centre for TB Research, Division of Molecular Biology and Human Genetics, Faculty of Health Sciences, Stellenbosch University, 7505 Tygerberg, South Africa</span></div><div class="aff-info" id="aff7"><span class="aff-symbol">∇</span> <span class="aff-text">CJH Consultants, Ford Cottage, South Weirs, Brockenhurst, Hampshire SO42 7UQ, U.K.</span></div><div class="aff-info" id="aff8"><span class="aff-symbol">○</span> <span class="aff-text">Strategic Health Innovation Partnerships (SHIP), South African Medical Research Council, Parow Valley, Cape Town, South Africa</span></div><div class="aff-info" id="aff9"><span class="aff-symbol">◆</span> <span class="aff-text">Cellzome GmbH, Molecular Discovery Research, GlaxoSmithKline, Meyerhofstrasse 1, Heidelberg 69117, Germany</span></div><div class="aff-info" id="aff10"><span class="aff-symbol">¶</span> <span class="aff-text">Diseases of the Developing World, GlaxoSmithKline, Calle Severo Ochoa 2, 28760 Tres Cantos, Madrid, Spain</span></div><div class="aff-info" id="aff11"><span class="aff-symbol">∞</span> <span class="aff-text">South African Medical Research Council Drug Discovery and Development Research Unit, Department of Chemistry, University of Cape Town, Rondebosch 7701, South Africa</span></div><div class="corresp-info"><strong>*</strong>S.R.G.: phone, +27 21 650 1250; e-mail, <a href="/cdn-cgi/l/email-protection#461527282223233668212e29343627222306332532682725683c27"><span class="__cf_email__" data-cfemail="3360525d575656431d545b5c4143525756734650471d52501d4952">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>K.C.: phone, +27 21 650 2553; e-mail, <a href="/cdn-cgi/l/email-protection#98f3fdf4f4e1b6fbf0f1faf9f4fdd8edfbecb6f9fbb6e2f9"><span class="__cf_email__" data-cfemail="2f444a434356014c47464d4e434a6f5a4c5b014e4c01554e">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01347&amp;href=/doi/10.1021%2Facs.jmedchem.7b01347" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 24</span><span class="cit-pageRange">, 10118–10134</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 17, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>11 September 2017</li><li><span class="item_label"><b>Published</b> online</span>7 December 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 28 December 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b01347" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01347</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice/index.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a><span class="article_header-cc-by text">with CC-BY<a href="/page/policy/authorchoice_ccby_termsofuse.html" title="License">license</a></span></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b01347"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3235</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">13</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b01347" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Novel Antitubercular 6-Dialkylaminopyrimidine Carboxamides from Phenotypic Whole-Cell High Throughput Screening of a SoftFocus Library: Structure–Activity Relationship and Target Identification Studies&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Colin&quot;,&quot;last_name&quot;:&quot;R. Wilson&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;K. Gessner&quot;},{&quot;first_name&quot;:&quot;Atica&quot;,&quot;last_name&quot;:&quot;Moosa&quot;},{&quot;first_name&quot;:&quot;Ronnett&quot;,&quot;last_name&quot;:&quot;Seldon&quot;},{&quot;first_name&quot;:&quot;Digby&quot;,&quot;last_name&quot;:&quot;F. Warner&quot;},{&quot;first_name&quot;:&quot;Valerie&quot;,&quot;last_name&quot;:&quot;Mizrahi&quot;},{&quot;first_name&quot;:&quot;Candice&quot;,&quot;last_name&quot;:&quot;Soares de Melo&quot;},{&quot;first_name&quot;:&quot;Sandile&quot;,&quot;last_name&quot;:&quot;B. Simelane&quot;},{&quot;first_name&quot;:&quot;Aloysius&quot;,&quot;last_name&quot;:&quot;Nchinda&quot;},{&quot;first_name&quot;:&quot;Efrem&quot;,&quot;last_name&quot;:&quot;Abay&quot;},{&quot;first_name&quot;:&quot;Dale&quot;,&quot;last_name&quot;:&quot;Taylor&quot;},{&quot;first_name&quot;:&quot;Mathew&quot;,&quot;last_name&quot;:&quot;Njoroge&quot;},{&quot;first_name&quot;:&quot;Christel&quot;,&quot;last_name&quot;:&quot;Brunschwig&quot;},{&quot;first_name&quot;:&quot;Nina&quot;,&quot;last_name&quot;:&quot;Lawrence&quot;},{&quot;first_name&quot;:&quot;Helena&quot;,&quot;last_name&quot;:&quot;I. M. Boshoff&quot;},{&quot;first_name&quot;:&quot;Clifton&quot;,&quot;last_name&quot;:&quot;E. Barry&quot;},{&quot;first_name&quot;:&quot;Frederick&quot;,&quot;last_name&quot;:&quot;A. Sirgel&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;van Helden&quot;},{&quot;first_name&quot;:&quot;C.&quot;,&quot;last_name&quot;:&quot;John Harris&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;Gordon&quot;},{&quot;first_name&quot;:&quot;Sonja&quot;,&quot;last_name&quot;:&quot;Ghidelli-Disse&quot;},{&quot;first_name&quot;:&quot;Hannah&quot;,&quot;last_name&quot;:&quot;Pflaumer&quot;},{&quot;first_name&quot;:&quot;Markus&quot;,&quot;last_name&quot;:&quot;Boesche&quot;},{&quot;first_name&quot;:&quot;Gerard&quot;,&quot;last_name&quot;:&quot;Drewes&quot;},{&quot;first_name&quot;:&quot;Olalla&quot;,&quot;last_name&quot;:&quot;Sanz&quot;},{&quot;first_name&quot;:&quot;Gracia&quot;,&quot;last_name&quot;:&quot;Santos&quot;},{&quot;first_name&quot;:&quot;Maria&quot;,&quot;last_name&quot;:&quot;José Rebollo-Lopez&quot;},{&quot;first_name&quot;:&quot;Beatriz&quot;,&quot;last_name&quot;:&quot;Urones&quot;},{&quot;first_name&quot;:&quot;Carolyn&quot;,&quot;last_name&quot;:&quot;Selenski&quot;},{&quot;first_name&quot;:&quot;Maria&quot;,&quot;last_name&quot;:&quot;Jose Lafuente-Monasterio&quot;},{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;Axtman&quot;},{&quot;first_name&quot;:&quot;Joël&quot;,&quot;last_name&quot;:&quot;Lelièvre&quot;},{&quot;first_name&quot;:&quot;Lluis&quot;,&quot;last_name&quot;:&quot;Ballell&quot;},{&quot;first_name&quot;:&quot;Rudolf&quot;,&quot;last_name&quot;:&quot;Mueller&quot;},{&quot;first_name&quot;:&quot;Leslie&quot;,&quot;last_name&quot;:&quot;J. Street&quot;},{&quot;first_name&quot;:&quot;Sandeep&quot;,&quot;last_name&quot;:&quot;R. Ghorpade&quot;},{&quot;first_name&quot;:&quot;Kelly&quot;,&quot;last_name&quot;:&quot;Chibale&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;07&quot;,&quot;issue&quot;:&quot;24&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;10118-10134&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b01347&quot;},&quot;abstract&quot;:&quot;A BioFocus DPI SoftFocus library of ∼35 000 compounds was screened against Mycobacterium tuberculosis (Mtb) in order to identify novel hits with antitubercular activity. The hits were evaluated in biology triage assays to exclude compounds suggested to function via frequently encountered promiscuous mechanisms of action including inhibition of the QcrB subunit of the cytochrome bc1 complex, disruption of cell–wall homeostasis, and DNA damage. Among the hits that passed this screening cascade, a 6-dialkylaminopyrimidine carboxamide series was prioritized for hit to lead optimization. Compounds from this series were active against clinical Mtb strains, while no cross-resistance to conventional antituberculosis drugs was observed. This suggested a novel mechanism of action, which was confirmed by chemoproteomic analysis leading to the identification of BCG_3193 and BCG_3827 as putative targets of the series with unknown function. Initial structure–activity relationship studies have resulted in compounds with mod&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01347&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01347" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01347&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01347" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01347&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01347" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01347&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01347&amp;href=/doi/10.1021/acs.jmedchem.7b01347" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b01347" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b01347" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01347&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b01347%26sid%3Dliteratum%253Aachs%26pmid%3D29148755%26genre%3Darticle%26aulast%3DWilson%26date%3D2017%26atitle%3DNovel%2BAntitubercular%2B6-Dialkylaminopyrimidine%2BCarboxamides%2Bfrom%2BPhenotypic%2BWhole-Cell%2BHigh%2BThroughput%2BScreening%2Bof%2Ba%2BSoftFocus%2BLibrary%253A%2BStructure%25E2%2580%2593Activity%2BRelationship%2Band%2BTarget%2BIdentification%2BStudies%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D24%26spage%3D10118%26epage%3D10134%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (3)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290658" title="Amides">Amides</a>,</li><li><a href="/action/doSearch?ConceptID=291011" title="High-performance liquid chromatography">High-performance liquid chromatography</a>,</li><li><a href="/action/doSearch?ConceptID=291465" title="Structure activity relationship">Structure activity relationship</a>,</li><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=291454" title="Solubility">Solubility</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/24" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/jmcmar.2017.60.issue-24/20171228/jmcmar.2017.60.issue-24.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/medium/jm-2017-01347e_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/large/jm-2017-01347e_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01347&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A BioFocus DPI SoftFocus library of ∼35 000 compounds was screened against <i>Mycobacterium tuberculosis</i> (Mtb) in order to identify novel hits with antitubercular activity. The hits were evaluated in biology triage assays to exclude compounds suggested to function via frequently encountered promiscuous mechanisms of action including inhibition of the QcrB subunit of the cytochrome <i>bc</i><sub>1</sub> complex, disruption of cell–wall homeostasis, and DNA damage. Among the hits that passed this screening cascade, a 6-dialkylaminopyrimidine carboxamide series was prioritized for hit to lead optimization. Compounds from this series were active against clinical Mtb strains, while no cross-resistance to conventional antituberculosis drugs was observed. This suggested a novel mechanism of action, which was confirmed by chemoproteomic analysis leading to the identification of BCG_3193 and BCG_3827 as putative targets of the series with unknown function. Initial structure–activity relationship studies have resulted in compounds with moderate to potent antitubercular activity and improved physicochemical properties.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32588" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32588" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Tuberculosis (TB) is one of the world’s most deadly infectious diseases, leading to 1.4 million deaths in 2015.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The disease is caused by <i>Mycobacterium tuberculosis</i> (Mtb) and primarily affects lower to middle income countries such as those in sub-Saharan Africa. A standard first-line four-drug regimen of rifampin, isoniazid, pyrazinamide, and ethambutol is used to treat drug-susceptible TB.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Although these drugs form the core of TB treatment regimens, they have become ineffective against resistant Mtb strains. TB that does not respond to at least isoniazid and rifampin, the two frontline drugs, is defined as multidrug resistant (MDR) TB. MDR TB that develops additional resistance to any fluoroquinolone and at least one of the three injectable second-line drugs (amikacin, kanamycin, or capreomycin) is referred to as extensively drug resistant (XDR) TB and is virtually untreatable.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> One of the main drivers behind the rise of resistance is the 6-month-long treatment required for drug-sensitive disease, resulting in poor patient adherence. Thus, the main goal of many TB drug discovery programs is the identification of compounds that will potentially contribute to treatment shortening, albeit there is no clear evidence as to how this can be accomplished.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> One possible approach is to identify compounds that inhibit novel targets and do not show cross-resistance to currently used anti-TB drugs. Various novel drug combinations can then be evaluated for their potential toward treatment shortening while establishing clinical effectiveness. Identifying compounds that exert their anti-TB effect through novel targets is not a trivial process. This is exemplified by the approval in 2012 of bedaquiline, the first new drug approved for the treatment of TB in more than 40 years with a novel mechanism of action (MOA) that involves inhibition of the mycobacterial ATP synthase.<a onclick="showRef(event, 'ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7">(5-7)</a></div><div class="NLM_p">Two hit-generation approaches that have been traditionally used are target-based and whole-cell screening.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> Historically, there has been extremely limited success with the target-based approach owing to the lack of translation from target activity to whole-cell activity. Nevertheless, efforts to discover and validate novel drug targets using various approaches must continue. This is exemplified by the recently reported validation of CoaBC as a bactericidal target using a chemical biology approach.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> On the other hand, a more successful approach has been phenotypic whole-cell high-throughput screening (HTS) of chemical libraries to identify novel chemotypes whose target is then identified retrospectively. There are several compounds in the TB drug pipeline that have been identified through whole-cell HTS. Examples include Q203 (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>), an inhibitor of the QcrB subunit of the cytochrome <i>bc</i><sub>1</sub> complex which is involved in electron transport.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Another example is SQ109 (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>) whose precise MOA remains to be elucidated but is believed to involve the mycobacterial membrane protein large 3, MmpL3, a mycolic acid transporter involved in cell wall synthesis,.<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> Similarly, some inhibitors of decaprenylphosphoryl-β-<span class="smallcaps smallerCapital">d</span>-ribose 2′-epimerase (DprE1), e.g., pBTZ,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> and azaindoles TBA7371<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15, 16)</a> are poised to enter clinical trials (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). While these compounds show promise as new anti-TB agents, their targets are yet to be clinically validated. This necessitates the need to continuously identify new chemical matter with alternative novel MOAs toward populating the TB drug pipeline.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/medium/jm-2017-01347e_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/large/jm-2017-01347e_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. New TB drug development candidates identified from whole cell screening.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/large/jm-2017-01347e_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01347&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In line with this, we initiated a HTS campaign using a diverse SoftFocus compound library<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> acquired from BioFocus and complemented this with a biology triage process that aimed specifically to exclude compounds acting on targets such as QcrB and the cell wall (e.g., MmpL3 and DprE1), as well as DNA damaging agents. The rationale was to exclude targets known for their promiscuity, with a large proportion of HTS hits having these as part of their MOA.<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18, 19)</a> There is also the question around whether or not compounds targeting cell wall metabolism can contribute to the much sought after treatment shortening.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Compounds that induce DNA damage were also excluded in order to avoid general cytotoxicity, as well as targets such as DNA gyrase whose clinically used inhibitors are exemplified by the fluoroquinolones. Along with an aminopyrazolo[1,5-<i>a</i>]pyrimidine chemical series,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> a 6-dialkylaminopyrimidine carboxamide scaffold was identified as a hit series with a potentially novel MOA, based on the initial biology triage process (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). Herein, we describe the synthesis, structure–activity relationship (SAR), in vitro absorption, distribution, metabolism, and excretion (ADME), and in vivo pharmacokinetic (PK) and biological profiles of this chemical series.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/medium/jm-2017-01347e_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/large/jm-2017-01347e_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Compound <b>1</b> and biology triage data.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/large/jm-2017-01347e_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01347&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42378" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42378" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2-1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Phenotypic Whole-Cell HTS and Biology Triage</h3><div class="NLM_p last">A screen of a BioFocus DPI SoftFocus library of ∼35 000 compounds against virulent Mtb H37Rv conducted at the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIAID/NIH, U.S.) led to a number of confirmed hits, which included compound <b>1</b> with a moderate minimum inhibitory concentration (MIC) value of 20 μM in albumin–dextrose complex (ADC) medium containing ∼0.4% bovine serum albumin (BSA). The compound was slightly more potent in GAST-Fe (glycerol-alanine-salts)<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> minimal medium, likely driven by the absence of BSA which allowed for higher free concentration of the compound under the assay conditions. Hence, GAST-Fe was used alongside the 7H9/ADC medium during further SAR exploration of the series. Compound <b>1</b> was tested in the three biology triage assays in order to assess activity against promiscuous targets. The compound did not show hypersensitivity against a cytochrome <i>bd</i> oxidase knockout mutant strain (<i>cyd</i>KO)<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21, 22)</a> and also retained activity against a QcrB mutant (<i>qcrB</i><sup>A317T</sup>), thereby eliminating this as potential target. Compound <b>1</b> also did not elicit a positive response in two standard bioluminescence reporter assays: P<i>iniB</i>-LUX,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> which is designed to detect compounds targeting Mtb cell wall biosynthesis, and P<i>recA</i>-LUX,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> which allows detection of genotoxic compounds (data in <a href="/doi/suppl/10.1021/acs.jmedchem.7b01347/suppl_file/jm7b01347_si_001.pdf" class="ext-link">Supporting Information</a>). Similar results were obtained with other analogues in the series obtained during SAR studies (data in <a href="/doi/suppl/10.1021/acs.jmedchem.7b01347/suppl_file/jm7b01347_si_001.pdf" class="ext-link">Supporting Information</a>). These results, along with chemoproteomics and cross-resistance studies (see biology results below), indicate that the 6-dialkylaminopyrimidine carboxamide series of compounds exemplified by compound <b>1</b> possess a novel MOA that is not shared with known TB drugs.</div></div><div id="sec2-1-1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> SAR Exploration Strategy</h3><div class="NLM_p">Compound <b>1</b> was identified as a suitable hit with a moderate minimum inhibitory concentration (MIC<sub>99</sub>) of 20 μM in 7H9/ADC medium, low toxicity against the mammalian Vero cell line (IC<sub>50</sub> of 287 μM), yet poor kinetic solubility (KS, <5 μM). The poor solubility was assumed to be related to the high lipophilicity and flat aromatic character of the molecule. Since there were very few active near neighbors identified from the screen, very limited information was available on further optimization scope with the scaffold to improve anti-TB activity while addressing the poor physicochemical properties and potential safety issues that may be associated with the scaffold. A detailed SAR plan as summarized in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a> was embarked upon. The molecule was divided into three parts for convenience: the central pyrimidine core, right-hand side (RHS) amide, and left-hand side (LHS) hydrophobic <i>N</i>-benzyl moiety (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>). The major SAR exploration focus was on understanding key hydrogen bond (HB) donor–acceptor interactions critical for activity, shape, and size of the central core, and scope for substitution/modification on either the RHS or LHS parts of the molecule to improve potency. The scope for addition of heteroatoms or polar groups into the molecule was also explored with the aim of reducing lipophilicity along with addressing related issues such as poor physicochemical properties and structure alerts such as the presence of potentially AMES positive anilines upon cleavage of the amide group.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/medium/jm-2017-01347e_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/large/jm-2017-01347e_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. SAR exploration strategy.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/large/jm-2017-01347e_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01347&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2-1-2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Synthesis</h3><div class="NLM_p">Compounds <b>1</b>–<b>20</b> were synthesized to explore the SAR around the <i>N</i>-methyl-1-phenylmethanamine motif (SAR on LHS, <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Compounds <b>21</b>–<b>30</b> were synthesized to explore the central pyrimidine core of the scaffold (SAR on central core, <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>), and compounds <b>31</b>–<b>54</b> were synthesized to explore the SAR around the amide portion of the scaffold (SAR on RHS, <a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). In general, target compounds were synthesized using either one of two routes. <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> was used to synthesize an advanced intermediate with a specific amide in place allowing for the exploration of the LHS of the molecule. The same route was also used to synthesize several of the core modifications. The route involved a straightforward two-step procedure starting from a chloro-heterocyclic-carboxylic acid, where coupling with corresponding amine using 1-[bis(dimethylamino)methylene]-1<i>H</i>-1,2,3-triazolo[4,5-<i>b</i>]pyridinium 3-oxide hexafluorophosphate (HATU) was first performed, followed by nucleophilic displacement of the relevant chloro group by an appropriate amine. Thus, synthesis of compounds <b>1</b>–<b>20</b> and <b>39</b> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) was achieved by coupling of 6-chloropyrimidine-4-carboxylic acid with aniline, 4-methoxyaniline, and 4-aminopyridine to give intermediates <b>55</b>, <b>56</b>, and <b>57</b>, respectively, followed by displacement of 6-chloro group with various amines. Compound <b>21</b> was synthesized by coupling of 4-chloropicolinic acid with aniline to form intermediate <b>58</b> followed by reaction with 1-(4-fluorophenyl)-<i>N</i>-methylmethanamine.</div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/medium/jm-2017-01347e_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/large/jm-2017-01347e_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Route for the Synthesis of 6-Aminopyrimidine-4-carboxamides and Alternative Cores<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/large/jm-2017-01347e_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01347&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) amine, DIPEA, HATU, DMF, 25 °C; (ii) amine, <i>i</i>-PrOH, DIPEA, 100 °C.</p></p></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SAR on the LHS</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/medium/jm-2017-01347e_0011.gif" alt="" id="GRAPHIC-d183e963-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/medium/jm-2017-01347e_0012.gif" alt="" id="gr10" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Kinetic solubility at pH 7.4.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">IC<sub>50</sub> on Vero cell lines.</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">MIC<sub>99</sub> from GFP strain based assay. ND: not determined.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SAR on the Central Core</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/medium/jm-2017-01347e_0013.gif" alt="" id="GRAPHIC-d183e993-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/medium/jm-2017-01347e_0014.gif" alt="" id="gr13" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Kinetic solubility at pH 7.4.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">IC<sub>50</sub> on Vero cell lines. ND: not determined.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. SAR on the RHS</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/medium/jm-2017-01347e_0015.gif" alt="" id="GRAPHIC-d183e1015-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/medium/jm-2017-01347e_0016.gif" alt="" id="gr15" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">Kinetic solubility at pH 7.4.</p></div><div class="footnote" id="t3fn2"><sup>Table b</sup><p class="last">IC<sub>50</sub> on Vero cell lines.</p></div><div class="footnote" id="t3fn3"><sup>Table c</sup><p class="last">MIC<sub>99</sub> from Mtb-GFP strain based assay. ND: not determined.</p></div></div><div></div></div><div class="NLM_p">Synthesis of compounds <b>22</b>–<b>26</b> (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>) with changes in the central core ring are summarized in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. Compound <b>22</b> was synthesized by nucleophilic displacement of <b>59</b> with 1-(4-fluorophenyl)-<i>N</i>-methylmethanamine followed by carbamoylation according to the procedure described by Ren et al.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Compound <b>23</b> was synthesized in a similar manner except the initial nucleophilic displacement step of <b>60</b> resulted in a mixture of the intended 4-chloro-<i>N</i>-(4-fluorobenzyl)-<i>N</i>-methylpyrimidin-2-amine (<b>61</b>) as well as the 2-chloro regioisomer in a 1:2 ratio. The pyridazine core replacement analogue was synthesized by heating 6-oxo-1,6-dihydropyridazine-4-carboxylic acid with POCl<sub>3</sub> followed by quenching of the 6-chloropyridazine-4-carbonyl chloride intermediate with aniline to afford <b>63</b>. Intermediate <b>63</b> was subsequently subjected to nucleophilic displacement with 1-(4-fluorophenyl)-<i>N</i>-methylmethanamine under microwave heating to deliver the final compound <b>24</b>. The pyridone analogue (<b>25</b>) was synthesized from the commercially available precursor, methyl coumalate (<b>64</b>), which was reacted with 4-fluorobenzylamine at room temperature (25 °C) to give the <i>N</i>-substituted pyridinone ester (<b>65</b>). The ester was then hydrolyzed using LiOH followed by an amide coupling to afford <b>25</b>. The thiazole analogue <b>26</b> was synthesized by reductive amination of methyl 2-aminothiazole-4-carboxylate <b>66</b> with 4-fluorobenzaldehyde and NaBH<sub>4</sub>, followed by methylation under basic conditions to afford <b>67</b>. Intermediate <b>67</b> was then subjected to the same hydrolysis and amide coupling conditions as <b>65</b> to afford <b>26</b>.</div><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/medium/jm-2017-01347e_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/large/jm-2017-01347e_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Routes Used To Access Core Modifications<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/large/jm-2017-01347e_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01347&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) 1-(4-fluorophenyl)-<i>N</i>-methylmethanamine, Et<sub>3</sub>N, dioxane, 60 °C; (ii) aniline, Mo(CO)<sub>6</sub>, Et<sub>3</sub>N, TBAC, toluene, tetraglyme, 150 °C; (iii) (a) POCl<sub>3</sub>, 110 °C; (b) aniline, Et<sub>3</sub>N; (iv) 4-fluorobenzylamine, Et<sub>3</sub>N, dioxane, microwave, 125 °C; (v) 4-fluorobenzylamine, H<sub>2</sub>O/EtOH (1.5:1), 25 °C; (vi) LiOH, MeOH; (vii) aniline, HATU, DMF, Et<sub>3</sub>N; (viii) 4-fluorobenzaldehyde, NaBH<sub>4</sub>, EtOH; (ix) MeI, K<sub>2</sub>CO<sub>3</sub>, DMF.</p></p></figure><div class="NLM_p">The 2- and 5-methylpyrimidine analogues <b>27</b> and <b>28</b> (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>) were synthesized in a similar fashion by condensation of the appropriate 1,4-diethyl ester and imidamide <b>68</b> and <b>69</b> to form the corresponding dihydropyrimidine carboxylic ester and acid intermediates <b>70</b> and <b>71</b>, respectively (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). Intermediate <b>70</b> was chlorinated using SOCl<sub>2</sub> followed by nucleophilic displacement of the 6-chloro with 1-(4-fluorophenyl)-<i>N</i>-methylmethanamine delivered <b>72</b>, which was then hydrolyzed under standard basic conditions followed by an amide coupling with HATU to produce <b>27</b>. Intermediate <b>71</b> was subjected to chlorination of both the hydroxyl and carboxylic acid groups using oxalyl chloride. The reaction was then quenched with aniline to afford <b>73</b> which was subsequently aminated with 1-(4-chlorophenyl)-<i>N</i>-methylmethanamine to afford <b>28</b>.</div><figure id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/medium/jm-2017-01347e_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/large/jm-2017-01347e_0010.jpeg" id="GRAPHIC-d183e1258-autogenerated" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of <b>27</b> and <b>28</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/large/jm-2017-01347e_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01347&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) (a) KOH, EtOH; (b) HCl; (ii) SOCl<sub>2</sub>, DMF; (iii) 1-(4-fluorophenyl)-<i>N</i>-methylmethanamine, K<sub>2</sub>CO<sub>3</sub>, DMF; (iv) LiOH, H<sub>2</sub>O:/THF (2:1), 25 °C; (v) HATU, DIPEA, DMF, 25 °C; (vi) (COCl)<sub>2</sub>, EtOAc, aniline; (vii) 1-(4-chlorophenyl)-<i>N</i>-methylmethanamine, <i>i</i>-PrOH, DIPEA, 100 °C.</p></p></figure><div class="NLM_p">In order to access an advanced intermediate that would allow for exploration of the RHS of the molecule (<b>31</b>, <b>33</b>–<b>38</b>, <b>40</b>–<b>52</b>), another relatively straightforward approach (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>), involving four steps from the commercially available methyl 2,4-dichloropyrimidine-6-carboxylate, was used. Briefly, quantitative amination by selective displacement of the 6-chloro group using an appropriate <i>N</i>-methyl-1-phenylmethanamine at 0 °C in THF followed by hydrogenation with 10% Pd/C and subsequent hydrolysis using LiOH in methanol afforded the carboxylic acid (<b>78</b>–<b>80</b>). Lastly, amide coupling with appropriate amines using HATU gave the desired carboxamide final compound. The intermediate as represented by <b>74</b> could be utilized to access 2-amino substiuted analogues such as <b>29</b> and <b>30</b>. Intermediate <b>74</b> was hydrolyzed using LiOH in THF/MeOH (1:1) followed by amide coupling with HATU and substitution of the 2-chloro group with an appropriate amine through heating in 2-propanol in the presence of triethylamine in a sealed tube, affording compounds <b>29</b> and <b>30</b>.</div><figure id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/medium/jm-2017-01347e_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/large/jm-2017-01347e_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. General Route for the Synthesis of 6-Aminopyrimidine-4-carboxamides and Selected Core Modifications<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/large/jm-2017-01347e_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01347&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) R-CH<sub>2</sub>NHCH<sub>3</sub>, THF, 0 °C; (ii) 10% Pd/C, H<sub>2</sub>, MeOH; (iii) LiOH, MeOH; (iv) amine, DIPEA, HATU, DMF; (v) LiOH, THF/H<sub>2</sub>O (1:1); (vi) NH<sub>3</sub> or cyclopropylamine, <i>i</i>-PrOH, Et<sub>3</sub>N, 100 °C.</p></p></figure><div class="NLM_p">The reverse amide <b>32</b> was synthesized by reacting 6-chloropyrimidin-4-amine <b>82</b> with benzoyl chloride in the presence of a base followed by nucleophilic substitution of the 6-chloro with 1-(4-fluorophenyl)-<i>N</i>-methylmethanamine (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>). The trifluoromethyl ketone, <b>83</b>, was synthesized from the free acid, <b>78</b>, via formation of a Weinreb amide followed by trifluoromethylation using TMS-CF<sub>3</sub>.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Reductive amination using NaCNBH<sub>3</sub> in the presence of TiCl<sub>4</sub> then afforded compound <b>53</b>. Finally, triazolyl compound <b>54</b> was synthesized by heating the hydrazide <b>84</b> with benzonitrile in refluxing butanol in the presence of potassium carbonate.</div><figure id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/medium/jm-2017-01347e_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/large/jm-2017-01347e_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthetic Schemes Used To Access Reverse Amide and Amide Isosteres<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/large/jm-2017-01347e_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01347&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) BzCl, DIPEA, THF, rt to 50 °C; (ii) 1-(4-fluorophenyl)-<i>N</i>-methylmethanamine, <i>i</i>-PrOH, Et<sub>3</sub>N, 100 °C; (iii) HATU, Et<sub>3</sub>N, <i>N</i>,<i>O</i>-dimethylhydroxylamine, DMF, rt; (iv) (a) TMS-CF<sub>3</sub>, toluene, 20% CsF; (b) TBAF, H<sub>2</sub>O, 50 °C; (v) 4-fluoroaniline, NaCNBH<sub>3</sub>, Et<sub>3</sub>N, TiCl<sub>4</sub>, MeOH, DCM (50:50), N<sub>2</sub>; (vi) benzonitrile, K<sub>2</sub>CO<sub>3</sub>, BuOH, 120 °C.</p></p></figure></div><div id="sec2-1-3" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> SAR on the LHS</h3><div class="NLM_p">After ascertaining that the 4-methoxy substituent of the phenyl carboxamide was not crucial for activity (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>; compound <b>2</b>, R<sub>1</sub> = H<b>)</b> the LHS (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) of the scaffold was varied to identify the key pharmacophore needed for activity while keeping the central pyrimidine core unchanged and the RHS constant as 4-methoxyphenyl or phenyl.</div><div class="NLM_p">Replacement of the aryl ring with a saturated cyclohexyl ring (compound <b>3</b>) led to considerable loss of activity, suggesting essentiality of an aromatic ring on the LHS. Similarly, replacement of the <i>N</i>-CH<sub>3</sub> linker with “O” or “NH” led to inactive compounds <b>4</b> and <b>5</b>, respectively, suggesting the critical importance of a tertiary nitrogen at the linker position or intolerance toward more polar “O” or “NH” groups. Furthermore, linker modifications such as addition of a methylene group (<i>N</i>-methylphenethyl, <b>6</b>) or removal of CH<sub>2</sub> (<i>N</i>-methylaniline, <b>7</b>), cyclization of the <i>N</i> onto the phenyl ring as tetrahydroisoquinoline moiety (<b>8</b>) or extension of <i>N</i>-methyl to <i>N</i>-ethyl (<b>9</b>) all led to loss or deterioration of MICs. This all indicated stringent shape requirements at this presumably hydrophobic part of the molecule.</div><div class="NLM_p">Realizing the essential nature of the aryl ring and the linker, we focused efforts on exploring substitution on the phenyl ring to improve potency and introduce polarity. Para-halogenated compounds <b>10</b> (4-F), <b>11</b> (4-Cl), and <b>12</b> (4-CF<sub>3</sub>) were at least ≥4-fold and ≥2-fold more potent in 7H9/ADC and GAST/Fe, respectively, compared to <b>1</b>. This was encouraging and the first sign of a SAR trend emerging and leading to the conclusion that a para-halogenated phenyl ring gave the best activity with 4-F phenyl compound <b>10</b> showing the most promise. Compounds with 3-F (<b>13</b>) and 3-Cl (<b>14</b>) were less potent compared to corresponding 4-halogenated analogues, whereas the 2-Cl analogue (<b>15</b>) was inactive up to the highest concentration tested, once again suggesting stringent shape requirements on the LHS. Addition of more polar groups such as 4-CN (<b>16</b>) and 4-SO<sub>2</sub>Me (<b>17</b>) led to deterioration or loss of MICs.</div><div class="NLM_p last">Up to this point, all compounds tested had poor aqueous solubility of ≤5 μM. In an attempt to improve solubility by introducing polarity, the phenyl ring was replaced with a pyridyl ring. Compound <b>18</b> with a 2-pyridyl ring was found to be inactive, whereas compound <b>19</b> with a 3-pyridyl ring was equipotent to compound <b>1</b> albeit with a much improved aqueous solubility of 150 μM at pH 7.4. Further substitution of the 3-pyridyl ring as in compound <b>20</b> with a 3-pyridyl-4-trifluoromethyl group retained similar activity but now with loss of solubility, albeit this substitution improved the in vivo pharmacokinetic properties as will be discussed in the DMPK section.</div></div><div id="sec2-1-4" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> SAR at the Central Core</h3><div class="NLM_p last">Exploration of the SAR around the central core of the scaffold was aimed at understanding whether or not the 4,6-disubstituted pyrimidine was essential for activity while retaining a 4-halo group on the LHS phenyl ring and a 4-methoxy, halogen, or hydrogen on the RHS phenyl ring. Initial efforts looked at shuffling the nitrogen atoms around the core ring, including the pyridine (<b>21</b>), pyrazine (<b>22</b>), and pyrimidine (<b>23</b>), with one of the nitrogen atoms shifted between the aminobenzyl and carboxamide groups, and the pyridazine (<b>24</b>) analogues. Only the pyridine retained partial activity at 10 μM in the GAST/Fe medium, which was not sufficient to warrant a scaffold hop. Compounds based on the pyrimidinone isostere (<b>25</b>) and thiazole (<b>26</b>) all lost activity. Lastly 5- and 2-substitutions (<b>27</b>, <b>28</b>, <b>29</b>, and <b>30</b>) on the pyrimidine core were evaluated and found to be similarly inactive. It was thus concluded that the original pyrimidine core was optimal for activity and could not be replaced with other diazine and heteroaromatic rings.</div></div><div id="sec2-1-5" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> SAR on the RHS</h3><div class="NLM_p">An extensive SAR exploration on the RHS was undertaken in order to evaluate the scope for optimization of potency and physicochemical properties (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). The free amide NH was deemed critical for potency as N-methylation (<b>31</b>) led to a complete loss in activity. Similarly, reversal of the amide functionality led to inactive compound <b>32</b>. For further exploration of substitution on the aryl ring of the amide, a 4-halophenyl or 4-CF<sub>3</sub>-3-pyridyl was fixed on the LHS of the scaffold. Replacement of the phenyl ring with an aliphatic chain such as isopropyl (<b>33</b>) was detrimental to activity, while replacement with a saturated cyclohexyl ring (<b>34</b>) resulted in retention of activity in the GAST/Fe medium albeit it was completely inactive in 7H9/ADC. The overall trend suggested a preference for an aryl ring on the RHS. Since the original hit contained a methoxy group, additional ethers were explored in the para position, including isopropoxy (<b>36</b>), 2-methoxyethoxy (<b>37</b>), and a <i>N</i>,<i>N</i>-dimethyl-2-ethoxy ether (<b>38</b>). Encouragingly, compounds <b>36</b> and <b>37</b> were some of the most active compounds synthesized up to this point but were poorly soluble (solubility pH 7.4 ≤ 5 μM). Compound <b>38</b> with the basic dimethylaminoethoxy side chain (predicted p<i>K</i><sub>a</sub> of 8.77) was less active (7H9/ADC MIC of 25 μM) even though it showed considerably improved aqueous solubility of 155 μM. Nonetheless, these results suggested scope for substitutions on the aryl ring to modulate physicochemical properties while retaining potency. Replacement of the phenyl ring with a 4-pyridyl ring, as in compound <b>39</b>, was tolerated indicating a wider scope for SAR exploration at this position with heterocycles and weakly basic substituents. Addition of a less basic <i>N</i>-methylpiperazine ring at the 4-position of the phenyl ring (predicted p<i>K</i><sub>a</sub> of 7.85) led to potent compound <b>40</b> which was poorly soluble at pH 7.4 but sufficiently soluble at a slightly acidic pH of 6.5 (refer to DMPK section). Solubility could be improved further by combining <i>N</i>-methylpiperazinylphenylamide on the RHS with a 4-CF<sub>3</sub>-3-pyridyl group on the LHS as in compound <b>41</b> with some loss in potency (MIC = 12.5 μM, solubility at pH 7.4 of 165 μM). Moving the <i>N</i>-methylpiperazine ring to the 3-position of the phenyl ring (<b>42</b>) was detrimental to activity with MIC values dropping by 10- to 30-fold. Similarly, 3-pyridyl-4-(<i>N</i>-methylpiperazinyl) analogue <b>43</b> was found to be much less potent (7H9/ADC MIC > 50 μM; GAST/Fe MIC = 19 μM). Compounds with neutral substituents at the 4-position of the phenyl ring like <i>N</i>-acetylpiperazinyl (<b>44</b>) or morpholino (compound <b>45</b>) retained good MICs (<5 μM) but were much less soluble. Interestingly, the 4-morpholino-2-pyridyl analogue (<b>46</b>) retained good MIC activity (2–3 μM) indicating scope for the introduction of a nitrogen into the phenyl ring to address potential reactivity issues of electron-rich anilines during further optimization.</div><div class="NLM_p">A small set of amides with five-membered heterocycles was synthesized to evaluate the scope for further SAR exploration at this position. Compounds with <i>N</i>-methylpyrazole (<b>47</b>), <i>N</i>-methyltriazolyl (<b>48</b>), and isoxazolyl (<b>49</b>) substituents were either inactive or weakly active. Compound <b>50</b> containing a 4-methylthiazolyl group showed a GAST MIC equivalent to its phenyl counterpart (5 μM). However, its MIC in 7H9/ADC medium (37 μM) was weaker and had a poor solubility (<5 μM). Similarly, compounds containing 1,3,4-thiadiazole moieties (<b>51</b> and <b>52</b>) showed reasonable MIC in GAST/Fe medium (∼5 μM) but had weaker potency in 7H9/ADC medium (12.5 and 50 μM, respectively). Unfortunately compounds with these moieties were cytotoxic in vitro and were also found to be toxic at higher doses in animal studies. Hence, these modifications were abandoned even though more lead-like DMPK properties were achieved with these compounds.</div><div class="NLM_p">Lastly, two amide isosteres CF<sub>3</sub>-amine (<b>53</b>)<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> and triazole (<b>54</b>)<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> were synthesized in an attempt to explore the scope for variation and in line with metabolite identification studies (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01347/suppl_file/jm7b01347_si_001.pdf" class="ext-link">Supporting Information Table S1</a>). Metabolite identification, performed on <b>12</b> and <b>51</b>, indicated cleavage of the amide bound on the RHS as a primary route of metabolism compared to N-demethylation on the LHS. Even though both these modifications resulted in compounds showing some activity, there was no improvement in other properties like solubility and hence were not explored further. Overall, as summarized in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>, the SAR around the LHS and the central core was narrow with fewer modifications tolerated; SAR around the RHS was more dynamic, allowing scope for further optimization. From this, several compounds were identified for further profiling both in vitro and in vivo.</div><figure id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/medium/jm-2017-01347e_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/large/jm-2017-01347e_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Summary of SAR.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/large/jm-2017-01347e_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01347&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2-1-6" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Biology Profiling</h3><div class="NLM_p">A spontaneous resistant mutant of <i>Mtb</i> H37Rv was successfully raised against compound <b>13</b>. Most of the analogues from the series were cross-resistant against this mutant except the thiadiazole analogues <b>50</b> and <b>51</b>, indicating additional targets and/or a different MOA (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). Additionally, these mutants were not cross-resistant to any known TB drugs, suggesting a potential novel MOA for the series. Unfortunately, whole genome sequencing of the mutant did not reveal any genetic polymorphism(s) suggestive of the target or MOA. Hence, further studies using different target identification approaches were explored in order to identify the molecular target of these compounds. Representative compounds were screened against drug-sensitive clinical isolates and were found to retain MICs similar to those in H37Rv (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Cross-Screening against <b>13</b>-Resistant Mutant<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">14 day GAST/Fe MIC<sub>99</sub> (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">against WT H37Rv</th><th class="colsep0 rowsep0" align="center">against <b>13</b>-resistant mutant</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">>160</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">>160</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">2.5–5</td><td class="colsep0 rowsep0" align="left">>160</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">>160</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left">1.25–5</td><td class="colsep0 rowsep0" align="left">>160</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Rif</td><td class="colsep0 rowsep0" align="left">0.012</td><td class="colsep0 rowsep0" align="left">0.012</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">INH</td><td class="colsep0 rowsep0" align="left">0.18</td><td class="colsep0 rowsep0" align="left">0.36</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">STREP</td><td class="colsep0 rowsep0" align="left">1.62</td><td class="colsep0 rowsep0" align="left">1.62</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ETB</td><td class="colsep0 rowsep0" align="left">2.3</td><td class="colsep0 rowsep0" align="left">2.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LEVO</td><td class="colsep0 rowsep0" align="left">0.64</td><td class="colsep0 rowsep0" align="left">1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">KAN</td><td class="colsep0 rowsep0" align="left">0.32</td><td class="colsep0 rowsep0" align="left">0.32</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Rif, rifampicin; INH, isoniazid; STREP, streptomycin; ETB, ethambutol; LEVO, levofloxacin; KAN, kanamycin.</p></div></div></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Activity against Clinical Isolates</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" align="center">MIC on ref strain (μM)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="rowsep1 colsep0" colspan="6" align="center">MIC against clinical isolates (μM)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">H37Rv</th><th class="colsep0 rowsep0" align="center">SAWC1125</th><th class="colsep0 rowsep0" align="center">SAWC3933</th><th class="colsep0 rowsep0" align="center">SAWC3385</th><th class="colsep0 rowsep0" align="center">SAWC3200</th><th class="colsep0 rowsep0" align="center">SAWC3388</th><th class="colsep0 rowsep0" align="center">SAWC3906</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left">1.25</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">0.31</td><td class="colsep0 rowsep0" align="left"><0.08</td><td class="colsep0 rowsep0" align="left">0.31</td><td class="colsep0 rowsep0" align="left">0.31</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="left">1.25–2.5</td><td class="colsep0 rowsep0" align="left">2.5–5</td><td class="colsep0 rowsep0" align="left">1.25–2.5</td><td class="colsep0 rowsep0" align="left">1.25</td><td class="colsep0 rowsep0" align="left">1.25</td><td class="colsep0 rowsep0" align="left">1.25–2.5</td><td class="colsep0 rowsep0" align="left">0.31–0.63</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left"><0.08</td><td class="colsep0 rowsep0" align="left">0.625</td><td class="colsep0 rowsep0" align="left"><0.08</td><td class="colsep0 rowsep0" align="left"><0.08</td><td class="colsep0 rowsep0" align="left">0.15</td><td class="colsep0 rowsep0" align="left"><0.08</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>52</b></td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">10–20</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">2.5–5</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">2.5–5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">MIC<sub>90</sub> readout from MABA assay in Middlebrook 7H9 medium; SAWC 1125, typical Beijing (lng 2.2); SAWC 3933, T1 (lng 4.2); SAWC 3385, Cas 1/Delhi (lng 3); SAWC 3200, X1 (lng 4.9); SAWC 3388, T1, Tuscany, T5/Rus (lng4.3); SAWC 3906, atypic Beijing (lng 2).</p></div></div></div></div><div id="sec2-1-7" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Chemoproteomics</h3><div class="NLM_p">In order to supplement our MOA identification efforts, we used a chemoproteomics approach to identify the potential target proteins of the 6-dialkylaminopyrimidine carboxamides. This affinity-based approach was recently successfully employed for the direct target identification of antitubercular compounds.<a onclick="showRef(event, 'ref28 ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref28 ref29 ref30">(28-30)</a> This approach is based on the modification of the compound <b>40</b> with a linker for covalent immobilization on sepharose-beads by <i>N</i>-hydroxysuccinamide (NHS) coupling. The modified compound <b>85</b> (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>, synthesis <a href="/doi/suppl/10.1021/acs.jmedchem.7b01347/suppl_file/jm7b01347_si_001.pdf" class="ext-link">Scheme S1</a>) retained antimycobacterial activity (MIC<sub>90</sub> = 18.6 μM as determined against <i>M. bovis</i> BCG) suggesting that the derivatization with the linker moiety did not interfere with target binding. The <b>85</b> beads were incubated with <i>Mycobacterium bovis</i> BCG extract, and proteins captured by the beads were digested with trypsin, labeled with isobaric mass tags (TMT 10plex), and quantitatively identified by liquid chromatography–tandem mass spectrometry (LC–MS/MS). In order to distinguish true targets from nonspecific background binding, the bacterial extracts were incubated prior to the bead-incubation step with the active test compound <b>40</b>, the inactive test compound <b>25</b>, or a vehicle (DMSO only) control. Only the active compound should bind to its target proteins in the lysate and thus reduce the binding of these proteins to the beads, but not the inactive compound. Indeed, two proteins, BCG_3193 (Rv3169) and BCG_3827 (Rv3768), showed reduced binding to the compound beads in the presence of competing “free” <b>40</b> (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>A) but not with inactive <b>25</b>, which suggests that these proteins are the potential targets of <b>40</b>. In order to estimate inhibitor potency, we performed the affinity step in the presence of different concentrations of active compound <b>40</b> in the protein extract, which allowed the determination of an apparent dissociation constant <i>K</i><sub>d</sub><sup>app</sup> (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>C). The <i>K</i><sub>d</sub><sup>app</sup> takes into consideration the affinity of the target for the bead-immobilized ligand. The latter effect can be deduced by measuring the depletion of the target protein by the beads.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> The apparent dissociation constant of compound <b>40</b> for BCG_3193 was determined in two separate experiments as 0.61 μM and 0.69 μM and for BCG_3827 as 2.1 μM and 3.8 μM (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>C). Both potential novel target proteins, BCG_3193/Rv3169 and BCG_3827/Rv3768 (contains a polyketide cyclase SnoaL-like domain, IPR009959), are conserved hypothetical proteins of unknown function. Both proteins are nonessential but notably found using Triton X-114 detergent phase separation for extraction of lipophilic proteins, suggesting they are associated with the cell envelope despite lacking detectable transmembrane helices.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></div><figure id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/medium/jm-2017-01347e_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/large/jm-2017-01347e_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Affinity chemoproteomics revealed BCG_3193 and BCG_3827, novel TB targets with unknown function, as targets of the 6-dialkylaminopyrimidine carboxamides. (A) BCG_3193 and BCG_3827 show reduced binding to 6-dialkylaminopyrimidine carboxamide analogue beads due to compound <b>40</b> binding, but no effect on these proteins was seen by the inactive compound. Shown are relative protein amounts captured by the beads in a log 2 scale. (B) Compound structures used for the affinity chemoproteomics experiments. (C) The apparent dissociation constant of compound <b>40</b> for BCG_3193 was determined in two different experiments as 0.61 μM and 0.69 μM and for BCG_3827 as 2.1 μM and 3.8 μM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/large/jm-2017-01347e_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01347&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2-1-8" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Physicochemical, DMPK, and hERG Profiles</h3><div class="NLM_p">Representative compounds were profiled for physicochemical properties and in vitro DMPK properties which included kinetic solubility, human plasma protein binding (PPB), microsomal metabolic stability (MS), and permeability, as shown in <a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. In Vitro ADME Properties, hERG Activity, and Caseum Distribution</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="6" align="center">compound</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"><b>12</b></th><th class="colsep0 rowsep0" align="center"><b>20</b></th><th class="colsep0 rowsep0" align="center"><b>36</b></th><th class="colsep0 rowsep0" align="center"><b>40</b></th><th class="colsep0 rowsep0" align="center"><b>51</b></th><th class="colsep0 rowsep0" align="center"><b>52</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cLogP<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">5.0</td><td class="colsep0 rowsep0" align="left">3.7</td><td class="colsep0 rowsep0" align="left">5.0</td><td class="colsep0 rowsep0" align="left">5.0</td><td class="colsep0 rowsep0" align="left">2.0</td><td class="colsep0 rowsep0" align="left">1.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FassiF solubility at pH 6.5 (μM)<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left"><5</td><td class="colsep0 rowsep0" align="left"><5</td><td class="colsep0 rowsep0" align="left">150</td><td class="colsep0 rowsep0" align="left"><5</td><td class="colsep0 rowsep0" align="left">195</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">solubility at pH 7.4 (μM)<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left"><5</td><td class="colsep0 rowsep0" align="left"><5</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left"><5</td><td class="colsep0 rowsep0" align="left">128</td><td class="colsep0 rowsep0" align="left">191</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PPB human fu<a class="ref internalNav" href="#t6fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">0.11</td><td class="colsep0 rowsep0" align="left">0.05</td><td class="colsep0 rowsep0" align="left">0.04</td><td class="colsep0 rowsep0" align="left">0.14</td><td class="colsep0 rowsep0" align="left">0.01</td><td class="colsep0 rowsep0" align="left">0.32</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PAMPA log <i>P</i><sub>app</sub><a class="ref internalNav" href="#t6fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">–4.9</td><td class="colsep0 rowsep0" align="left">–3.8</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">–4.5</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">–3.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MS H/R/M % remaining after 30 min<a class="ref internalNav" href="#t6fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">55/87/60</td><td class="colsep0 rowsep0" align="left">85/72/87</td><td class="colsep0 rowsep0" align="left">64/43/37</td><td class="colsep0 rowsep0" align="left">57/37/21</td><td class="colsep0 rowsep0" align="left">67/65/74</td><td class="colsep0 rowsep0" align="left">100/88/78</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hERG IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t6fn7" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="left">3.3</td><td class="colsep0 rowsep0" align="left">5.6</td><td class="colsep0 rowsep0" align="left">4.1</td><td class="colsep0 rowsep0" align="left">0.9</td><td class="colsep0 rowsep0" align="left">4.2</td><td class="colsep0 rowsep0" align="left">14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">caseum distribution unbound (%)<a class="ref internalNav" href="#t6fn8" aria-label="h">h</a></td><td class="colsep0 rowsep0" align="left">0.1</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">0.1</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">3.6</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">Calculated log <i>P</i> (StarDrop).</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last">Fasted-state simulated intestinal fluid, pH 6.5.</p></div><div class="footnote" id="t6fn3"><sup>c</sup><p class="last">Kinetic solubility.</p></div><div class="footnote" id="t6fn4"><sup>d</sup><p class="last">Plasma proteing binding <i>fu -</i> fraction unbound.</p></div><div class="footnote" id="t6fn5"><sup>e</sup><p class="last">Parallel artificial membrane permeability assay.</p></div><div class="footnote" id="t6fn6"><sup>f</sup><p class="last">Metabolic stability: H, human; R, rat; M, mice.</p></div><div class="footnote" id="t6fn7"><sup>g</sup><p class="last">Tested at Essen BioScience using IonWorks patch clamp electrophysiology.</p></div><div class="footnote" id="t6fn8"><sup>h</sup><p class="last">Assay using surrogate caseum, ND: not determined.</p></div></div></div><div class="NLM_p">As discussed previously, most of the compounds based on phenyl amides had poor to moderate solubility at pH 7.4 except those with basic solubilizing side chains (e.g., compounds <b>38</b> and <b>41</b>). These compounds showed considerably improved solubility in slightly acidic Fassif medium (fasted-state simulated intestinal fluid, pH 6.5),<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> e.g., compound <b>40</b> (kinetic solubility at pH 7.4 of <5 μM; kinetic solubility in Fassif of 150 μM). This may be relevant for oral absorption of these compounds. Compounds containing heterocyclic amides like thiadiazole compounds <b>51</b> and <b>52</b> had good solubility of >100 μM in both media. In general, compounds in the series had 5–10% free fraction in human plasma as measured in a PPB assay while some more polar compounds like <b>52</b> had up to 30% free fraction in human plasma. The ability of compounds to cross biological membranes by passive diffusion was assessed using the PAMPA assay.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> All compounds tested showed good to moderate permeability with values ranging between −3.8 and −4.9 log <i>P</i><sub>app</sub> presumably due to their lipophilic character<sub>.</sub> Caseum binding was also assessed for certain compounds in order to give some insight into the ability of the compounds to permeate the caseous necrotic regions of granulomas to access the bacteria.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Compound <b>52</b> had the highest free fraction (3.6% unbound) from the compounds assessed with phenyl compounds generally being highly bound (0.06–0.1% unbound). Further safety profiling was conducted against the human ether-a-go-go-related gene (hERG) potassium channel, and compounds were found to be low micromolar inhibitors. While hERG activity is a well-established safety concern,<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> compounds were not optimized to remove hERG activity due to the initial focus being on increasing potency and solubility.</div><div class="NLM_p">In general, compounds showed moderate metabolism in human, mouse, and rat liver microsomes except compound <b>40</b>, which showed rapid in vitro clearance. The compounds were also tested in male C57/BL6 mice for pharmacokinetic parameters at an intravenous dose of 2 mg/kg and an oral dose of 20 mg/kg (<a class="ref internalNav" href="#tbl7" aria-label="Table 7">Table 7</a>). Most of the compounds showed low in vivo clearance in mice in accordance with their in vitro microsomal metabolic stability. Compound <b>40</b> showed low clearance iv clearance despite its poor microsomal stability, probably due to extensive tissue distribution as indicated by high volume of distribution (Vd = 21.8 L/kg). Most of the compounds had moderate to good oral bioavailability. Moderate permeability was sufficient to give good oral absorption as well as moderate bioavailability for compounds with low solubility (<b>12</b> and <b>20</b>). Compound, <b>52</b> with a thiadiazole group at LHS showed improved physicochemical and ADME parameters such as good solubility, improved microsomal stability leading to higher oral absorption, higher AUC and better bioavailability of 67%. Unfortunately, this compound was found to be toxic to mice when dosed orally above 50 mg/kg and hence was not progressed any further.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Pharmacokinetic Parameters in Male C57/BL6 Mouse Blood<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center"><b>12</b></th><th class="rowsep1 colsep0" colspan="2" align="center"><b>20</b></th><th class="rowsep1 colsep0" colspan="2" align="center"><b>40</b></th><th class="rowsep1 colsep0" colspan="2" align="center"><b>51</b></th><th class="rowsep1 colsep0" colspan="2" align="center"><b>52</b></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">dose (mg/kg)</th><th class="colsep0 rowsep0" align="center">oral 20</th><th class="colsep0 rowsep0" align="center">iv 5</th><th class="colsep0 rowsep0" align="center">oral 20</th><th class="colsep0 rowsep0" align="center">iv 5</th><th class="colsep0 rowsep0" align="center">oral 20</th><th class="colsep0 rowsep0" align="center">iv 5</th><th class="colsep0 rowsep0" align="center">oral 20</th><th class="colsep0 rowsep0" align="center">iv 5</th><th class="colsep0 rowsep0" align="center">oral 20</th><th class="colsep0 rowsep0" align="center">iv 5</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">apparent <i>t</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="left">8.7</td><td class="colsep0 rowsep0" align="left">4.6</td><td class="colsep0 rowsep0" align="left">7.2</td><td class="colsep0 rowsep0" align="left">0.7</td><td class="colsep0 rowsep0" align="left">15.8</td><td class="colsep0 rowsep0" align="left">10.3</td><td class="colsep0 rowsep0" align="left">4.4</td><td class="colsep0 rowsep0" align="left">5.1</td><td class="colsep0 rowsep0" align="left">3.0</td><td class="colsep0 rowsep0" align="left">3.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL<sub>total</sub> (mL min<sup>–1</sup> kg<sup>–1</sup>)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">11.3</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">11.2</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">26.3</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">11.1</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">6.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Vd (L/kg)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">4.3</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.7</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">21.8</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">4.8</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (μM)</td><td class="colsep0 rowsep0" align="left">2.2</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">3.4</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.42</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2.58</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">10.8</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>max</sub> (h)</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>0–∞</sub> (min·μM)</td><td class="colsep0 rowsep0" align="left">1334</td><td class="colsep0 rowsep0" align="left">1224</td><td class="colsep0 rowsep0" align="left">1999</td><td class="colsep0 rowsep0" align="left">1179</td><td class="colsep0 rowsep0" align="left">564</td><td class="colsep0 rowsep0" align="left">540</td><td class="colsep0 rowsep0" align="left">1022</td><td class="colsep0 rowsep0" align="left">1329</td><td class="colsep0 rowsep0" align="left">5614</td><td class="colsep0 rowsep0" align="left">2106</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">oral bioavailability (%)</td><td class="colsep0 rowsep0" align="left">28</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">42</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">26</td><td class="colsep0 rowsep0" align="left">—</td><td class="colsep0 rowsep0" align="left">19</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">67</td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">iv, intravenous; <i>t</i><sub>1/2</sub>, elimination half-life; CL, plasma clearance; Vd, volume of distribution; <i>C</i><sub>max</sub>, maximum (peak) plasma concentration following oral administration; AUC, area under the curve.</p></div></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01048" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01048" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Screening of a Biofocus library led to the identification of 6-dialkylaminopyrimidine carboxamides with potent antitubercular properties and a novel mode of action. A biology triage cascade allowed deprioritization of compounds potentially acting through inhibition of QcrB, cell-wall targets and DNA damage. Cross-resistance studies of TB drugs against the resistant mutant raised against this series indicate a potentially novel MOA for the series, and this was reinforced by chemoproteomic studies albeit the exact target (and MOA) remains unknown. Detailed SAR studies have demonstrated limitations as well as scope for further optimization of these series to deliver lead-like compounds with potent anti-TB properties and oral bioavailability.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85277" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85277" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4-1" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Biology</h3><div class="NLM_p last">Biology triage assays were carried out as described in ref <a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">23</a>.</div></div><div id="sec4-1-1" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> DMPK</h3><div class="NLM_p last">All protocols for in vitro DMPK studies and mouse PK studies are available in the supplementary document. Animal studies were conducted following guidelines and policies as stipulated in the UCT Research Ethics Code for Use of Animals in Research and Teaching after review and approval of the experimental protocol by the UCT Senate Animal Ethics Committee (Protocol FHS-AEC 013/032)</div></div><div id="sec4-2" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Chemoproteomics</h3><div class="NLM_p">Chemoproteomics experiments were performed as previously described.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Briefly, sepharose beads were derivatized with compound <b>85</b> at a concentration of 0.04 mM and subsequently washed and equilibrated in lysis buffer (50 mM Tris-HCl, pH 7.4, 0.4% Igepal-CA630, 1.5 mM MgCl<sub>2</sub>, 5% glycerol, 150 mM NaCl, 25 mM NaF, 1 mM Na<sub>3</sub>VO<sub>4</sub>, 1 mM DTT, and one Complete EDTA-free protease inhibitor tablet (Roche) per 25 mL). The <b>85</b> beads were incubated at 4 °C for 1 h with 0.1 mL (0.25 mg) <i>M. bovis BCG</i> extract, which was preincubated with compound or DMSO (vehicle control). Our experimental design employed isobaric tandem mass tags (TMTs)<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> which allowed us to analyze 10 samples together by LC–MS/MS enabling the relative quantification of proteins across these samples. The experiments were configured to generate values for the affinity of the beads to the bound proteins (“depletion” values, four samples) and to allow determination of IC<sub>50</sub> values (six samples) in a single experiment. Samples 1 and 2 were vehicle control duplicates, samples 3 and 4 were duplicates of the “rebinding” experiment, and samples 5–10 served to generate IC<sub>50</sub> values by adding compound over a range of 5 concentrations (highest concentration of 30 μM, then four dilution steps of 1:4 each). In the “rebinding” experiment, the nonbound fraction from the first bead incubation step was incubated again with “fresh” beads, allowing the determination of target depletion by the beads. Apparent dissociation constants were determined by taking into account the protein depletion by the beads.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> A repeat experiment was performed with vehicle control versus 20 μM and 5 μM compound. The beads were transferred to filter plates (Durapore PVDF membrane, Merck Millipore), washed extensively with lysis buffer, and eluted with SDS sample buffer. Proteins were alkylated, separated on 4–12% Bis-Tris NuPAGE (Life Technologies), and stained with colloidal Coomassie. Gel lanes were cut into three slices and subjected to in-gel digest using LysC for 2 h and trypsin overnight. Digestion, labeling with TMT isobaric mass tags, peptide fractionation, and mass spectrometric analyses were performed.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Proteins were quantified by isobaric mass tagging and LC–MS/MS. The proteins.fasta file for <i>M. bovis</i> BCG was downloaded on May 11, 2011, and supplemented with the sequences of bovine serum albumin, porcine trypsin, and mouse, rat, sheep, and dog keratins. Decoy versions of all proteins were created and added. The search database contained a total of 11 492 protein sequences, 50% forward and 50% reverse. Protein identification and quantification were performed.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Proteins identified with >1 unique peptide matches were considered for further data analysis.</div><div class="NLM_p last">All commercial reagents were purchased from Sigma-Aldrich, Combi-blocks, Waterstone, or Fluorochem and were used without further purification. Solvents were used as received unless otherwise stated. Analytical thin-layer chromatography (TLC) was performed on SiO<sub>2</sub> plates on aluminum backing. Visualization was accomplished by UV irradiation at 254 and 220 nm. Flash column chromatography was performed using a Teledyne ISCO flash purification system with SiO<sub>2</sub> 60 (particle size 0.040–0.055 mm, 230–400 mesh). Purity of all final derivatives for biological testing was confirmed to be >95% as determined using an Agilent 1260 Infinity binary pump, Agilent 1260 Infinity diode array detector (DAD), Agilent 1290 Infinity column compartment, Agilent 1260 Infinity standard autosampler, and a Agilent 6120 quadrupole (single) mass spectrometer, equipped with APCI and ESI multimode ionization source. Using a Kinetex Core C18 2.6 μm column (50 mm × 3 mm); mobile phase B of 0.4% acetic acid, 10 mM ammonium acetate in a 9:1 ratio of HPLC grade methanol and type 1 water, mobile phase A of 0.4% acetic acid in 10 mM ammonium acetate in HPLC grade (type 1) water, with flow rate of 0.9 mL/min, detector diode array (DAD). Or an Agilent UPLC–MS was used: Agilent Technologies 6150 quadrupole, ES ionization, coupled with an Agilent Technologies 1290 Infinity II series UPLC system Agilent 1290 series HPLC at two wavelengths 254 and 290 nm using the following conditions: Kinetex 1.7 μm Evo C18 100A, LC column 50 mm × 2.1 mm, solvent A of 0.1% (formic acid) water, solvent B of 0.1% (formic acid) acetonitrile. The structures of the intermediates and end products were confirmed by <sup>1</sup>H NMR and mass spectrometry. Proton magnetic resonance spectra were determined in an appropriate deuterated solvent on a Varian Mercury spectrometer at 300 MHz or a Varian Unity spectrometer at 400 MHz.</div></div><div id="sec4-3" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> General Protocol for Synthesis of Compounds <b>1</b>–<b>21</b> and <b>28</b></h3><div class="NLM_p last">The appropriate 6-chloro-<i>N</i>-phenylpyrimidine-4-carboxamide (1 equiv), <i>N</i>-methylbenzylamine (1.2 equiv), and DIPEA (2 equiv) were added to a 50 mL round-bottomed flask containing <i>i</i>-PrOH (10 mL) and heated to reflux overnight. Compounds that precipitated upon cooling were filtered and washed with cold EtOH. For those that did not precipitate, the <i>i</i>-PrOH was removed under vacuum and the residue redissolved in EtOAc (20 mL) and washed with a saturated aqueous solution of NaHCO<sub>3</sub>, the organic layer dried and removed under reduced pressure. The resulting solid or residue was either recrystallized from EtOH or purified by flash column chromatography to afford the appropriate 6-(benzyl(methyl)amino)-<i>N</i>-phenylpyrimidine-4-carboxamide.</div></div><div id="sec4-3-1" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 6-(Benzyl(methyl)amino)-<i>N</i>-(4-methoxyphenyl)pyrimidine-4-carboxamide (<b>1</b>)</h3><div class="NLM_p last">Yield 52%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.43 (s, 1H), 8.67 (s, 1H) 7.91–7.71 (m, 2H), 7.46–7.17 (m, 6H), 7.05–6.80 (m, 2H), 4.92 (s, 2H), 3.75 (s, 3H), 3.17 (s, 3H). LC–MS (ESI): <i>m</i>/<i>z</i> 349.2 [M + H]<sup>+</sup>. HPLC purity 100%.</div></div><div id="sec4-3-2" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 6-(Benzyl(methyl)amino)-<i>N</i>-phenylpyrimidine-4-carboxamide (<b>2</b>)</h3><div class="NLM_p last">Yield 98%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.49 (s, 1H), 8.66 (s, 1H), 7.85 (d, <i>J</i> = 8.0 Hz, 2H), 7.36–7.21 (m, 8H), 7.11 (t, <i>J</i> = 7.2 Hz, 1H), 4.90 (s, 2H) and 3.15 (s, 3H). LC–MS (ESI): <i>m</i>/<i>z</i> 319.2 [M + H]<sup>+</sup>. HPLC purity 99%.</div></div><div id="sec4-3-3" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 6-((Cyclohexylmethyl)(methyl)amino)-<i>N</i>-phenylpyrimidine-4-carboxamide (<b>3</b>)</h3><div class="NLM_p last">Yield 12.5%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.50 (s, 1H), 8.68 (s, 1H), 7.93 (d, <i>J</i> = 8.0 Hz, 2H), 7.40 (m, 2H), 7.27 (s, 1H), 7.16 (t, <i>J</i> = 8.0 Hz, 1H), 3.54 (s, 2H), 3.13 (s, 3H), 1.86–1.62 (m, 6H), 1.25–0.96 (m, 5H). LC–MS (ESI): <i>m</i>/<i>z</i> 325.2 [M + H]<sup>+</sup>. HPLC purity 99%.</div></div><div id="sec4-3-4" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 6-(Benzyloxy)-<i>N</i>-phenylpyrimidine-4-carboxamide (<b>4</b>)</h3><div class="NLM_p last">Yield 86%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.64 (s, 1H), 8.99 (s, 1H), 7.87 (d, <i>J</i> = 8.0 Hz, 2H), 7.51–7.47 (m, 3H), 7.41–7.33 (m, 4H), 7.21 (m, 1H), 7.13 (t, <i>J</i> = 8.0 Hz, 1H) and 5.52 (s, 2H). LC–MS (ESI): <i>m</i>/<i>z</i> 306.1 [M + H]<sup>+</sup>. HPLC purity 98%.</div></div><div id="sec4-3-5" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 6-(Benzylamino)-<i>N</i>-phenylpyrimidine-4-carboxamide (<b>5</b>)</h3><div class="NLM_p last">Yield 85%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.43 (s, 1H), 8.57 (d, <i>J</i> = 0.8 Hz, 1H), 8.39 (t, <i>J</i> = 8.0 Hz, 1H), 7.85 (d, <i>J</i> = 8.0 Hz, 2H), 7.36–7.24 (m, 8H), 7.11 (t, <i>J</i> = 7.2 Hz, 1H), 4.61 (s, 2H). LC–MS (ESI): <i>m</i>/<i>z</i> 305.2 [M + H]<sup>+</sup>. HPLC purity 99%.</div></div><div id="sec4-3-6" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 6-(Methyl(phenethyl)amino)-<i>N</i>-phenylpyrimidine-4-carboxamide (<b>6</b>)</h3><div class="NLM_p last">Yield 97%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.47 (s, 1H), 8.62 (s, 1H), 7.86 (d, <i>J</i> = 8.0 Hz, 2H), 7.39–7.10 (m, 9H), 3.84 (m, 2H), 3.05 (s, 3H) and 2.87 (t, <i>J</i> = 7.2 Hz, 2H). LC–MS (ESI): <i>m</i>/<i>z</i> 333.2 [M + H]<sup>+</sup>. HPLC purity 99%.</div></div><div id="sec4-3-7" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 6-(Methyl(phenyl)amino)-<i>N</i>-phenylpyrimidine-4-carboxamide (<b>7</b>)</h3><div class="NLM_p last">Yield 84%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.49 (s, 1H), 8.75 (d, <i>J</i> = 1.2 Hz, 1H), 7.81 (dd, <i>J</i> = 8.4, 1.2 Hz, 2H), 7.57–7.30 (m, 7H), 7.10 (t, <i>J</i> = 8.0 Hz, 1H), 6.96 (d, <i>J</i> = 1.2 Hz, 1H), 3.49 (s, 3H). LC–MS (ESI): <i>m</i>/<i>z</i> 305.2 [M + H]<sup>+</sup>. HPLC purity 99%.</div></div><div id="sec4-3-8" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 6-(3,4-Dihydroisoquinolin-2(1<i>H</i>)-yl)-<i>N</i>-phenylpyrimidine-4-carboxamide (<b>8</b>)</h3><div class="NLM_p last">Yield 40%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.50 (s, 1H), 8.69 (s, 1H), 7.88 (d, <i>J</i> = 8.0 Hz, 2H), 7.45 (s, 1H) 7.38–7.20 (m, 6H), 7.12 (t, <i>J</i> = 8.0 Hz, 1H), 4.84 (s, 2H), 3.92 (m, 2H) and 2.93 (t, <i>J</i> = 8.0 Hz, 2H). LC–MS (ESI): <i>m</i>/<i>z</i> 331.2 [M + H]<sup>+</sup>. HPLC purity 99%.</div></div><div id="sec4-3-9" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 6-((4-Chlorobenzyl)(ethyl)amino)-<i>N</i>-phenylpyrimidine-4-carboxamide (<b>9</b>)</h3><div class="NLM_p last">Yield 15%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.48 (s, 1H), 8.66 (s, 1H), 7.85 (d, <i>J</i> = 8.0 Hz, 2H), 7.39–7.24 (m, 7H), 7.11 (t, <i>J</i> = 8.0 Hz, 1H), 4.84 (s, 2H), 3.62 (s, 2H) and 1.12 (t, <i>J</i> = 8.0 Hz, 3H). LC–MS (ESI): <i>m</i>/<i>z</i> 367.1 [M + H]<sup>+</sup>. HPLC purity 99%.</div></div><div id="sec4-3-10" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 6-((4-Fluorobenzyl)(methyl)amino)-<i>N</i>-phenylpyrimidine-4-carboxamide (<b>10</b>)</h3><div class="NLM_p last">Yield 48%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.54 (s, 1H), 8.70 (s, 1H), 7.90 (d, <i>J</i> = 8.0 Hz, 2H), 7.40–7.12 (m, 8H), 4.93 (s, 2H) and 3.21 (s, 3H). LC–MS (ESI): <i>m</i>/<i>z</i> 337.2 [M + H]<sup>+</sup>. HPLC purity 99%.</div></div><div id="sec4-3-11" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 6-((4-Chlorobenzyl)(methyl)amino)-<i>N</i>-phenylpyrimidine-4-carboxamide (<b>11</b>)</h3><div class="NLM_p last">Yield 81%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.50 (s, 1H), 8.66 (s, 1H), 7.85 (d, <i>J</i> = 8.0 Hz, 2H), 7.39–7.24 (m, 7H), 7.11 (t, 8.0 = Hz, 1H), 4.89 (s, 2H) and 3.15 (s, 3H). LC–MS (ESI): <i>m</i>/<i>z</i> 353.1 [M + H]<sup>+</sup>. HPLC purity 99%.</div></div><div id="sec4-3-12" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 6-(Methyl(4-(trifluoromethyl)benzyl)amino)-<i>N</i>-phenylpyrimidine-4-carboxamide (<b>12</b>)</h3><div class="NLM_p last">Yield 92%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.40 (s, 1H), 8.55 (s, 1H), 7.85 (m, 3H), 7.34 (t, <i>J</i> = 8.0 Hz, 2H), 7.17 (s, 1H), 7.11 (t, <i>J</i> = 8.0 Hz, 1H), 4.10 (m, 1H), 3.86 (m, 2H), 3.41 (m, 2H), 1.87 (m, 2H) and 1.46 (m, 2H). LC–MS (ESI): <i>m</i>/<i>z</i> 387.1 [M + H]<sup>+</sup>. HPLC purity 99%.</div></div><div id="sec4-3-13" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 6-((3-Fluorobenzyl)(methyl)amino)-<i>N</i>-(4-methoxyphenyl)pyrimidine-4-carboxamide (<b>13</b>)</h3><div class="NLM_p last">Yield 58%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.41 (s, 1H), 8.64 (s, 1H), 7.77 (d, <i>J</i> = 9.0 Hz, 2H), 7.38 (m, 1H), 7.28 (s, 1H), 7.10–7.04 (m, 3H), 6.92 (d, <i>J</i> = 9.0 Hz, 2H), 4.91 (s, 2H), 3.73 (s, 3H) and 3.16 (s, 3H). LC–MS (ESI): <i>m</i>/<i>z</i> 367.2 [M + H]<sup>+</sup>. HPLC purity 99%.</div></div><div id="sec4-3-14" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 6-((3-Chlorobenzyl)(methyl)amino)-<i>N</i>-phenylpyrimidine-4-carboxamide (<b>14</b>)</h3><div class="NLM_p last">Yield 91%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.50 (s, 1H), 8.67 (s, 1H), 7.86 (d, <i>J</i> = 8.4 Hz, 2H), 7.36–7.12 (m, 8H), 4.91 (s, 2H), and 3.16 (s, 3H). LC–MS (ESI): <i>m</i>/<i>z</i> 353.1 [M + H]<sup>+</sup>. HPLC purity 98%</div></div><div id="sec4-3-15" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 6-((2-Chlorobenzyl)(methyl)amino)-<i>N</i>-phenylpyrimidine-4-carboxamide (<b>15</b>)</h3><div class="NLM_p last">Yield 91%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.50 (s, 1H), 8.65 (s, 1H), 7.85 (d, <i>J</i> = 8.4 Hz, 2H), 7.50–7.07 (m, 8H), 4.95 (s, 2H), and 3.20 (s, 3H). LC–MS (ESI): <i>m</i>/<i>z</i> 353.1 [M + H]<sup>+</sup>. HPLC purity 96%.</div></div><div id="sec4-3-16" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 6-((4-Cyanobenzyl)(methyl)amino)-<i>N</i>-phenylpyrimidine-4-carboxamide (<b>16</b>)</h3><div class="NLM_p last">Yield 71%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.50 (s, 1H), 8.65 (s, 1H), 7.86 (d, <i>J</i> = 8.0 Hz, 2H), 7.79 (d, <i>J</i> = 8.0 Hz, 2H) 7.42–7.31 (m, 5H), 7.11 (t, <i>J</i> = 8.0 Hz, 1H), 4.99 (s, 2H) and 3.19 (s, 3H). LC–MS (ESI): <i>m</i>/<i>z</i> 344.2 [M + H]<sup>+</sup>. HPLC purity 99%.</div></div><div id="sec4-3-17" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 6-(Methyl(4-(methylsulfonyl)benzyl)amino)-<i>N</i>-phenylpyrimidine-4-carboxamide (<b>17</b>)</h3><div class="NLM_p last">Yield 48%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.54 (s, 1H), 8.69 (s, 1H), 7.89 (dd, <i>J</i> = 8.6, 7.0 Hz, 4H), 7.61–7.44 (m, 2H), 7.44–7.25 (m, 3H), 7.25–7.06 (m, 1H), 5.05 (s, 2H), 3.21 (d, <i>J</i> = 7.0 Hz, 6H). LC–MS (ESI): <i>m</i>/<i>z</i> 397.1 [M + H]<sup>+</sup>. HPLC purity 100%.</div></div><div id="sec4-3-18" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 6-(Methyl(pyridin-2-ylmethyl)amino)-<i>N</i>-phenylpyrimidine-4-carboxamide (<b>18</b>)</h3><div class="NLM_p last">Yield 93%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.48 (s, 1H), 8.63 (s, 1H), 8.51 (d, <i>J</i> = 4 Hz, 1H), 7.85 (d, <i>J</i> = 8.0 Hz, 2H), 7.74 (t, <i>J</i> = 8.0 Hz, 1H), 7.37–7.23 (m, 5H), 7.11 (t, <i>J</i> = 8.0 Hz, 1H), 4.97 (s, 2H) and 3.24 (s, 3H). LC–MS (ESI): <i>m</i>/<i>z</i> 320.2 [M + H]<sup>+</sup>. HPLC purity 97%.</div></div><div id="sec4-3-19" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 6-(Methyl(pyridin-3-ylmethyl)amino)-<i>N</i>-phenylpyrimidine-4-carboxamide (<b>19</b>)</h3><div class="NLM_p last">Yield 84%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.53 (s, 1H), 8.69 (d, <i>J</i> = 1.1 Hz, 1H), 8.59–8.38 (m, 2H), 7.99–7.75 (m, 2H), 7.66 (dt, <i>J</i> = 7.9, 2.0 Hz, 1H), 7.50–7.25 (m, 4H), 7.25–6.97 (m, 1H), 4.96 (s, 2H), 3.19 (s, 3H). LC–MS (ESI): <i>m</i>/<i>z</i> 320.2 [M + H]<sup>+</sup>. HPLC purity 100%.</div></div><div id="sec4-3-20" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 6-(Methyl((6-(trifluoromethyl)pyridin-3-yl)methyl)amino)-<i>N</i>-phenylpyrimidine-4-carboxamide (<b>20</b>)</h3><div class="NLM_p last">Yield 35%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.52 (s, 1H), 8.69 (m, 2H), 7.86 (m, 4H), 7.35 (m, 3H), 7.13 (m, 1H), 5.05 (s, 2H) and 3.22 (s, 3H). LC–MS (ESI): <i>m</i>/<i>z</i> 388.2 [M + H]<sup>+</sup>. HPLC purity 98%.</div></div><div id="sec4-3-21" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 4-((4-Fluorobenzyl)(methyl)amino)-<i>N</i>-phenylpicolinamide (<b>21</b>)</h3><div class="NLM_p last">Yield 26%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>): 10.40 (br s, 1H), 8.82 (d, <i>J</i> = 6 Hz, 1H), 7.82 (d, <i>J</i> = 6 Hz, 2H), 7.72 (s, 1H), 7.39 (d, <i>J</i> = 9 Hz, 2H), 7.15–7.25 (m, 3H), 7.1 (t, <i>J</i> = 9 Hz, 2H), 6.65–6.75 (m, 1H), 4.68 (s, 2H), δ 3.19 (s, 3H) . LC–MS (ESI): <i>m</i>/<i>z</i> 336.1 [M + H]<sup>+</sup>. HPLC purity 98%.</div></div><div id="sec4-3-22" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 6-((4-Fluorobenzyl)(methyl)amino)-<i>N</i>-(4-fluorophenyl)pyrazine-2-carboxamide (<b>22</b>)</h3><div class="NLM_p last">Yield 30%. A mixture of 95 mg (0.37 mmol) of 6-chloro-<i>N</i>-(4-fluorobenzyl)-<i>N</i>-methylpyrazin-2-amine, 100 mg (0.90 mmol) of 4-fluoroaniline, 100 mg (0.38 mmol) of molybdenum hexacarbonyl, 100 mg of tetrabutylammonium chloride, and 500 mg of triethylamine in 3 mL of toluene and 2 mL of tetraethylene glycol dimethyl ether was heated under nitrogen in a pressure tube to 150 °C for 4 h. The cooled mixture was evaporated onto silica gel. Silica flash chromatography (EtOAc/Hex 30/70 to 50/50) yielded 40 mg as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 9.24 (s, 1H), 8.65 (s, 1H), 8.22 (s, 1H), 7.55–7.50 (m, 2H), 7.19–7.13 (m, 2H), 7.02–6.96 (m, 4H), 4.75 (s, 2H), 3.20 (s, 3H). LC–MS (ESI): <i>m</i>/<i>z</i> 355.1 [M + H]<sup>+</sup>. HPLC purity 99%.</div></div><div id="sec4-3-23" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 2-((4-Fluorobenzyl)(methyl)amino)-<i>N</i>-(4-methoxyphenyl)pyrimidine-4-carboxamide (<b>23</b>)</h3><div class="NLM_p last">Yield 93%. A mixture of 50 mg (0.20 mmol) of 4-chloro-<i>N</i>-(4-fluorobenzyl)-<i>N</i>-methylpyrimidin-2-amine, 100 mg (0.81 mmol) of 4-methoxyaniline, 100 mg (0.38 mmol) if molybdenum hexacarbonyl, 100 mg of tetrabutylammonium chloridem and 500 mg of triethylamine in 3 mL of toluene and 2 mL of tetraethylene glycol dimethyl ether was heated under nitrogen in a pressure tube to 150 °C for 4 h. The cooled mix was diluted with 60 mL of water and extracted with EtOAc (2 × 50 mL), dried over Na<sub>2</sub>SO<sub>4</sub> and the solvent evaporated. Flash chromatography (EtOAc/Hex 20/80 to 40/60) yielded 67 mg (93%) as a white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 9.51 (s, 1H), 8.63 (d, <i>J</i> = 6.0 Hz, 1H), 7.59 (d, <i>J</i> = 9.0 Hz, 2H), 7.44 (d, <i>J</i> = 6.0 Hz, 1H), 7.31–7.26 (m, 2H), 7.09–7.03 (m, 2H), 6.94 (d, <i>J</i> = 9.0 Hz, 2H), 4.95 (s, 2H), 3.84 (s, 3H), 3.30 (s, 3H). LC–MS (ESI): <i>m</i>/<i>z</i> 367.1 [M + H]<sup>+</sup>. HPLC purity 99%.</div></div><div id="sec4-3-24" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 6-((4-Fluorobenzyl)(methyl)amino)-<i>N</i>-phenylpyridazine-4-carboxamide (<b>24</b>)</h3><div class="NLM_p last">Yield 28%. In a 10 mL CEM microwave tube, 6-chloro-<i>N</i>-phenylpyridazine-4-carboxamide (50 mg, 0.214 mmol), 1-(4-fluorophenyl)-<i>N</i>-methylmethanamine (32.8 mg, 0.235 mmol), and Et<sub>3</sub>N (0.060 mL, 0.428 mmol) were mixed in 1,4-dioxane (0.5 mL). The mixture was microwaved at 125 °C and 200 W in CEM microwave for 6 h. Solvent was evaporated and the residue was purified by prep-HPLC to give a buff colored powder. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.50 (br s, 1H), 8.91 (d, <i>J</i> = 3 Hz, 1H), 7.72–7.75 (m, 2H), 7.46 (d, <i>J</i> = 3 Hz, 1H), 7.30–7.42 (m, 4H), 7.14–7.20 (m,3H), 4.95 (s, 2H),3.18 (s, 3H). LC–MS (ESI): <i>m</i>/<i>z</i> 337.1 [M + H]<sup>+</sup>. HPLC purity 99%.</div></div><div id="sec4-3-25" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 1-(4-Fluorobenzyl)-6-oxo-<i>N</i>-phenyl-1,6-dihydropyridine-3-carboxamide (<b>25</b>)</h3><div class="NLM_p">Yield 44% over 2 steps.</div><div id="secz" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> Step 1</h4><div class="NLM_p last">In a 7 mL reaction vial, methyl 1-(4-fluorobenzyl)-6-oxo-1,6-dihydropyridine-3-carboxylate (100 mg, 0.383 mmol) was dissolved in MeOH (4 mL), and LiOH (92 mg, 3.83 mmol) was added to the solution and stirred at rt overnight. Methanol was removed under vacuum, and the residue was dissolved in water. Aqueous layer was extracted with ethyl acetate. Aqueous layer was then cooled in ice-bath and acidified with concentrated HCl. Precipitated solid was extracted with ethyl acetate. Ethyl acetate layer was then dried on anhydrous MgSO<sub>4</sub> and concentrated under vacuum to give an off-white solid, 1-(4-fluorobenzyl)-6-oxo-1,6-dihydropyridine-3-carboxylic acid. Yield 95%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.33 (br s, 1H), 8.60 (d, J= 3 Hz, 1H), 7.80 (dd, <i>J</i> = 9, 3 Hz, 1H), 7.38–7.43 (m, 2H), 7.15–7.21 (m, 2H), 6.45 (d, <i>J</i> = 9 Hz, 1H), 5.18 (s, 2H). LC–MS (ESI): <i>m</i>/<i>z</i> 248.1 [M – H]<sup>−</sup>. HPLC purity 94%.</div></div><div id="sec4-3-25-1" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> Step 2</h4><div class="NLM_p last">In a 7 mL reaction vial, 1-(4-fluorobenzyl)-6-oxo-1,6-dihydropyridine-3-carboxylic acid (50 mg, 0.202 mmol) was dissolved in DMF (1 mL), and to it were added Et<sub>3</sub>N (0.056 mL, 0.404 mmol) and HATU (115 mg, 0.303 mmol). The mixture was stirred for 30 min at 25 °C. Aniline (0.022 mL, 0.243 mmol) was then added and the solution stirred at 25 °C for 24 h. Reaction mixture was diluted with ethyl acetate and washed with 10% LiCl solution (2 × 15 mL), saturated aqueous NaHCO<sub>3</sub> solution, and brine. The EtOAc layer was then dried and evaporated under vacuum. The residue was chromatographed on Biotage using 10 g prepacked silica gel column and 0–90% EtOAc in hexane as eluent. Pure fractions were combined and evaporated under vacuum. The syrupy residue was triturated with a 3:1 DCM/hexane mixture, and precipitated solid was removed by filtration. Filtrate was evaporated and the residue was crystallized from ethanol to afford <b>25</b> as colorless crystalline needles. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.98 (br s, 1H), 8.62 (d, <i>J</i> = 3 Hz, 1H), 8.01 (dd, <i>J</i> = 9, 3 Hz, 1H), 7.68 (d, <i>J</i> = 6 Hz, 2H), 7.40–7.45 (m, 2H), 7.35 (t, <i>J</i> = 9H, 2H), 7.17–23 (m, 2H), 7.10 (t, <i>J</i> = 9 Hz, 1H), 6.52 (d, <i>J</i> = 12 Hz, 1H),5.18 (s, 2H) . LC–MS (ESI): <i>m</i>/<i>z</i> 323.1 [M + H]<sup>+</sup>. HPLC purity 95%.</div></div></div><div id="sec4-3-26" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 2-((4-Fluorobenzyl)(methyl)amino)-<i>N</i>-phenylthiazole-4-carboxamide (<b>26</b>)</h3><div class="NLM_p">50% over 2-steps.</div><div id="sec4-3-26-1" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> Step 1. 2-((4-Fluorobenzyl)(methyl)amino)thiazole-4-carboxylic Acid</h4><div class="NLM_p last">Yield 81%. In a 7 mL glass vial, methyl 2-((4-fluorobenzyl)(methyl)amino)thiazole-4-carboxylate (150 mg, 0.535 mmol) was dissolved in methanol (2 mL). LiOH (128 mg, 5.35 mmol) was added to the solution, and the mixture was stirred at rt overnight. LC–MS indicated complete hydrolysis. Methanol was removed under reduced pressue. Residue was taken up in water and washed with ethyl acetate. Aqueous layer was cooled and acidified with dilute HCl. Precipitated acid was extracted with dichloromethane. Dichloromethane layer was washed with brine, dried on anhydrous MgSO<sub>4</sub>, and concentrated under vacuum to give a buff colored powder, 2-((4-fluorobenzyl)(methyl)amino)thiazole-4-carboxylic acid. Yield 81%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub><i>6</i></sub>) δ 7.52 (s, 1H), 7.25–7.29 (m, 2H), 7.07 (t, <i>J</i> = 9 Hz, 2H), 4.71 (s, 2H), 3.09 (s, 3H). LC–MS (ESI): <i>m</i>/<i>z</i> 267.1 [M + H]<sup>+</sup>. HPLC purity 88%. Product was used without further purification in the next step.</div></div><div id="sec4-3-26-2" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> Step 2</h4><div class="NLM_p last">In a 7 mL glass vial, 2-((4-fluorobenzyl)(methyl)amino)thiazole-4-carboxylic acid (50 mg, 0.188 mmol) was dissolved in dry DMF (2 mL). HATU (107 mg, 0.282 mmol) and Et<sub>3</sub>N (0.052 mL, 0.376 mmol) were then added to the mixture and stirred at 25 °C for 30 min. Aniline was then added (0.021 mL, 0.225 mmol) and stirred at 25 °C overnight. LCMS indicated complete reaction. Reaction mixture was diluted with ethyl acetate and washed with successively with dilute HCl, water, saturated NaHCO<sub>3</sub> solution, and brine. The sample was dried on anhydrous MgSO<sub>4</sub> and concentrated under vacuum. Residue was purified on Biotage using 10 g silica gel column and 0–50% ethyl acetate in hexane as eluent. Pure fractions were combined and concentrated to give <b>26</b> as a light yellow colored solid. Yield 62%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.73 (br s, 1H), 7.77 (dd, <i>J</i> = 9 Hz, 1 Hz, 2H), 7.52 (s, 1H), 7.33–7.44 (m, 4H), 7.17–7.23 (m. 2H), 7.08–7.13 (m, 1H), 4.83 (s, 2H), 3.08 (s, 3H). LC–MS (ESI): <i>m</i>/<i>z</i> 342.1 [M + H]<sup>+</sup>. HPLC purity 95%.</div></div></div><div id="sec4-3-27" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> 6-((4-Fluorobenzyl)(methyl)amino)-<i>N</i>-(4-fluorophenyl)-5-methylpyrimidine-4-carboxamide (<b>27</b>)</h3><div class="NLM_p">Yield 17% over 2 steps.</div><div id="sec4-3-27-1" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> Step 1</h4><div class="NLM_p last">To ethyl 6-((4-fluorobenzyl)(methyl)amino)-5-methylpyrimidine-4-carboxylate <b>4</b> (0.25 g, 0.82 mmol) in THF (3 mL) were added lithium hydroxide monohydrate (0.138 g, 3.3 mmol) and water (1.5 mL). The reaction mixture was stirred at room temperature for 16 h. The reaction mixture was concentrated under vacuum, cooled to 0 °C, and acidified with citric acid solution. The acidified mixture was extracted with ethyl acetate. The organic layer was dried over anhydrous sodium sulfate and concentrated under vacuum to yield the product, 6-((4-fluorobenzyl)(methyl)amino)-5-methylpyrimidine-4-carboxylic acid. Yield 88.4%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 12.48 (s, 1H), 8.45 (s, 1H), 7.32 (d, <i>J</i> = 5.60 Hz, 2H), 7.17 (d, <i>J</i> = 9.20 Hz, 2H), 4.71 (s, 2H), 3.17 (s, 3H). LC–MS (APCI): <i>m</i>/<i>z</i> 276.0 [M + H]<sup>+</sup>.</div></div><div id="sec4-3-27-2" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> Step 2</h4><div class="NLM_p last">To a solution of 6-((4-fluorobenzyl)(methyl)amino)-5-methylpyrimidine-4-carboxylic acid <b>5</b> (0.20 g, 0.72 mmol) in DMF (3 mL) was added diisopropylethylamine (0.232 g, 1.8 mmol), HATU (0.41 g, 1.08 mmol), and 4-fluoroanililne (0.08 g, 0.7 mmol) at 0 °C. The reaction mixture was stirred at room temperature for 16 h. Water was added to the reaction mixture and extracted with ethyl acetate. The organic layer was washed with water, dried over anhydrous sodium sulfate, concentrated under vacuum to get a crude product. It was purified by column chromatography on 60–120 mesh silica gel with 10% ethyl acetate in hexanes as eluent to yield <b>27</b> (0.055 g). Yield 20%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 10.20 (s, 1H), 8.56 (s, 1H), 7.73–7.70 (m, 2H), 7.30–7.26 (m, 2H), 7.10–7.04 (m, 4H), 4.69 (s, 2H), 3.01 (s, 3H), 2.63 (s, 3H). LC–MS (APCI): <i>m</i>/<i>z</i> 369.2 [M + H]<sup>+</sup>. HPLC purity 100%.</div></div></div><div id="sec4-3-28" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> 6-((4-Chlorobenzyl)(methyl)amino)-2-methyl-<i>N</i>-phenylpyrimidine-4-carboxamide (<b>28</b>)</h3><div class="NLM_p">Reaction was according to general synthesis final step of compounds <b>1</b>–<b>21</b>. Yield 95%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.31 (s, 1H), 7.82 (d, <i>J</i> = 8.0 Hz, 2H), 7.36 (m, 4H), 7.25 (d, <i>J</i> = 8.0 Hz, 2H), 7.12 (m, 2H), 4.87 (s, 2H), 3.11 (s, 3H) and 2.52 (s, 3H). LC–MS (ESI): 367.1 <i>m</i>/<i>z</i> [M + H]<sup>+</sup>. HPLC purity 98%.</div><div class="NLM_p last">Compounds <b>29</b> and <b>30</b> were both synthesized according to the general synthetic procedure below. Ethyl 2-chloro-6-((4-chlorobenzyl)(methyl)amino)pyrimidine-4-carboxylate (1 equiv), DIPEA (2 equiv), and the appropriate amine (1.2 equiv) were added to a pressure tube containing <i>i-</i>PrOH, and the tube was sealed and heated to 120 °C overnight. The solution was then cooled and the resulting precipitate filtered off to afford the intended product as a white solid.</div></div><div id="sec4-3-29" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> 2-Amino-6-((4-chlorobenzyl)(methyl)amino)-<i>N</i>-(4-methoxyphenyl)pyrimidine-4-carboxamide (<b>29</b>)</h3><div class="NLM_p last">Yield 68%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.64 (s, 1H), 7.66–7.49 (m, 2H), 7.29–7.14 (m, 2H), 7.13–7.00 (m, 2H), 6.91–6.73 (m, 3H), 5.11–4.49 (m, 4H), 3.74 (s, 3H), 2.98 (s, 3H).. LC–MS (ESI): <i>m</i>/<i>z</i> 398.1 [M + H]<sup>+</sup>. HPLC purity 96%.</div></div><div id="sec4-3-30" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> 6-((4-Chlorobenzyl)(methyl)amino)-2-(cyclopropylamino)-<i>N</i>-(4-methoxyphenyl)pyrimidine-4-carboxamide (<b>30</b>)</h3><div class="NLM_p">Yield 71%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.81 (s, 1H), 7.67–7.45 (m, 2H), 7.26–7.17 (m, 2H), 7.10 (d, <i>J</i> = 8.1 Hz, 2H), 6.88–6.75 (m, 3H), 5.06 (s, 1H), 4.74 (s, 2H), 3.74 (d, <i>J</i> = 0.9 Hz, 3H), 3.03 (s, 3H), 2.69 (td, <i>J</i> = 5.8, 4.8, 2.6 Hz, 1H), 0.74–0.63 (m, 2H), 0.49 (m, 2H). LC–MS (ESI): <i>m</i>/<i>z</i> 438.2 [M + H]<sup>+</sup>. HPLC purity 95%.</div><div class="NLM_p last">General synthetic protocol for compounds <b>31</b> and <b>33</b>–<b>52</b> is as follows: The appropriate 6-(benzyl(methyl)amino)pyrimidine-4-carboxylic acid (1 equiv), DIPEA (3 equiv), and HATU (1.5 equiv) were dissolved in DMF and stirred for 10 min. To the solution was then added the appropriate amine, and the mixture was stirred at rt overnight. Final compounds were either isolated by precipitation with water and recrystallization with EtOH or extracted with EtOAc and washed successively with 10% LiCl, saturated aqueous NaHCO<sub>3</sub> and brine and then purified by silica flash chromatography.</div></div><div id="sec4-3-31" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> 6-(Benzyl(methyl)amino)-<i>N</i>-methyl-<i>N</i>-phenylpyrimidine-4-carboxamide (<b>31</b>)</h3><div class="NLM_p last">Yield 67%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.25 (s, 1H), 7.34–7.06 (m, 10H), 6.68 (m, 1H), 4.72 (s, 2H), 2.97 (s, 3H) and 2.48 (s, 3H). LC–MS (ESI): <i>m</i>/<i>z</i> 333.2 [M + H]<sup>+</sup>. HPLC purity 99%.</div></div><div id="sec4-3-32" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> <i>N</i>-(6-((4-Fluorobenzyl)(methyl)amino)pyrimidin-4-yl)benzamide (<b>32</b>)</h3><div class="NLM_p last">Yield 20%. To a stirred solution of 6-chloropyrimidin-4-amine (500 mg, 3.86 mmol) and DIPEA (1.348 mL, 7.72 mmol) in dry THF (20 mL) was added dropwise benzoyl chloride (0.672 mL, 5.79 mmol). The solution was heated at 50 °C for 12 h. The crude reaction mixture was adsorbed onto silica and purification attempted on an ISCO flash purification system; solvent system gradient from 0% to 70% EtOAc in Hex over 15 min. Single peak isolated contained both product and impurity. LC–MS (ESI): <i>m</i>/<i>z</i> 234.1 [M + H]<sup>+</sup>. Purity 64%. Crude material from previous step was dissolved in <i>i</i>-PrOH and <i>N</i>-methyl-1-phenylmethanamine (349 mg, 2.88 mmol) and DIPEA (0.837 mL, 4.79 mmol) added and heated at 100 °C for 4 h. The resulting solution was adsorbed directly onto silica gel and purified on ISCO purification system using a 4 g silica prepacked cartridge and solvent system from 0% to 100% EtOAc in hexane over 15 min to afford a pale cream solid. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.69 (s, 1H), 8.36 (d, <i>J</i> = 1.1 Hz, 1H), 8.05–7.95 (m, 2H), 7.65–7.57 (m, 1H), 7.57–7.46 (m, 3H), 7.40–7.30 (m, 2H), 7.30–7.19 (m, 2H), 4.85 (s, 2H), 3.07 (s, 3H). LC–MS (ESI): <i>m</i>/<i>z</i> 337.2 [M + H]<sup>+</sup>. HPLC purity 99%.</div></div><div id="sec4-3-33" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> <i>N</i>-Isopropyl-6-(methyl(4-(trifluoromethyl)benzyl)amino)pyrimidine-4-carboxamide (<b>33</b>)</h3><div class="NLM_p last">Yield 20%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.58 (s, 1H), 8.41 (d, <i>J</i> = 8.4 Hz, 1H), 7.70 (d, <i>J</i> = 8.0 Hz, 2H), 7.43 (d, <i>J</i> = 8.0 Hz, 2H), 7.21 (s, 1H), 4.99 (s, 2H), 4.08 (h, <i>J</i> = 6.5 Hz, 1H), 3.18 (d, <i>J</i> = 4.3 Hz, 3H) and 1.18 (d, <i>J</i> = 6.7 Hz, 6H). LC–MS (ESI): <i>m</i>/<i>z</i> 353.2 [M + H]<sup>+</sup>. HPLC purity 98%.</div></div><div id="sec4-3-34" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> <i>N</i>-Cyclohexyl-6-(methyl(4-(trifluoromethyl)benzyl)amino)pyrimidine-4-carboxamide (<b>34</b>)</h3><div class="NLM_p last">Yield 60%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.58 (s, 1H), 8.38 (d, <i>J</i> = 8.5 Hz, 1H), 7.70 (d, <i>J</i> = 8.1 Hz, 2H), 7.43 (d, <i>J</i> = 8.0 Hz, 2H), 7.20 (s, 1H), 4.99 (s, 2H), 3.93–3.53 (m, 1H), 3.17 (s, 3H), 1.90–1.51 (m, 5H), 1.51–1.00 (m, 5H). LC–MS (ESI): <i>m</i>/<i>z</i> 393.2 [M + H]<sup>+</sup>. HPLC purity 100%.</div></div><div id="sec4-3-35" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> 6-((4-Fluorobenzyl)(methyl)amino)-<i>N</i>-(4-methoxyphenyl)pyrimidine-4-carboxamide (<b>35</b>)</h3><div class="NLM_p last">Yield 68%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.40 (s, 1H), 8.65 (d, <i>J</i> = 1.2 Hz, 1H), 7.77 (d, <i>J</i> = 9.0 Hz, 2H), 7.32–7.24 (m, 3H), 7.15 (t, <i>J</i> = 8.8 Hz, 2H), 6.91 (d, <i>J</i> = 9.1 Hz, 2H), 4.88 (s, 2H), 3.73 (s, 3H), 3.13 (s, 3H). LC–MS (ESI): <i>m</i>/<i>z</i> 367.2 [M + H]<sup>+</sup>. HPLC purity 97%.</div></div><div id="sec4-3-36" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> 6-((4-Fluorobenzyl)(methyl)amino)-<i>N</i>-(4-isopropoxyphenyl)pyrimidine-4-carboxamide (<b>36</b>)</h3><div class="NLM_p last">Yield 63%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.92–9.74 (m, 1H), 8.61 (s, 1H), 7.63 (d, <i>J</i> = 8.9 Hz, 2H), 7.40 (dd, <i>J</i> = 1.2, 0.5 Hz, 1H), 7.18 (dd, <i>J</i> = 8.5, 5.4 Hz, 2H), 7.00 (t, <i>J</i> = 8.6 Hz, 2H), 6.89 (d, <i>J</i> = 8.9 Hz, 2H), 4.86 (s, 2H), 4.51 (hept, <i>J</i> = 6.1 Hz, 1H), 3.11 (s, 3H), 1.40–1.29 (m, 6H). LC–MS (ESI): <i>m</i>/<i>z</i> 395.2 [M + H]<sup>+</sup>. HPLC purity 99%.</div></div><div id="sec4-3-37" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> 6-((4-Fluorobenzyl)(methyl)amino)-<i>N</i>-(4-(2-methoxyethoxy)phenyl)pyrimidine-4-carboxamide (<b>37</b>)</h3><div class="NLM_p last">Yield 45%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.44 (s, 1H), 8.67 (d, <i>J</i> = 1.1 Hz, 1H), 7.78 (d, <i>J</i> = 9.0 Hz, 2H), 7.36–7.24 (m, 3H), 7.17 (t, <i>J</i> = 8.8 Hz, 2H), 6.94 (d, <i>J</i> = 9.1 Hz, 2H), 4.90 (s, 2H), 4.25–3.96 (m, 2H), 3.73–3.53 (m, 2H), 3.30 (s, 3H), 3.16 (s, 3H). LC–MS (APCI): <i>m</i>/<i>z</i> 411.2 [M + H]<sup>+</sup>. HPLC purity 95%.</div></div><div id="sec4-3-38" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> <i>N</i>-(4-(2-(Dimethylamino)ethoxy)phenyl)-6-((4-fluorobenzyl)(methyl)amino)pyrimidine-4-carboxamide (<b>38</b>)</h3><div class="NLM_p last">Yield 25%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.45 (s, 1H), 8.68 (s, 1H), 7.79 (d, <i>J</i> = 8.6 Hz, 2H), 7.38–7.24 (m, 3H), 7.17 (t, <i>J</i> = 8.7 Hz, 2H), 6.96 (d, <i>J</i> = 8.6 Hz, 2H), 4.90 (s, 2H), 4.10 (t, <i>J</i> = 5.7 Hz, 2H), 3.16 (s, 3H), 2.81 (t, <i>J</i> = 5.7 Hz, 2H), 2.36 (s, 6H). LC–MS (APCI): <i>m</i>/<i>z</i> 424.2.2 [M + H]<sup>+</sup>. HPLC purity 95%.</div></div><div id="sec4-3-39" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> 6-((4-Chlorobenzyl)(methyl)amino)-<i>N</i>-(pyridin-4-yl)pyrimidine-4-carboxamide (<b>39</b>)</h3><div class="NLM_p last">Yield 35%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.88 (s, 1H), 8.68 (s, 1H), 8.48 (d, <i>J</i> = 5.6 Hz, 2H), 7.89 (d, <i>J</i> = 5.6 Hz, 2H), 7.38 (d, <i>J</i> = 8.1 Hz, 2H), 7.33–7.22 (m, 3H), 4.90 (s, 2H), 3.15 (s, 2H). LC–MS (ESI): <i>m</i>/<i>z</i> 354.1 [M + H]<sup>+</sup>. HPLC purity 100%.</div></div><div id="sec4-3-40" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> 6-(Methyl(4-(trifluoromethyl)benzyl)amino)-<i>N</i>-(4-(4-methylpiperazin-1-yl)phenyl)pyrimidine-4-carboxamide (<b>40</b>)</h3><div class="NLM_p last">Yield 74%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.75 (s, 1H), 8.74 (s, 1H), 7.79 (d, <i>J</i> = 9 Hz, 2H), 7.76 (s, 1H), 7.73 (d, <i>J</i> = 9 Hz, 2H), 7.50 (d, <i>J</i> = 9 Hz, 2H), 7.03 (d, <i>J</i> = 6 Hz, 2H), 5.11 (s, 2H), 3.80 (d, <i>J</i> = 9H, 2H), 3.29 (s, 3H), 3.04–3.21 (m, 5H), 2.82 (m, 3H). LC–MS (ESI): <i>m</i>/<i>z</i> 485.1 [M + H]<sup>+</sup>. HPLC purity 98%.</div></div><div id="sec4-3-41" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> 6-(Methyl((6-(trifluoromethyl)pyridin-3-yl)methyl)amino)-<i>N</i>-(4-(4-methylpiperazin-1-yl)phenyl)pyrimidine-4-carboxamide (<b>41</b>)</h3><div class="NLM_p last">Yield 45%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.37 (s, 1H), 8.71 (d, <i>J</i> = 6 Hz, 2H), 7.94 (d, <i>J</i> = 9 Hz, 1H), 7.87 (d, <i>J</i> = 9 Hz, 1H), 7.77 (d, <i>J</i> = 9H, 2H), 7.47 (s, 1H), 7.02 (d, <i>J</i> = 9 Hz, 2H), 5.09 (s, 2H), 3.80 (d, <i>J</i> = 15 Hz, 2H), 3.26 (s, 3H), 3.00–3.21 (m, 6H), 2.83 (d, <i>J</i> = 6 Hz, 3H). LC–MS (ESI): <i>m</i>/<i>z</i> 486.2 [M + H]<sup>+</sup>. HPLC purity 98%.</div></div><div id="sec4-3-42" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> 6-((4-Fluorobenzyl)(methyl)amino)-<i>N</i>-(3-(4-methylpiperazin-1-yl)phenyl)pyrimidine-4-carboxamide (<b>42</b>)</h3><div class="NLM_p last">Yield 12%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.34 (s, 1H), 8.68 (s, 1H), 7.51 (t, <i>J</i> = 2.2 Hz, 1H), 7.40–7.23 (m, 4H), 7.24–7.10 (m, 3H), 6.73 (dd, <i>J</i> = 8.2, 2.4 Hz, 1H), 4.90 (s, 2H), 3.38 (s, 4H), 3.16 (s, 7H), 2.26 (s, 3H). LC–MS (APCI): <i>m</i>/<i>z</i> 435.2 [M + H]<sup>+</sup>. HPLC purity 97%.</div></div><div id="sec4-3-43" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> 6-((4-Fluorobenzyl)(methyl)amino)-<i>N</i>-(6-(4-methylpiperazin-1-yl)pyridin-3-yl)pyrimidine-4-carboxamide (<b>43</b>)</h3><div class="NLM_p last">Yield 29%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.58 (s, 1H), 8.55 (s, 1H), 7.91–7.65 (m, 2H), 7.45–7.26 (m, 2H), 7.28–7.03 (m, 4H), 4.72 (s, 2H), 3.32 (s, 8H) 3.02 (s, 3H), 2.35 (s, 3H). LC–MS (APCI): <i>m</i>/<i>z</i> 436.2 [M + H]<sup>+</sup>. HPLC purity 97%.</div></div><div id="sec4-3-44" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> <i>N</i>-(4-(4-Acetylpiperazin-1-yl)phenyl)-6-(methyl((6-(trifluoromethyl)pyridin-3-yl)methyl)amino)pyrimidine-4-carboxamide (<b>44</b>)</h3><div class="NLM_p last">Yield 38%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.39 (s, 1H), 8.71 (s, 1H), 8.67 (s, 1H), 7.96–7.86 (m, 2H), 7.75 (d, <i>J</i> = 9.1 Hz, 2H), 7.34 (s, 1H), 6.97 (d, <i>J</i> = 9.1 Hz, 2H), 5.07 (s, 2H), 3.62–3.50 (m, 4H), 3.23 (s, 3H), 3.18–3.04 (m, 4H), 2.05 (s, 3H). LC–MS (ESI): <i>m</i>/<i>z</i> 514.1 [M + H]<sup>+</sup>. HPLC purity 87.75%</div></div><div id="sec4-3-45" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> 6-((4-Fluorobenzyl)(methyl)amino)-<i>N</i>-(4-morpholinophenyl)pyrimidine-4-carboxamide (<b>45</b>)</h3><div class="NLM_p last">Yield 30%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.36 (s, 1H), 8.66 (s, 1H), 7.74 (d, <i>J</i> = 9.0 Hz, 2H), 7.35–7.10 (m, 5H), 6.94 (d, <i>J</i> = 9.1 Hz, 2H), 4.90 (s, 2H), 3.83–3.68 (m, 4H), 3.16 (s, 3H), 3.12–3.03 (m, 4H). LC–MS (ESI): <i>m</i>/<i>z</i> 422.1 [M + H]<sup>+</sup>. HPLC purity 100%</div></div><div id="sec4-3-46" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> 6-(Methyl((6-(trifluoromethyl)pyridin-3-yl)methyl)amino)-<i>N</i>-(5-morpholinopyridin-2-yl)pyrimidine-4-carboxamide (<b>46</b>)</h3><div class="NLM_p last">Yield 23%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.19 (s, 1H), 8.72 (d, <i>J</i> = 2.0 Hz, 1H), 8.68 (s, 1H), 8.12 (m, 2H), 7.93 (d, <i>J</i> = 8.1 Hz, 1H), 7.87 (d, <i>J</i> = 8.1 Hz, 1H), 7.52 (dd, <i>J</i> = 9.1, 3.1 Hz, 1H), 7.39 (d, <i>J</i> = 1.2 Hz, 1H), 5.08 (s, 2H), 3.76 (m, 4H), 3.25 (s, 3H), 3.17 (m, 4H). LC–MS (ESI): <i>m</i>/<i>z</i> 474.2 [M + H]<sup>+</sup>. HPLC purity 97%</div></div><div id="sec4-3-47" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> 6-((4-Fluorobenzyl)(methyl)amino)-<i>N</i>-(1-methyl-1H-pyrazol-3-yl)pyrimidine-4-carboxamide (<b>47</b>)</h3><div class="NLM_p last">Yield 54%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.20 (s, 1H), 8.53 (d, <i>J</i> = 1.2 Hz, 1H), 7.30 (d, <i>J</i> = 1.2 Hz, 1H), 7.21 (d, <i>J</i> = 2.3 Hz, 1H), 7.15–7.08 (m, 2H), 6.93 (t, <i>J</i> = 8.7 Hz, 2H), 6.73 (d, <i>J</i> = 2.3 Hz, 1H), 4.78 (s, 2H), 3.76 (s, 3H), 3.03 (s, 3H). LC–MS (ESI): <i>m</i>/<i>z</i> 341.2 [M + H]<sup>+</sup>. HPLC purity 100%</div></div><div id="sec4-3-48" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> 6-(Methyl(4-(trifluoromethyl)benzyl)amino)-<i>N</i>-(1-methyl-1<i>H</i>-1,2,4-triazol-3-yl)pyrimidine-4-carboxamide (<b>48</b>)</h3><div class="NLM_p last">Yield 49%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.46 (s, 1H), 8.66 (s, 1H), 8.39 (s, 1H), 7.71 (d, <i>J</i> = 8.0 Hz, 2H), 7.46 (d, <i>J</i> = 8.0 Hz, 2H), 7.28 (s, 1H), 5.02 (s, 2H), 3.85 (s, 3H), 3.20 (s, 3H). LC–MS (ESI): <i>m</i>/<i>z</i> 392.2 [M + H]<sup>+</sup>. HPLC purity 99%</div></div><div id="sec4-3-49" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> 6-((4-Fluorobenzyl)(methyl)amino)-<i>N</i>-(isoxazol-3-yl)pyrimidine-4-carboxamide (<b>49</b>)</h3><div class="NLM_p last">Yield 6%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.95 (s, 1H), 8.86 (d, <i>J</i> = 1.8 Hz, 1H), 8.67 (d, <i>J</i> = 1.2 Hz, 1H), 7.33–7.24 (m, 3H), 7.16 (t, <i>J</i> = 8.8 Hz, 2H), 6.98 (d, <i>J</i> = 1.7 Hz, 1H), 4.89 (s, 2H), 3.30 (s, 3H). LC–MS (ESI): <i>m</i>/<i>z</i> 328.0 [M + H]<sup>+</sup>. HPLC purity 99%</div></div><div id="sec4-3-50" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> 6-((4-Fluorobenzyl)(methyl)amino)-<i>N</i>-(4-methylthiazol-2-yl)pyrimidine-4-carboxamide (<b>50</b>)</h3><div class="NLM_p last">Yield 6%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.75 (s, 1H), 8.67 (d, <i>J</i> = 1.1 Hz, 1H), 7.36–7.23 (m, 3H), 7.24–7.09 (m, 2H), 6.91 (q, <i>J</i> = 0.9 Hz, 1H), 4.90 (s, 2H), 3.16 (s, 3H), 2.31 (d, <i>J</i> = 1.1 Hz, 3H). LC–MS (ESI): <i>m</i>/<i>z</i> 358.0 [M + H]<sup>+</sup>. HPLC purity 99%</div></div><div id="sec4-3-51" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> 6-((4-Fluorobenzyl)(methyl)amino)-<i>N</i>-(1,3,4-thiadiazol-2-yl)pyrimidine-4-carboxamide (<b>51</b>)</h3><div class="NLM_p last">Yield 47%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.48 (s, 1H), 9.26 (d, <i>J</i> = 1.6 Hz, 1H), 8.68 (s, 1H), 7.33 (s, 1H), 7.28 (t, <i>J</i> = 6.2 Hz, 2H), 7.15 (t, <i>J</i> = 8.1 Hz, 2H), 4.88 (s, 2H), 3.13 (s, 3H). LC–MS (ESI): <i>m</i>/<i>z</i> 345.1 [M + H]<sup>+</sup>. HPLC purity 100%</div></div><div id="sec4-3-52" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> 6-(Methyl((6-(trifluoromethyl)pyridin-3-yl)methyl)amino)-<i>N</i>-(1,3,4-thiadiazol-2-yl)pyrimidine-4-carboxamide (<b>52</b>)</h3><div class="NLM_p last">Yield 30%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.61 (s, 1H), 9.29 (s, 1H), 8.72 (s, 2H), 7.95–7.86 (m, 2H), 7.42 (s, 1H), 5.08 (s, 2H) and 3.24 (s, 3H). LC–MS (ESI): <i>m</i>/<i>z</i> 396.1 [M + H]<sup>+</sup>. HPLC purity 96%</div></div><div id="sec4-3-53" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88"> <i>N</i>-(4-Fluorobenzyl)-<i>N</i>-methyl-6-(2,2,2-trifluoro-1-((4-fluorophenyl)amino)ethyl)pyrimidin-4-amine (<b>53</b>)</h3><div class="NLM_p last">A solution of 4-fluoroaniline (42.6 mg, 0.383 mmol), Et<sub>3</sub>N (0.133 mL, 0.958 mmol), titanium tetrachloride (0.035 mL, 0.319 mmol), and 2,2,2-trifluoro-1-(6-((4-fluorobenzyl)(methyl)amino)pyrimidin-4-yl)ethan-1-one (100 mg, 0.319 mmol) in dry DCM (10 mL) under nitrogen was stirred at rt for 18 h. Sodium cyanoborohydride (80 mg, 1.277 mmol) was then added portionwise and the reaction stirred for a further 30 min. The reaction was then quenched with water (10 mL) and washed with brine (10 mL). The organic layer was separated, dried, and adsorbed onto silica and purified by silica flash chromatography to afford a clear oil. Yield 37%. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.68 (d, <i>J</i> = 1.1 Hz, 1H), 7.25–7.13 (m, 2H), 7.03 (t, <i>J</i> = 8.6 Hz, 2H), 6.92 (t, <i>J</i> = 8.7 Hz, 2H), 6.81–6.66 (m, 2H), 6.51 (s, 1H), 5.40 (s, 1H), 5.06–4.55 (m, 3H), 3.08 (s, 3H). LC–MS (ESI): <i>m</i>/<i>z</i> 409.1 [M + H]<sup>+</sup>. HPLC purity 97%</div></div><div id="sec4-3-54" class="NLM_sec NLM_sec_level_2"><div id="ac_i89" class="anchor-spacer"></div><h3 class="article-section__title" id="_i89"> <i>N</i>-(4-Fluorobenzyl)-<i>N</i>-methyl-6-(5-phenyl-4<i>H</i>-1,2,4-triazol-3-yl)pyrimidin-4-amine (<b>54</b>)</h3><div class="NLM_p last">A solution of potassium carbonate, benzonitrile, and 6-((4-fluorobenzyl)(methyl)amino)pyrimidine-4-carbohydrazide in <i>n</i>-butanol (4 mL) was heated in a sealed tube overnight. The resulting mixture was concentrated onto silica and purified by silica flash column chromatography, EtOAc/Hex (1:1), to afford an off white solid. Yield 61%. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.66 (d, <i>J</i> = 1.1 Hz, 1H), 8.14–8.00 (m, 2H), 7.60–7.41 (m, 3H), 7.41–7.25 (m, 3H), 7.18 (t, <i>J</i> = 8.9 Hz, 2H), 4.92 (s, 2H), 3.16 (s, 3H). LC–MS (ESI): <i>m</i>/<i>z</i> 361.2 [M + H]<sup>+</sup>. HPLC 97%.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i90"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01347">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63120" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63120" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b01347" class="ext-link">10.1021/acs.jmedchem.7b01347</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Synthesis and analytical data of intermediates, chemoproteomics materials and methods, microbiology assays, in vitro ADMET assays, metabolite identification studies, and mouse pharmacokinetic studies (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01347/suppl_file/jm7b01347_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">MS/MM data for profiling of <b>25</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01347/suppl_file/jm7b01347_si_002.xls" class="ext-link">XLS</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01347/suppl_file/jm7b01347_si_003.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01347/suppl_file/jm7b01347_si_001.pdf">jm7b01347_si_001.pdf (947.52 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01347/suppl_file/jm7b01347_si_002.xls">jm7b01347_si_002.xls (588.5 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01347/suppl_file/jm7b01347_si_003.csv">jm7b01347_si_003.csv (3.96 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b01347" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60606" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60606" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sandeep R. Ghorpade</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry,
Drug Discovery and Development Centre (H3D), University of Cape Town, Rondebosch 7701, South Africa</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9311-1572" title="Orcid link">http://orcid.org/0000-0002-9311-1572</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#ca99aba4aeafafbae4ada2a5b8baabaeaf8abfa9bee4aba9e4b0ab"><span class="__cf_email__" data-cfemail="1a497b747e7f7f6a347d7275686a7b7e7f5a6f796e347b7934607b">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kelly Chibale</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry,
Drug Discovery and Development Centre (H3D), University of Cape Town, Rondebosch 7701, South Africa</span>; 
    <span class="hlFld-Affiliation affiliation">Institute of Infectious Disease and Molecular
Medicine, University of Cape Town, Rondebosch 7701, South Africa</span>; 
    <span class="hlFld-Affiliation affiliation">South African Medical Research Council
Drug Discovery and Development Research Unit, Department of Chemistry, University of Cape Town, Rondebosch 7701, South Africa</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1327-4727" title="Orcid link">http://orcid.org/0000-0002-1327-4727</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e68d838a8a9fc8858e8f84878a83a6938592c88785c89c87"><span class="__cf_email__" data-cfemail="254e4049495c0b464d4c47444940655046510b44460b5f44">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Colin R. Wilson</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry,
Drug Discovery and Development Centre (H3D), University of Cape Town, Rondebosch 7701, South Africa</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard K. Gessner</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry,
Drug Discovery and Development Centre (H3D), University of Cape Town, Rondebosch 7701, South Africa</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Atica Moosa</span> - <span class="hlFld-Affiliation affiliation">SAMRC/NHLS/UCT Molecular Mycobacteriology Research Unit, Department
of Pathology, University of Cape Town, Rondebosch 7701, South Africa</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ronnett Seldon</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry,
Drug Discovery and Development Centre (H3D), University of Cape Town, Rondebosch 7701, South Africa</span>; 
    <span class="hlFld-Affiliation affiliation">Institute of Infectious Disease and Molecular
Medicine, University of Cape Town, Rondebosch 7701, South Africa</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Digby F. Warner</span> - <span class="hlFld-Affiliation affiliation">SAMRC/NHLS/UCT Molecular Mycobacteriology Research Unit, Department
of Pathology, University of Cape Town, Rondebosch 7701, South Africa</span>; 
    <span class="hlFld-Affiliation affiliation">Institute of Infectious Disease and Molecular
Medicine, University of Cape Town, Rondebosch 7701, South Africa</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Valerie Mizrahi</span> - <span class="hlFld-Affiliation affiliation">SAMRC/NHLS/UCT Molecular Mycobacteriology Research Unit, Department
of Pathology, University of Cape Town, Rondebosch 7701, South Africa</span>; 
    <span class="hlFld-Affiliation affiliation">Institute of Infectious Disease and Molecular
Medicine, University of Cape Town, Rondebosch 7701, South Africa</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4824-9115" title="Orcid link">http://orcid.org/0000-0003-4824-9115</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Candice Soares de Melo</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry,
Drug Discovery and Development Centre (H3D), University of Cape Town, Rondebosch 7701, South Africa</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sandile B. Simelane</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry,
Drug Discovery and Development Centre (H3D), University of Cape Town, Rondebosch 7701, South Africa</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aloysius Nchinda</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry,
Drug Discovery and Development Centre (H3D), University of Cape Town, Rondebosch 7701, South Africa</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Efrem Abay</span> - <span class="hlFld-Affiliation affiliation">Department of Medicine, Division of Clinical Pharmacology, Drug Discovery
and Development Centre (H3D), University
of Cape Town, Observatory, 7925, South Africa</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dale Taylor</span> - <span class="hlFld-Affiliation affiliation">Department of Medicine, Division of Clinical Pharmacology, Drug Discovery
and Development Centre (H3D), University
of Cape Town, Observatory, 7925, South Africa</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mathew Njoroge</span> - <span class="hlFld-Affiliation affiliation">Department of Medicine, Division of Clinical Pharmacology, Drug Discovery
and Development Centre (H3D), University
of Cape Town, Observatory, 7925, South Africa</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christel Brunschwig</span> - <span class="hlFld-Affiliation affiliation">Department of Medicine, Division of Clinical Pharmacology, Drug Discovery
and Development Centre (H3D), University
of Cape Town, Observatory, 7925, South Africa</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nina Lawrence</span> - <span class="hlFld-Affiliation affiliation">Department of Medicine, Division of Clinical Pharmacology, Drug Discovery
and Development Centre (H3D), University
of Cape Town, Observatory, 7925, South Africa</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Helena I. M. Boshoff</span> - <span class="hlFld-Affiliation affiliation">Tuberculosis Research Section, Laboratory
of Clinical Infectious Diseases, National
Institute of Allergy and Infectious Diseases, National Institutes
of Health, Bethesda, Maryland 20892, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Clifton E. Barry</span> - <span class="hlFld-Affiliation affiliation">Tuberculosis Research Section, Laboratory
of Clinical Infectious Diseases, National
Institute of Allergy and Infectious Diseases, National Institutes
of Health, Bethesda, Maryland 20892, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Frederick A. Sirgel</span> - <span class="hlFld-Affiliation affiliation">DST/NRF Centre of Excellence for Biomedical TB Research,
SA MRC Centre for TB Research, Division of Molecular Biology and Human
Genetics, Faculty of Health Sciences, Stellenbosch
University, 7505 Tygerberg, South Africa</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul van Helden</span> - <span class="hlFld-Affiliation affiliation">DST/NRF Centre of Excellence for Biomedical TB Research,
SA MRC Centre for TB Research, Division of Molecular Biology and Human
Genetics, Faculty of Health Sciences, Stellenbosch
University, 7505 Tygerberg, South Africa</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">C. John Harris</span> - <span class="hlFld-Affiliation affiliation">CJH Consultants, Ford Cottage, South Weirs, Brockenhurst, Hampshire SO42 7UQ, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard Gordon</span> - <span class="hlFld-Affiliation affiliation">Strategic Health Innovation Partnerships
(SHIP), South African Medical Research Council, Parow Valley, Cape Town, South
Africa</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sonja Ghidelli-Disse</span> - <span class="hlFld-Affiliation affiliation">Cellzome GmbH, Molecular Discovery Research, GlaxoSmithKline, Meyerhofstrasse 1, Heidelberg 69117, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hannah Pflaumer</span> - <span class="hlFld-Affiliation affiliation">Cellzome GmbH, Molecular Discovery Research, GlaxoSmithKline, Meyerhofstrasse 1, Heidelberg 69117, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Markus Boesche</span> - <span class="hlFld-Affiliation affiliation">Cellzome GmbH, Molecular Discovery Research, GlaxoSmithKline, Meyerhofstrasse 1, Heidelberg 69117, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gerard Drewes</span> - <span class="hlFld-Affiliation affiliation">Cellzome GmbH, Molecular Discovery Research, GlaxoSmithKline, Meyerhofstrasse 1, Heidelberg 69117, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Olalla Sanz</span> - <span class="hlFld-Affiliation affiliation">Diseases of the Developing
World, GlaxoSmithKline, Calle Severo Ochoa 2, 28760 Tres Cantos, Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gracia Santos</span> - <span class="hlFld-Affiliation affiliation">Diseases of the Developing
World, GlaxoSmithKline, Calle Severo Ochoa 2, 28760 Tres Cantos, Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maria José Rebollo-Lopez</span> - <span class="hlFld-Affiliation affiliation">Diseases of the Developing
World, GlaxoSmithKline, Calle Severo Ochoa 2, 28760 Tres Cantos, Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Beatriz Urones</span> - <span class="hlFld-Affiliation affiliation">Diseases of the Developing
World, GlaxoSmithKline, Calle Severo Ochoa 2, 28760 Tres Cantos, Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carolyn Selenski</span> - <span class="hlFld-Affiliation affiliation">Diseases of the Developing
World, GlaxoSmithKline, Calle Severo Ochoa 2, 28760 Tres Cantos, Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maria Jose Lafuente-Monasterio</span> - <span class="hlFld-Affiliation affiliation">Diseases of the Developing
World, GlaxoSmithKline, Calle Severo Ochoa 2, 28760 Tres Cantos, Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew Axtman</span> - <span class="hlFld-Affiliation affiliation">Diseases of the Developing
World, GlaxoSmithKline, Calle Severo Ochoa 2, 28760 Tres Cantos, Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joël Lelièvre</span> - <span class="hlFld-Affiliation affiliation">Diseases of the Developing
World, GlaxoSmithKline, Calle Severo Ochoa 2, 28760 Tres Cantos, Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lluis Ballell</span> - <span class="hlFld-Affiliation affiliation">Diseases of the Developing
World, GlaxoSmithKline, Calle Severo Ochoa 2, 28760 Tres Cantos, Madrid, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rudolf Mueller</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry,
Drug Discovery and Development Centre (H3D), University of Cape Town, Rondebosch 7701, South Africa</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Leslie J. Street</span> - <span class="hlFld-Affiliation affiliation">Department of Chemistry,
Drug Discovery and Development Centre (H3D), University of Cape Town, Rondebosch 7701, South Africa</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>K.C. and R.G. came up with the original idea of screening the SoftFocus library against Mycobacterium tuberculosis to identify hits for medicinal chemistry progression. H.I.M.B. and C.E.B facilitated the screening of the SoftFocus library and analyzed the data. Chemical synthesis for hit evaluation and SAR expansion were conducted by R.K.G., C.R.W., C.S.d.M., S.B.S., A.N., R.M., and S.R.G. SAR analysis and compound design were conducted by L.S., S.R.G., C.R.W., R.K.G., R.M. C.J.H., and K. C. Biology triage and MIC assays were performed by R.S. D.F.W. and V.M. were involved in the analysis of biology triage results and provided intellectual input into the overall biology of the project. A.M. was responsible for mutant generation and cross-screening of compounds against the mutants. F.A.S. and P.v.H. conducted and analyzed screening data against the clinical isolates. E.A., D.T., M.N., C.B., and N.L. performed and analyzed DMPK experiments. B.U., C.S., and A.A. performed the synthesis of derivatives for chemoproteomics experiments. O.S., G.S., M.J.R.-L., M.J.L.-M., H.P., S.G.-D., M.B., and G.D. performed the chemoproteomics and related biology experiments. J.L. and L.B. provided the leadership and intellectual inputs into the chemoproteomics experiments. C.R.W. and S.R.G. wrote the manuscript which was further edited by L.S., H.I.M.B, C.E.B., F.A.S., D.F.W., and C.B. and was finally reviewed and edited by K.C. The chemoproteomics section of the manuscript was written by the personnel involved in performing the experiments.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i92">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28005" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28005" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors acknowledge the following: Dr. Sridevi Bashayam, Syngene, India, and her team for profound chemistry support; Marianna de Kock and Claudia Spies, DST/NRF Centre of Excellence for Biomedical Tuberculosis Research/SAMRC Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Health Sciences, Stellenbosch University, Tygerberg, South Africa, for excellent technical assistance for excellent technical support in generating MICs against clinical TB isolates; Dr. Michael Whitty and Dr. David Waterson for insightful scientific consultation during the course of the project. The project was funded through a Global Health Grant (Grant OPP1066878) received from the Bill and Melinda Gates Foundation, the Division of Intramural Research of the NIAID/NIH and the Strategic Health Innovation Partnerships (SHIP) unit of the South African Medical Research Council (SAMRC). The University of Cape Town, SAMRC, and South African Research Chairs Initiative of the Department of Science and Technology, administered through the South African National Research Foundation, are gratefully acknowledged for support (K.C.).</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i93" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i93"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i94" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i94"> Abbreviations Used</h2><tr><td class="NLM_term">TB</td><td class="NLM_def"><p class="first last">tuberculosis</p></td></tr><tr><td class="NLM_term">Mtb</td><td class="NLM_def"><p class="first last"><i>Mycobacterium tuberculosis</i></p></td></tr><tr><td class="NLM_term">MIC</td><td class="NLM_def"><p class="first last">minimum inhibitory concentration</p></td></tr><tr><td class="NLM_term">GFP</td><td class="NLM_def"><p class="first last">green fluorescent protein</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the curve</p></td></tr><tr><td class="NLM_term">fu</td><td class="NLM_def"><p class="first last">fraction unbound</p></td></tr><tr><td class="NLM_term">CFU</td><td class="NLM_def"><p class="first last">colony-forming unit</p></td></tr><tr><td class="NLM_term">rt</td><td class="NLM_def"><p class="first last">room temperature</p></td></tr><tr><td class="NLM_term">EtOH</td><td class="NLM_def"><p class="first last">ethanol</p></td></tr><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last">diisopropylethylamine</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">BuOH</td><td class="NLM_def"><p class="first last">butanol</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last">1-[bis(dimethylamino)methylene]-1<i>H</i>-1,2,3-triazolo[4,5-<i>b</i>]pyridinium 3-oxide hexafluorophosphate</p></td></tr><tr><td class="NLM_term">TBAC</td><td class="NLM_def"><p class="first last">tetrabutylammonium chloride</p></td></tr><tr><td class="NLM_term">POCl<sub>3</sub></td><td class="NLM_def"><p class="first last">phosphorus(V) oxychloride</p></td></tr><tr><td class="NLM_term">SOCl<sub>2</sub></td><td class="NLM_def"><p class="first last">thionyl chloride</p></td></tr><tr><td class="NLM_term">NaBH<sub>4</sub></td><td class="NLM_def"><p class="first last">sodium borohydride</p></td></tr><tr><td class="NLM_term">NaCNBH<sub>3</sub></td><td class="NLM_def"><p class="first last">sodium cyanoborohydride</p></td></tr><tr><td class="NLM_term">TiCl<sub>4</sub></td><td class="NLM_def"><p class="first last">titanium(IV) chloride</p></td></tr><tr><td class="NLM_term">TMT</td><td class="NLM_def"><p class="first last">tandem mass tag</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i95">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62651" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62651" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 37 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span>World Health Organisation. Global Tuberculosis Report. <a href="http://apps.who.int/iris/bitstream/10665/250441/1/9789241565394-eng.pdf?ua=1" class="extLink">http://apps.who.int/iris/bitstream/10665/250441/1/9789241565394-eng.pdf?ua=1</a> (accessed Dec 12,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=World+Health+Organisation.+Global+Tuberculosis+Report.+http%3A%2F%2Fapps.who.int%2Firis%2Fbitstream%2F10665%2F250441%2F1%2F9789241565394-eng.pdf%3Fua%3D1+%28accessed+Dec+12%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Dover, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coxon, G. D.</span><span> </span><span class="NLM_article-title">Current Status and Research Strategies in Tuberculosis Drug Development Miniperspective</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">6157</span><span class="NLM_x">–</span> <span class="NLM_lpage">6165</span><span class="refDoi"> DOI: 10.1021/jm200305q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200305q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6157-6165&author=L.+G.+Doverauthor=G.+D.+Coxon&title=Current+Status+and+Research+Strategies+in+Tuberculosis+Drug+Development+Miniperspective&doi=10.1021%2Fjm200305q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Fjm200305q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200305q%26sid%3Dliteratum%253Aachs%26aulast%3DDover%26aufirst%3DL.%2BG.%26aulast%3DCoxon%26aufirst%3DG.%2BD.%26atitle%3DCurrent%2520Status%2520and%2520Research%2520Strategies%2520in%2520Tuberculosis%2520Drug%2520Development%2520Miniperspective%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D6157%26epage%3D6165%26doi%3D10.1021%2Fjm200305q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Olaru, I. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lange, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heyckendorf, J.</span><span> </span><span class="NLM_article-title">Personalized Medicine for Patients with MDR-TB</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">852</span><span class="NLM_x">–</span> <span class="NLM_lpage">855</span><span class="refDoi"> DOI: 10.1093/jac/dkv354</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=10.1093%2Fjac%2Fdkv354" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=26507429" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFyltrzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2016&pages=852-855&author=I.+D.+Olaruauthor=C.+Langeauthor=J.+Heyckendorf&title=Personalized+Medicine+for+Patients+with+MDR-TB&doi=10.1093%2Fjac%2Fdkv354"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Personalized medicine for patients with MDR-TB</span></div><div class="casAuthors">Olaru, Ioana D.; Lange, Christoph; Heyckendorf, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">852-855</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  The emergence of MDR-TB is a cause of great concern due to difficulties in patient management and poor treatment outcomes.  Currently the duration of treatment and the choice of drugs for patients with MDR-TB are standardized in many countries.  This might not be the best approach since the optimal therapy may depend on different pathogen- and host-related features.  Combining the introduction of technol. innovations such as whole bacillary genome sequencing for the identification of drug-resistance-assocd. mutations, therapeutic drug monitoring and host-directed therapies with an individualized approach to MDR-TB management will likely lead to more tolerable, shorter and more efficient treatment regimens and an increase in the quality of life of those affected by MDR-TB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEel9T6BdndrVg90H21EOLACvtfcHk0liqR8Shg5mfNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFyltrzE&md5=c75a5f06760614e994deda46fa5f0a8f</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkv354&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkv354%26sid%3Dliteratum%253Aachs%26aulast%3DOlaru%26aufirst%3DI.%2BD.%26aulast%3DLange%26aufirst%3DC.%26aulast%3DHeyckendorf%26aufirst%3DJ.%26atitle%3DPersonalized%2520Medicine%2520for%2520Patients%2520with%2520MDR-TB%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2016%26volume%3D71%26spage%3D852%26epage%3D855%26doi%3D10.1093%2Fjac%2Fdkv354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Warner, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizrahi, V.</span><span> </span><span class="NLM_article-title">Shortening Treatment for Tuberculosis - Back to Basics</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">371</span><span class="NLM_x">, </span> <span class="NLM_fpage">1642</span><span class="NLM_x">–</span> <span class="NLM_lpage">1643</span><span class="refDoi"> DOI: 10.1056/NEJMe1410977</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=10.1056%2FNEJMe1410977" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=25337754" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVSlurzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2014&pages=1642-1643&author=D.+F.+Warnerauthor=V.+Mizrahi&title=Shortening+Treatment+for+Tuberculosis+-+Back+to+Basics&doi=10.1056%2FNEJMe1410977"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Shortening treatment for tuberculosis - back to basics</span></div><div class="casAuthors">Warner, Digby F.; Mizrahi, Valerie</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">371</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1642-1643, 2 pp.</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSmHouUi5u-7Vg90H21EOLACvtfcHk0liqR8Shg5mfNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVSlurzM&md5=2f7287c4dded7f468f73ff4674db201d</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1056%2FNEJMe1410977&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMe1410977%26sid%3Dliteratum%253Aachs%26aulast%3DWarner%26aufirst%3DD.%2BF.%26aulast%3DMizrahi%26aufirst%3DV.%26atitle%3DShortening%2520Treatment%2520for%2520Tuberculosis%2520-%2520Back%2520to%2520Basics%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2014%26volume%3D371%26spage%3D1642%26epage%3D1643%26doi%3D10.1056%2FNEJMe1410977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Andries, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhasselt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillemont, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gohlmann, H. W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neefs, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winkler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Gestel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timmerman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Chaffoy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huitric, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cambau, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truffot-Pernot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lounis, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarlier, V.</span><span> </span><span class="NLM_article-title">A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium Tuberculosis</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">307</span><span class="NLM_x">, </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">227</span><span class="refDoi"> DOI: 10.1126/science.1106753</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=10.1126%2Fscience.1106753" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=15591164" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisVKkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=307&publication_year=2005&pages=223-227&author=K.+Andriesauthor=P.+Verhasseltauthor=J.+Guillemontauthor=H.+W.+H.+Gohlmannauthor=J.-M.+Neefsauthor=H.+Winklerauthor=J.+Van+Gestelauthor=P.+Timmermanauthor=M.+Zhuauthor=E.+Leeauthor=P.+Williamsauthor=D.+de+Chaffoyauthor=E.+Huitricauthor=S.+Hoffnerauthor=E.+Cambauauthor=C.+Truffot-Pernotauthor=N.+Lounisauthor=V.+Jarlier&title=A+Diarylquinoline+Drug+Active+on+the+ATP+Synthase+of+Mycobacterium+Tuberculosis&doi=10.1126%2Fscience.1106753"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis</span></div><div class="casAuthors">Andries, Koen; Verhasselt, Peter; Guillemont, Jerome; Goehlmann, Hinrich W. H.; Neefs, Jean-Marc; Winkler, Hans; Van Gestel, Jef; Timmerman, Philip; Zhu, Min; Lee, Ennis; Williams, Peter; de Chaffoy, Didier; Huitric, Emma; Hoffner, Sven; Cambau, Emmanuelle; Truffot-Pernot, Chantal; Lounis, Nacer; Jarlier, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">307</span>
        (<span class="NLM_cas:issue">5707</span>),
    <span class="NLM_cas:pages">223-227</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The incidence of tuberculosis has been increasing substantially on a worldwide basis over the past decade, but no tuberculosis-specific drugs have been discovered in 40 years.  We identified a diarylquinoline, R207910, that potently inhibits both drug-sensitive and drug-resistant Mycobacterium tuberculosis in vitro (min. inhibitory concn. 0.06 μg/mL).  In mice, R207910 exceeded the bactericidal activities of isoniazid and rifampin by at least 1 log unit.  Substitution of drugs included in the World Health Organization's first-line tuberculosis treatment regimen (rifampin, isoniazid, and pyrazinamide) with R207910 accelerated bactericidal activity, leading to complete culture conversion after 2 mo of treatment in some combinations.  A single dose of R207910 inhibited mycobacterial growth for 1 wk.  Plasma levels assocd. with efficacy in mice were well tolerated in healthy human volunteers.  Mutants selected in vitro suggest that the drug targets the proton pump of ATP (ATP) synthase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9LY7RSAIXUrVg90H21EOLACvtfcHk0lgKV5bf5Zv9cA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisVKkug%253D%253D&md5=099b643f173bb77e70cf1aa6e9871ffe</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1126%2Fscience.1106753&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1106753%26sid%3Dliteratum%253Aachs%26aulast%3DAndries%26aufirst%3DK.%26aulast%3DVerhasselt%26aufirst%3DP.%26aulast%3DGuillemont%26aufirst%3DJ.%26aulast%3DGohlmann%26aufirst%3DH.%2BW.%2BH.%26aulast%3DNeefs%26aufirst%3DJ.-M.%26aulast%3DWinkler%26aufirst%3DH.%26aulast%3DVan%2BGestel%26aufirst%3DJ.%26aulast%3DTimmerman%26aufirst%3DP.%26aulast%3DZhu%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DE.%26aulast%3DWilliams%26aufirst%3DP.%26aulast%3Dde%2BChaffoy%26aufirst%3DD.%26aulast%3DHuitric%26aufirst%3DE.%26aulast%3DHoffner%26aufirst%3DS.%26aulast%3DCambau%26aufirst%3DE.%26aulast%3DTruffot-Pernot%26aufirst%3DC.%26aulast%3DLounis%26aufirst%3DN.%26aulast%3DJarlier%26aufirst%3DV.%26atitle%3DA%2520Diarylquinoline%2520Drug%2520Active%2520on%2520the%2520ATP%2520Synthase%2520of%2520Mycobacterium%2520Tuberculosis%26jtitle%3DScience%26date%3D2005%26volume%3D307%26spage%3D223%26epage%3D227%26doi%3D10.1126%2Fscience.1106753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Horsburgh, C. R.,  Jr</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barry, C. E.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lange, C.</span><span> </span><span class="NLM_article-title">Treatment of Tuberculosis</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">373</span><span class="NLM_x">, </span> <span class="NLM_fpage">2149</span><span class="NLM_x">–</span> <span class="NLM_lpage">2160</span><span class="refDoi"> DOI: 10.1056/NEJMra1413919</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=10.1056%2FNEJMra1413919" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=26605929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BC28XntVSkt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=373&publication_year=2015&pages=2149-2160&author=C.+R.+Horsburghauthor=C.+E.+Barryauthor=C.+Lange&title=Treatment+of+Tuberculosis&doi=10.1056%2FNEJMra1413919"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of tuberculosis</span></div><div class="casAuthors">Horsburgh, C. Robert, Jr.; Barry, Clifton E., III; Lange, Christoph</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">373</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">2149-2160</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Tuberculosis, a scourge since prehistoric times, affects more than 9 million people and causes the death of 1.5 million people each year.  Effective treatment has been available for 60 years, but such treatment takes at least 6 mo, and resistance to the drugs, which is increasing throughout the world, threatens the effectiveness of treatment.1 This review summarizes the theor. principles of tuberculosis treatment, current therapeutic approaches, areas of uncertainty, and persistent challenges.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNp74TLwDRXLVg90H21EOLACvtfcHk0lgKV5bf5Zv9cA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XntVSkt7o%253D&md5=96775985ab332aa82ccc4ab5481e6fe0</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1056%2FNEJMra1413919&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra1413919%26sid%3Dliteratum%253Aachs%26aulast%3DHorsburgh%26aufirst%3DC.%2BR.%26aulast%3DBarry%26aufirst%3DC.%2BE.%26aulast%3DLange%26aufirst%3DC.%26atitle%3DTreatment%2520of%2520Tuberculosis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2015%26volume%3D373%26spage%3D2149%26epage%3D2160%26doi%3D10.1056%2FNEJMra1413919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Fox, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menzies, D.</span><span> </span><span class="NLM_article-title">A Review of the Evidence for Using Bedaquiline (TMC207) to Treat Multi-Drug Resistant Tuberculosis</span> <span class="citation_source-journal">Infect. Dis. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">144</span><span class="refDoi"> DOI: 10.1007/s40121-013-0009-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=10.1007%2Fs40121-013-0009-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=25134476" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A280%3ADC%252BC2M%252FjtV2rtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2013&pages=123-144&author=G.+J.+Foxauthor=D.+Menzies&title=A+Review+of+the+Evidence+for+Using+Bedaquiline+%28TMC207%29+to+Treat+Multi-Drug+Resistant+Tuberculosis&doi=10.1007%2Fs40121-013-0009-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">A Review of the Evidence for Using Bedaquiline (TMC207) to Treat Multi-Drug Resistant Tuberculosis</span></div><div class="casAuthors">Fox Gregory J; Menzies Dick</div><div class="citationInfo"><span class="NLM_cas:title">Infectious diseases and therapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">123-44</span>
        ISSN:<span class="NLM_cas:issn">2193-8229</span>.
    </div><div class="casAbstract">Existing therapies for multi-drug resistant tuberculosis (MDR-TB) have substantial limitations, in terms of their effectiveness, side-effect profile, and complexity of administration.  Bedaquiline is a novel diarylquinoline antibiotic that has recently been investigated as an adjunct to existing therapies for MDR-TB.  Currently, limited clinical data are available to evaluate the drug's safety and effectiveness.  In two small randomized-controlled clinical studies, bedaquiline given for 8 or 24 weeks has been shown to improve surrogate microbiological markers of treatment response, but trials have not yet evaluated its impact on clinical failure and relapse.  Safety concerns include an increased mortality in the bedaquiline arm of one study, an increased incidence of QT segment prolongation on electrocardiogram, and hepatotoxicity.  Until further research data are available, the use of bedaquiline should be confined to settings where carefully selected patients can be closely monitored.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTlWFOQsVg1oaNc3HjJRoFAfW6udTcc2ebRuZlwQkLH2Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M%252FjtV2rtg%253D%253D&md5=0cd964c385e6bc327878d5c5203b3f06</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1007%2Fs40121-013-0009-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40121-013-0009-3%26sid%3Dliteratum%253Aachs%26aulast%3DFox%26aufirst%3DG.%2BJ.%26aulast%3DMenzies%26aufirst%3DD.%26atitle%3DA%2520Review%2520of%2520the%2520Evidence%2520for%2520Using%2520Bedaquiline%2520%2528TMC207%2529%2520to%2520Treat%2520Multi-Drug%2520Resistant%2520Tuberculosis%26jtitle%3DInfect.%2520Dis.%2520Ther.%26date%3D2013%26volume%3D2%26spage%3D123%26epage%3D144%26doi%3D10.1007%2Fs40121-013-0009-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Manjunatha, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. W.</span><span> </span><span class="NLM_article-title">Perspective: Challenges and Opportunities in TB Drug Discovery from Phenotypic Screening</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">5087</span><span class="NLM_x">–</span> <span class="NLM_lpage">5097</span><span class="refDoi"> DOI: 10.1016/j.bmc.2014.12.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=10.1016%2Fj.bmc.2014.12.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=25577708" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BC2MXltVamtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=5087-5097&author=U.+H.+Manjunathaauthor=P.+W.+Smith&title=Perspective%3A+Challenges+and+Opportunities+in+TB+Drug+Discovery+from+Phenotypic+Screening&doi=10.1016%2Fj.bmc.2014.12.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Perspective: Challenges and opportunities in TB drug discovery from phenotypic screening</span></div><div class="casAuthors">Manjunatha, Ujjini H.; Smith, Paul W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5087-5097</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Tuberculosis poses a major global health problem and multi-drug resistant strains are increasingly prevalent.  Hence there is an urgent need to discover new TB drugs.  Cell based phenotypic screening represents a powerful approach to identify anti-mycobacterial compds. and elucidate novel targets.  Three high throughput phenotypic screens were performed at NITD against mycobacterium.  Hits were identified and chem. series selected for optimization.  This produced compds. with good in vitro anti-mycobacterial activity and pharmacokinetic properties.  Some compds. displayed oral activity in mouse efficacy models of TB.  Herein, the authors review the TB discovery efforts at NITD and share experiences in optimization of phenotypic hits, describing challenges encountered and lessons learned.  The authors also offer perspectives to facilitate future selection and advancement of phenotypic hits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGbroyRLtEcrVg90H21EOLACvtfcHk0lgKV5bf5Zv9cA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXltVamtg%253D%253D&md5=8d03c078275a58fa6629eaa9f36a5073</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.12.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.12.031%26sid%3Dliteratum%253Aachs%26aulast%3DManjunatha%26aufirst%3DU.%2BH.%26aulast%3DSmith%26aufirst%3DP.%2BW.%26atitle%3DPerspective%253A%2520Challenges%2520and%2520Opportunities%2520in%2520TB%2520Drug%2520Discovery%2520from%2520Phenotypic%2520Screening%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D5087%26epage%3D5097%26doi%3D10.1016%2Fj.bmc.2014.12.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Kana, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karakousis, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parish, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dick, T.</span><span> </span><span class="NLM_article-title">Future Target-Based Drug Discovery for Tuberculosis?</span> <span class="citation_source-journal">Tuberculosis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">551</span><span class="NLM_x">–</span> <span class="NLM_lpage">556</span><span class="refDoi"> DOI: 10.1016/j.tube.2014.10.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=10.1016%2Fj.tube.2014.10.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=25458615" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVWitL%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2014&pages=551-556&author=B.+D.+Kanaauthor=P.+C.+Karakousisauthor=T.+Parishauthor=T.+Dick&title=Future+Target-Based+Drug+Discovery+for+Tuberculosis%3F&doi=10.1016%2Fj.tube.2014.10.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Future target-based drug discovery for tuberculosis?</span></div><div class="casAuthors">Kana, Bavesh Davandra; Karakousis, Petros C.; Parish, Tanya; Dick, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Tuberculosis (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">551-556</span>CODEN:
                <span class="NLM_cas:coden">TUBECU</span>;
        ISSN:<span class="NLM_cas:issn">1472-9792</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">New drugs that retain potency against multidrug/extensively drug-resistant strains of Mycobacterium tuberculosis, with the addnl. benefit of a shortened treatment duration and ease of administration, are urgently needed by tuberculosis (TB) control programs.  Efforts to develop this new generation of treatment interventions have been plagued with numerous problems, the most significant being our insufficient understanding of mycobacterial metab. during disease.  This, combined with limited chem. diversity and poor entry of small mols. into the cell, has limited the no. of new bioactive agents that result from drug screening efforts.  The biochem., target-driven approach to drug development has been largely abandoned in the TB field, to be replaced by whole-cell or target-based whole-cell screening approaches.  In this context, the properties of a good drug target are unclear, since these are directly detd. by the ability to find compds., using current screening algorithms, which are able to kill M. tuberculosis.  In this review, we discuss issues related to the identification and validation of drug targets and highlight some key properties for promising targets.  Some of these include essentiality for growth, vulnerability, druggability, reduced propensity to evolve drug resistance and target location to facilitate ready access to drugs during chemotherapy.  We present these in the context of recent drugs that have emerged through various approaches with the aim of consolidating the knowledge gained from these experiences to inform future efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwa9Dp4ihtM7Vg90H21EOLACvtfcHk0licgSPYUUxw7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVWitL%252FE&md5=c0489ca8150d64b78842ee8edaa94bf1</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.tube.2014.10.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tube.2014.10.003%26sid%3Dliteratum%253Aachs%26aulast%3DKana%26aufirst%3DB.%2BD.%26aulast%3DKarakousis%26aufirst%3DP.%2BC.%26aulast%3DParish%26aufirst%3DT.%26aulast%3DDick%26aufirst%3DT.%26atitle%3DFuture%2520Target-Based%2520Drug%2520Discovery%2520for%2520Tuberculosis%253F%26jtitle%3DTuberculosis%26date%3D2014%26volume%3D94%26spage%3D551%26epage%3D556%26doi%3D10.1016%2Fj.tube.2014.10.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Evans, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trujillo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eoh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehrt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnappinger, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boshoff, H. I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhee, K. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barry, C. E.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizrahi, V.</span><span> </span><span class="NLM_article-title">Validation of CoaBC as a Bactericidal Target in the Coenzyme A Pathway of Mycobacterium Tuberculosis</span> <span class="citation_source-journal">ACS Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">958</span><span class="NLM_x">–</span> <span class="NLM_lpage">968</span><span class="refDoi"> DOI: 10.1021/acsinfecdis.6b00150</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.6b00150" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFOntrrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2016&pages=958-968&author=J.+C.+Evansauthor=C.+Trujilloauthor=Z.+Wangauthor=H.+Eohauthor=S.+Ehrtauthor=D.+Schnappingerauthor=H.+I.+M.+Boshoffauthor=K.+Y.+Rheeauthor=C.+E.+Barryauthor=V.+Mizrahi&title=Validation+of+CoaBC+as+a+Bactericidal+Target+in+the+Coenzyme+A+Pathway+of+Mycobacterium+Tuberculosis&doi=10.1021%2Facsinfecdis.6b00150"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Validation of CoaBC as a Bactericidal Target in the Coenzyme A Pathway of Mycobacterium tuberculosis</span></div><div class="casAuthors">Evans, Joanna C.; Trujillo, Carolina; Wang, Zhe; Eoh, Hyungjin; Ehrt, Sabine; Schnappinger, Dirk; Boshoff, Helena I. M.; Rhee, Kyu Y.; Barry, Clifton E.; Mizrahi, Valerie</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">958-968</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mycobacterium tuberculosis relies on its own ability to biosynthesize CoA in order to meet the needs of the myriad enzymic reactions that depend on this cofactor for activity.  As such, the essential pantothenate and CoA biosynthesis pathways have attracted attention as targets for tuberculosis drug development.  To identify the optimal step for CoA pathway disruption in M. tuberculosis, we constructed and characterized a panel of conditional knockdown mutants in CoA pathway genes.  Here, we report that silencing of coaBC was bactericidal in vitro whereas silencing of panB, panC or coaE was bacteriostatic over the same time course.  Silencing of coaBC was likewise bactericidal in vivo, whether initiated at infection, or during either the acute or chronic stages of infection, confirming that CoaBC is required for M. tuberculosis to grow and persist in mice, and arguing against significant CoaBC bypass via transport and assimilation of host-derived pantetheine in this animal model.  These results provide convincing genetic validation of CoaBC as a new bactericidal drug target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfN-82uCtflLVg90H21EOLACvtfcHk0licgSPYUUxw7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFOntrrE&md5=cf81d758a786257d7c3a9f43cda60ea4</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.6b00150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.6b00150%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DJ.%2BC.%26aulast%3DTrujillo%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DEoh%26aufirst%3DH.%26aulast%3DEhrt%26aufirst%3DS.%26aulast%3DSchnappinger%26aufirst%3DD.%26aulast%3DBoshoff%26aufirst%3DH.%2BI.%2BM.%26aulast%3DRhee%26aufirst%3DK.%2BY.%26aulast%3DBarry%26aufirst%3DC.%2BE.%26aulast%3DMizrahi%26aufirst%3DV.%26atitle%3DValidation%2520of%2520CoaBC%2520as%2520a%2520Bactericidal%2520Target%2520in%2520the%2520Coenzyme%2520A%2520Pathway%2520of%2520Mycobacterium%2520Tuberculosis%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2016%26volume%3D2%26spage%3D958%26epage%3D968%26doi%3D10.1021%2Facsinfecdis.6b00150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Pethe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bifani, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiricek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeon, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cechetto, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christophe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kempf, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenaerts, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pham, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seo, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seo, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yim, S.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nam, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, C.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chua, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nanjundappa, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, S. P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wintjens, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nehrbass, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">No, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, S.-N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nam, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span> </span><span class="NLM_article-title">Discovery of Q203, a Potent Clinical Candidate for the Treatment of Tuberculosis</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1157</span><span class="NLM_x">–</span> <span class="NLM_lpage">1160</span><span class="refDoi"> DOI: 10.1038/nm.3262</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=10.1038%2Fnm.3262" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=23913123" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1WhtrzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=1157-1160&author=K.+Petheauthor=P.+Bifaniauthor=J.+Jangauthor=S.+Kangauthor=S.+Parkauthor=S.+Ahnauthor=J.+Jiricekauthor=J.+Jungauthor=H.+K.+Jeonauthor=J.+Cechettoauthor=T.+Christopheauthor=H.+Leeauthor=M.+Kempfauthor=M.+Jacksonauthor=A.+J.+Lenaertsauthor=H.+Phamauthor=V.+Jonesauthor=M.+J.+Seoauthor=Y.+M.+Kimauthor=M.+Seoauthor=J.+J.+Seoauthor=D.+Parkauthor=Y.+Koauthor=I.+Choiauthor=R.+Kimauthor=S.+Y.+Kimauthor=S.+Limauthor=S.-A.+Yimauthor=J.+Namauthor=H.+Kangauthor=H.+Kwonauthor=C.-T.+Ohauthor=Y.+Choauthor=Y.+Jangauthor=J.+Kimauthor=A.+Chuaauthor=B.+H.+Tanauthor=M.+B.+Nanjundappaauthor=S.+P.+S.+Raoauthor=W.+S.+Barnesauthor=R.+Wintjensauthor=J.+R.+Walkerauthor=S.+Alonsoauthor=S.+Leeauthor=J.+Kimauthor=S.+Ohauthor=T.+Ohauthor=U.+Nehrbassauthor=S.-J.+Hanauthor=Z.+Noauthor=J.+Leeauthor=P.+Brodinauthor=S.-N.+Choauthor=K.+Namauthor=J.+Kim&title=Discovery+of+Q203%2C+a+Potent+Clinical+Candidate+for+the+Treatment+of+Tuberculosis&doi=10.1038%2Fnm.3262"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis</span></div><div class="casAuthors">Pethe, Kevin; Bifani, Pablo; Jang, Jichan; Kang, Sunhee; Park, Seijin; Ahn, Sujin; Jiricek, Jan; Jung, Juyoung; Jeon, Hee Kyoung; Cechetto, Jonathan; Christophe, Thierry; Lee, Honggun; Kempf, Marie; Jackson, Mary; Lenaerts, Anne J.; Pham, Ha; Jones, Victoria; Seo, Min Jung; Kim, Young Mi; Seo, Mooyoung; Seo, Jeong Jea; Park, Dongsik; Ko, Yoonae; Choi, Inhee; Kim, Ryangyeo; Kim, Se Yeon; Lim, Seung Bin; Yim, Seung-Ae; Nam, Jiyoun; Kang, Hwankyu; Kwon, Haejin; Oh, Chun-Taek; Cho, Yoojin; Jang, Yunhee; Kim, Junghwan; Chua, Adeline; Tan, Bee Huat; Nanjundappa, Mahesh B.; Rao, Srinivasa P. S.; Barnes, Whitney S.; Wintjens, Rene; Walker, John R.; Alonso, Sylvie; Lee, Saeyeon; Kim, Jungjun; Oh, Soohyun; Oh, Taegwon; Nehrbass, Ulf; Han, Sung-Jun; No, Zaesung; Lee, Jinhwa; Brodin, Priscille; Cho, Sang-Nae; Nam, Kiyean; Kim, Jaeseung</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1157-1160</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">New therapeutic strategies are needed to combat the tuberculosis pandemic and the spread of multidrug-resistant (MDR) and extensively drug-resistant (XDR) forms of the disease, which remain a serious public health challenge worldwide.  The most urgent clin. need is to discover potent agents capable of reducing the duration of MDR and XDR tuberculosis therapy with a success rate comparable to that of current therapies for drug-susceptible tuberculosis.  The last decade has seen the discovery of new agent classes for the management of tuberculosis, several of which are currently in clin. trials.  However, given the high attrition rate of drug candidates during clin. development and the emergence of drug resistance, the discovery of addnl. clin. candidates is clearly needed.  Here, we report on a promising class of imidazopyridine amide (IPA) compds. that block Mycobacterium tuberculosis growth by targeting the respiratory cytochrome bc1 complex.  The optimized IPA compd. Q203 inhibited the growth of MDR and XDR M. tuberculosis clin. isolates in culture broth medium in the low nanomolar range and was efficacious in a mouse model of tuberculosis at a dose less than 1 mg per kg body wt., which highlights the potency of this compd.  In addn., Q203 displays pharmacokinetic and safety profiles compatible with once-daily dosing.  Together, our data indicate that Q203 is a promising new clin. candidate for the treatment of tuberculosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqNkAj8BKYybVg90H21EOLACvtfcHk0liImqRYId0u0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1WhtrzK&md5=b865009db53f5b4bc15948ded64ef064</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnm.3262&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3262%26sid%3Dliteratum%253Aachs%26aulast%3DPethe%26aufirst%3DK.%26aulast%3DBifani%26aufirst%3DP.%26aulast%3DJang%26aufirst%3DJ.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DPark%26aufirst%3DS.%26aulast%3DAhn%26aufirst%3DS.%26aulast%3DJiricek%26aufirst%3DJ.%26aulast%3DJung%26aufirst%3DJ.%26aulast%3DJeon%26aufirst%3DH.%2BK.%26aulast%3DCechetto%26aufirst%3DJ.%26aulast%3DChristophe%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DKempf%26aufirst%3DM.%26aulast%3DJackson%26aufirst%3DM.%26aulast%3DLenaerts%26aufirst%3DA.%2BJ.%26aulast%3DPham%26aufirst%3DH.%26aulast%3DJones%26aufirst%3DV.%26aulast%3DSeo%26aufirst%3DM.%2BJ.%26aulast%3DKim%26aufirst%3DY.%2BM.%26aulast%3DSeo%26aufirst%3DM.%26aulast%3DSeo%26aufirst%3DJ.%2BJ.%26aulast%3DPark%26aufirst%3DD.%26aulast%3DKo%26aufirst%3DY.%26aulast%3DChoi%26aufirst%3DI.%26aulast%3DKim%26aufirst%3DR.%26aulast%3DKim%26aufirst%3DS.%2BY.%26aulast%3DLim%26aufirst%3DS.%26aulast%3DYim%26aufirst%3DS.-A.%26aulast%3DNam%26aufirst%3DJ.%26aulast%3DKang%26aufirst%3DH.%26aulast%3DKwon%26aufirst%3DH.%26aulast%3DOh%26aufirst%3DC.-T.%26aulast%3DCho%26aufirst%3DY.%26aulast%3DJang%26aufirst%3DY.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DChua%26aufirst%3DA.%26aulast%3DTan%26aufirst%3DB.%2BH.%26aulast%3DNanjundappa%26aufirst%3DM.%2BB.%26aulast%3DRao%26aufirst%3DS.%2BP.%2BS.%26aulast%3DBarnes%26aufirst%3DW.%2BS.%26aulast%3DWintjens%26aufirst%3DR.%26aulast%3DWalker%26aufirst%3DJ.%2BR.%26aulast%3DAlonso%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DOh%26aufirst%3DS.%26aulast%3DOh%26aufirst%3DT.%26aulast%3DNehrbass%26aufirst%3DU.%26aulast%3DHan%26aufirst%3DS.-J.%26aulast%3DNo%26aufirst%3DZ.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DBrodin%26aufirst%3DP.%26aulast%3DCho%26aufirst%3DS.-N.%26aulast%3DNam%26aufirst%3DK.%26aulast%3DKim%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520Q203%252C%2520a%2520Potent%2520Clinical%2520Candidate%2520for%2520the%2520Treatment%2520of%2520Tuberculosis%26jtitle%3DNat.%2520Med.%26date%3D2013%26volume%3D19%26spage%3D1157%26epage%3D1160%26doi%3D10.1038%2Fnm.3262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Sacksteder, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Protopopova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barry, C. E.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andries, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nacy, C. A.</span><span> </span><span class="NLM_article-title">Discovery and Development of SQ109: A New Antitubercular Drug with a Novel Mechanism of Action</span> <span class="citation_source-journal">Future Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">823</span><span class="NLM_x">–</span> <span class="NLM_lpage">837</span><span class="refDoi"> DOI: 10.2217/fmb.12.56</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=10.2217%2Ffmb.12.56" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=22827305" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtV2isLbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=823-837&author=K.+A.+Sackstederauthor=M.+Protopopovaauthor=C.+E.+Barryauthor=K.+Andriesauthor=C.+A.+Nacy&title=Discovery+and+Development+of+SQ109%3A+A+New+Antitubercular+Drug+with+a+Novel+Mechanism+of+Action&doi=10.2217%2Ffmb.12.56"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and development of SQ109: a new antitubercular drug with a novel mechanism of action</span></div><div class="casAuthors">Sacksteder, Katherine A.; Protopopova, Marina; Barry, Clifton E.; Andries, Koen; Nacy, Carol A.</div><div class="citationInfo"><span class="NLM_cas:title">Future Microbiology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">823-837</span>CODEN:
                <span class="NLM_cas:coden">FMUIAR</span>;
        ISSN:<span class="NLM_cas:issn">1746-0913</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">A review.  Existing drugs have limited efficacy against the rising threat of drug-resistant TB, have significant side effects, and must be given in combinations of four to six drugs for at least 6 mo for drug-sensitive TB and up to 24 mo for drug-resistant TB.  The long treatment duration has led to increased patient noncompliance with therapy.  This, in turn, drives the development of addnl. drug resistance in a spiral that has resulted in some forms of TB being currently untreatable by existing drugs.  New antitubercular drugs in development, particularly those with mechanisms of action that are different from existing first- and second-line TB drugs, are anticipated to be effective against both drug-sensitive and drug-resistant TB.  SQ109 is a new TB drug candidate with a novel mechanism of action that was safe and well tolerated in Phase I and early Phase II clin. trials.  We describe herein the identification, development and characterization of SQ109 as a promising new antitubercular drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrm7rdJnt1LOrVg90H21EOLACvtfcHk0liImqRYId0u0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtV2isLbM&md5=c4aaa50d56d54573e6bef6b514c38753</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2217%2Ffmb.12.56&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Ffmb.12.56%26sid%3Dliteratum%253Aachs%26aulast%3DSacksteder%26aufirst%3DK.%2BA.%26aulast%3DProtopopova%26aufirst%3DM.%26aulast%3DBarry%26aufirst%3DC.%2BE.%26aulast%3DAndries%26aufirst%3DK.%26aulast%3DNacy%26aufirst%3DC.%2BA.%26atitle%3DDiscovery%2520and%2520Development%2520of%2520SQ109%253A%2520A%2520New%2520Antitubercular%2520Drug%2520with%2520a%2520Novel%2520Mechanism%2520of%2520Action%26jtitle%3DFuture%2520Microbiol.%26date%3D2012%26volume%3D7%26spage%3D823%26epage%3D837%26doi%3D10.2217%2Ffmb.12.56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Xu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meshcheryakov, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poce, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chng, S.-S.</span><span> </span><span class="NLM_article-title">MmpL3 Is the Flippase for Mycolic Acids in Mycobacteria</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">7993</span><span class="NLM_x">–</span> <span class="NLM_lpage">7998</span><span class="refDoi"> DOI: 10.1073/pnas.1700062114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=10.1073%2Fpnas.1700062114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=28698380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFCrtL7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2017&pages=7993-7998&author=Z.+Xuauthor=V.+A.+Meshcheryakovauthor=G.+Poceauthor=S.-S.+Chng&title=MmpL3+Is+the+Flippase+for+Mycolic+Acids+in+Mycobacteria&doi=10.1073%2Fpnas.1700062114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">MmpL3 is the flippase for mycolic acids in mycobacteria</span></div><div class="casAuthors">Xu, Zhujun; Meshcheryakov, Vladimir A.; Poce, Giovanna; Chng, Shu-Sin</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">7993-7998</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The defining feature of the mycobacterial outer membrane (OM) is the presence of mycolic acids (MAs), which, in part, render the bilayer extremely hydrophobic and impermeable to external insults, including many antibiotics.  Although the biosynthetic pathway of MAs is well studied, the mechanism(s) by which these lipids are transported across the cell envelope is(are) much less known.  Mycobacterial membrane protein Large 3 (MmpL3), an essential inner membrane (IM) protein, is implicated in MA transport, but its exact function has not been elucidated.  It is believed to be the cellular target of several antimycobacterial compds.; however, evidence for direct inhibition of MmpL3 activity is also lacking.  Here, we establish that MmpL3 is the MA flippase at the IM of mycobacteria and is the mol. target of BM212, a 1,5-diarylpyrrole compd.  We develop assays that selectively access mycolates on the surface of Mycobacterium smegmatis spheroplasts, allowing us to monitor flipping of MAs across the IM.  Using these assays, we establish the mechanism of action of BM212 as a potent MmpL3 inhibitor, and use it as a mol. probe to demonstrate the requirement for functional MmpL3 in the transport of MAs across the IM.  Finally, we show that BM212 binds MmpL3 directly and inhibits its activity.  Our work provides fundamental insights into OM biogenesis and MA transport in mycobacteria.  Furthermore, our assays serve as an important platform for accelerating the validation of small mols. that target MmpL3, and their development as future antituberculosis drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWxm4S6r1fJLVg90H21EOLACvtfcHk0liImqRYId0u0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFCrtL7O&md5=1c8a806ca2a1eaebefe7c1e6bf3bcab9</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1700062114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1700062114%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DMeshcheryakov%26aufirst%3DV.%2BA.%26aulast%3DPoce%26aufirst%3DG.%26aulast%3DChng%26aufirst%3DS.-S.%26atitle%3DMmpL3%2520Is%2520the%2520Flippase%2520for%2520Mycolic%2520Acids%2520in%2520Mycobacteria%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2017%26volume%3D114%26spage%3D7993%26epage%3D7998%26doi%3D10.1073%2Fpnas.1700062114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Makarov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lechartier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neres, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Sar, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raadsen, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartkoorn, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryabova, O. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vocat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decosterd, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Widmer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buclin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bitter, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andries, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pojer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyson, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, S. T.</span><span> </span><span class="NLM_article-title">Towards a New Combination Therapy for Tuberculosis with next Generation Benzothiazinones</span> <span class="citation_source-journal">EMBO Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">372</span><span class="NLM_x">–</span> <span class="NLM_lpage">383</span><span class="refDoi"> DOI: 10.1002/emmm.201303575</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=10.1002%2Femmm.201303575" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=24500695" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjvVyjtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=372-383&author=V.+Makarovauthor=B.+Lechartierauthor=M.+Zhangauthor=J.+Neresauthor=A.+M.+van+der+Sarauthor=S.+A.+Raadsenauthor=R.+C.+Hartkoornauthor=O.+B.+Ryabovaauthor=A.+Vocatauthor=L.+A.+Decosterdauthor=N.+Widmerauthor=T.+Buclinauthor=W.+Bitterauthor=K.+Andriesauthor=F.+Pojerauthor=P.+J.+Dysonauthor=S.+T.+Cole&title=Towards+a+New+Combination+Therapy+for+Tuberculosis+with+next+Generation+Benzothiazinones&doi=10.1002%2Femmm.201303575"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Towards a new combination therapy for tuberculosis with next generation benzothiazinones</span></div><div class="casAuthors">Makarov, Vadim; Lechartier, Benoit; Zhang, Ming; Neres, Joao; van der Sar, Astrid M.; Raadsen, Susanne A.; Hartkoorn, Ruben C.; Ryabova, Olga B.; Vocat, Anthony; Decosterd, Laurent A.; Widmer, Nicolas; Buclin, Thierry; Bitter, Wilbert; Andries, Koen; Pojer, Florence; Dyson, Paul J.; Cole, Stewart T.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">372-383</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The benzothiazinone lead compd., BTZ043, kills Mycobacterium tuberculosis by inhibiting the essential flavo-enzyme DprE1, decaprenylphosphoryl-beta-D-ribose 2-epimerase.  Here, we synthesized a new series of piperazine-contg. benzothiazinones (PBTZ) and show that, like BTZ043, the preclin. candidate PBTZ169 binds covalently to DprE1.  The crystal structure of the DprE1-PBTZ169 complex reveals formation of a semimercaptal adduct with Cys387 in the active site and explains the irreversible inactivation of the enzyme.  Compared to BTZ043, PBTZ169 has improved potency, safety and efficacy in zebrafish and mouse models of tuberculosis (TB).  When combined with other TB drugs, PBTZ169 showed additive activity against M. tuberculosis in vitro except with bedaquiline (BDQ) where synergy was obsd.  A new regimen comprising PBTZ169, BDQ and pyrazinamide was found to be more efficacious than the std. three drug treatment in a murine model of chronic disease.  PBTZ169 is thus an attractive drug candidate to treat TB in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_BD_M46wCiLVg90H21EOLACvtfcHk0lgXrhVYHtCxlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjvVyjtLw%253D&md5=5393e68ca6f35be17ae10a397b443907</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1002%2Femmm.201303575&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Femmm.201303575%26sid%3Dliteratum%253Aachs%26aulast%3DMakarov%26aufirst%3DV.%26aulast%3DLechartier%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DNeres%26aufirst%3DJ.%26aulast%3Dvan%2Bder%2BSar%26aufirst%3DA.%2BM.%26aulast%3DRaadsen%26aufirst%3DS.%2BA.%26aulast%3DHartkoorn%26aufirst%3DR.%2BC.%26aulast%3DRyabova%26aufirst%3DO.%2BB.%26aulast%3DVocat%26aufirst%3DA.%26aulast%3DDecosterd%26aufirst%3DL.%2BA.%26aulast%3DWidmer%26aufirst%3DN.%26aulast%3DBuclin%26aufirst%3DT.%26aulast%3DBitter%26aufirst%3DW.%26aulast%3DAndries%26aufirst%3DK.%26aulast%3DPojer%26aufirst%3DF.%26aulast%3DDyson%26aufirst%3DP.%2BJ.%26aulast%3DCole%26aufirst%3DS.%2BT.%26atitle%3DTowards%2520a%2520New%2520Combination%2520Therapy%2520for%2520Tuberculosis%2520with%2520next%2520Generation%2520Benzothiazinones%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2014%26volume%3D6%26spage%3D372%26epage%3D383%26doi%3D10.1002%2Femmm.201303575" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Shirude, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shandil, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosagrahara, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hameed, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinde, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bathula, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humnabadkar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panduga, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambady, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hegde, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whiteaker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLaughlin, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madhavapeddi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramachandran, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaur, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narayan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guptha, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Awasthy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narayan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahadevaswamy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vishwas, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahuja, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prabhakar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bharath, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kale, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramaiah, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choudhury, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sambandamurthy, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solapure, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyer, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narayanan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatterji, M.</span><span> </span><span class="NLM_article-title">Azaindoles: Noncovalent DprE1 Inhibitors from Scaffold Morphing Efforts, Kill Mycobacterium Tuberculosis and Are Efficacious in Vivo</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">9701</span><span class="NLM_x">–</span> <span class="NLM_lpage">9708</span><span class="refDoi"> DOI: 10.1021/jm401382v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401382v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslCku7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=9701-9708&author=P.+S.+Shirudeauthor=R.+Shandilauthor=C.+Sadlerauthor=M.+Naikauthor=V.+Hosagraharaauthor=S.+Hameedauthor=V.+Shindeauthor=C.+Bathulaauthor=V.+Humnabadkarauthor=N.+Kumarauthor=J.+Reddyauthor=V.+Pandugaauthor=S.+Sharmaauthor=A.+Ambadyauthor=N.+Hegdeauthor=J.+Whiteakerauthor=R.+E.+McLaughlinauthor=H.+Gardnerauthor=P.+Madhavapeddiauthor=V.+Ramachandranauthor=P.+Kaurauthor=A.+Narayanauthor=S.+Gupthaauthor=D.+Awasthyauthor=C.+Narayanauthor=J.+Mahadevaswamyauthor=K.+Vishwasauthor=V.+Ahujaauthor=A.+Srivastavaauthor=K.+Prabhakarauthor=S.+Bharathauthor=R.+Kaleauthor=M.+Ramaiahauthor=N.+R.+Choudhuryauthor=V.+K.+Sambandamurthyauthor=S.+Solapureauthor=P.+S.+Iyerauthor=S.+Narayananauthor=M.+Chatterji&title=Azaindoles%3A+Noncovalent+DprE1+Inhibitors+from+Scaffold+Morphing+Efforts%2C+Kill+Mycobacterium+Tuberculosis+and+Are+Efficacious+in+Vivo&doi=10.1021%2Fjm401382v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Azaindoles: Noncovalent DprE1 Inhibitors from Scaffold Morphing Efforts, Kill Mycobacterium tuberculosis and Are Efficacious in Vivo</span></div><div class="casAuthors">Shirude, Pravin S.; Shandil, Radha; Sadler, Claire; Naik, Maruti; Hosagrahara, Vinayak; Hameed, Shahul; Shinde, Vikas; Bathula, Chandramohan; Humnabadkar, Vaishali; Kumar, Naveen; Reddy, Jitendar; Panduga, Vijender; Sharma, Sreevalli; Ambady, Anisha; Hegde, Naina; Whiteaker, James; McLaughlin, Robert E.; Gardner, Humphrey; Madhavapeddi, Prashanti; Ramachandran, Vasanthi; Kaur, Parvinder; Narayan, Ashwini; Guptha, Supreeth; Awasthy, Disha; Narayan, Chandan; Mahadevaswamy, Jyothi; Vishwas, K. G.; Ahuja, Vijaykamal; Srivastava, Abhishek; Prabhakar, K. R.; Bharath, Sowmya; Kale, Ramesh; Ramaiah, Manjunatha; Choudhury, Nilanjana Roy; Sambandamurthy, Vasan K.; Solapure, Suresh; Iyer, Pravin S.; Narayanan, Shridhar; Chatterji, Monalisa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9701-9708</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report 1,4-azaindoles as a new inhibitor class that kills Mycobacterium tuberculosis in vitro and demonstrates efficacy in mouse tuberculosis models.  The series emerged from scaffold morphing efforts and was demonstrated to noncovalently inhibit decaprenylphosphoryl-β-d-ribose2'-epimerase (DprE1).  With "drug-like" properties and no expectation of pre-existing resistance in the clinic, this chem. class has the potential to be developed as a therapy for drug-sensitive and drug-resistant tuberculosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqskQvJK4M2yrVg90H21EOLACvtfcHk0lgXrhVYHtCxlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslCku7fM&md5=eba42d1952b164f66fd0ca620aaa4f19</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm401382v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401382v%26sid%3Dliteratum%253Aachs%26aulast%3DShirude%26aufirst%3DP.%2BS.%26aulast%3DShandil%26aufirst%3DR.%26aulast%3DSadler%26aufirst%3DC.%26aulast%3DNaik%26aufirst%3DM.%26aulast%3DHosagrahara%26aufirst%3DV.%26aulast%3DHameed%26aufirst%3DS.%26aulast%3DShinde%26aufirst%3DV.%26aulast%3DBathula%26aufirst%3DC.%26aulast%3DHumnabadkar%26aufirst%3DV.%26aulast%3DKumar%26aufirst%3DN.%26aulast%3DReddy%26aufirst%3DJ.%26aulast%3DPanduga%26aufirst%3DV.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DAmbady%26aufirst%3DA.%26aulast%3DHegde%26aufirst%3DN.%26aulast%3DWhiteaker%26aufirst%3DJ.%26aulast%3DMcLaughlin%26aufirst%3DR.%2BE.%26aulast%3DGardner%26aufirst%3DH.%26aulast%3DMadhavapeddi%26aufirst%3DP.%26aulast%3DRamachandran%26aufirst%3DV.%26aulast%3DKaur%26aufirst%3DP.%26aulast%3DNarayan%26aufirst%3DA.%26aulast%3DGuptha%26aufirst%3DS.%26aulast%3DAwasthy%26aufirst%3DD.%26aulast%3DNarayan%26aufirst%3DC.%26aulast%3DMahadevaswamy%26aufirst%3DJ.%26aulast%3DVishwas%26aufirst%3DK.%26aulast%3DAhuja%26aufirst%3DV.%26aulast%3DSrivastava%26aufirst%3DA.%26aulast%3DPrabhakar%26aufirst%3DK.%26aulast%3DBharath%26aufirst%3DS.%26aulast%3DKale%26aufirst%3DR.%26aulast%3DRamaiah%26aufirst%3DM.%26aulast%3DChoudhury%26aufirst%3DN.%2BR.%26aulast%3DSambandamurthy%26aufirst%3DV.%2BK.%26aulast%3DSolapure%26aufirst%3DS.%26aulast%3DIyer%26aufirst%3DP.%2BS.%26aulast%3DNarayanan%26aufirst%3DS.%26aulast%3DChatterji%26aufirst%3DM.%26atitle%3DAzaindoles%253A%2520Noncovalent%2520DprE1%2520Inhibitors%2520from%2520Scaffold%2520Morphing%2520Efforts%252C%2520Kill%2520Mycobacterium%2520Tuberculosis%2520and%2520Are%2520Efficacious%2520in%2520Vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D9701%26epage%3D9708%26doi%3D10.1021%2Fjm401382v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Chatterji, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shandil, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manjunatha, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solapure, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramachandran, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saralaya, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panduga, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">KR, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mdluli, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyer, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narayanan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirude, P. S.</span><span> </span><span class="NLM_article-title">1,4-Azaindole, A Potential Drug Candidate for Treatment of Tuberculosis</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">5325</span><span class="NLM_x">–</span> <span class="NLM_lpage">5331</span><span class="refDoi"> DOI: 10.1128/AAC.03233-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=10.1128%2FAAC.03233-14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=24957839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1eqsL7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2014&pages=5325-5331&author=M.+Chatterjiauthor=R.+Shandilauthor=M.+R.+Manjunathaauthor=S.+Solapureauthor=V.+Ramachandranauthor=N.+Kumarauthor=R.+Saralayaauthor=V.+Pandugaauthor=J.+Reddyauthor=P.+KRauthor=S.+Sharmaauthor=C.+Sadlerauthor=C.+B.+Cooperauthor=K.+Mdluliauthor=P.+S.+Iyerauthor=S.+Narayananauthor=P.+S.+Shirude&title=1%2C4-Azaindole%2C+A+Potential+Drug+Candidate+for+Treatment+of+Tuberculosis&doi=10.1128%2FAAC.03233-14"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">1,4-azaindole, a potential drug candidate for treatment of tuberculosis</span></div><div class="casAuthors">Chatterji, Monalisa; Shandil, Radha; Manjunatha, M. R.; Solapure, Suresh; Ramachandran, Vasanthi; Kumar, Naveen; Saralaya, Ramanatha; Panduga, Vijender; Reddy, Jitendar; Prabhakar, K. R.; Sharma, Sreevalli; Sadler, Claire; Cooper, Christopher B.; Mdluli, Khisi; Iyer, Pravin S.; Narayanan, Shridhar; Shirude, Pravin S.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">5325-5331, 8 pp.</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">New therapeutic strategies against multidrug-resistant (MDR) and extensively drug-resistant (XDR) Mycobacterium tuberculosis are urgently required to combat the global tuberculosis (TB) threat.  Toward this end, we previously reported the identification of 1,4-azaindoles, a promising class of compds. with potent antitubercular activity through noncovalent inhibition of decaprenylphosphoryl-β-d-ribose 2'-epimerase (DprE1).  Further, this series was optimized to improve its physicochem. properties and pharmacokinetics in mice.  Here, we describe the short-listing of a potential clin. candidate, compd. 2, that has potent cellular activity, drug-like properties, efficacy in mouse and rat chronic TB infection models, and minimal in vitro safety risks.  We also demonstrate that the compds., including compd. 2, have no antagonistic activity with other anti-TB drugs.  Moreover, compd. 2 shows synergy with PA824 and TMC207 in vitro, and the synergy effect is translated in vivo with TMC207.  The series is predicted to have a low clearance in humans, and the predicted human dose for compd. 2 is ≤ 1 g/day.  Altogether, our data suggest that a 1,4-azaindole (compd. 2) is a promising candidate for the development of a novel anti-TB drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrW_tEuW_mDx7Vg90H21EOLACvtfcHk0lhC1jHl_-WrSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1eqsL7N&md5=992bbd235d99bb1f8f05612966f76bc9</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1128%2FAAC.03233-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.03233-14%26sid%3Dliteratum%253Aachs%26aulast%3DChatterji%26aufirst%3DM.%26aulast%3DShandil%26aufirst%3DR.%26aulast%3DManjunatha%26aufirst%3DM.%2BR.%26aulast%3DSolapure%26aufirst%3DS.%26aulast%3DRamachandran%26aufirst%3DV.%26aulast%3DKumar%26aufirst%3DN.%26aulast%3DSaralaya%26aufirst%3DR.%26aulast%3DPanduga%26aufirst%3DV.%26aulast%3DReddy%26aufirst%3DJ.%26aulast%3DKR%26aufirst%3DP.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DSadler%26aufirst%3DC.%26aulast%3DCooper%26aufirst%3DC.%2BB.%26aulast%3DMdluli%26aufirst%3DK.%26aulast%3DIyer%26aufirst%3DP.%2BS.%26aulast%3DNarayanan%26aufirst%3DS.%26aulast%3DShirude%26aufirst%3DP.%2BS.%26atitle%3D1%252C4-Azaindole%252C%2520A%2520Potential%2520Drug%2520Candidate%2520for%2520Treatment%2520of%2520Tuberculosis%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2014%26volume%3D58%26spage%3D5325%26epage%3D5331%26doi%3D10.1128%2FAAC.03233-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Harris, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheppard, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slater, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stouten, P. F. W.</span><span> </span><span class="NLM_article-title">The Design and Application of Target-Focused Compound Libraries</span> <span class="citation_source-journal">Comb. Chem. High Throughput Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">521</span><span class="NLM_x">–</span> <span class="NLM_lpage">531</span><span class="refDoi"> DOI: 10.2174/138620711795767802</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=10.2174%2F138620711795767802" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=21521154" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnvVSmu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2011&pages=521-531&author=J.+C.+Harrisauthor=R.+D.+Hillauthor=D.+W.+Sheppardauthor=M.+J.+Slaterauthor=P.+F.+W.+Stouten&title=The+Design+and+Application+of+Target-Focused+Compound+Libraries&doi=10.2174%2F138620711795767802"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The design and application of target-focused compound libraries</span></div><div class="casAuthors">Harris, C. John; Hill, Richard D.; Sheppard, David W.; Slater, Martin J.; Stouten, Pieter F. W.</div><div class="citationInfo"><span class="NLM_cas:title">Combinatorial Chemistry & High Throughput Screening</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">521-531</span>CODEN:
                <span class="NLM_cas:coden">CCHSFU</span>;
        ISSN:<span class="NLM_cas:issn">1386-2073</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Target-focused compd. libraries are collections of compds. which are designed to interact with an individual protein target or, frequently, a family of related targets (such as kinases, voltage-gated ion channels, serine/cysteine proteases).  They are used for screening against therapeutic targets in order to find hit compds. that might be further developed into drugs.  The design of such libraries generally utilizes structural information about the target or family of interest.  In the absence of such structural information, a chemogenomic model that incorporates sequence and mutagenesis data to predict the properties of the binding site can be employed.  A third option, usually pursued when no structural data are available, utilizes knowledge of the ligands of the target from' which focused libraries can be developed via scaffold hopping.  Consequently, the methods used for the design of target-focused libraries vary according to the quantity and quality of structural or ligand data that is available for each target family.  This article describes examples of each of these design approaches and illustrates them with case studies, which highlight some of the issues and successes obsd. when screening target-focused libraries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKS2t0qb2xBbVg90H21EOLACvtfcHk0lhC1jHl_-WrSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnvVSmu70%253D&md5=9070e45f5b842fccfee38c15e6cb6127</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.2174%2F138620711795767802&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138620711795767802%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DJ.%2BC.%26aulast%3DHill%26aufirst%3DR.%2BD.%26aulast%3DSheppard%26aufirst%3DD.%2BW.%26aulast%3DSlater%26aufirst%3DM.%2BJ.%26aulast%3DStouten%26aufirst%3DP.%2BF.%2BW.%26atitle%3DThe%2520Design%2520and%2520Application%2520of%2520Target-Focused%2520Compound%2520Libraries%26jtitle%3DComb.%2520Chem.%2520High%2520Throughput%2520Screening%26date%3D2011%26volume%3D14%26spage%3D521%26epage%3D531%26doi%3D10.2174%2F138620711795767802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Lechartier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rybniker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zumla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, S. T.</span><span> </span><span class="NLM_article-title">Tuberculosis Drug Discovery in the Post-Post-Genomic Era</span> <span class="citation_source-journal">EMBO Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">158</span><span class="NLM_x">–</span> <span class="NLM_lpage">168</span><span class="refDoi"> DOI: 10.1002/emmm.201201772</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=10.1002%2Femmm.201201772" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=24401837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFWktb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=158-168&author=B.+Lechartierauthor=J.+Rybnikerauthor=A.+Zumlaauthor=S.+T.+Cole&title=Tuberculosis+Drug+Discovery+in+the+Post-Post-Genomic+Era&doi=10.1002%2Femmm.201201772"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Tuberculosis drug discovery in the post-post-genomic era</span></div><div class="casAuthors">Lechartier, Benoit; Rybniker, Jan; Zumla, Alimuddin; Cole, Stewart T.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">158-168</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The expectation that genomics would result in new therapeutic interventions for infectious diseases remains unfulfilled.  In the post-genomic era, the decade immediately following the availability of the genome sequence of Mycobacterium tuberculosis, tuberculosis (TB) drug discovery relied heavily on the target-based approach but this proved unsuccessful leading to a return to whole cell screening.  Genomics underpinned screening by providing knowledge and many enabling technologies, most importantly whole genome resequencing to find resistance mutations and targets, and this resulted in a selection of leads and new TB drug candidates that are reviewed here.  Unexpectedly, many new targets were found to be 'promiscuous' as they were inhibited by a variety of different compds.  In the post-post-genomics era, more advanced technologies have been implemented and these include high-content screening, screening for inhibitors of latency, the use of conditional knock-down mutants for validated targets and siRNA screens.  In addn., immunomodulation and pharmacol. manipulation of host functions are being explored in an attempt to widen our therapeutic options.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwFEZdeRp7hLVg90H21EOLACvtfcHk0lgf33jvKBiNVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFWktb4%253D&md5=7db5bd8d9e76b1d69df6966fb75a9712</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Femmm.201201772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Femmm.201201772%26sid%3Dliteratum%253Aachs%26aulast%3DLechartier%26aufirst%3DB.%26aulast%3DRybniker%26aufirst%3DJ.%26aulast%3DZumla%26aufirst%3DA.%26aulast%3DCole%26aufirst%3DS.%2BT.%26atitle%3DTuberculosis%2520Drug%2520Discovery%2520in%2520the%2520Post-Post-Genomic%2520Era%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2014%26volume%3D6%26spage%3D158%26epage%3D168%26doi%3D10.1002%2Femmm.201201772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Hoagland, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, R. E.</span><span> </span><span class="NLM_article-title">New Agents for the Treatment of Drug-Resistant Mycobacterium Tuberculosis</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">55</span><span class="NLM_x">–</span> <span class="NLM_lpage">72</span><span class="refDoi"> DOI: 10.1016/j.addr.2016.04.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=10.1016%2Fj.addr.2016.04.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=27151308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BC28XntlSns7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2016&pages=55-72&author=D.+T.+Hoaglandauthor=J.+Liuauthor=R.+B.+Leeauthor=R.+E.+Lee&title=New+Agents+for+the+Treatment+of+Drug-Resistant+Mycobacterium+Tuberculosis&doi=10.1016%2Fj.addr.2016.04.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">New agents for the treatment of drug-resistant Mycobacterium tuberculosis</span></div><div class="casAuthors">Hoagland, Daniel T.; Liu, Jiuyu; Lee, Robin B.; Lee, Richard E.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">55-72</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Inadequate dosing and incomplete treatment regimens, coupled with the ability of the tuberculosis bacilli to cause latent infections that are tolerant of currently used drugs, have fueled the rise of multidrug-resistant tuberculosis (MDR-TB).  Treatment of MDR-TB infections is a major clin. challenge that has few viable or effective solns.; therefore patients face a poor prognosis and years of treatment.  This review focuses on emerging drug classes that have the potential for treating MDR-TB and highlights their particular strengths as leads including their mode of action, in vivo efficacy, and key medicinal chem. properties.  Examples include the newly approved drugs bedaquiline and delaminid, and other agents in clin. and late preclin. development pipeline for the treatment of MDR-TB.  Herein, we discuss the challenges to developing drugs to treat tuberculosis and how the field has adapted to these difficulties, with an emphasis on drug discovery approaches that might produce more effective agents and treatment regimens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBEswjNcHj27Vg90H21EOLACvtfcHk0lgf33jvKBiNVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XntlSns7c%253D&md5=7c8ca15b9b493cceaf3d51d93b9afcec</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2016.04.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2016.04.026%26sid%3Dliteratum%253Aachs%26aulast%3DHoagland%26aufirst%3DD.%2BT.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DR.%2BB.%26aulast%3DLee%26aufirst%3DR.%2BE.%26atitle%3DNew%2520Agents%2520for%2520the%2520Treatment%2520of%2520Drug-Resistant%2520Mycobacterium%2520Tuberculosis%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2016%26volume%3D102%26spage%3D55%26epage%3D72%26doi%3D10.1016%2Fj.addr.2016.04.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Soares de Melo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, T.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Der Westhuyzen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessner, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Street, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgans, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warner, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moosa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naran, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boshoff, H. I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barry, C. E.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chibale, K.</span><span> </span><span class="NLM_article-title">Aminopyrazolo[1,5-A]pyrimidines as Potential Inhibitors of Mycobacterium Tuberculosis: Structure Activity Relationships and ADME Characterization</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">7240</span><span class="NLM_x">–</span> <span class="NLM_lpage">7250</span><span class="refDoi"> DOI: 10.1016/j.bmc.2015.10.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=10.1016%2Fj.bmc.2015.10.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=26522089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslent7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=7240-7250&author=C.+Soares+de+Meloauthor=T.-S.+Fengauthor=R.+van+Der+Westhuyzenauthor=R.+K.+Gessnerauthor=L.+J.+Streetauthor=G.+L.+Morgansauthor=D.+F.+Warnerauthor=A.+Moosaauthor=K.+Naranauthor=N.+Lawrenceauthor=H.+I.+M.+Boshoffauthor=C.+E.+Barryauthor=C.+J.+Harrisauthor=R.+Gordonauthor=K.+Chibale&title=Aminopyrazolo%5B1%2C5-A%5Dpyrimidines+as+Potential+Inhibitors+of+Mycobacterium+Tuberculosis%3A+Structure+Activity+Relationships+and+ADME+Characterization&doi=10.1016%2Fj.bmc.2015.10.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Aminopyrazolo[1,5-a]pyrimidines as potential inhibitors of Mycobacterium tuberculosis: Structure activity relationships and ADME characterization</span></div><div class="casAuthors">Soares de Melo, Candice; Feng, Tzu-Shean; van der Westhuyzen, Renier; Gessner, Richard K.; Street, Leslie J.; Morgans, Garreth L.; Warner, Digby F.; Moosa, Atica; Naran, Krupa; Lawrence, Nina; Boshoff, Helena I. M.; Barry, Clifton E., III; Harris, C. John; Gordon, Richard; Chibale, Kelly</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7240-7250</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Whole-cell high-throughput screening of a diverse SoftFocus library against Mycobacterium tuberculosis (Mtb) generated a novel aminopyrazolo[1,5-a]pyrimidine hit series.  The synthesis and structure activity relationship studies identified compds. with potent antimycobacterial activity.  The SAR of over 140 compds. shows that the 2-pyridylmethylamine moiety at the C-7 position of the pyrazolopyrimidine scaffold was important for Mtb activity, whereas the C-3 position offered a higher degree of flexibility.  The series was also profiled for in vitro cytotoxicity and microsomal metabolic stability as well as physicochem. properties.  Consequently liabilities to be addressed in a future lead optimization campaign have been identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTbOBTZI7RdrVg90H21EOLACvtfcHk0lgf33jvKBiNVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslent7zL&md5=29c1f665f7c8e2039e9ae1c9d9aa2d1e</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.10.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.10.021%26sid%3Dliteratum%253Aachs%26aulast%3DSoares%2Bde%2BMelo%26aufirst%3DC.%26aulast%3DFeng%26aufirst%3DT.-S.%26aulast%3Dvan%2BDer%2BWesthuyzen%26aufirst%3DR.%26aulast%3DGessner%26aufirst%3DR.%2BK.%26aulast%3DStreet%26aufirst%3DL.%2BJ.%26aulast%3DMorgans%26aufirst%3DG.%2BL.%26aulast%3DWarner%26aufirst%3DD.%2BF.%26aulast%3DMoosa%26aufirst%3DA.%26aulast%3DNaran%26aufirst%3DK.%26aulast%3DLawrence%26aufirst%3DN.%26aulast%3DBoshoff%26aufirst%3DH.%2BI.%2BM.%26aulast%3DBarry%26aufirst%3DC.%2BE.%26aulast%3DHarris%26aufirst%3DC.%2BJ.%26aulast%3DGordon%26aufirst%3DR.%26aulast%3DChibale%26aufirst%3DK.%26atitle%3DAminopyrazolo%255B1%252C5-A%255Dpyrimidines%2520as%2520Potential%2520Inhibitors%2520of%2520Mycobacterium%2520Tuberculosis%253A%2520Structure%2520Activity%2520Relationships%2520and%2520ADME%2520Characterization%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D7240%26epage%3D7250%26doi%3D10.1016%2Fj.bmc.2015.10.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Arora, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochoa-Montano, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsang, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blundell, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawes, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizrahi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayliss, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackenzie, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleghorn, L. A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyatt, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uh, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barry, C. E.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boshoff, H. I.</span><span> </span><span class="NLM_article-title">Respiratory Flexibility in Response to Inhibition of Cytochrome C Oxidase in Mycobacterium Tuberculosis</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">6962</span><span class="NLM_x">–</span> <span class="NLM_lpage">6965</span><span class="refDoi"> DOI: 10.1128/AAC.03486-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=10.1128%2FAAC.03486-14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=25155596" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVGjsr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2014&pages=6962-6965&author=K.+Aroraauthor=B.+Ochoa-Montanoauthor=P.+S.+Tsangauthor=T.+L.+Blundellauthor=S.+S.+Dawesauthor=V.+Mizrahiauthor=T.+Baylissauthor=C.+J.+Mackenzieauthor=L.+A.+T.+Cleghornauthor=P.+C.+Rayauthor=P.+G.+Wyattauthor=E.+Uhauthor=J.+Leeauthor=C.+E.+Barryauthor=H.+I.+Boshoff&title=Respiratory+Flexibility+in+Response+to+Inhibition+of+Cytochrome+C+Oxidase+in+Mycobacterium+Tuberculosis&doi=10.1128%2FAAC.03486-14"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Respiratory flexibility in response to inhibition of cytochrome c oxidase in Mycobacterium tuberculosis</span></div><div class="casAuthors">Arora, Kriti; Ochoa-Montano, Bernardo; Tsang, Patricia S.; Blundell, Tom L.; Dawes, Stephanie S.; Mizrahi, Valerie; Bayliss, Tracy; MacKenzie, Claire J.; Cleghorn, Laura A. T.; Ray, Peter C.; Wyatt, Paul G.; Uh, Eugene; Lee, Jinwoo; Barry, Clifton E.; Boshoff, Helena I.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">6962-6965, 5 pp.</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">We report here a series of five chem. diverse scaffolds that have in vitro activities on replicating and hypoxic nonreplicating bacilli by targeting the respiratory bc1 complex in Mycobacterium tuberculosis in a strain-dependent manner.  Deletion of the cytochrome bd oxidase generated a hypersusceptible mutant in which resistance was acquired by a mutation in qcrB.  These results highlight the promiscuity of the bc1 complex and the risk of targeting energy metab. with new drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwNeXOHcpwObVg90H21EOLACvtfcHk0lhEkTIwrpiH2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVGjsr7I&md5=0d9c0195533460bedb0b8e06b66508ef</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1128%2FAAC.03486-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.03486-14%26sid%3Dliteratum%253Aachs%26aulast%3DArora%26aufirst%3DK.%26aulast%3DOchoa-Montano%26aufirst%3DB.%26aulast%3DTsang%26aufirst%3DP.%2BS.%26aulast%3DBlundell%26aufirst%3DT.%2BL.%26aulast%3DDawes%26aufirst%3DS.%2BS.%26aulast%3DMizrahi%26aufirst%3DV.%26aulast%3DBayliss%26aufirst%3DT.%26aulast%3DMackenzie%26aufirst%3DC.%2BJ.%26aulast%3DCleghorn%26aufirst%3DL.%2BA.%2BT.%26aulast%3DRay%26aufirst%3DP.%2BC.%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26aulast%3DUh%26aufirst%3DE.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DBarry%26aufirst%3DC.%2BE.%26aulast%3DBoshoff%26aufirst%3DH.%2BI.%26atitle%3DRespiratory%2520Flexibility%2520in%2520Response%2520to%2520Inhibition%2520of%2520Cytochrome%2520C%2520Oxidase%2520in%2520Mycobacterium%2520Tuberculosis%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2014%26volume%3D58%26spage%3D6962%26epage%3D6965%26doi%3D10.1128%2FAAC.03486-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Moosa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamprecht, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arora, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barry, C. E.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boshoff, H. I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ioerger, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steyn, A. J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizrahi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warner, D. F.</span><span> </span><span class="NLM_article-title">Susceptibility of Mycobacterium Tuberculosis Cytochrome Bd Oxidase Mutants to Compounds Targeting the Terminal Respiratory Oxidase, Cytochrome c</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">e01338-17</span><span class="refDoi"> DOI: 10.1128/AAC.01338-17</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=10.1128%2FAAC.01338-17" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=28760899" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2017&pages=e01338-17&author=A.+Moosaauthor=D.+A.+Lamprechtauthor=K.+Aroraauthor=C.+E.+Barryauthor=H.+I.+M.+Boshoffauthor=T.+R.+Ioergerauthor=A.+J.+C.+Steynauthor=V.+Mizrahiauthor=D.+F.+Warner&title=Susceptibility+of+Mycobacterium+Tuberculosis+Cytochrome+Bd+Oxidase+Mutants+to+Compounds+Targeting+the+Terminal+Respiratory+Oxidase%2C+Cytochrome+c&doi=10.1128%2FAAC.01338-17"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1128%2FAAC.01338-17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01338-17%26sid%3Dliteratum%253Aachs%26aulast%3DMoosa%26aufirst%3DA.%26aulast%3DLamprecht%26aufirst%3DD.%2BA.%26aulast%3DArora%26aufirst%3DK.%26aulast%3DBarry%26aufirst%3DC.%2BE.%26aulast%3DBoshoff%26aufirst%3DH.%2BI.%2BM.%26aulast%3DIoerger%26aufirst%3DT.%2BR.%26aulast%3DSteyn%26aufirst%3DA.%2BJ.%2BC.%26aulast%3DMizrahi%26aufirst%3DV.%26aulast%3DWarner%26aufirst%3DD.%2BF.%26atitle%3DSusceptibility%2520of%2520Mycobacterium%2520Tuberculosis%2520Cytochrome%2520Bd%2520Oxidase%2520Mutants%2520to%2520Compounds%2520Targeting%2520the%2520Terminal%2520Respiratory%2520Oxidase%252C%2520Cytochrome%2520c%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2017%26volume%3D61%26spage%3De01338-17%26doi%3D10.1128%2FAAC.01338-17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Naran, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moosa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barry, C. E.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boshoff, H. I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizrahi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warner, D. F.</span><span> </span><span class="NLM_article-title">Bioluminescent Reporters for Rapid Mechanism of Action Assessment in Tuberculosis Drug Discovery</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">6748</span><span class="NLM_x">–</span> <span class="NLM_lpage">6757</span><span class="refDoi"> DOI: 10.1128/AAC.01178-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=10.1128%2FAAC.01178-16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=27572410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitV2ntbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2016&pages=6748-6757&author=K.+Naranauthor=A.+Moosaauthor=C.+E.+Barryauthor=H.+I.+M.+Boshoffauthor=V.+Mizrahiauthor=D.+F.+Warner&title=Bioluminescent+Reporters+for+Rapid+Mechanism+of+Action+Assessment+in+Tuberculosis+Drug+Discovery&doi=10.1128%2FAAC.01178-16"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Bioluminescent reporters for rapid mechanism of action assessment in tuberculosis drug discovery</span></div><div class="casAuthors">Naran, Krupa; Moosa, Atica; Barry, Clifton E., III; Boshoff, Helena I. M.; Mizrahi, Valerie; Warner, Digby F.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">6748-6757</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The tuberculosis (TB) drug discovery pipeline is fueled by compds.identified in whole-cell screens against the causative agent, Mycobacterium tuberculosis.  Phenotypic screening enables the selection of mols.that inhibit essential cellular functions in live, intact bacilli grown under a chosen in vitro condition.  However, deducing the mechanism of action (MOA), which is important to avoid promiscuous targets, often requires significant biol.resources in a lengthy process that risks decoupling medicinal chem.and biol.efforts.  Therefore, there is a need to develop methods enabling rapid MOA assessment of putative "actives" for triage decisions.  Here, we describe a modified version of a bioluminescence reporter assay that allows nondestructive detection of compds.targeting either of two macromol.processes in M.tuberculosis: cell wall biosynthesis or maintenance of DNA integrity.  Coupling the luxCDABE operon from Photorhabdus luminescens to mycobacterial promoters driving expression of the iniBAC operon (PiniB-LUX) or the DNA damage-inducible genes, recA (PrecA-LUX) or radA (PradA-LUX), provided quant.detection in real time of compds.triggering expression of any of these promoters over an extended 10- to 12-day incubation.  Testing against known anti-TB agents confirmed the specificity of each reporter in registering the MOA of the applied antibiotic in M.tuberculosis, independent of bactericidal or bacteriostatic activity.  Moreover, profiles obtained for exptl.compds.indicated the potential to infer complex MOAs in which multiple cellular processes are disrupted.  These results demonstrate the utility of the reporters for early triage of compds.based on the provisional MOA and suggest their application to investigate polypharmacol.in known and exptl.anti-TB agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1CWtsv8h-h7Vg90H21EOLACvtfcHk0lhEkTIwrpiH2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitV2ntbo%253D&md5=6f08794b0ae28a909e1282adfe642cb5</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1128%2FAAC.01178-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01178-16%26sid%3Dliteratum%253Aachs%26aulast%3DNaran%26aufirst%3DK.%26aulast%3DMoosa%26aufirst%3DA.%26aulast%3DBarry%26aufirst%3DC.%2BE.%26aulast%3DBoshoff%26aufirst%3DH.%2BI.%2BM.%26aulast%3DMizrahi%26aufirst%3DV.%26aulast%3DWarner%26aufirst%3DD.%2BF.%26atitle%3DBioluminescent%2520Reporters%2520for%2520Rapid%2520Mechanism%2520of%2520Action%2520Assessment%2520in%2520Tuberculosis%2520Drug%2520Discovery%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2016%26volume%3D60%26spage%3D6748%26epage%3D6757%26doi%3D10.1128%2FAAC.01178-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Ren, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamane, M.</span><span> </span><span class="NLM_article-title">Mo(CO)6-Mediated Carbamoylation of Aryl Halides</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">8410</span><span class="NLM_x">–</span> <span class="NLM_lpage">8415</span><span class="refDoi"> DOI: 10.1021/jo101611g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo101611g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVeru7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2010&pages=8410-8415&author=W.+Renauthor=M.+Yamane&title=Mo%28CO%296-Mediated+Carbamoylation+of+Aryl+Halides&doi=10.1021%2Fjo101611g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Mo(CO)6-Mediated Carbamoylation of Aryl Halides</span></div><div class="casAuthors">Ren, Wei; Yamane, Motoki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8410-8415</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A simple method for the synthesis of amides, e.g., I has been developed by molybdenum-mediated carbamoylation of aryl halides.  Whereas the conventional palladium-catalyzed three-component coupling reaction requires a large excess of gaseous carbon monoxide, the incorporation of carbon monoxide in this Mo-mediated carbamoylation reaction is so efficient that it requires only a slight excess amt. of carbon monoxide in the form of its molybdenum complex, Mo(CO)6.  The reaction is applicable for the synthesis of a wide variety of not only secondary and tertiary amides but also primary amides by using aq. ammonia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdBEDAmViaN7Vg90H21EOLACvtfcHk0lhEkTIwrpiH2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVeru7bL&md5=d4c9de917a2d39248caa5a09769159a3</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjo101611g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo101611g%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DW.%26aulast%3DYamane%26aufirst%3DM.%26atitle%3DMo%2528CO%25296-Mediated%2520Carbamoylation%2520of%2520Aryl%2520Halides%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2010%26volume%3D75%26spage%3D8410%26epage%3D8415%26doi%3D10.1021%2Fjo101611g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Rudzinski, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leadbeater, N. E.</span><span> </span><span class="NLM_article-title">A Weinreb Amide Approach to the Synthesis of Trifluoromethylketones</span> <span class="citation_source-journal">Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">9610</span><span class="NLM_x">–</span> <span class="NLM_lpage">9612</span><span class="refDoi"> DOI: 10.1039/c2cc35037h</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=10.1039%2Fc2cc35037h" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=22911019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht12qsrrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2012&pages=9610-9612&author=D.+M.+Rudzinskiauthor=C.+B.+Kellyauthor=N.+E.+Leadbeater&title=A+Weinreb+Amide+Approach+to+the+Synthesis+of+Trifluoromethylketones&doi=10.1039%2Fc2cc35037h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">A Weinreb amide approach to the synthesis of trifluoromethylketones</span></div><div class="casAuthors">Rudzinski, DiAndra M.; Kelly, Christopher B.; Leadbeater, Nicholas E.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">77</span>),
    <span class="NLM_cas:pages">9610-9612</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A novel route to access trifluoromethylketones (TFMKs) from Weinreb amides is reported.  This represents the first documented case of the Ruppert-Prakash reagent (TMS-CF3) reacting in a constructive manner with an amide and enables synthesis of TFMKs without risk of over-trifluoromethylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsdturpJ_XzrVg90H21EOLACvtfcHk0lgGTDrtx16kFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht12qsrrO&md5=b6772eb545451112d3e8df62aa805c24</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1039%2Fc2cc35037h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2cc35037h%26sid%3Dliteratum%253Aachs%26aulast%3DRudzinski%26aufirst%3DD.%2BM.%26aulast%3DKelly%26aufirst%3DC.%2BB.%26aulast%3DLeadbeater%26aufirst%3DN.%2BE.%26atitle%3DA%2520Weinreb%2520Amide%2520Approach%2520to%2520the%2520Synthesis%2520of%2520Trifluoromethylketones%26jtitle%3DChem.%2520Commun.%26date%3D2012%26volume%3D48%26spage%3D9610%26epage%3D9612%26doi%3D10.1039%2Fc2cc35037h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Gauthier, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chauret, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cromlish, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmarais, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duong, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falgueyret, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimmel, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamontagne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Léger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeRiche, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massé, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKay, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoll-Griffith, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oballa, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percival, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riendeau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seto, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thérien, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truong, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venuti, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesolowski, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamboni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, W. C.</span><span> </span><span class="NLM_article-title">The Discovery of Odanacatib (MK-0822), a Selective Inhibitor of Cathepsin K</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">923</span><span class="NLM_x">–</span> <span class="NLM_lpage">928</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2007.12.047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=10.1016%2Fj.bmcl.2007.12.047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=18226527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFWktro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=923-928&author=J.+Y.+Gauthierauthor=N.+Chauretauthor=W.+Cromlishauthor=S.+Desmaraisauthor=L.+T.+Duongauthor=J.+P.+Falgueyretauthor=D.+B.+Kimmelauthor=S.+Lamontagneauthor=S.+L%C3%A9gerauthor=T.+LeRicheauthor=C.+S.+Liauthor=F.+Mass%C3%A9author=D.+J.+McKayauthor=D.+A.+Nicoll-Griffithauthor=R.+M.+Oballaauthor=J.+T.+Palmerauthor=M.+D.+Percivalauthor=D.+Riendeauauthor=J.+Robichaudauthor=G.+A.+Rodanauthor=S.+B.+Rodanauthor=C.+Setoauthor=M.+Th%C3%A9rienauthor=V.+L.+Truongauthor=M.+C.+Venutiauthor=G.+Wesolowskiauthor=R.+N.+Youngauthor=R.+Zamboniauthor=W.+C.+Black&title=The+Discovery+of+Odanacatib+%28MK-0822%29%2C+a+Selective+Inhibitor+of+Cathepsin+K&doi=10.1016%2Fj.bmcl.2007.12.047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K</span></div><div class="casAuthors">Gauthier, Jacques Yves; Chauret, Nathalie; Cromlish, Wanda; Desmarais, Sylvie; Duong, Le T.; Falgueyret, Jean-Pierre; Kimmel, Donald B.; Lamontagne, Sonia; Leger, Serge; LeRiche, Tammy; Li, Chun Sing; Masse, Frederic; McKay, Daniel J.; Nicoll-Griffith, Deborah A.; Oballa, Renata M.; Palmer, James T.; Percival, M. David; Riendeau, Denis; Robichaud, Joel; Rodan, Gideon A.; Rodan, Sevgi B.; Seto, Carmai; Therien, Michel; Truong, Vouy-Linh; Venuti, Michael C.; Wesolowski, Gregg; Young, Robert N.; Zamboni, Robert; Black, W. Cameron</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">923-928</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Odanacatib is a potent, selective, and neutral cathepsin K inhibitor which was developed to address the metabolic liabilities of the Cat K inhibitor L-873724.  Substituting P1 and modifying the P2 side chain led to a metabolically robust inhibitor with a long half-life in preclin. species.  Odanacatib was more selective in whole cell assays than the published Cat K inhibitors balicatib and relacatib.  Evaluation in dermal fibroblast culture showed minimal intracellular collagen accumulation relative to less selective Cat K inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7ytNI-SBgarVg90H21EOLACvtfcHk0lgGTDrtx16kFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFWktro%253D&md5=e432a420a3ec99c784117750b9bbeda8</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.12.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.12.047%26sid%3Dliteratum%253Aachs%26aulast%3DGauthier%26aufirst%3DJ.%2BY.%26aulast%3DChauret%26aufirst%3DN.%26aulast%3DCromlish%26aufirst%3DW.%26aulast%3DDesmarais%26aufirst%3DS.%26aulast%3DDuong%26aufirst%3DL.%2BT.%26aulast%3DFalgueyret%26aufirst%3DJ.%2BP.%26aulast%3DKimmel%26aufirst%3DD.%2BB.%26aulast%3DLamontagne%26aufirst%3DS.%26aulast%3DL%25C3%25A9ger%26aufirst%3DS.%26aulast%3DLeRiche%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DC.%2BS.%26aulast%3DMass%25C3%25A9%26aufirst%3DF.%26aulast%3DMcKay%26aufirst%3DD.%2BJ.%26aulast%3DNicoll-Griffith%26aufirst%3DD.%2BA.%26aulast%3DOballa%26aufirst%3DR.%2BM.%26aulast%3DPalmer%26aufirst%3DJ.%2BT.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26aulast%3DRiendeau%26aufirst%3DD.%26aulast%3DRobichaud%26aufirst%3DJ.%26aulast%3DRodan%26aufirst%3DG.%2BA.%26aulast%3DRodan%26aufirst%3DS.%2BB.%26aulast%3DSeto%26aufirst%3DC.%26aulast%3DTh%25C3%25A9rien%26aufirst%3DM.%26aulast%3DTruong%26aufirst%3DV.%2BL.%26aulast%3DVenuti%26aufirst%3DM.%2BC.%26aulast%3DWesolowski%26aufirst%3DG.%26aulast%3DYoung%26aufirst%3DR.%2BN.%26aulast%3DZamboni%26aufirst%3DR.%26aulast%3DBlack%26aufirst%3DW.%2BC.%26atitle%3DThe%2520Discovery%2520of%2520Odanacatib%2520%2528MK-0822%2529%252C%2520a%2520Selective%2520Inhibitor%2520of%2520Cathepsin%2520K%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D923%26epage%3D928%26doi%3D10.1016%2Fj.bmcl.2007.12.047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Bock, V. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Speijer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiemstra, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Maarseveen, J. H.</span><span> </span><span class="NLM_article-title">1,2,3-Triazoles as Peptide Bond Isosteres: Synthesis and Biological Evaluation of Cyclotetrapeptide Mimics</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">971</span><span class="NLM_x">–</span> <span class="NLM_lpage">975</span><span class="refDoi"> DOI: 10.1039/b616751a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=10.1039%2Fb616751a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=17340013" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BD2sXisV2gtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2007&pages=971-975&author=V.+D.+Bockauthor=D.+Speijerauthor=H.+Hiemstraauthor=J.+H.+van+Maarseveen&title=1%2C2%2C3-Triazoles+as+Peptide+Bond+Isosteres%3A+Synthesis+and+Biological+Evaluation+of+Cyclotetrapeptide+Mimics&doi=10.1039%2Fb616751a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">1,2,3-Triazoles as peptide bond isosteres: synthesis and biological evaluation of cyclotetrapeptide mimics</span></div><div class="casAuthors">Bock, Victoria D.; Speijer, Dave; Hiemstra, Henk; Van Maarseveen, Jan H.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">971-975</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Since the discovery of CuI-catalyzed click chem., the field of peptidomimetics has expanded to include 1,4-connected 1,2,3-triazoles as useful peptide bond isosteres.  Here, the synthesis of triazole-contg. analogs of the naturally occurring tyrosinase inhibitor cyclo-[Pro-Val-Pro-Tyr] was reported.  It was shown that the analogs, e.g., I, retained enzyme inhibitory activity, which demonstrated the effectiveness of a 1,4-connected 1,2,3-triazole as a trans peptide bond isostere.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPWV4DeB-x67Vg90H21EOLACvtfcHk0lgGTDrtx16kFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXisV2gtL8%253D&md5=4af400adf8141cd1ac02d9812fa14477</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1039%2Fb616751a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb616751a%26sid%3Dliteratum%253Aachs%26aulast%3DBock%26aufirst%3DV.%2BD.%26aulast%3DSpeijer%26aufirst%3DD.%26aulast%3DHiemstra%26aufirst%3DH.%26aulast%3Dvan%2BMaarseveen%26aufirst%3DJ.%2BH.%26atitle%3D1%252C2%252C3-Triazoles%2520as%2520Peptide%2520Bond%2520Isosteres%253A%2520Synthesis%2520and%2520Biological%2520Evaluation%2520of%2520Cyclotetrapeptide%2520Mimics%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2007%26volume%3D5%26spage%3D971%26epage%3D975%26doi%3D10.1039%2Fb616751a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Cox, J. A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahams, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alemparte, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghidelli-Disse, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rullas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angulo-Barturen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurcha, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nataraj, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bethell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remuiñán, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Encinas, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jervis, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cammack, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruse, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bantscheff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fütterer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barros, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewes, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besra, G. S.</span><span> </span><span class="NLM_article-title">THPP Target Assignment Reveals EchA6 as an Essential Fatty Acid Shuttle in Mycobacteria</span> <span class="citation_source-journal">Nat. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">15006</span><span class="refDoi"> DOI: 10.1038/nmicrobiol.2015.6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=10.1038%2Fnmicrobiol.2015.6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=27571973" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkvFyqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2016&pages=15006&author=J.+A.+G.+Coxauthor=K.+A.+Abrahamsauthor=C.+Alemparteauthor=S.+Ghidelli-Disseauthor=J.+Rullasauthor=I.+Angulo-Barturenauthor=A.+Singhauthor=S.+S.+Gurchaauthor=V.+Natarajauthor=S.+Bethellauthor=M.+J.+Remui%C3%B1%C3%A1nauthor=L.+Encinasauthor=P.+J.+Jervisauthor=N.+C.+Cammackauthor=A.+Bhattauthor=U.+Kruseauthor=M.+Bantscheffauthor=K.+F%C3%BCttererauthor=D.+Barrosauthor=L.+Ballellauthor=G.+Drewesauthor=G.+S.+Besra&title=THPP+Target+Assignment+Reveals+EchA6+as+an+Essential+Fatty+Acid+Shuttle+in+Mycobacteria&doi=10.1038%2Fnmicrobiol.2015.6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">THPP target assignment reveals EchA6 as an essential fatty acid shuttle in Mycobacteria</span></div><div class="casAuthors">Cox, Jonathan A. G.; Abrahams, Katherine A.; Alemparte, Carlos; Ghidelli-Disse, Sonja; Rullas, Joaquin; Angulo-Barturen, Inigo; Singh, Albel; Gurcha, Sudagar S.; Nataraj, Vijayashankar; Bethell, Stephen; Remuinan, Modesto J.; Encinas, Lourdes; Jervis, Peter J.; Cammack, Nicholas C.; Bhatt, Apoorva; Kruse, Ulrich; Bantscheff, Marcus; Futterer, Klaus; Barros, David; Ballell, Lluis; Drewes, Gerard; Besra, Gurdyal S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Microbiology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">15006</span>CODEN:
                <span class="NLM_cas:coden">NMAICH</span>;
        ISSN:<span class="NLM_cas:issn">2058-5276</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Phenotypic screens for bactericidal compds. against drug-resistant tuberculosis are beginning to yield novel inhibitors.  However, reliable target identification remains challenging.  Here, we show that tetrahydropyrazo[1,5-a]pyrimidine-3-carboxamide (THPP) selectively pulls down EchA6 in a stereospecific manner, instead of the previously assigned target Mycobacterium tuberculosis MmpL3.  While homologous to mammalian enoyl-CoA hydratases, EchA6 is non-catalytic yet essential and binds long-chain acyl-CoAs.  THPP inhibitors compete with CoA-binding, suppress mycolic acid synthesis, and are bactericidal in a mouse model of chronic tuberculosis infection.  A point mutation, W133A, abrogated THPP-binding and increased both the in vitro min. inhibitory concn. and the in vivo ED 99 in mice.  Surprisingly, EchA6 interacts with selected enzymes of fatty acid synthase II (FAS-II) in bacterial two-hybrid assays, suggesting essentiality may be linked to feeding long-chain fatty acids to FAS-II.  Finally, our data show that spontaneous resistance-conferring mutations can potentially obscure the actual target or alternative targets of small mol. inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplCDIm9BSu47Vg90H21EOLACvtfcHk0lhMGB_81l-QWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkvFyqtbk%253D&md5=d1704f5bc0a939f1213078f71cdcbf49</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fnmicrobiol.2015.6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnmicrobiol.2015.6%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DJ.%2BA.%2BG.%26aulast%3DAbrahams%26aufirst%3DK.%2BA.%26aulast%3DAlemparte%26aufirst%3DC.%26aulast%3DGhidelli-Disse%26aufirst%3DS.%26aulast%3DRullas%26aufirst%3DJ.%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26aulast%3DSingh%26aufirst%3DA.%26aulast%3DGurcha%26aufirst%3DS.%2BS.%26aulast%3DNataraj%26aufirst%3DV.%26aulast%3DBethell%26aufirst%3DS.%26aulast%3DRemui%25C3%25B1%25C3%25A1n%26aufirst%3DM.%2BJ.%26aulast%3DEncinas%26aufirst%3DL.%26aulast%3DJervis%26aufirst%3DP.%2BJ.%26aulast%3DCammack%26aufirst%3DN.%2BC.%26aulast%3DBhatt%26aufirst%3DA.%26aulast%3DKruse%26aufirst%3DU.%26aulast%3DBantscheff%26aufirst%3DM.%26aulast%3DF%25C3%25BCtterer%26aufirst%3DK.%26aulast%3DBarros%26aufirst%3DD.%26aulast%3DBallell%26aufirst%3DL.%26aulast%3DDrewes%26aufirst%3DG.%26aulast%3DBesra%26aufirst%3DG.%2BS.%26atitle%3DTHPP%2520Target%2520Assignment%2520Reveals%2520EchA6%2520as%2520an%2520Essential%2520Fatty%2520Acid%2520Shuttle%2520in%2520Mycobacteria%26jtitle%3DNat.%2520Microbiol.%26date%3D2016%26volume%3D1%26spage%3D15006%26doi%3D10.1038%2Fnmicrobiol.2015.6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Abrahams, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghidelli-Disse, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rullas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rebollo-López, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurcha, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, J. A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendoza, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiménez-Navarro, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martínez-Martínez, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shillings, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Argyrou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casanueva, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loman, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moynihan, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lelièvre, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selenski, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Axtman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kremer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bantscheff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angulo-Barturen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izquierdo, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cammack, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewes, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barros, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besra, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, R. H.</span><span> </span><span class="NLM_article-title">Identification of KasA as the Cellular Target of an Anti-Tubercular Scaffold</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">12581</span><span class="refDoi"> DOI: 10.1038/ncomms12581</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=10.1038%2Fncomms12581" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=27581223" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVOru7%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=12581&author=K.+A.+Abrahamsauthor=C.+Chungauthor=S.+Ghidelli-Disseauthor=J.+Rullasauthor=M.+J.+Rebollo-L%C3%B3pezauthor=S.+S.+Gurchaauthor=J.+A.+G.+Coxauthor=A.+Mendozaauthor=E.+Jim%C3%A9nez-Navarroauthor=M.+S.+Mart%C3%ADnez-Mart%C3%ADnezauthor=M.+Neuauthor=A.+Shillingsauthor=P.+Homesauthor=A.+Argyrouauthor=R.+Casanuevaauthor=N.+J.+Lomanauthor=P.+J.+Moynihanauthor=J.+Leli%C3%A8vreauthor=C.+Selenskiauthor=M.+Axtmanauthor=L.+Kremerauthor=M.+Bantscheffauthor=I.+Angulo-Barturenauthor=M.+C.+Izquierdoauthor=N.+C.+Cammackauthor=G.+Drewesauthor=L.+Ballellauthor=D.+Barrosauthor=G.+S.+Besraauthor=R.+H.+Bates&title=Identification+of+KasA+as+the+Cellular+Target+of+an+Anti-Tubercular+Scaffold&doi=10.1038%2Fncomms12581"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of KasA as the cellular target of an anti-tubercular scaffold</span></div><div class="casAuthors">Abrahams, Katherine A.; Chung, Chun-wa; Ghidelli-Disse, Sonja; Rullas, Joaquin; Rebollo-Lopez, Maria Jose; Gurcha, Sudagar S.; Cox, Jonathan A. G.; Mendoza, Alfonso; Jimenez-Navarro, Elena; Martinez-Martinez, Maria Santos; Neu, Margarete; Shillings, Anthony; Homes, Paul; Argyrou, Argyrides; Casanueva, Ruth; Loman, Nicholas J.; Moynihan, Patrick J.; Lelievre, Joel; Selenski, Carolyn; Axtman, Matthew; Kremer, Laurent; Bantscheff, Marcus; Angulo-Barturen, Inigo; Izquierdo, Monica Cacho; Cammack, Nicholas C.; Drewes, Gerard; Ballell, Lluis; Barros, David; Besra, Gurdyal S.; Bates, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">12581</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Phenotypic screens for bactericidal compds. are starting to yield promising hits against tuberculosis.  In this regard, whole-genome sequencing of spontaneous resistant mutants generated against an indazole sulfonamide (GSK3011724A) identifies several specific single-nucleotide polymorphisms in the essential Mycobacterium tuberculosis β-ketoacyl synthase (kas) A gene.  Here, this genomic-based target assignment is confirmed by biochem. assays, chem. proteomics and structural resoln. of a KasA-GSK3011724A complex by X-ray crystallog.  Finally, M. tuberculosis GSK3011724A-resistant mutants increase the in vitro min. inhibitory concn. and the in vivo 99% ED in mice, establishing in vitro and in vivo target engagement.  Surprisingly, the lack of target engagement of the related β-ketoacyl synthases (FabH and KasB) suggests a different mode of inhibition when compared with other Kas inhibitors of fatty acid biosynthesis in bacteria.  These results clearly identify KasA as the biol. target of GSK3011724A and validate this enzyme for further drug discovery efforts against tuberculosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGockW3Zu8ZMEbVg90H21EOLACvtfcHk0lhMGB_81l-QWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVOru7%252FI&md5=a1206008e181383854e026f36ad27489</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fncomms12581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms12581%26sid%3Dliteratum%253Aachs%26aulast%3DAbrahams%26aufirst%3DK.%2BA.%26aulast%3DChung%26aufirst%3DC.%26aulast%3DGhidelli-Disse%26aufirst%3DS.%26aulast%3DRullas%26aufirst%3DJ.%26aulast%3DRebollo-L%25C3%25B3pez%26aufirst%3DM.%2BJ.%26aulast%3DGurcha%26aufirst%3DS.%2BS.%26aulast%3DCox%26aufirst%3DJ.%2BA.%2BG.%26aulast%3DMendoza%26aufirst%3DA.%26aulast%3DJim%25C3%25A9nez-Navarro%26aufirst%3DE.%26aulast%3DMart%25C3%25ADnez-Mart%25C3%25ADnez%26aufirst%3DM.%2BS.%26aulast%3DNeu%26aufirst%3DM.%26aulast%3DShillings%26aufirst%3DA.%26aulast%3DHomes%26aufirst%3DP.%26aulast%3DArgyrou%26aufirst%3DA.%26aulast%3DCasanueva%26aufirst%3DR.%26aulast%3DLoman%26aufirst%3DN.%2BJ.%26aulast%3DMoynihan%26aufirst%3DP.%2BJ.%26aulast%3DLeli%25C3%25A8vre%26aufirst%3DJ.%26aulast%3DSelenski%26aufirst%3DC.%26aulast%3DAxtman%26aufirst%3DM.%26aulast%3DKremer%26aufirst%3DL.%26aulast%3DBantscheff%26aufirst%3DM.%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26aulast%3DIzquierdo%26aufirst%3DM.%2BC.%26aulast%3DCammack%26aufirst%3DN.%2BC.%26aulast%3DDrewes%26aufirst%3DG.%26aulast%3DBallell%26aufirst%3DL.%26aulast%3DBarros%26aufirst%3DD.%26aulast%3DBesra%26aufirst%3DG.%2BS.%26aulast%3DBates%26aufirst%3DR.%2BH.%26atitle%3DIdentification%2520of%2520KasA%2520as%2520the%2520Cellular%2520Target%2520of%2520an%2520Anti-Tubercular%2520Scaffold%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D12581%26doi%3D10.1038%2Fncomms12581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Park, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacitto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayliss, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleghorn, L. A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arora, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ioerger, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sacchettini, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blundell, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ascher, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dartois, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonnala, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Via, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizrahi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epemolu, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stojanovski, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simeons, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osuna-Cabello, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacKenzie, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A. R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murugesan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchanan, K. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huggett, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuccotto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rebollo-Lopez, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lafuente-Monasterio, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lelièvre, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selenski, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Axtman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghidelli-Disse, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pflaumer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bosche, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewes, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freiberg, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurnick, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srikumaran, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kempf, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyatt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barry, C. E.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boshoff, H. I.</span><span> </span><span class="NLM_article-title">Essential but Not Vulnerable: Indazole Sulfonamides Targeting Inosine Monophosphate Dehydrogenase as Potential Leads against Mycobacterium Tuberculosis</span> <span class="citation_source-journal">ACS Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">18</span><span class="NLM_x">–</span> <span class="NLM_lpage">33</span><span class="refDoi"> DOI: 10.1021/acsinfecdis.6b00103</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.6b00103" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1amsL3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2017&pages=18-33&author=Y.+Parkauthor=A.+Pacittoauthor=T.+Baylissauthor=L.+A.+T.+Cleghornauthor=Z.+Wangauthor=T.+Hartmanauthor=K.+Aroraauthor=T.+R.+Ioergerauthor=J.+Sacchettiniauthor=M.+Rizziauthor=S.+Doniniauthor=T.+L.+Blundellauthor=D.+B.+Ascherauthor=K.+Rheeauthor=A.+Bredaauthor=N.+Zhouauthor=V.+Dartoisauthor=S.+R.+Jonnalaauthor=L.+E.+Viaauthor=V.+Mizrahiauthor=O.+Epemoluauthor=L.+Stojanovskiauthor=F.+Simeonsauthor=M.+Osuna-Cabelloauthor=L.+Ellisauthor=C.+J.+MacKenzieauthor=A.+R.+C.+Smithauthor=S.+H.+Davisauthor=D.+Murugesanauthor=K.+I.+Buchananauthor=P.+A.+Turnerauthor=M.+Huggettauthor=F.+Zuccottoauthor=M.+J.+Rebollo-Lopezauthor=M.+J.+Lafuente-Monasterioauthor=O.+Sanzauthor=G.+S.+Diazauthor=J.+Leli%C3%A8vreauthor=L.+Ballellauthor=C.+Selenskiauthor=M.+Axtmanauthor=S.+Ghidelli-Disseauthor=H.+Pflaumerauthor=M.+Boscheauthor=G.+Drewesauthor=G.+M.+Freibergauthor=M.+D.+Kurnickauthor=M.+Srikumaranauthor=D.+J.+Kempfauthor=S.+R.+Greenauthor=P.+C.+Rayauthor=K.+Readauthor=P.+Wyattauthor=C.+E.+Barryauthor=H.+I.+Boshoff&title=Essential+but+Not+Vulnerable%3A+Indazole+Sulfonamides+Targeting+Inosine+Monophosphate+Dehydrogenase+as+Potential+Leads+against+Mycobacterium+Tuberculosis&doi=10.1021%2Facsinfecdis.6b00103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Essential but Not Vulnerable: Indazole Sulfonamides Targeting Inosine Monophosphate Dehydrogenase as Potential Leads against Mycobacterium tuberculosis</span></div><div class="casAuthors">Park, Yumi; Pacitto, Angela; Bayliss, Tracy; Cleghorn, Laura A. T.; Wang, Zhe; Hartman, Travis; Arora, Kriti; Ioerger, Thomas R.; Sacchettini, Jim; Rizzi, Menico; Donini, Stefano; Blundell, Tom L.; Ascher, David B.; Rhee, Kyu; Breda, Ardala; Zhou, Nian; Dartois, Veronique; Jonnala, Surendranadha Reddy; Via, Laura E.; Mizrahi, Valerie; Epemolu, Ola; Stojanovski, Laste; Simeons, Fred; Osuna-Cabello, Maria; Ellis, Lucy; MacKenzie, Claire J.; Smith, Alasdair R. C.; Davis, Susan H.; Murugesan, Dinakaran; Buchanan, Kirsteen I.; Turner, Penelope A.; Huggett, Margaret; Zuccotto, Fabio; Rebollo-Lopez, Maria Jose; Lafuente-Monasterio, Maria Jose; Sanz, Olalla; Diaz, Gracia Santos; Lelievre, Joel; Ballell, Lluis; Selenski, Carolyn; Axtman, Matthew; Ghidelli-Disse, Sonja; Pflaumer, Hannah; Bosche, Markus; Drewes, Gerard; Freiberg, Gail M.; Kurnick, Matthew D.; Srikumaran, Myron; Kempf, Dale J.; Green, Simon R.; Ray, Peter C.; Read, Kevin; Wyatt, Paul; Barry, Clifton E.; Boshoff, Helena I.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">18-33</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A potent, noncytotoxic indazole sulfonamide was identified by high-throughput screening of >100,000 synthetic compds. for activity against Mycobacterium tuberculosis (Mtb).  This noncytotoxic compd. did not directly inhibit cell wall biogenesis but triggered a slow lysis of Mtb cells as measured by release of intracellular green fluorescent protein (GFP).  Isolation of resistant mutants followed by whole-genome sequencing showed an unusual gene amplification of a 40 gene region spanning Rv3371 to Rv3411c and in one case a potential promoter mutation upstream of guaB2 (Rv3411c) encoding inosine monophosphate dehydrogenase (IMPDH).  Subsequent biochem. validation confirmed direct inhibition of IMPDH by an uncompetitive mode of inhibition and growth inhibition could be rescued by supplementation with guanine, a bypass mechanism for the IMPDH pathway.  Beads contg. immobilized indazole sulfonamides specifically interacted with IMPDH in cell lysates.  X-ray crystallog. of the IMPDH-IMP-inhibitor complex revealed that the primary interactions of these compds. with IMPDH were direct pi-pi interactions with the IMP substrate.  Advanced lead compds. in this series with acceptable pharmacokinetic properties failed to show efficacy in acute or chronic murine models of tuberculosis (TB).  Time-kill expts. in vitro suggest that sustained exposure to drug concns. above MIC for 24 h were required for a cidal effect, levels that have been difficult to achieve in vivo.  Direct measurement of guanine levels in resected lung tissue from tuberculosis infected animals and patients revealed 0.5-2 mM concns. in caseum and normal lung tissue.  The high lesional levels of guanine and the slow lytic, growth-rate dependent, effect of IMPDH inhibition pose challenges to developing drugs against this target for use in treating TB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGQUg6PXv9hbVg90H21EOLACvtfcHk0li9MargIpCilg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1amsL3P&md5=fe98ee102c3e265f0a4e70ff1f94a063</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.6b00103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.6b00103%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DY.%26aulast%3DPacitto%26aufirst%3DA.%26aulast%3DBayliss%26aufirst%3DT.%26aulast%3DCleghorn%26aufirst%3DL.%2BA.%2BT.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DHartman%26aufirst%3DT.%26aulast%3DArora%26aufirst%3DK.%26aulast%3DIoerger%26aufirst%3DT.%2BR.%26aulast%3DSacchettini%26aufirst%3DJ.%26aulast%3DRizzi%26aufirst%3DM.%26aulast%3DDonini%26aufirst%3DS.%26aulast%3DBlundell%26aufirst%3DT.%2BL.%26aulast%3DAscher%26aufirst%3DD.%2BB.%26aulast%3DRhee%26aufirst%3DK.%26aulast%3DBreda%26aufirst%3DA.%26aulast%3DZhou%26aufirst%3DN.%26aulast%3DDartois%26aufirst%3DV.%26aulast%3DJonnala%26aufirst%3DS.%2BR.%26aulast%3DVia%26aufirst%3DL.%2BE.%26aulast%3DMizrahi%26aufirst%3DV.%26aulast%3DEpemolu%26aufirst%3DO.%26aulast%3DStojanovski%26aufirst%3DL.%26aulast%3DSimeons%26aufirst%3DF.%26aulast%3DOsuna-Cabello%26aufirst%3DM.%26aulast%3DEllis%26aufirst%3DL.%26aulast%3DMacKenzie%26aufirst%3DC.%2BJ.%26aulast%3DSmith%26aufirst%3DA.%2BR.%2BC.%26aulast%3DDavis%26aufirst%3DS.%2BH.%26aulast%3DMurugesan%26aufirst%3DD.%26aulast%3DBuchanan%26aufirst%3DK.%2BI.%26aulast%3DTurner%26aufirst%3DP.%2BA.%26aulast%3DHuggett%26aufirst%3DM.%26aulast%3DZuccotto%26aufirst%3DF.%26aulast%3DRebollo-Lopez%26aufirst%3DM.%2BJ.%26aulast%3DLafuente-Monasterio%26aufirst%3DM.%2BJ.%26aulast%3DSanz%26aufirst%3DO.%26aulast%3DDiaz%26aufirst%3DG.%2BS.%26aulast%3DLeli%25C3%25A8vre%26aufirst%3DJ.%26aulast%3DBallell%26aufirst%3DL.%26aulast%3DSelenski%26aufirst%3DC.%26aulast%3DAxtman%26aufirst%3DM.%26aulast%3DGhidelli-Disse%26aufirst%3DS.%26aulast%3DPflaumer%26aufirst%3DH.%26aulast%3DBosche%26aufirst%3DM.%26aulast%3DDrewes%26aufirst%3DG.%26aulast%3DFreiberg%26aufirst%3DG.%2BM.%26aulast%3DKurnick%26aufirst%3DM.%2BD.%26aulast%3DSrikumaran%26aufirst%3DM.%26aulast%3DKempf%26aufirst%3DD.%2BJ.%26aulast%3DGreen%26aufirst%3DS.%2BR.%26aulast%3DRay%26aufirst%3DP.%2BC.%26aulast%3DRead%26aufirst%3DK.%26aulast%3DWyatt%26aufirst%3DP.%26aulast%3DBarry%26aufirst%3DC.%2BE.%26aulast%3DBoshoff%26aufirst%3DH.%2BI.%26atitle%3DEssential%2520but%2520Not%2520Vulnerable%253A%2520Indazole%2520Sulfonamides%2520Targeting%2520Inosine%2520Monophosphate%2520Dehydrogenase%2520as%2520Potential%2520Leads%2520against%2520Mycobacterium%2520Tuberculosis%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2017%26volume%3D3%26spage%3D18%26epage%3D33%26doi%3D10.1021%2Facsinfecdis.6b00103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Bantscheff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopf, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savitski, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dittmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grandi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michon, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlegl, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becher, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergamini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boesche, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delling, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dümpelfeld, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eberhard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huthmacher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poeckel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reader, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strunk, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweetman, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruse, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neubauer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramsden, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewes, G.</span><span> </span><span class="NLM_article-title">Chemoproteomics Profiling of HDAC Inhibitors Reveals Selective Targeting of HDAC Complexes</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">255</span><span class="NLM_x">–</span> <span class="NLM_lpage">265</span><span class="refDoi"> DOI: 10.1038/nbt.1759</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=10.1038%2Fnbt.1759" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=21258344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BC3MXps1ahug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=255-265&author=M.+Bantscheffauthor=C.+Hopfauthor=M.+M.+Savitskiauthor=A.+Dittmannauthor=P.+Grandiauthor=A.-M.+Michonauthor=J.+Schleglauthor=Y.+Abrahamauthor=I.+Becherauthor=G.+Bergaminiauthor=M.+Boescheauthor=M.+Dellingauthor=B.+D%C3%BCmpelfeldauthor=D.+Eberhardauthor=C.+Huthmacherauthor=T.+Mathiesonauthor=D.+Poeckelauthor=V.+Readerauthor=K.+Strunkauthor=G.+Sweetmanauthor=U.+Kruseauthor=G.+Neubauerauthor=N.+G.+Ramsdenauthor=G.+Drewes&title=Chemoproteomics+Profiling+of+HDAC+Inhibitors+Reveals+Selective+Targeting+of+HDAC+Complexes&doi=10.1038%2Fnbt.1759"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes</span></div><div class="casAuthors">Bantscheff, Marcus; Hopf, Carsten; Savitski, Mikhail M.; Dittmann, Antje; Grandi, Paola; Michon, Anne-Marie; Schlegl, Judith; Abraham, Yann; Becher, Isabelle; Bergamini, Giovanna; Boesche, Markus; Delling, Manja; Duempelfeld, Birgit; Eberhard, Dirk; Huthmacher, Carola; Mathieson, Toby; Poeckel, Daniel; Reader, Valerie; Strunk, Katja; Sweetman, Gavain; Kruse, Ulrich; Neubauer, Gitte; Ramsden, Nigel G.; Drewes, Gerard</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">255-265</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The development of selective histone deacetylase (HDAC) inhibitors with anti-cancer and anti-inflammatory properties remains challenging in large part owing to the difficulty of probing the interaction of small mols. with megadalton protein complexes.  A combination of affinity capture and quant. mass spectrometry revealed the selectivity with which 16 HDAC inhibitors target multiple HDAC complexes scaffolded by ELM-SANT domain subunits, including a novel mitotic deacetylase complex (MiDAC).  Inhibitors clustered according to their target profiles with stronger binding of aminobenzamides to the HDAC NCoR complex than to the HDAC Sin3 complex.  We identified several non-HDAC targets for hydroxamate inhibitors.  HDAC inhibitors with distinct profiles have correspondingly different effects on downstream targets.  We also identified the anti-inflammatory drug bufexamac as a class IIb (HDAC6, HDAC10) HDAC inhibitor.  Our approach enables the discovery of novel targets and inhibitors and suggests that the selectivity of HDAC inhibitors should be evaluated in the context of HDAC complexes and not purified catalytic subunits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWdsITjgu14rVg90H21EOLACvtfcHk0li9MargIpCilg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXps1ahug%253D%253D&md5=3a826d143fb793719a56fba3c410d51e</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fnbt.1759&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.1759%26sid%3Dliteratum%253Aachs%26aulast%3DBantscheff%26aufirst%3DM.%26aulast%3DHopf%26aufirst%3DC.%26aulast%3DSavitski%26aufirst%3DM.%2BM.%26aulast%3DDittmann%26aufirst%3DA.%26aulast%3DGrandi%26aufirst%3DP.%26aulast%3DMichon%26aufirst%3DA.-M.%26aulast%3DSchlegl%26aufirst%3DJ.%26aulast%3DAbraham%26aufirst%3DY.%26aulast%3DBecher%26aufirst%3DI.%26aulast%3DBergamini%26aufirst%3DG.%26aulast%3DBoesche%26aufirst%3DM.%26aulast%3DDelling%26aufirst%3DM.%26aulast%3DD%25C3%25BCmpelfeld%26aufirst%3DB.%26aulast%3DEberhard%26aufirst%3DD.%26aulast%3DHuthmacher%26aufirst%3DC.%26aulast%3DMathieson%26aufirst%3DT.%26aulast%3DPoeckel%26aufirst%3DD.%26aulast%3DReader%26aufirst%3DV.%26aulast%3DStrunk%26aufirst%3DK.%26aulast%3DSweetman%26aufirst%3DG.%26aulast%3DKruse%26aufirst%3DU.%26aulast%3DNeubauer%26aufirst%3DG.%26aulast%3DRamsden%26aufirst%3DN.%2BG.%26aulast%3DDrewes%26aufirst%3DG.%26atitle%3DChemoproteomics%2520Profiling%2520of%2520HDAC%2520Inhibitors%2520Reveals%2520Selective%2520Targeting%2520of%2520HDAC%2520Complexes%26jtitle%3DNat.%2520Biotechnol.%26date%3D2011%26volume%3D29%26spage%3D255%26epage%3D265%26doi%3D10.1038%2Fnbt.1759" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Målen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pathak, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Søfteland, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Souza, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiker, H. G.</span><span> </span><span class="NLM_article-title">Definition of Novel Cell Envelope Associated Proteins in Triton X-114 Extracts of Mycobacterium Tuberculosis H37Rv</span> <span class="citation_source-journal">BMC Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">132</span><span class="refDoi"> DOI: 10.1186/1471-2180-10-132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=10.1186%2F1471-2180-10-132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=20429878" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A280%3ADC%252BC3czlsVGjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=132&author=H.+M%C3%A5lenauthor=S.+Pathakauthor=T.+S%C3%B8ftelandauthor=G.+A.+de+Souzaauthor=H.+G.+Wiker&title=Definition+of+Novel+Cell+Envelope+Associated+Proteins+in+Triton+X-114+Extracts+of+Mycobacterium+Tuberculosis+H37Rv&doi=10.1186%2F1471-2180-10-132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Definition of novel cell envelope associated proteins in Triton X-114 extracts of Mycobacterium tuberculosis H37Rv</span></div><div class="casAuthors">Malen Hiwa; Pathak Sharad; Softeland Tina; de Souza Gustavo A; Wiker Harald G</div><div class="citationInfo"><span class="NLM_cas:title">BMC microbiology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">132</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Membrane- and membrane-associated proteins are important for the pathogenicity of bacteria.  We have analysed the content of these proteins in virulent Mycobacterium tuberculosis H37Rv using Triton X-114 detergent-phase separation for extraction of lipophilic proteins, followed by their identification with high resolution mass spectrometry.  RESULTS:  In total, 1417 different proteins were identified.  In silico analysis of the identified proteins revealed that 248 proteins had at least one predicted trans-membrane region.  Also, 64 of the identified proteins were predicted lipoproteins, and 54 proteins were predicted as outer membrane proteins.  Three-hundred-and-ninety-five of the observed proteins, including 91 integral membrane proteins were described for the first time.  Comparison of abundance levels of the identified proteins was performed using the exponentially modified protein abundance index (emPAI) which takes into account the number of the observable peptides to the number of experimentally observed peptide ions for a given protein.  The outcome showed that among the membrane-and membrane-associated proteins several proteins are present with high relative abundance.  Further, a close examination of the lipoprotein LpqG (Rv3623) which is only detected in the membrane fractions of M. tuberculosis but not in M. bovis, revealed that the homologous gene in M. bovis lack the signal peptide and lipobox motif, suggesting impaired export to the membrane.  CONCLUSIONS:  Altogether, we have identified a substantial proportion of membrane- and membrane-associated proteins of M. tuberculosis H37Rv, compared the relative abundance of the identified proteins and also revealed subtle differences between the different members of the M. tuberculosis complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTlM3gu7QTAcO2mnZh2OgS0fW6udTcc2ebAwmWm0hRKi7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3czlsVGjsA%253D%253D&md5=de3193520f418826f094e3cb6d1b0f88</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1186%2F1471-2180-10-132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2180-10-132%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25A5len%26aufirst%3DH.%26aulast%3DPathak%26aufirst%3DS.%26aulast%3DS%25C3%25B8fteland%26aufirst%3DT.%26aulast%3Dde%2BSouza%26aufirst%3DG.%2BA.%26aulast%3DWiker%26aufirst%3DH.%2BG.%26atitle%3DDefinition%2520of%2520Novel%2520Cell%2520Envelope%2520Associated%2520Proteins%2520in%2520Triton%2520X-114%2520Extracts%2520of%2520Mycobacterium%2520Tuberculosis%2520H37Rv%26jtitle%3DBMC%2520Microbiol.%26date%3D2010%26volume%3D10%26spage%3D132%26doi%3D10.1186%2F1471-2180-10-132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Augustijns, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wuyts, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hens, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Annaert, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brouwers, J.</span><span> </span><span class="NLM_article-title">A Review of Drug Solubility in Human Intestinal Fluids: Implications for the Prediction of Oral Absorption</span> <span class="citation_source-journal">Eur. J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">322</span><span class="NLM_x">–</span> <span class="NLM_lpage">332</span><span class="refDoi"> DOI: 10.1016/j.ejps.2013.08.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=10.1016%2Fj.ejps.2013.08.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=23994640" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVyltL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=322-332&author=P.+Augustijnsauthor=B.+Wuytsauthor=B.+Hensauthor=P.+Annaertauthor=J.+Butlerauthor=J.+Brouwers&title=A+Review+of+Drug+Solubility+in+Human+Intestinal+Fluids%3A+Implications+for+the+Prediction+of+Oral+Absorption&doi=10.1016%2Fj.ejps.2013.08.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">A review of drug solubility in human intestinal fluids: Implications for the prediction of oral absorption</span></div><div class="casAuthors">Augustijns, Patrick; Wuyts, Benjamin; Hens, Bart; Annaert, Pieter; Butler, James; Brouwers, Joachim</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">322-332</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The purpose of this paper is to collate all recently published soly. data of orally administered drugs in human intestinal fluids (HIF) that were aspirated from the upper small intestine (duodenum and jejunum).  The data set comprises in total 102 soly. values in fasted state HIF and 37 soly. values in fed state HIF, covering 59 different drugs.  Despite differences in the protocol for HIF sampling and subsequent handling, this summary of HIF solubilities provides a crit. ref. data set to judge the value of simulated media for intestinal soly. estn.  In this regard, the review includes correlations between the reported solubilizing capacity of HIF and fasted or fed state simulated intestinal fluid (FaSSIF/FeSSIF).  Correlating with HIF solubilities enables the optimal use of soly. measurements in simulated biorelevant media to obtain accurate ests. of intestinal soly. during drug development.  Considering the fraction of poorly sol. new mol. entities in contemporary drug discovery, adequate prediction of intestinal soly. is crit. for efficient lead optimization, early candidate profiling, and further development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8IijZQJ8SKrVg90H21EOLACvtfcHk0lgshUECQOjN3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVyltL3L&md5=4e7a43d3d0cfe514577f6b10a1ba0c97</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2013.08.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2013.08.027%26sid%3Dliteratum%253Aachs%26aulast%3DAugustijns%26aufirst%3DP.%26aulast%3DWuyts%26aufirst%3DB.%26aulast%3DHens%26aufirst%3DB.%26aulast%3DAnnaert%26aufirst%3DP.%26aulast%3DButler%26aufirst%3DJ.%26aulast%3DBrouwers%26aufirst%3DJ.%26atitle%3DA%2520Review%2520of%2520Drug%2520Solubility%2520in%2520Human%2520Intestinal%2520Fluids%253A%2520Implications%2520for%2520the%2520Prediction%2520of%2520Oral%2520Absorption%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2014%26volume%3D57%26spage%3D322%26epage%3D332%26doi%3D10.1016%2Fj.ejps.2013.08.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Kansy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gubernator, K.</span><span> </span><span class="NLM_article-title">Physicochemical High Throughput Screening: Parallel Artificial Membrane Permeation Assay in the Description of Passive Absorption Processes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1007</span><span class="NLM_x">–</span> <span class="NLM_lpage">1010</span><span class="refDoi"> DOI: 10.1021/jm970530e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm970530e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADyaK1cXhs12kt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=1007-1010&author=M.+Kansyauthor=F.+Sennerauthor=K.+Gubernator&title=Physicochemical+High+Throughput+Screening%3A+Parallel+Artificial+Membrane+Permeation+Assay+in+the+Description+of+Passive+Absorption+Processes&doi=10.1021%2Fjm970530e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Physicochemical High Throughput Screening: Parallel Artificial Membrane Permeation Assay in the Description of Passive Absorption Processes</span></div><div class="casAuthors">Kansy, Manfred; Senner, Frank; Gubernator, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1007-1010</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The majority of pharmaceutical discovery projects aim for an orally available form of a new therapeutic principle.  One obstacle for per oral treatment is intestinal absorption.  A simple predictive exptl. method to assess the potential of intestinal absorption is therefore highly welcome.  The authors describe here the PAMPA (Parallel Artificial Membrane Permeation Assay) method, a simple, robust, high throughput screen (HTS) which has been shown to be predictive for passive diffusion through membranes and thus for oral absorption.  In addn. PAMPA can deliver information in parallel on the lipophilicity, the ionization state and the soly. of a compd.  Therefore PAMPA complements HTS, combinatorial chem. and parallel synthesis efforts in preclin. pharmaceutical research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqcwCGodCr1rVg90H21EOLACvtfcHk0lgshUECQOjN3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhs12kt70%253D&md5=85d8ab409313b583de52348eb4d895da</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm970530e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970530e%26sid%3Dliteratum%253Aachs%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DSenner%26aufirst%3DF.%26aulast%3DGubernator%26aufirst%3DK.%26atitle%3DPhysicochemical%2520High%2520Throughput%2520Screening%253A%2520Parallel%2520Artificial%2520Membrane%2520Permeation%2520Assay%2520in%2520the%2520Description%2520of%2520Passive%2520Absorption%2520Processes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D1007%26epage%3D1010%26doi%3D10.1021%2Fjm970530e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Sarathy, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuccotto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsinpin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandberg, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Via, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marriner, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masquelin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyatt, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dartois, V.</span><span> </span><span class="NLM_article-title">Prediction of Drug Penetration in Tuberculosis Lesions</span> <span class="citation_source-journal">ACS Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">552</span><span class="NLM_x">–</span> <span class="NLM_lpage">563</span><span class="refDoi"> DOI: 10.1021/acsinfecdis.6b00051</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.6b00051" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVCjtr%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2016&pages=552-563&author=J.+P.+Sarathyauthor=F.+Zuccottoauthor=H.+Hsinpinauthor=L.+Sandbergauthor=L.+E.+Viaauthor=G.+A.+Marrinerauthor=T.+Masquelinauthor=P.+G.+Wyattauthor=P.+C.+Rayauthor=V.+Dartois&title=Prediction+of+Drug+Penetration+in+Tuberculosis+Lesions&doi=10.1021%2Facsinfecdis.6b00051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of Drug Penetration in Tuberculosis Lesions</span></div><div class="casAuthors">Sarathy, Jansy P.; Zuccotto, Fabio; Hsinpin, Ho; Sandberg, Lars; Via, Laura E.; Marriner, Gwendolyn A.; Masquelin, Thierry; Wyatt, Paul; Ray, Peter; Dartois, Veronique</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">552-563</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The penetration of antibiotics in necrotic tuberculosis lesions is heterogeneous and drug-specific, but the factors underlying such differential partitioning are unknown.  We hypothesized that drug binding to macromols. in necrotic foci (or caseum) prevents passive drug diffusion through avascular caseum, a crit. site of infection.  Using a caseum binding assay and MALDI mass spectrometry imaging of tuberculosis drugs, we showed that binding to caseum inversely correlates with passive diffusion into the necrotic core.  We developed a high-throughput assay relying on rapid equil. dialysis and a caseum surrogate designed to mimic the compn. of native caseum.  A set of 279 compds. was profiled in this assay to generate a large data set and explore the physicochem. drivers of free diffusion into caseum.  Principle component anal. and modeling of the data set delivered an in silico signature predictive of caseum binding, combining 69 mol. descriptors.  Among the major pos. drivers of binding were high lipophilicity and poor soly.  Determinants of mol. shape such as the no. of rings, particularly arom. rings, no. of sp2 carbon counts, and vol.-to-surface ratio neg. correlated with the free fraction, indicating that low-mol.-wt. nonflat compds. are more likely to exhibit low caseum binding properties and diffuse effectively through caseum.  To provide simple guidance in the property-based design of new compds., a rule of thumb was derived whereby the sum of the hydrophobicity (clogP) and arom. ring count is proportional to caseum binding.  These tools can be used to ensure desirable lesion partitioning and guide the selection of optimal regimens against tuberculosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosriLLKTq-DLVg90H21EOLACvtfcHk0lg4IWUKMZYd8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVCjtr%252FJ&md5=53cd208be87cb190dc64b2f24fc008ab</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.6b00051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.6b00051%26sid%3Dliteratum%253Aachs%26aulast%3DSarathy%26aufirst%3DJ.%2BP.%26aulast%3DZuccotto%26aufirst%3DF.%26aulast%3DHsinpin%26aufirst%3DH.%26aulast%3DSandberg%26aufirst%3DL.%26aulast%3DVia%26aufirst%3DL.%2BE.%26aulast%3DMarriner%26aufirst%3DG.%2BA.%26aulast%3DMasquelin%26aufirst%3DT.%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26aulast%3DRay%26aufirst%3DP.%2BC.%26aulast%3DDartois%26aufirst%3DV.%26atitle%3DPrediction%2520of%2520Drug%2520Penetration%2520in%2520Tuberculosis%2520Lesions%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2016%26volume%3D2%26spage%3D552%26epage%3D563%26doi%3D10.1021%2Facsinfecdis.6b00051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Haverkamp, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breithardt, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camm, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janse, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antzelevitch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Escande, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, R.</span><span> </span><span class="NLM_article-title">The Potential for QT Prolongation and Proarrhythmia by Non-Antiarrhythmic Drugs: Clinical and Regulatory Implications. Report on a Policy Conference of the European Society of Cardiology</span> <span class="citation_source-journal">Eur. Heart J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1216</span><span class="NLM_x">–</span> <span class="NLM_lpage">1231</span><span class="refDoi"> DOI: 10.1053/euhj.2000.2249</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=10.1053%2Feuhj.2000.2249" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=10924311" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A280%3ADC%252BD3cvjs1aiuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2000&pages=1216-1231&author=W.+Haverkampauthor=G.+Breithardtauthor=A.+J.+Cammauthor=M.+J.+Janseauthor=M.+R.+Rosenauthor=C.+Antzelevitchauthor=D.+Escandeauthor=M.+Franzauthor=M.+Malikauthor=A.+Mossauthor=R.+Shah&title=The+Potential+for+QT+Prolongation+and+Proarrhythmia+by+Non-Antiarrhythmic+Drugs%3A+Clinical+and+Regulatory+Implications.+Report+on+a+Policy+Conference+of+the+European+Society+of+Cardiology&doi=10.1053%2Feuhj.2000.2249"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a policy conference of the European Society of Cardiology</span></div><div class="casAuthors">Haverkamp W; Breithardt G; Camm A J; Janse M J; Rosen M R; Antzelevitch C; Escande D; Franz M; Malik M; Moss A; Shah R</div><div class="citationInfo"><span class="NLM_cas:title">European heart journal</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1216-31</span>
        ISSN:<span class="NLM_cas:issn">0195-668X</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTimf7TsooszfSAs_PE1QvifW6udTcc2ea9LHCaT-bClbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3cvjs1aiuw%253D%253D&md5=f2b59d1e8806c5d389f5435ec78925bb</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1053%2Feuhj.2000.2249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Feuhj.2000.2249%26sid%3Dliteratum%253Aachs%26aulast%3DHaverkamp%26aufirst%3DW.%26aulast%3DBreithardt%26aufirst%3DG.%26aulast%3DCamm%26aufirst%3DA.%2BJ.%26aulast%3DJanse%26aufirst%3DM.%2BJ.%26aulast%3DRosen%26aufirst%3DM.%2BR.%26aulast%3DAntzelevitch%26aufirst%3DC.%26aulast%3DEscande%26aufirst%3DD.%26aulast%3DFranz%26aufirst%3DM.%26aulast%3DMalik%26aufirst%3DM.%26aulast%3DMoss%26aufirst%3DA.%26aulast%3DShah%26aufirst%3DR.%26atitle%3DThe%2520Potential%2520for%2520QT%2520Prolongation%2520and%2520Proarrhythmia%2520by%2520Non-Antiarrhythmic%2520Drugs%253A%2520Clinical%2520and%2520Regulatory%2520Implications.%2520Report%2520on%2520a%2520Policy%2520Conference%2520of%2520the%2520European%2520Society%2520of%2520Cardiology%26jtitle%3DEur.%2520Heart%2520J.%26date%3D2000%26volume%3D21%26spage%3D1216%26epage%3D1231%26doi%3D10.1053%2Feuhj.2000.2249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Werner, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweetman, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savitski, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bantscheff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savitski, M. M.</span><span> </span><span class="NLM_article-title">Ion Coalescence of Neutron Encoded TMT 10-Plex Reporter Ions</span> <span class="citation_source-journal">Anal. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">3594</span><span class="NLM_x">–</span> <span class="NLM_lpage">3601</span><span class="refDoi"> DOI: 10.1021/ac500140s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ac500140s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjsVSlsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2014&pages=3594-3601&author=T.+Wernerauthor=G.+Sweetmanauthor=M.+F.+Savitskiauthor=T.+Mathiesonauthor=M.+Bantscheffauthor=M.+M.+Savitski&title=Ion+Coalescence+of+Neutron+Encoded+TMT+10-Plex+Reporter+Ions&doi=10.1021%2Fac500140s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Ion Coalescence of Neutron Encoded TMT 10-Plex Reporter Ions</span></div><div class="casAuthors">Werner, Thilo; Sweetman, Gavain; Savitski, Maria Faelth; Mathieson, Toby; Bantscheff, Marcus; Savitski, Mikhail M.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Chemistry (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3594-3601</span>CODEN:
                <span class="NLM_cas:coden">ANCHAM</span>;
        ISSN:<span class="NLM_cas:issn">0003-2700</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Isobaric mass tag-based quant. proteomics strategies such as iTRAQ and TMT utilize reporter ions in the low mass range of tandem MS spectra for relative quantification.  The recent extension of TMT multiplexing to 10 conditions has been enabled by utilizing neutron encoded tags with reporter ion m/z differences of 6 mDa.  The baseline resoln. of these closely spaced tags is possible due to the high resolving power of current day mass spectrometers.  In this work we evaluated the performance of the TMT10 isobaric mass tags on the Q Exactive Orbitrap mass spectrometers for the first time and demonstrated comparable quantification accuracy and precision to what can be achieved on the Orbitrap Elite mass spectrometers.  However, we discovered, upon anal. of complex proteomics samples on the Q Exactive Orbitrap mass spectrometers, that the proximate TMT10 reporter ion pairs become prone to coalescence.  The fusion of the different reporter ion signals into a single measurable entity has a detrimental effect on peptide and protein quantification.  We established that the main reason for coalescence is the commonly accepted max. ion target for MS2 spectra of 1e6 on the Q Exactive instruments.  The coalescence artifact was completely removed by lowering the max. ion target for MS2 spectra from 1e6 to 2e5 without any losses in identification depth or quantification quality of proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWEX7QZakgM7Vg90H21EOLACvtfcHk0li0GDrdQ1V8hQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjsVSlsrc%253D&md5=da3546478628dff1b4a1775491a621d5</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fac500140s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fac500140s%26sid%3Dliteratum%253Aachs%26aulast%3DWerner%26aufirst%3DT.%26aulast%3DSweetman%26aufirst%3DG.%26aulast%3DSavitski%26aufirst%3DM.%2BF.%26aulast%3DMathieson%26aufirst%3DT.%26aulast%3DBantscheff%26aufirst%3DM.%26aulast%3DSavitski%26aufirst%3DM.%2BM.%26atitle%3DIon%2520Coalescence%2520of%2520Neutron%2520Encoded%2520TMT%252010-Plex%2520Reporter%2520Ions%26jtitle%3DAnal.%2520Chem.%26date%3D2014%26volume%3D86%26spage%3D3594%26epage%3D3601%26doi%3D10.1021%2Fac500140s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 13 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Vinayak Singh, <span class="NLM_string-name hlFld-ContribAuthor">Kelly Chibale</span>. </span><span class="cited-content_cbyCitation_article-title">Strategies to Combat Multi-Drug Resistance in Tuberculosis. </span><span class="cited-content_cbyCitation_journal-name">Accounts of Chemical Research</span><span> <strong>2021,</strong> <em>54 </em>
                                    (10)
                                     , 2361-2376. <a href="https://doi.org/10.1021/acs.accounts.0c00878" title="DOI URL">https://doi.org/10.1021/acs.accounts.0c00878</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.accounts.0c00878&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.accounts.0c00878%26sid%3Dliteratum%253Aachs%26jtitle%3DAccounts%2520of%2520Chemical%2520Research%26atitle%3DStrategies%252Bto%252BCombat%252BMulti-Drug%252BResistance%252Bin%252BTuberculosis%26aulast%3DSingh%26aufirst%3DVinayak%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D24122020%26date%3D22042021%26volume%3D54%26issue%3D10%26spage%3D2361%26epage%3D2376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Candice Soares de Melo, Vinayak Singh, Alissa Myrick, Sandile B. Simelane, Dale Taylor, Christel Brunschwig, Nina Lawrence, Dirk Schnappinger, Curtis A. Engelhart, Anuradha Kumar, Tanya Parish, Qin Su, Timothy G. Myers, Helena I. M. Boshoff, Clifton E. Barry, III, Frederick A. Sirgel, Paul D. van Helden, Kirsteen I. Buchanan, Tracy Bayliss, Simon R. Green, Peter C. Ray, Paul G. Wyatt, Gregory S. Basarab, Charles J. Eyermann, Kelly Chibale, <span class="NLM_string-name hlFld-ContribAuthor">Sandeep R. Ghorpade</span>. </span><span class="cited-content_cbyCitation_article-title">Antitubercular 2-Pyrazolylpyrimidinones: Structure–Activity Relationship and Mode-of-Action Studies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (1)
                                     , 719-740. <a href="https://doi.org/10.1021/acs.jmedchem.0c01727" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01727</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01727&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01727%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAntitubercular%252B2-Pyrazolylpyrimidinones%25253A%252BStructure%2525E2%252580%252593Activity%252BRelationship%252Band%252BMode-of-Action%252BStudies%26aulast%3DSoares%2Bde%2BMelo%26aufirst%3DCandice%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D01102020%26date%3D04012021%26volume%3D64%26issue%3D1%26spage%3D719%26epage%3D740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Vadim Makarov, Elena Salina, Robert C. Reynolds, Phyo Phyo Kyaw Zin, <span class="NLM_string-name hlFld-ContribAuthor">Sean Ekins</span>. </span><span class="cited-content_cbyCitation_article-title">Molecule Property Analyses of Active Compounds for Mycobacterium tuberculosis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (17)
                                     , 8917-8955. <a href="https://doi.org/10.1021/acs.jmedchem.9b02075" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b02075</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b02075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b02075%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMolecule%252BProperty%252BAnalyses%252Bof%252BActive%252BCompounds%252Bfor%252BMycobacterium%252Btuberculosis%26aulast%3DMakarov%26aufirst%3DVadim%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D13122019%26date%3D20042020%26date%3D07042020%26volume%3D63%26issue%3D17%26spage%3D8917%26epage%3D8955" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chané  Erasmus</span>, <span class="hlFld-ContribAuthor ">Janine  Aucamp</span>, <span class="hlFld-ContribAuthor ">Frans J.  Smit</span>, <span class="hlFld-ContribAuthor ">Ronnett  Seldon</span>, <span class="hlFld-ContribAuthor ">Audrey  Jordaan</span>, <span class="hlFld-ContribAuthor ">Digby F.  Warner</span>, <span class="hlFld-ContribAuthor ">David D.  N'Da</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and comparison of in vitro dual anti-infective activities of novel naphthoquinone hybrids and atovaquone. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>114 </em>, 105118. <a href="https://doi.org/10.1016/j.bioorg.2021.105118" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.105118</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.105118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.105118%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DSynthesis%252Band%252Bcomparison%252Bof%252Bin%252Bvitro%252Bdual%252Banti-infective%252Bactivities%252Bof%252Bnovel%252Bnaphthoquinone%252Bhybrids%252Band%252Batovaquone%26aulast%3DErasmus%26aufirst%3DChan%25C3%25A9%26date%3D2021%26volume%3D114%26spage%3D105118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Melissa D.  Chengalroyen</span>, <span class="hlFld-ContribAuthor ">Audrey  Jordaan</span>, <span class="hlFld-ContribAuthor ">Ronnett  Seldon</span>, <span class="hlFld-ContribAuthor ">Thomas  Ioerger</span>, <span class="hlFld-ContribAuthor ">Scott G.  Franzblau</span>, <span class="hlFld-ContribAuthor ">Mohamed  Nasr</span>, <span class="hlFld-ContribAuthor ">Digby F.  Warner</span>, <span class="hlFld-ContribAuthor ">Valerie  Mizrahi</span>. </span><span class="cited-content_cbyCitation_article-title">Biological Profiling Enables Rapid Mechanistic Classification of Phenotypic Screening Hits and Identification of KatG Activation-Dependent Pyridine Carboxamide Prodrugs With Activity Against Mycobacterium tuberculosis. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Cellular and Infection Microbiology</span><span> <strong>2020,</strong> <em>10 </em><a href="https://doi.org/10.3389/fcimb.2020.582416" title="DOI URL">https://doi.org/10.3389/fcimb.2020.582416</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fcimb.2020.582416&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffcimb.2020.582416%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Cellular%2520and%2520Infection%2520Microbiology%26atitle%3DBiological%252BProfiling%252BEnables%252BRapid%252BMechanistic%252BClassification%252Bof%252BPhenotypic%252BScreening%252BHits%252Band%252BIdentification%252Bof%252BKatG%252BActivation-Dependent%252BPyridine%252BCarboxamide%252BProdrugs%252BWith%252BActivity%252BAgainst%252BMycobacterium%252Btuberculosis%26aulast%3DChengalroyen%26aufirst%3DMelissa%2BD.%26date%3D2020%26date%3D2020%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Clinton G. L.  Veale</span>, <span class="hlFld-ContribAuthor ">Ronel  Müller</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Highlights in Anti‐infective Medicinal Chemistry from South Africa. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2020,</strong> <em>15 </em>
                                    (10)
                                     , 809-826. <a href="https://doi.org/10.1002/cmdc.202000086" title="DOI URL">https://doi.org/10.1002/cmdc.202000086</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000086%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DRecent%252BHighlights%252Bin%252BAnti%2525E2%252580%252590infective%252BMedicinal%252BChemistry%252Bfrom%252BSouth%252BAfrica%26aulast%3DVeale%26aufirst%3DClinton%2BG.%2BL.%26date%3D2020%26date%3D2020%26volume%3D15%26issue%3D10%26spage%3D809%26epage%3D826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nonkululeko H.  Zuma</span>, <span class="hlFld-ContribAuthor ">Frans J.  Smit</span>, <span class="hlFld-ContribAuthor ">Ronnett  Seldon</span>, <span class="hlFld-ContribAuthor ">Janine  Aucamp</span>, <span class="hlFld-ContribAuthor ">Audrey  Jordaan</span>, <span class="hlFld-ContribAuthor ">Digby F.  Warner</span>, <span class="hlFld-ContribAuthor ">David D.  N'Da</span>. </span><span class="cited-content_cbyCitation_article-title">Single-step synthesis and in vitro anti-mycobacterial activity of novel nitrofurantoin analogues. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>96 </em>, 103587. <a href="https://doi.org/10.1016/j.bioorg.2020.103587" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.103587</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.103587&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.103587%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DSingle-step%252Bsynthesis%252Band%252Bin%252Bvitro%252Banti-mycobacterial%252Bactivity%252Bof%252Bnovel%252Bnitrofurantoin%252Banalogues%26aulast%3DZuma%26aufirst%3DNonkululeko%2BH.%26date%3D2020%26volume%3D96%26spage%3D103587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Blessing D.  Mkhonazi</span>, <span class="hlFld-ContribAuthor ">Malibongwe  Shandu</span>, <span class="hlFld-ContribAuthor ">Ronewa  Tshinavhe</span>, <span class="hlFld-ContribAuthor ">Sandile B.  Simelane</span>, <span class="hlFld-ContribAuthor ">Paseka T.  Moshapo</span>. </span><span class="cited-content_cbyCitation_article-title">Solvent-Free Iron(III) Chloride-Catalyzed Direct Amidation of Esters. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (5)
                                     , 1040. <a href="https://doi.org/10.3390/molecules25051040" title="DOI URL">https://doi.org/10.3390/molecules25051040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25051040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25051040%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSolvent-Free%252BIron%252528III%252529%252BChloride-Catalyzed%252BDirect%252BAmidation%252Bof%252BEsters%26aulast%3DMkhonazi%26aufirst%3DBlessing%2BD.%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D5%26spage%3D1040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qiuji  Cui</span>, <span class="hlFld-ContribAuthor ">Shuai  Lu</span>, <span class="hlFld-ContribAuthor ">Bingwei  Ni</span>, <span class="hlFld-ContribAuthor ">Xian  Zeng</span>, <span class="hlFld-ContribAuthor ">Ying  Tan</span>, <span class="hlFld-ContribAuthor ">Ya Dong  Chen</span>, <span class="hlFld-ContribAuthor ">Hongping  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Improved Prediction of Aqueous Solubility of Novel Compounds by Going Deeper With Deep Learning. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Oncology</span><span> <strong>2020,</strong> <em>10 </em><a href="https://doi.org/10.3389/fonc.2020.00121" title="DOI URL">https://doi.org/10.3389/fonc.2020.00121</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fonc.2020.00121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffonc.2020.00121%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Oncology%26atitle%3DImproved%252BPrediction%252Bof%252BAqueous%252BSolubility%252Bof%252BNovel%252BCompounds%252Bby%252BGoing%252BDeeper%252BWith%252BDeep%252BLearning%26aulast%3DCui%26aufirst%3DQiuji%26date%3D2020%26date%3D2020%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Romana  Machníková</span>, <span class="hlFld-ContribAuthor ">Lucie  Janovská</span>, <span class="hlFld-ContribAuthor ">Lucie  Brulíková</span>. </span><span class="cited-content_cbyCitation_article-title">Solid-phase synthetic approach towards new pyrimidines as potential antibacterial agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2020,</strong> <em>1200 </em>, 127101. <a href="https://doi.org/10.1016/j.molstruc.2019.127101" title="DOI URL">https://doi.org/10.1016/j.molstruc.2019.127101</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2019.127101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2019.127101%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DSolid-phase%252Bsynthetic%252Bapproach%252Btowards%252Bnew%252Bpyrimidines%252Bas%252Bpotential%252Bantibacterial%252Bagents%26aulast%3DMachn%25C3%25ADkov%25C3%25A1%26aufirst%3DRomana%26date%3D2020%26volume%3D1200%26spage%3D127101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Frans J.  Smit</span>, <span class="hlFld-ContribAuthor ">Ronnett  Seldon</span>, <span class="hlFld-ContribAuthor ">Janine  Aucamp</span>, <span class="hlFld-ContribAuthor ">Audrey  Jordaan</span>, <span class="hlFld-ContribAuthor ">Digby F.  Warner</span>, <span class="hlFld-ContribAuthor ">David D.  N’Da</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and antimycobacterial activity of disubstituted benzyltriazoles. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2019,</strong> <em>28 </em>
                                    (12)
                                     , 2279-2293. <a href="https://doi.org/10.1007/s00044-019-02458-7" title="DOI URL">https://doi.org/10.1007/s00044-019-02458-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-019-02458-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-019-02458-7%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DSynthesis%252Band%252Bantimycobacterial%252Bactivity%252Bof%252Bdisubstituted%252Bbenzyltriazoles%26aulast%3DSmit%26aufirst%3DFrans%2BJ.%26date%3D2019%26date%3D2019%26volume%3D28%26issue%3D12%26spage%3D2279%26epage%3D2293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hawra  Al-Ghafli</span>, <span class="hlFld-ContribAuthor ">Sahal  Al-Hajoj</span>. </span><span class="cited-content_cbyCitation_article-title">Clinical Management of Drug-resistant Mycobacterium tuberculosis Strains: Pathogen-targeted Versus Host-directed Treatment Approaches. </span><span class="cited-content_cbyCitation_journal-name">Current Pharmaceutical Biotechnology</span><span> <strong>2019,</strong> <em>20 </em>
                                    (4)
                                     , 272-284. <a href="https://doi.org/10.2174/1389201019666180731120544" title="DOI URL">https://doi.org/10.2174/1389201019666180731120544</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1389201019666180731120544&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1389201019666180731120544%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Pharmaceutical%2520Biotechnology%26atitle%3DClinical%252BManagement%252Bof%252BDrug-resistant%252BMycobacterium%252Btuberculosis%252BStrains%25253A%252BPathogen-targeted%252BVersus%252BHost-directed%252BTreatment%252BApproaches%26aulast%3DAl-Ghafli%26aufirst%3DHawra%26date%3D2019%26volume%3D20%26issue%3D4%26spage%3D272%26epage%3D284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Veronika  Šlachtová</span>, <span class="hlFld-ContribAuthor ">Lucie  Janovská</span>, <span class="hlFld-ContribAuthor ">Lucie  Brulíková</span>. </span><span class="cited-content_cbyCitation_article-title">Solid phase synthesis of new thiazolidinedione-pyrimidine conjugates and their antibacterial properties. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2019,</strong> <em>1183 </em>, 182-189. <a href="https://doi.org/10.1016/j.molstruc.2019.01.073" title="DOI URL">https://doi.org/10.1016/j.molstruc.2019.01.073</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2019.01.073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2019.01.073%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DSolid%252Bphase%252Bsynthesis%252Bof%252Bnew%252Bthiazolidinedione-pyrimidine%252Bconjugates%252Band%252Btheir%252Bantibacterial%252Bproperties%26aulast%3D%25C5%25A0lachtov%25C3%25A1%26aufirst%3DVeronika%26date%3D2019%26volume%3D1183%26spage%3D182%26epage%3D189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/medium/jm-2017-01347e_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/large/jm-2017-01347e_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01347&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/medium/jm-2017-01347e_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/large/jm-2017-01347e_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. New TB drug development candidates identified from whole cell screening.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/large/jm-2017-01347e_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01347&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/medium/jm-2017-01347e_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/large/jm-2017-01347e_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Compound <b>1</b> and biology triage data.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/large/jm-2017-01347e_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01347&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/medium/jm-2017-01347e_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/large/jm-2017-01347e_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. SAR exploration strategy.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/large/jm-2017-01347e_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01347&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/medium/jm-2017-01347e_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/large/jm-2017-01347e_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Route for the Synthesis of 6-Aminopyrimidine-4-carboxamides and Alternative Cores<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/large/jm-2017-01347e_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01347&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) amine, DIPEA, HATU, DMF, 25 °C; (ii) amine, <i>i</i>-PrOH, DIPEA, 100 °C.</p></p></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/medium/jm-2017-01347e_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/large/jm-2017-01347e_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Routes Used To Access Core Modifications<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/large/jm-2017-01347e_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01347&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) 1-(4-fluorophenyl)-<i>N</i>-methylmethanamine, Et<sub>3</sub>N, dioxane, 60 °C; (ii) aniline, Mo(CO)<sub>6</sub>, Et<sub>3</sub>N, TBAC, toluene, tetraglyme, 150 °C; (iii) (a) POCl<sub>3</sub>, 110 °C; (b) aniline, Et<sub>3</sub>N; (iv) 4-fluorobenzylamine, Et<sub>3</sub>N, dioxane, microwave, 125 °C; (v) 4-fluorobenzylamine, H<sub>2</sub>O/EtOH (1.5:1), 25 °C; (vi) LiOH, MeOH; (vii) aniline, HATU, DMF, Et<sub>3</sub>N; (viii) 4-fluorobenzaldehyde, NaBH<sub>4</sub>, EtOH; (ix) MeI, K<sub>2</sub>CO<sub>3</sub>, DMF.</p></p></figure><figure data-id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/medium/jm-2017-01347e_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/large/jm-2017-01347e_0010.jpeg" id="rightTab-GRAPHIC-d183e1258-autogenerated" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of <b>27</b> and <b>28</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/large/jm-2017-01347e_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01347&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) (a) KOH, EtOH; (b) HCl; (ii) SOCl<sub>2</sub>, DMF; (iii) 1-(4-fluorophenyl)-<i>N</i>-methylmethanamine, K<sub>2</sub>CO<sub>3</sub>, DMF; (iv) LiOH, H<sub>2</sub>O:/THF (2:1), 25 °C; (v) HATU, DIPEA, DMF, 25 °C; (vi) (COCl)<sub>2</sub>, EtOAc, aniline; (vii) 1-(4-chlorophenyl)-<i>N</i>-methylmethanamine, <i>i</i>-PrOH, DIPEA, 100 °C.</p></p></figure><figure data-id="sch4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/medium/jm-2017-01347e_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/large/jm-2017-01347e_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. General Route for the Synthesis of 6-Aminopyrimidine-4-carboxamides and Selected Core Modifications<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/large/jm-2017-01347e_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01347&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) R-CH<sub>2</sub>NHCH<sub>3</sub>, THF, 0 °C; (ii) 10% Pd/C, H<sub>2</sub>, MeOH; (iii) LiOH, MeOH; (iv) amine, DIPEA, HATU, DMF; (v) LiOH, THF/H<sub>2</sub>O (1:1); (vi) NH<sub>3</sub> or cyclopropylamine, <i>i</i>-PrOH, Et<sub>3</sub>N, 100 °C.</p></p></figure><figure data-id="sch5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/medium/jm-2017-01347e_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/large/jm-2017-01347e_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthetic Schemes Used To Access Reverse Amide and Amide Isosteres<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/large/jm-2017-01347e_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01347&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) BzCl, DIPEA, THF, rt to 50 °C; (ii) 1-(4-fluorophenyl)-<i>N</i>-methylmethanamine, <i>i</i>-PrOH, Et<sub>3</sub>N, 100 °C; (iii) HATU, Et<sub>3</sub>N, <i>N</i>,<i>O</i>-dimethylhydroxylamine, DMF, rt; (iv) (a) TMS-CF<sub>3</sub>, toluene, 20% CsF; (b) TBAF, H<sub>2</sub>O, 50 °C; (v) 4-fluoroaniline, NaCNBH<sub>3</sub>, Et<sub>3</sub>N, TiCl<sub>4</sub>, MeOH, DCM (50:50), N<sub>2</sub>; (vi) benzonitrile, K<sub>2</sub>CO<sub>3</sub>, BuOH, 120 °C.</p></p></figure><figure data-id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/medium/jm-2017-01347e_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/large/jm-2017-01347e_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Summary of SAR.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/large/jm-2017-01347e_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01347&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/medium/jm-2017-01347e_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/large/jm-2017-01347e_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Affinity chemoproteomics revealed BCG_3193 and BCG_3827, novel TB targets with unknown function, as targets of the 6-dialkylaminopyrimidine carboxamides. (A) BCG_3193 and BCG_3827 show reduced binding to 6-dialkylaminopyrimidine carboxamide analogue beads due to compound <b>40</b> binding, but no effect on these proteins was seen by the inactive compound. Shown are relative protein amounts captured by the beads in a log 2 scale. (B) Compound structures used for the affinity chemoproteomics experiments. (C) The apparent dissociation constant of compound <b>40</b> for BCG_3193 was determined in two different experiments as 0.61 μM and 0.69 μM and for BCG_3827 as 2.1 μM and 3.8 μM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01347/20171221/images/large/jm-2017-01347e_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01347&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i95">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70655" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70655" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 37 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span>World Health Organisation. Global Tuberculosis Report. <a href="http://apps.who.int/iris/bitstream/10665/250441/1/9789241565394-eng.pdf?ua=1" class="extLink">http://apps.who.int/iris/bitstream/10665/250441/1/9789241565394-eng.pdf?ua=1</a> (accessed Dec 12,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=World+Health+Organisation.+Global+Tuberculosis+Report.+http%3A%2F%2Fapps.who.int%2Firis%2Fbitstream%2F10665%2F250441%2F1%2F9789241565394-eng.pdf%3Fua%3D1+%28accessed+Dec+12%2C+2016%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Dover, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coxon, G. D.</span><span> </span><span class="NLM_article-title">Current Status and Research Strategies in Tuberculosis Drug Development Miniperspective</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">6157</span><span class="NLM_x">–</span> <span class="NLM_lpage">6165</span><span class="refDoi"> DOI: 10.1021/jm200305q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200305q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=6157-6165&author=L.+G.+Doverauthor=G.+D.+Coxon&title=Current+Status+and+Research+Strategies+in+Tuberculosis+Drug+Development+Miniperspective&doi=10.1021%2Fjm200305q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Fjm200305q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200305q%26sid%3Dliteratum%253Aachs%26aulast%3DDover%26aufirst%3DL.%2BG.%26aulast%3DCoxon%26aufirst%3DG.%2BD.%26atitle%3DCurrent%2520Status%2520and%2520Research%2520Strategies%2520in%2520Tuberculosis%2520Drug%2520Development%2520Miniperspective%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D6157%26epage%3D6165%26doi%3D10.1021%2Fjm200305q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Olaru, I. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lange, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heyckendorf, J.</span><span> </span><span class="NLM_article-title">Personalized Medicine for Patients with MDR-TB</span> <span class="citation_source-journal">J. Antimicrob. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">852</span><span class="NLM_x">–</span> <span class="NLM_lpage">855</span><span class="refDoi"> DOI: 10.1093/jac/dkv354</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=10.1093%2Fjac%2Fdkv354" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=26507429" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFyltrzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2016&pages=852-855&author=I.+D.+Olaruauthor=C.+Langeauthor=J.+Heyckendorf&title=Personalized+Medicine+for+Patients+with+MDR-TB&doi=10.1093%2Fjac%2Fdkv354"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Personalized medicine for patients with MDR-TB</span></div><div class="casAuthors">Olaru, Ioana D.; Lange, Christoph; Heyckendorf, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">852-855</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">A review.  The emergence of MDR-TB is a cause of great concern due to difficulties in patient management and poor treatment outcomes.  Currently the duration of treatment and the choice of drugs for patients with MDR-TB are standardized in many countries.  This might not be the best approach since the optimal therapy may depend on different pathogen- and host-related features.  Combining the introduction of technol. innovations such as whole bacillary genome sequencing for the identification of drug-resistance-assocd. mutations, therapeutic drug monitoring and host-directed therapies with an individualized approach to MDR-TB management will likely lead to more tolerable, shorter and more efficient treatment regimens and an increase in the quality of life of those affected by MDR-TB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEel9T6BdndrVg90H21EOLACvtfcHk0lj-ZWfbR_98ZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFyltrzE&md5=c75a5f06760614e994deda46fa5f0a8f</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkv354&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkv354%26sid%3Dliteratum%253Aachs%26aulast%3DOlaru%26aufirst%3DI.%2BD.%26aulast%3DLange%26aufirst%3DC.%26aulast%3DHeyckendorf%26aufirst%3DJ.%26atitle%3DPersonalized%2520Medicine%2520for%2520Patients%2520with%2520MDR-TB%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2016%26volume%3D71%26spage%3D852%26epage%3D855%26doi%3D10.1093%2Fjac%2Fdkv354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Warner, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizrahi, V.</span><span> </span><span class="NLM_article-title">Shortening Treatment for Tuberculosis - Back to Basics</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">371</span><span class="NLM_x">, </span> <span class="NLM_fpage">1642</span><span class="NLM_x">–</span> <span class="NLM_lpage">1643</span><span class="refDoi"> DOI: 10.1056/NEJMe1410977</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=10.1056%2FNEJMe1410977" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=25337754" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVSlurzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2014&pages=1642-1643&author=D.+F.+Warnerauthor=V.+Mizrahi&title=Shortening+Treatment+for+Tuberculosis+-+Back+to+Basics&doi=10.1056%2FNEJMe1410977"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Shortening treatment for tuberculosis - back to basics</span></div><div class="casAuthors">Warner, Digby F.; Mizrahi, Valerie</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">371</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">1642-1643, 2 pp.</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSmHouUi5u-7Vg90H21EOLACvtfcHk0lj9-sBH5791qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVSlurzM&md5=2f7287c4dded7f468f73ff4674db201d</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1056%2FNEJMe1410977&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMe1410977%26sid%3Dliteratum%253Aachs%26aulast%3DWarner%26aufirst%3DD.%2BF.%26aulast%3DMizrahi%26aufirst%3DV.%26atitle%3DShortening%2520Treatment%2520for%2520Tuberculosis%2520-%2520Back%2520to%2520Basics%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2014%26volume%3D371%26spage%3D1642%26epage%3D1643%26doi%3D10.1056%2FNEJMe1410977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Andries, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhasselt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guillemont, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gohlmann, H. W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neefs, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winkler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Gestel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timmerman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Chaffoy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huitric, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cambau, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truffot-Pernot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lounis, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarlier, V.</span><span> </span><span class="NLM_article-title">A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium Tuberculosis</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">307</span><span class="NLM_x">, </span> <span class="NLM_fpage">223</span><span class="NLM_x">–</span> <span class="NLM_lpage">227</span><span class="refDoi"> DOI: 10.1126/science.1106753</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=10.1126%2Fscience.1106753" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=15591164" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisVKkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=307&publication_year=2005&pages=223-227&author=K.+Andriesauthor=P.+Verhasseltauthor=J.+Guillemontauthor=H.+W.+H.+Gohlmannauthor=J.-M.+Neefsauthor=H.+Winklerauthor=J.+Van+Gestelauthor=P.+Timmermanauthor=M.+Zhuauthor=E.+Leeauthor=P.+Williamsauthor=D.+de+Chaffoyauthor=E.+Huitricauthor=S.+Hoffnerauthor=E.+Cambauauthor=C.+Truffot-Pernotauthor=N.+Lounisauthor=V.+Jarlier&title=A+Diarylquinoline+Drug+Active+on+the+ATP+Synthase+of+Mycobacterium+Tuberculosis&doi=10.1126%2Fscience.1106753"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis</span></div><div class="casAuthors">Andries, Koen; Verhasselt, Peter; Guillemont, Jerome; Goehlmann, Hinrich W. H.; Neefs, Jean-Marc; Winkler, Hans; Van Gestel, Jef; Timmerman, Philip; Zhu, Min; Lee, Ennis; Williams, Peter; de Chaffoy, Didier; Huitric, Emma; Hoffner, Sven; Cambau, Emmanuelle; Truffot-Pernot, Chantal; Lounis, Nacer; Jarlier, Vincent</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">307</span>
        (<span class="NLM_cas:issue">5707</span>),
    <span class="NLM_cas:pages">223-227</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The incidence of tuberculosis has been increasing substantially on a worldwide basis over the past decade, but no tuberculosis-specific drugs have been discovered in 40 years.  We identified a diarylquinoline, R207910, that potently inhibits both drug-sensitive and drug-resistant Mycobacterium tuberculosis in vitro (min. inhibitory concn. 0.06 μg/mL).  In mice, R207910 exceeded the bactericidal activities of isoniazid and rifampin by at least 1 log unit.  Substitution of drugs included in the World Health Organization's first-line tuberculosis treatment regimen (rifampin, isoniazid, and pyrazinamide) with R207910 accelerated bactericidal activity, leading to complete culture conversion after 2 mo of treatment in some combinations.  A single dose of R207910 inhibited mycobacterial growth for 1 wk.  Plasma levels assocd. with efficacy in mice were well tolerated in healthy human volunteers.  Mutants selected in vitro suggest that the drug targets the proton pump of ATP (ATP) synthase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9LY7RSAIXUrVg90H21EOLACvtfcHk0lj9-sBH5791qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisVKkug%253D%253D&md5=099b643f173bb77e70cf1aa6e9871ffe</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1126%2Fscience.1106753&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1106753%26sid%3Dliteratum%253Aachs%26aulast%3DAndries%26aufirst%3DK.%26aulast%3DVerhasselt%26aufirst%3DP.%26aulast%3DGuillemont%26aufirst%3DJ.%26aulast%3DGohlmann%26aufirst%3DH.%2BW.%2BH.%26aulast%3DNeefs%26aufirst%3DJ.-M.%26aulast%3DWinkler%26aufirst%3DH.%26aulast%3DVan%2BGestel%26aufirst%3DJ.%26aulast%3DTimmerman%26aufirst%3DP.%26aulast%3DZhu%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DE.%26aulast%3DWilliams%26aufirst%3DP.%26aulast%3Dde%2BChaffoy%26aufirst%3DD.%26aulast%3DHuitric%26aufirst%3DE.%26aulast%3DHoffner%26aufirst%3DS.%26aulast%3DCambau%26aufirst%3DE.%26aulast%3DTruffot-Pernot%26aufirst%3DC.%26aulast%3DLounis%26aufirst%3DN.%26aulast%3DJarlier%26aufirst%3DV.%26atitle%3DA%2520Diarylquinoline%2520Drug%2520Active%2520on%2520the%2520ATP%2520Synthase%2520of%2520Mycobacterium%2520Tuberculosis%26jtitle%3DScience%26date%3D2005%26volume%3D307%26spage%3D223%26epage%3D227%26doi%3D10.1126%2Fscience.1106753" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Horsburgh, C. R.,  Jr</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barry, C. E.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lange, C.</span><span> </span><span class="NLM_article-title">Treatment of Tuberculosis</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">373</span><span class="NLM_x">, </span> <span class="NLM_fpage">2149</span><span class="NLM_x">–</span> <span class="NLM_lpage">2160</span><span class="refDoi"> DOI: 10.1056/NEJMra1413919</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=10.1056%2FNEJMra1413919" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=26605929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BC28XntVSkt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=373&publication_year=2015&pages=2149-2160&author=C.+R.+Horsburghauthor=C.+E.+Barryauthor=C.+Lange&title=Treatment+of+Tuberculosis&doi=10.1056%2FNEJMra1413919"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of tuberculosis</span></div><div class="casAuthors">Horsburgh, C. Robert, Jr.; Barry, Clifton E., III; Lange, Christoph</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">373</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">2149-2160</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Tuberculosis, a scourge since prehistoric times, affects more than 9 million people and causes the death of 1.5 million people each year.  Effective treatment has been available for 60 years, but such treatment takes at least 6 mo, and resistance to the drugs, which is increasing throughout the world, threatens the effectiveness of treatment.1 This review summarizes the theor. principles of tuberculosis treatment, current therapeutic approaches, areas of uncertainty, and persistent challenges.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNp74TLwDRXLVg90H21EOLACvtfcHk0lg3RY4y3qOHkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XntVSkt7o%253D&md5=96775985ab332aa82ccc4ab5481e6fe0</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1056%2FNEJMra1413919&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMra1413919%26sid%3Dliteratum%253Aachs%26aulast%3DHorsburgh%26aufirst%3DC.%2BR.%26aulast%3DBarry%26aufirst%3DC.%2BE.%26aulast%3DLange%26aufirst%3DC.%26atitle%3DTreatment%2520of%2520Tuberculosis%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2015%26volume%3D373%26spage%3D2149%26epage%3D2160%26doi%3D10.1056%2FNEJMra1413919" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Fox, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menzies, D.</span><span> </span><span class="NLM_article-title">A Review of the Evidence for Using Bedaquiline (TMC207) to Treat Multi-Drug Resistant Tuberculosis</span> <span class="citation_source-journal">Infect. Dis. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">144</span><span class="refDoi"> DOI: 10.1007/s40121-013-0009-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=10.1007%2Fs40121-013-0009-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=25134476" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A280%3ADC%252BC2M%252FjtV2rtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2013&pages=123-144&author=G.+J.+Foxauthor=D.+Menzies&title=A+Review+of+the+Evidence+for+Using+Bedaquiline+%28TMC207%29+to+Treat+Multi-Drug+Resistant+Tuberculosis&doi=10.1007%2Fs40121-013-0009-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">A Review of the Evidence for Using Bedaquiline (TMC207) to Treat Multi-Drug Resistant Tuberculosis</span></div><div class="casAuthors">Fox Gregory J; Menzies Dick</div><div class="citationInfo"><span class="NLM_cas:title">Infectious diseases and therapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">123-44</span>
        ISSN:<span class="NLM_cas:issn">2193-8229</span>.
    </div><div class="casAbstract">Existing therapies for multi-drug resistant tuberculosis (MDR-TB) have substantial limitations, in terms of their effectiveness, side-effect profile, and complexity of administration.  Bedaquiline is a novel diarylquinoline antibiotic that has recently been investigated as an adjunct to existing therapies for MDR-TB.  Currently, limited clinical data are available to evaluate the drug's safety and effectiveness.  In two small randomized-controlled clinical studies, bedaquiline given for 8 or 24 weeks has been shown to improve surrogate microbiological markers of treatment response, but trials have not yet evaluated its impact on clinical failure and relapse.  Safety concerns include an increased mortality in the bedaquiline arm of one study, an increased incidence of QT segment prolongation on electrocardiogram, and hepatotoxicity.  Until further research data are available, the use of bedaquiline should be confined to settings where carefully selected patients can be closely monitored.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTlWFOQsVg1oaNc3HjJRoFAfW6udTcc2eYRlg7vUbXYsbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M%252FjtV2rtg%253D%253D&md5=0cd964c385e6bc327878d5c5203b3f06</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1007%2Fs40121-013-0009-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40121-013-0009-3%26sid%3Dliteratum%253Aachs%26aulast%3DFox%26aufirst%3DG.%2BJ.%26aulast%3DMenzies%26aufirst%3DD.%26atitle%3DA%2520Review%2520of%2520the%2520Evidence%2520for%2520Using%2520Bedaquiline%2520%2528TMC207%2529%2520to%2520Treat%2520Multi-Drug%2520Resistant%2520Tuberculosis%26jtitle%3DInfect.%2520Dis.%2520Ther.%26date%3D2013%26volume%3D2%26spage%3D123%26epage%3D144%26doi%3D10.1007%2Fs40121-013-0009-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Manjunatha, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. W.</span><span> </span><span class="NLM_article-title">Perspective: Challenges and Opportunities in TB Drug Discovery from Phenotypic Screening</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">5087</span><span class="NLM_x">–</span> <span class="NLM_lpage">5097</span><span class="refDoi"> DOI: 10.1016/j.bmc.2014.12.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=10.1016%2Fj.bmc.2014.12.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=25577708" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BC2MXltVamtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=5087-5097&author=U.+H.+Manjunathaauthor=P.+W.+Smith&title=Perspective%3A+Challenges+and+Opportunities+in+TB+Drug+Discovery+from+Phenotypic+Screening&doi=10.1016%2Fj.bmc.2014.12.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Perspective: Challenges and opportunities in TB drug discovery from phenotypic screening</span></div><div class="casAuthors">Manjunatha, Ujjini H.; Smith, Paul W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5087-5097</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Tuberculosis poses a major global health problem and multi-drug resistant strains are increasingly prevalent.  Hence there is an urgent need to discover new TB drugs.  Cell based phenotypic screening represents a powerful approach to identify anti-mycobacterial compds. and elucidate novel targets.  Three high throughput phenotypic screens were performed at NITD against mycobacterium.  Hits were identified and chem. series selected for optimization.  This produced compds. with good in vitro anti-mycobacterial activity and pharmacokinetic properties.  Some compds. displayed oral activity in mouse efficacy models of TB.  Herein, the authors review the TB discovery efforts at NITD and share experiences in optimization of phenotypic hits, describing challenges encountered and lessons learned.  The authors also offer perspectives to facilitate future selection and advancement of phenotypic hits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGbroyRLtEcrVg90H21EOLACvtfcHk0licD8uHMIYSug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXltVamtg%253D%253D&md5=8d03c078275a58fa6629eaa9f36a5073</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.12.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.12.031%26sid%3Dliteratum%253Aachs%26aulast%3DManjunatha%26aufirst%3DU.%2BH.%26aulast%3DSmith%26aufirst%3DP.%2BW.%26atitle%3DPerspective%253A%2520Challenges%2520and%2520Opportunities%2520in%2520TB%2520Drug%2520Discovery%2520from%2520Phenotypic%2520Screening%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D5087%26epage%3D5097%26doi%3D10.1016%2Fj.bmc.2014.12.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Kana, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karakousis, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parish, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dick, T.</span><span> </span><span class="NLM_article-title">Future Target-Based Drug Discovery for Tuberculosis?</span> <span class="citation_source-journal">Tuberculosis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">551</span><span class="NLM_x">–</span> <span class="NLM_lpage">556</span><span class="refDoi"> DOI: 10.1016/j.tube.2014.10.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=10.1016%2Fj.tube.2014.10.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=25458615" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVWitL%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2014&pages=551-556&author=B.+D.+Kanaauthor=P.+C.+Karakousisauthor=T.+Parishauthor=T.+Dick&title=Future+Target-Based+Drug+Discovery+for+Tuberculosis%3F&doi=10.1016%2Fj.tube.2014.10.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Future target-based drug discovery for tuberculosis?</span></div><div class="casAuthors">Kana, Bavesh Davandra; Karakousis, Petros C.; Parish, Tanya; Dick, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Tuberculosis (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">551-556</span>CODEN:
                <span class="NLM_cas:coden">TUBECU</span>;
        ISSN:<span class="NLM_cas:issn">1472-9792</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">New drugs that retain potency against multidrug/extensively drug-resistant strains of Mycobacterium tuberculosis, with the addnl. benefit of a shortened treatment duration and ease of administration, are urgently needed by tuberculosis (TB) control programs.  Efforts to develop this new generation of treatment interventions have been plagued with numerous problems, the most significant being our insufficient understanding of mycobacterial metab. during disease.  This, combined with limited chem. diversity and poor entry of small mols. into the cell, has limited the no. of new bioactive agents that result from drug screening efforts.  The biochem., target-driven approach to drug development has been largely abandoned in the TB field, to be replaced by whole-cell or target-based whole-cell screening approaches.  In this context, the properties of a good drug target are unclear, since these are directly detd. by the ability to find compds., using current screening algorithms, which are able to kill M. tuberculosis.  In this review, we discuss issues related to the identification and validation of drug targets and highlight some key properties for promising targets.  Some of these include essentiality for growth, vulnerability, druggability, reduced propensity to evolve drug resistance and target location to facilitate ready access to drugs during chemotherapy.  We present these in the context of recent drugs that have emerged through various approaches with the aim of consolidating the knowledge gained from these experiences to inform future efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwa9Dp4ihtM7Vg90H21EOLACvtfcHk0licD8uHMIYSug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVWitL%252FE&md5=c0489ca8150d64b78842ee8edaa94bf1</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.tube.2014.10.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tube.2014.10.003%26sid%3Dliteratum%253Aachs%26aulast%3DKana%26aufirst%3DB.%2BD.%26aulast%3DKarakousis%26aufirst%3DP.%2BC.%26aulast%3DParish%26aufirst%3DT.%26aulast%3DDick%26aufirst%3DT.%26atitle%3DFuture%2520Target-Based%2520Drug%2520Discovery%2520for%2520Tuberculosis%253F%26jtitle%3DTuberculosis%26date%3D2014%26volume%3D94%26spage%3D551%26epage%3D556%26doi%3D10.1016%2Fj.tube.2014.10.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Evans, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trujillo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eoh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ehrt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnappinger, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boshoff, H. I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhee, K. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barry, C. E.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizrahi, V.</span><span> </span><span class="NLM_article-title">Validation of CoaBC as a Bactericidal Target in the Coenzyme A Pathway of Mycobacterium Tuberculosis</span> <span class="citation_source-journal">ACS Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">958</span><span class="NLM_x">–</span> <span class="NLM_lpage">968</span><span class="refDoi"> DOI: 10.1021/acsinfecdis.6b00150</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.6b00150" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFOntrrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2016&pages=958-968&author=J.+C.+Evansauthor=C.+Trujilloauthor=Z.+Wangauthor=H.+Eohauthor=S.+Ehrtauthor=D.+Schnappingerauthor=H.+I.+M.+Boshoffauthor=K.+Y.+Rheeauthor=C.+E.+Barryauthor=V.+Mizrahi&title=Validation+of+CoaBC+as+a+Bactericidal+Target+in+the+Coenzyme+A+Pathway+of+Mycobacterium+Tuberculosis&doi=10.1021%2Facsinfecdis.6b00150"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Validation of CoaBC as a Bactericidal Target in the Coenzyme A Pathway of Mycobacterium tuberculosis</span></div><div class="casAuthors">Evans, Joanna C.; Trujillo, Carolina; Wang, Zhe; Eoh, Hyungjin; Ehrt, Sabine; Schnappinger, Dirk; Boshoff, Helena I. M.; Rhee, Kyu Y.; Barry, Clifton E.; Mizrahi, Valerie</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">958-968</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mycobacterium tuberculosis relies on its own ability to biosynthesize CoA in order to meet the needs of the myriad enzymic reactions that depend on this cofactor for activity.  As such, the essential pantothenate and CoA biosynthesis pathways have attracted attention as targets for tuberculosis drug development.  To identify the optimal step for CoA pathway disruption in M. tuberculosis, we constructed and characterized a panel of conditional knockdown mutants in CoA pathway genes.  Here, we report that silencing of coaBC was bactericidal in vitro whereas silencing of panB, panC or coaE was bacteriostatic over the same time course.  Silencing of coaBC was likewise bactericidal in vivo, whether initiated at infection, or during either the acute or chronic stages of infection, confirming that CoaBC is required for M. tuberculosis to grow and persist in mice, and arguing against significant CoaBC bypass via transport and assimilation of host-derived pantetheine in this animal model.  These results provide convincing genetic validation of CoaBC as a new bactericidal drug target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfN-82uCtflLVg90H21EOLACvtfcHk0licD8uHMIYSug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFOntrrE&md5=cf81d758a786257d7c3a9f43cda60ea4</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.6b00150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.6b00150%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DJ.%2BC.%26aulast%3DTrujillo%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DEoh%26aufirst%3DH.%26aulast%3DEhrt%26aufirst%3DS.%26aulast%3DSchnappinger%26aufirst%3DD.%26aulast%3DBoshoff%26aufirst%3DH.%2BI.%2BM.%26aulast%3DRhee%26aufirst%3DK.%2BY.%26aulast%3DBarry%26aufirst%3DC.%2BE.%26aulast%3DMizrahi%26aufirst%3DV.%26atitle%3DValidation%2520of%2520CoaBC%2520as%2520a%2520Bactericidal%2520Target%2520in%2520the%2520Coenzyme%2520A%2520Pathway%2520of%2520Mycobacterium%2520Tuberculosis%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2016%26volume%3D2%26spage%3D958%26epage%3D968%26doi%3D10.1021%2Facsinfecdis.6b00150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Pethe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bifani, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiricek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeon, H. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cechetto, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christophe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kempf, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenaerts, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pham, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seo, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seo, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yim, S.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nam, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, C.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chua, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nanjundappa, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, S. P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wintjens, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nehrbass, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, S.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">No, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, S.-N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nam, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span> </span><span class="NLM_article-title">Discovery of Q203, a Potent Clinical Candidate for the Treatment of Tuberculosis</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1157</span><span class="NLM_x">–</span> <span class="NLM_lpage">1160</span><span class="refDoi"> DOI: 10.1038/nm.3262</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=10.1038%2Fnm.3262" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=23913123" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1WhtrzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=1157-1160&author=K.+Petheauthor=P.+Bifaniauthor=J.+Jangauthor=S.+Kangauthor=S.+Parkauthor=S.+Ahnauthor=J.+Jiricekauthor=J.+Jungauthor=H.+K.+Jeonauthor=J.+Cechettoauthor=T.+Christopheauthor=H.+Leeauthor=M.+Kempfauthor=M.+Jacksonauthor=A.+J.+Lenaertsauthor=H.+Phamauthor=V.+Jonesauthor=M.+J.+Seoauthor=Y.+M.+Kimauthor=M.+Seoauthor=J.+J.+Seoauthor=D.+Parkauthor=Y.+Koauthor=I.+Choiauthor=R.+Kimauthor=S.+Y.+Kimauthor=S.+Limauthor=S.-A.+Yimauthor=J.+Namauthor=H.+Kangauthor=H.+Kwonauthor=C.-T.+Ohauthor=Y.+Choauthor=Y.+Jangauthor=J.+Kimauthor=A.+Chuaauthor=B.+H.+Tanauthor=M.+B.+Nanjundappaauthor=S.+P.+S.+Raoauthor=W.+S.+Barnesauthor=R.+Wintjensauthor=J.+R.+Walkerauthor=S.+Alonsoauthor=S.+Leeauthor=J.+Kimauthor=S.+Ohauthor=T.+Ohauthor=U.+Nehrbassauthor=S.-J.+Hanauthor=Z.+Noauthor=J.+Leeauthor=P.+Brodinauthor=S.-N.+Choauthor=K.+Namauthor=J.+Kim&title=Discovery+of+Q203%2C+a+Potent+Clinical+Candidate+for+the+Treatment+of+Tuberculosis&doi=10.1038%2Fnm.3262"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis</span></div><div class="casAuthors">Pethe, Kevin; Bifani, Pablo; Jang, Jichan; Kang, Sunhee; Park, Seijin; Ahn, Sujin; Jiricek, Jan; Jung, Juyoung; Jeon, Hee Kyoung; Cechetto, Jonathan; Christophe, Thierry; Lee, Honggun; Kempf, Marie; Jackson, Mary; Lenaerts, Anne J.; Pham, Ha; Jones, Victoria; Seo, Min Jung; Kim, Young Mi; Seo, Mooyoung; Seo, Jeong Jea; Park, Dongsik; Ko, Yoonae; Choi, Inhee; Kim, Ryangyeo; Kim, Se Yeon; Lim, Seung Bin; Yim, Seung-Ae; Nam, Jiyoun; Kang, Hwankyu; Kwon, Haejin; Oh, Chun-Taek; Cho, Yoojin; Jang, Yunhee; Kim, Junghwan; Chua, Adeline; Tan, Bee Huat; Nanjundappa, Mahesh B.; Rao, Srinivasa P. S.; Barnes, Whitney S.; Wintjens, Rene; Walker, John R.; Alonso, Sylvie; Lee, Saeyeon; Kim, Jungjun; Oh, Soohyun; Oh, Taegwon; Nehrbass, Ulf; Han, Sung-Jun; No, Zaesung; Lee, Jinhwa; Brodin, Priscille; Cho, Sang-Nae; Nam, Kiyean; Kim, Jaeseung</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1157-1160</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">New therapeutic strategies are needed to combat the tuberculosis pandemic and the spread of multidrug-resistant (MDR) and extensively drug-resistant (XDR) forms of the disease, which remain a serious public health challenge worldwide.  The most urgent clin. need is to discover potent agents capable of reducing the duration of MDR and XDR tuberculosis therapy with a success rate comparable to that of current therapies for drug-susceptible tuberculosis.  The last decade has seen the discovery of new agent classes for the management of tuberculosis, several of which are currently in clin. trials.  However, given the high attrition rate of drug candidates during clin. development and the emergence of drug resistance, the discovery of addnl. clin. candidates is clearly needed.  Here, we report on a promising class of imidazopyridine amide (IPA) compds. that block Mycobacterium tuberculosis growth by targeting the respiratory cytochrome bc1 complex.  The optimized IPA compd. Q203 inhibited the growth of MDR and XDR M. tuberculosis clin. isolates in culture broth medium in the low nanomolar range and was efficacious in a mouse model of tuberculosis at a dose less than 1 mg per kg body wt., which highlights the potency of this compd.  In addn., Q203 displays pharmacokinetic and safety profiles compatible with once-daily dosing.  Together, our data indicate that Q203 is a promising new clin. candidate for the treatment of tuberculosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqNkAj8BKYybVg90H21EOLACvtfcHk0lglTMCU0UUC8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1WhtrzK&md5=b865009db53f5b4bc15948ded64ef064</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnm.3262&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.3262%26sid%3Dliteratum%253Aachs%26aulast%3DPethe%26aufirst%3DK.%26aulast%3DBifani%26aufirst%3DP.%26aulast%3DJang%26aufirst%3DJ.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DPark%26aufirst%3DS.%26aulast%3DAhn%26aufirst%3DS.%26aulast%3DJiricek%26aufirst%3DJ.%26aulast%3DJung%26aufirst%3DJ.%26aulast%3DJeon%26aufirst%3DH.%2BK.%26aulast%3DCechetto%26aufirst%3DJ.%26aulast%3DChristophe%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DH.%26aulast%3DKempf%26aufirst%3DM.%26aulast%3DJackson%26aufirst%3DM.%26aulast%3DLenaerts%26aufirst%3DA.%2BJ.%26aulast%3DPham%26aufirst%3DH.%26aulast%3DJones%26aufirst%3DV.%26aulast%3DSeo%26aufirst%3DM.%2BJ.%26aulast%3DKim%26aufirst%3DY.%2BM.%26aulast%3DSeo%26aufirst%3DM.%26aulast%3DSeo%26aufirst%3DJ.%2BJ.%26aulast%3DPark%26aufirst%3DD.%26aulast%3DKo%26aufirst%3DY.%26aulast%3DChoi%26aufirst%3DI.%26aulast%3DKim%26aufirst%3DR.%26aulast%3DKim%26aufirst%3DS.%2BY.%26aulast%3DLim%26aufirst%3DS.%26aulast%3DYim%26aufirst%3DS.-A.%26aulast%3DNam%26aufirst%3DJ.%26aulast%3DKang%26aufirst%3DH.%26aulast%3DKwon%26aufirst%3DH.%26aulast%3DOh%26aufirst%3DC.-T.%26aulast%3DCho%26aufirst%3DY.%26aulast%3DJang%26aufirst%3DY.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DChua%26aufirst%3DA.%26aulast%3DTan%26aufirst%3DB.%2BH.%26aulast%3DNanjundappa%26aufirst%3DM.%2BB.%26aulast%3DRao%26aufirst%3DS.%2BP.%2BS.%26aulast%3DBarnes%26aufirst%3DW.%2BS.%26aulast%3DWintjens%26aufirst%3DR.%26aulast%3DWalker%26aufirst%3DJ.%2BR.%26aulast%3DAlonso%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DOh%26aufirst%3DS.%26aulast%3DOh%26aufirst%3DT.%26aulast%3DNehrbass%26aufirst%3DU.%26aulast%3DHan%26aufirst%3DS.-J.%26aulast%3DNo%26aufirst%3DZ.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DBrodin%26aufirst%3DP.%26aulast%3DCho%26aufirst%3DS.-N.%26aulast%3DNam%26aufirst%3DK.%26aulast%3DKim%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520Q203%252C%2520a%2520Potent%2520Clinical%2520Candidate%2520for%2520the%2520Treatment%2520of%2520Tuberculosis%26jtitle%3DNat.%2520Med.%26date%3D2013%26volume%3D19%26spage%3D1157%26epage%3D1160%26doi%3D10.1038%2Fnm.3262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Sacksteder, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Protopopova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barry, C. E.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andries, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nacy, C. A.</span><span> </span><span class="NLM_article-title">Discovery and Development of SQ109: A New Antitubercular Drug with a Novel Mechanism of Action</span> <span class="citation_source-journal">Future Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">823</span><span class="NLM_x">–</span> <span class="NLM_lpage">837</span><span class="refDoi"> DOI: 10.2217/fmb.12.56</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=10.2217%2Ffmb.12.56" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=22827305" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtV2isLbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=823-837&author=K.+A.+Sackstederauthor=M.+Protopopovaauthor=C.+E.+Barryauthor=K.+Andriesauthor=C.+A.+Nacy&title=Discovery+and+Development+of+SQ109%3A+A+New+Antitubercular+Drug+with+a+Novel+Mechanism+of+Action&doi=10.2217%2Ffmb.12.56"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and development of SQ109: a new antitubercular drug with a novel mechanism of action</span></div><div class="casAuthors">Sacksteder, Katherine A.; Protopopova, Marina; Barry, Clifton E.; Andries, Koen; Nacy, Carol A.</div><div class="citationInfo"><span class="NLM_cas:title">Future Microbiology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">823-837</span>CODEN:
                <span class="NLM_cas:coden">FMUIAR</span>;
        ISSN:<span class="NLM_cas:issn">1746-0913</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">A review.  Existing drugs have limited efficacy against the rising threat of drug-resistant TB, have significant side effects, and must be given in combinations of four to six drugs for at least 6 mo for drug-sensitive TB and up to 24 mo for drug-resistant TB.  The long treatment duration has led to increased patient noncompliance with therapy.  This, in turn, drives the development of addnl. drug resistance in a spiral that has resulted in some forms of TB being currently untreatable by existing drugs.  New antitubercular drugs in development, particularly those with mechanisms of action that are different from existing first- and second-line TB drugs, are anticipated to be effective against both drug-sensitive and drug-resistant TB.  SQ109 is a new TB drug candidate with a novel mechanism of action that was safe and well tolerated in Phase I and early Phase II clin. trials.  We describe herein the identification, development and characterization of SQ109 as a promising new antitubercular drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrm7rdJnt1LOrVg90H21EOLACvtfcHk0lhCZmLaSgfSpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtV2isLbM&md5=c4aaa50d56d54573e6bef6b514c38753</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2217%2Ffmb.12.56&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Ffmb.12.56%26sid%3Dliteratum%253Aachs%26aulast%3DSacksteder%26aufirst%3DK.%2BA.%26aulast%3DProtopopova%26aufirst%3DM.%26aulast%3DBarry%26aufirst%3DC.%2BE.%26aulast%3DAndries%26aufirst%3DK.%26aulast%3DNacy%26aufirst%3DC.%2BA.%26atitle%3DDiscovery%2520and%2520Development%2520of%2520SQ109%253A%2520A%2520New%2520Antitubercular%2520Drug%2520with%2520a%2520Novel%2520Mechanism%2520of%2520Action%26jtitle%3DFuture%2520Microbiol.%26date%3D2012%26volume%3D7%26spage%3D823%26epage%3D837%26doi%3D10.2217%2Ffmb.12.56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Xu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meshcheryakov, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poce, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chng, S.-S.</span><span> </span><span class="NLM_article-title">MmpL3 Is the Flippase for Mycolic Acids in Mycobacteria</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">7993</span><span class="NLM_x">–</span> <span class="NLM_lpage">7998</span><span class="refDoi"> DOI: 10.1073/pnas.1700062114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=10.1073%2Fpnas.1700062114" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=28698380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFCrtL7O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2017&pages=7993-7998&author=Z.+Xuauthor=V.+A.+Meshcheryakovauthor=G.+Poceauthor=S.-S.+Chng&title=MmpL3+Is+the+Flippase+for+Mycolic+Acids+in+Mycobacteria&doi=10.1073%2Fpnas.1700062114"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">MmpL3 is the flippase for mycolic acids in mycobacteria</span></div><div class="casAuthors">Xu, Zhujun; Meshcheryakov, Vladimir A.; Poce, Giovanna; Chng, Shu-Sin</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">7993-7998</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The defining feature of the mycobacterial outer membrane (OM) is the presence of mycolic acids (MAs), which, in part, render the bilayer extremely hydrophobic and impermeable to external insults, including many antibiotics.  Although the biosynthetic pathway of MAs is well studied, the mechanism(s) by which these lipids are transported across the cell envelope is(are) much less known.  Mycobacterial membrane protein Large 3 (MmpL3), an essential inner membrane (IM) protein, is implicated in MA transport, but its exact function has not been elucidated.  It is believed to be the cellular target of several antimycobacterial compds.; however, evidence for direct inhibition of MmpL3 activity is also lacking.  Here, we establish that MmpL3 is the MA flippase at the IM of mycobacteria and is the mol. target of BM212, a 1,5-diarylpyrrole compd.  We develop assays that selectively access mycolates on the surface of Mycobacterium smegmatis spheroplasts, allowing us to monitor flipping of MAs across the IM.  Using these assays, we establish the mechanism of action of BM212 as a potent MmpL3 inhibitor, and use it as a mol. probe to demonstrate the requirement for functional MmpL3 in the transport of MAs across the IM.  Finally, we show that BM212 binds MmpL3 directly and inhibits its activity.  Our work provides fundamental insights into OM biogenesis and MA transport in mycobacteria.  Furthermore, our assays serve as an important platform for accelerating the validation of small mols. that target MmpL3, and their development as future antituberculosis drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWxm4S6r1fJLVg90H21EOLACvtfcHk0lhCZmLaSgfSpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFCrtL7O&md5=1c8a806ca2a1eaebefe7c1e6bf3bcab9</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1700062114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1700062114%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DMeshcheryakov%26aufirst%3DV.%2BA.%26aulast%3DPoce%26aufirst%3DG.%26aulast%3DChng%26aufirst%3DS.-S.%26atitle%3DMmpL3%2520Is%2520the%2520Flippase%2520for%2520Mycolic%2520Acids%2520in%2520Mycobacteria%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2017%26volume%3D114%26spage%3D7993%26epage%3D7998%26doi%3D10.1073%2Fpnas.1700062114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Makarov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lechartier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neres, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Sar, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raadsen, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartkoorn, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryabova, O. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vocat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decosterd, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Widmer, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buclin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bitter, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andries, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pojer, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyson, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, S. T.</span><span> </span><span class="NLM_article-title">Towards a New Combination Therapy for Tuberculosis with next Generation Benzothiazinones</span> <span class="citation_source-journal">EMBO Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">372</span><span class="NLM_x">–</span> <span class="NLM_lpage">383</span><span class="refDoi"> DOI: 10.1002/emmm.201303575</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=10.1002%2Femmm.201303575" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=24500695" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjvVyjtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=372-383&author=V.+Makarovauthor=B.+Lechartierauthor=M.+Zhangauthor=J.+Neresauthor=A.+M.+van+der+Sarauthor=S.+A.+Raadsenauthor=R.+C.+Hartkoornauthor=O.+B.+Ryabovaauthor=A.+Vocatauthor=L.+A.+Decosterdauthor=N.+Widmerauthor=T.+Buclinauthor=W.+Bitterauthor=K.+Andriesauthor=F.+Pojerauthor=P.+J.+Dysonauthor=S.+T.+Cole&title=Towards+a+New+Combination+Therapy+for+Tuberculosis+with+next+Generation+Benzothiazinones&doi=10.1002%2Femmm.201303575"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Towards a new combination therapy for tuberculosis with next generation benzothiazinones</span></div><div class="casAuthors">Makarov, Vadim; Lechartier, Benoit; Zhang, Ming; Neres, Joao; van der Sar, Astrid M.; Raadsen, Susanne A.; Hartkoorn, Ruben C.; Ryabova, Olga B.; Vocat, Anthony; Decosterd, Laurent A.; Widmer, Nicolas; Buclin, Thierry; Bitter, Wilbert; Andries, Koen; Pojer, Florence; Dyson, Paul J.; Cole, Stewart T.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">372-383</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The benzothiazinone lead compd., BTZ043, kills Mycobacterium tuberculosis by inhibiting the essential flavo-enzyme DprE1, decaprenylphosphoryl-beta-D-ribose 2-epimerase.  Here, we synthesized a new series of piperazine-contg. benzothiazinones (PBTZ) and show that, like BTZ043, the preclin. candidate PBTZ169 binds covalently to DprE1.  The crystal structure of the DprE1-PBTZ169 complex reveals formation of a semimercaptal adduct with Cys387 in the active site and explains the irreversible inactivation of the enzyme.  Compared to BTZ043, PBTZ169 has improved potency, safety and efficacy in zebrafish and mouse models of tuberculosis (TB).  When combined with other TB drugs, PBTZ169 showed additive activity against M. tuberculosis in vitro except with bedaquiline (BDQ) where synergy was obsd.  A new regimen comprising PBTZ169, BDQ and pyrazinamide was found to be more efficacious than the std. three drug treatment in a murine model of chronic disease.  PBTZ169 is thus an attractive drug candidate to treat TB in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_BD_M46wCiLVg90H21EOLACvtfcHk0lhWtE9jiTPn-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjvVyjtLw%253D&md5=5393e68ca6f35be17ae10a397b443907</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1002%2Femmm.201303575&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Femmm.201303575%26sid%3Dliteratum%253Aachs%26aulast%3DMakarov%26aufirst%3DV.%26aulast%3DLechartier%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DNeres%26aufirst%3DJ.%26aulast%3Dvan%2Bder%2BSar%26aufirst%3DA.%2BM.%26aulast%3DRaadsen%26aufirst%3DS.%2BA.%26aulast%3DHartkoorn%26aufirst%3DR.%2BC.%26aulast%3DRyabova%26aufirst%3DO.%2BB.%26aulast%3DVocat%26aufirst%3DA.%26aulast%3DDecosterd%26aufirst%3DL.%2BA.%26aulast%3DWidmer%26aufirst%3DN.%26aulast%3DBuclin%26aufirst%3DT.%26aulast%3DBitter%26aufirst%3DW.%26aulast%3DAndries%26aufirst%3DK.%26aulast%3DPojer%26aufirst%3DF.%26aulast%3DDyson%26aufirst%3DP.%2BJ.%26aulast%3DCole%26aufirst%3DS.%2BT.%26atitle%3DTowards%2520a%2520New%2520Combination%2520Therapy%2520for%2520Tuberculosis%2520with%2520next%2520Generation%2520Benzothiazinones%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2014%26volume%3D6%26spage%3D372%26epage%3D383%26doi%3D10.1002%2Femmm.201303575" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Shirude, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shandil, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosagrahara, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hameed, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinde, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bathula, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humnabadkar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panduga, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ambady, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hegde, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whiteaker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLaughlin, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madhavapeddi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramachandran, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaur, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narayan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guptha, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Awasthy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narayan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahadevaswamy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vishwas, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahuja, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prabhakar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bharath, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kale, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramaiah, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choudhury, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sambandamurthy, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solapure, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyer, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narayanan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatterji, M.</span><span> </span><span class="NLM_article-title">Azaindoles: Noncovalent DprE1 Inhibitors from Scaffold Morphing Efforts, Kill Mycobacterium Tuberculosis and Are Efficacious in Vivo</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">9701</span><span class="NLM_x">–</span> <span class="NLM_lpage">9708</span><span class="refDoi"> DOI: 10.1021/jm401382v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm401382v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslCku7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=9701-9708&author=P.+S.+Shirudeauthor=R.+Shandilauthor=C.+Sadlerauthor=M.+Naikauthor=V.+Hosagraharaauthor=S.+Hameedauthor=V.+Shindeauthor=C.+Bathulaauthor=V.+Humnabadkarauthor=N.+Kumarauthor=J.+Reddyauthor=V.+Pandugaauthor=S.+Sharmaauthor=A.+Ambadyauthor=N.+Hegdeauthor=J.+Whiteakerauthor=R.+E.+McLaughlinauthor=H.+Gardnerauthor=P.+Madhavapeddiauthor=V.+Ramachandranauthor=P.+Kaurauthor=A.+Narayanauthor=S.+Gupthaauthor=D.+Awasthyauthor=C.+Narayanauthor=J.+Mahadevaswamyauthor=K.+Vishwasauthor=V.+Ahujaauthor=A.+Srivastavaauthor=K.+Prabhakarauthor=S.+Bharathauthor=R.+Kaleauthor=M.+Ramaiahauthor=N.+R.+Choudhuryauthor=V.+K.+Sambandamurthyauthor=S.+Solapureauthor=P.+S.+Iyerauthor=S.+Narayananauthor=M.+Chatterji&title=Azaindoles%3A+Noncovalent+DprE1+Inhibitors+from+Scaffold+Morphing+Efforts%2C+Kill+Mycobacterium+Tuberculosis+and+Are+Efficacious+in+Vivo&doi=10.1021%2Fjm401382v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Azaindoles: Noncovalent DprE1 Inhibitors from Scaffold Morphing Efforts, Kill Mycobacterium tuberculosis and Are Efficacious in Vivo</span></div><div class="casAuthors">Shirude, Pravin S.; Shandil, Radha; Sadler, Claire; Naik, Maruti; Hosagrahara, Vinayak; Hameed, Shahul; Shinde, Vikas; Bathula, Chandramohan; Humnabadkar, Vaishali; Kumar, Naveen; Reddy, Jitendar; Panduga, Vijender; Sharma, Sreevalli; Ambady, Anisha; Hegde, Naina; Whiteaker, James; McLaughlin, Robert E.; Gardner, Humphrey; Madhavapeddi, Prashanti; Ramachandran, Vasanthi; Kaur, Parvinder; Narayan, Ashwini; Guptha, Supreeth; Awasthy, Disha; Narayan, Chandan; Mahadevaswamy, Jyothi; Vishwas, K. G.; Ahuja, Vijaykamal; Srivastava, Abhishek; Prabhakar, K. R.; Bharath, Sowmya; Kale, Ramesh; Ramaiah, Manjunatha; Choudhury, Nilanjana Roy; Sambandamurthy, Vasan K.; Solapure, Suresh; Iyer, Pravin S.; Narayanan, Shridhar; Chatterji, Monalisa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9701-9708</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report 1,4-azaindoles as a new inhibitor class that kills Mycobacterium tuberculosis in vitro and demonstrates efficacy in mouse tuberculosis models.  The series emerged from scaffold morphing efforts and was demonstrated to noncovalently inhibit decaprenylphosphoryl-β-d-ribose2'-epimerase (DprE1).  With "drug-like" properties and no expectation of pre-existing resistance in the clinic, this chem. class has the potential to be developed as a therapy for drug-sensitive and drug-resistant tuberculosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqskQvJK4M2yrVg90H21EOLACvtfcHk0lh4oM5LD-ctGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslCku7fM&md5=eba42d1952b164f66fd0ca620aaa4f19</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm401382v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401382v%26sid%3Dliteratum%253Aachs%26aulast%3DShirude%26aufirst%3DP.%2BS.%26aulast%3DShandil%26aufirst%3DR.%26aulast%3DSadler%26aufirst%3DC.%26aulast%3DNaik%26aufirst%3DM.%26aulast%3DHosagrahara%26aufirst%3DV.%26aulast%3DHameed%26aufirst%3DS.%26aulast%3DShinde%26aufirst%3DV.%26aulast%3DBathula%26aufirst%3DC.%26aulast%3DHumnabadkar%26aufirst%3DV.%26aulast%3DKumar%26aufirst%3DN.%26aulast%3DReddy%26aufirst%3DJ.%26aulast%3DPanduga%26aufirst%3DV.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DAmbady%26aufirst%3DA.%26aulast%3DHegde%26aufirst%3DN.%26aulast%3DWhiteaker%26aufirst%3DJ.%26aulast%3DMcLaughlin%26aufirst%3DR.%2BE.%26aulast%3DGardner%26aufirst%3DH.%26aulast%3DMadhavapeddi%26aufirst%3DP.%26aulast%3DRamachandran%26aufirst%3DV.%26aulast%3DKaur%26aufirst%3DP.%26aulast%3DNarayan%26aufirst%3DA.%26aulast%3DGuptha%26aufirst%3DS.%26aulast%3DAwasthy%26aufirst%3DD.%26aulast%3DNarayan%26aufirst%3DC.%26aulast%3DMahadevaswamy%26aufirst%3DJ.%26aulast%3DVishwas%26aufirst%3DK.%26aulast%3DAhuja%26aufirst%3DV.%26aulast%3DSrivastava%26aufirst%3DA.%26aulast%3DPrabhakar%26aufirst%3DK.%26aulast%3DBharath%26aufirst%3DS.%26aulast%3DKale%26aufirst%3DR.%26aulast%3DRamaiah%26aufirst%3DM.%26aulast%3DChoudhury%26aufirst%3DN.%2BR.%26aulast%3DSambandamurthy%26aufirst%3DV.%2BK.%26aulast%3DSolapure%26aufirst%3DS.%26aulast%3DIyer%26aufirst%3DP.%2BS.%26aulast%3DNarayanan%26aufirst%3DS.%26aulast%3DChatterji%26aufirst%3DM.%26atitle%3DAzaindoles%253A%2520Noncovalent%2520DprE1%2520Inhibitors%2520from%2520Scaffold%2520Morphing%2520Efforts%252C%2520Kill%2520Mycobacterium%2520Tuberculosis%2520and%2520Are%2520Efficacious%2520in%2520Vivo%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D9701%26epage%3D9708%26doi%3D10.1021%2Fjm401382v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Chatterji, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shandil, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manjunatha, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solapure, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramachandran, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saralaya, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panduga, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">KR, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mdluli, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iyer, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narayanan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirude, P. S.</span><span> </span><span class="NLM_article-title">1,4-Azaindole, A Potential Drug Candidate for Treatment of Tuberculosis</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">5325</span><span class="NLM_x">–</span> <span class="NLM_lpage">5331</span><span class="refDoi"> DOI: 10.1128/AAC.03233-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=10.1128%2FAAC.03233-14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=24957839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1eqsL7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2014&pages=5325-5331&author=M.+Chatterjiauthor=R.+Shandilauthor=M.+R.+Manjunathaauthor=S.+Solapureauthor=V.+Ramachandranauthor=N.+Kumarauthor=R.+Saralayaauthor=V.+Pandugaauthor=J.+Reddyauthor=P.+KRauthor=S.+Sharmaauthor=C.+Sadlerauthor=C.+B.+Cooperauthor=K.+Mdluliauthor=P.+S.+Iyerauthor=S.+Narayananauthor=P.+S.+Shirude&title=1%2C4-Azaindole%2C+A+Potential+Drug+Candidate+for+Treatment+of+Tuberculosis&doi=10.1128%2FAAC.03233-14"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">1,4-azaindole, a potential drug candidate for treatment of tuberculosis</span></div><div class="casAuthors">Chatterji, Monalisa; Shandil, Radha; Manjunatha, M. R.; Solapure, Suresh; Ramachandran, Vasanthi; Kumar, Naveen; Saralaya, Ramanatha; Panduga, Vijender; Reddy, Jitendar; Prabhakar, K. R.; Sharma, Sreevalli; Sadler, Claire; Cooper, Christopher B.; Mdluli, Khisi; Iyer, Pravin S.; Narayanan, Shridhar; Shirude, Pravin S.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">5325-5331, 8 pp.</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">New therapeutic strategies against multidrug-resistant (MDR) and extensively drug-resistant (XDR) Mycobacterium tuberculosis are urgently required to combat the global tuberculosis (TB) threat.  Toward this end, we previously reported the identification of 1,4-azaindoles, a promising class of compds. with potent antitubercular activity through noncovalent inhibition of decaprenylphosphoryl-β-d-ribose 2'-epimerase (DprE1).  Further, this series was optimized to improve its physicochem. properties and pharmacokinetics in mice.  Here, we describe the short-listing of a potential clin. candidate, compd. 2, that has potent cellular activity, drug-like properties, efficacy in mouse and rat chronic TB infection models, and minimal in vitro safety risks.  We also demonstrate that the compds., including compd. 2, have no antagonistic activity with other anti-TB drugs.  Moreover, compd. 2 shows synergy with PA824 and TMC207 in vitro, and the synergy effect is translated in vivo with TMC207.  The series is predicted to have a low clearance in humans, and the predicted human dose for compd. 2 is ≤ 1 g/day.  Altogether, our data suggest that a 1,4-azaindole (compd. 2) is a promising candidate for the development of a novel anti-TB drug.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrW_tEuW_mDx7Vg90H21EOLACvtfcHk0lhas_YGt0LSjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1eqsL7N&md5=992bbd235d99bb1f8f05612966f76bc9</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1128%2FAAC.03233-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.03233-14%26sid%3Dliteratum%253Aachs%26aulast%3DChatterji%26aufirst%3DM.%26aulast%3DShandil%26aufirst%3DR.%26aulast%3DManjunatha%26aufirst%3DM.%2BR.%26aulast%3DSolapure%26aufirst%3DS.%26aulast%3DRamachandran%26aufirst%3DV.%26aulast%3DKumar%26aufirst%3DN.%26aulast%3DSaralaya%26aufirst%3DR.%26aulast%3DPanduga%26aufirst%3DV.%26aulast%3DReddy%26aufirst%3DJ.%26aulast%3DKR%26aufirst%3DP.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DSadler%26aufirst%3DC.%26aulast%3DCooper%26aufirst%3DC.%2BB.%26aulast%3DMdluli%26aufirst%3DK.%26aulast%3DIyer%26aufirst%3DP.%2BS.%26aulast%3DNarayanan%26aufirst%3DS.%26aulast%3DShirude%26aufirst%3DP.%2BS.%26atitle%3D1%252C4-Azaindole%252C%2520A%2520Potential%2520Drug%2520Candidate%2520for%2520Treatment%2520of%2520Tuberculosis%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2014%26volume%3D58%26spage%3D5325%26epage%3D5331%26doi%3D10.1128%2FAAC.03233-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Harris, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheppard, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slater, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stouten, P. F. W.</span><span> </span><span class="NLM_article-title">The Design and Application of Target-Focused Compound Libraries</span> <span class="citation_source-journal">Comb. Chem. High Throughput Screening</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">521</span><span class="NLM_x">–</span> <span class="NLM_lpage">531</span><span class="refDoi"> DOI: 10.2174/138620711795767802</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=10.2174%2F138620711795767802" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=21521154" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnvVSmu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2011&pages=521-531&author=J.+C.+Harrisauthor=R.+D.+Hillauthor=D.+W.+Sheppardauthor=M.+J.+Slaterauthor=P.+F.+W.+Stouten&title=The+Design+and+Application+of+Target-Focused+Compound+Libraries&doi=10.2174%2F138620711795767802"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The design and application of target-focused compound libraries</span></div><div class="casAuthors">Harris, C. John; Hill, Richard D.; Sheppard, David W.; Slater, Martin J.; Stouten, Pieter F. W.</div><div class="citationInfo"><span class="NLM_cas:title">Combinatorial Chemistry & High Throughput Screening</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">521-531</span>CODEN:
                <span class="NLM_cas:coden">CCHSFU</span>;
        ISSN:<span class="NLM_cas:issn">1386-2073</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Target-focused compd. libraries are collections of compds. which are designed to interact with an individual protein target or, frequently, a family of related targets (such as kinases, voltage-gated ion channels, serine/cysteine proteases).  They are used for screening against therapeutic targets in order to find hit compds. that might be further developed into drugs.  The design of such libraries generally utilizes structural information about the target or family of interest.  In the absence of such structural information, a chemogenomic model that incorporates sequence and mutagenesis data to predict the properties of the binding site can be employed.  A third option, usually pursued when no structural data are available, utilizes knowledge of the ligands of the target from' which focused libraries can be developed via scaffold hopping.  Consequently, the methods used for the design of target-focused libraries vary according to the quantity and quality of structural or ligand data that is available for each target family.  This article describes examples of each of these design approaches and illustrates them with case studies, which highlight some of the issues and successes obsd. when screening target-focused libraries.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKS2t0qb2xBbVg90H21EOLACvtfcHk0lhas_YGt0LSjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnvVSmu70%253D&md5=9070e45f5b842fccfee38c15e6cb6127</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.2174%2F138620711795767802&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138620711795767802%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DJ.%2BC.%26aulast%3DHill%26aufirst%3DR.%2BD.%26aulast%3DSheppard%26aufirst%3DD.%2BW.%26aulast%3DSlater%26aufirst%3DM.%2BJ.%26aulast%3DStouten%26aufirst%3DP.%2BF.%2BW.%26atitle%3DThe%2520Design%2520and%2520Application%2520of%2520Target-Focused%2520Compound%2520Libraries%26jtitle%3DComb.%2520Chem.%2520High%2520Throughput%2520Screening%26date%3D2011%26volume%3D14%26spage%3D521%26epage%3D531%26doi%3D10.2174%2F138620711795767802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Lechartier, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rybniker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zumla, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, S. T.</span><span> </span><span class="NLM_article-title">Tuberculosis Drug Discovery in the Post-Post-Genomic Era</span> <span class="citation_source-journal">EMBO Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">158</span><span class="NLM_x">–</span> <span class="NLM_lpage">168</span><span class="refDoi"> DOI: 10.1002/emmm.201201772</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=10.1002%2Femmm.201201772" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=24401837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFWktb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=158-168&author=B.+Lechartierauthor=J.+Rybnikerauthor=A.+Zumlaauthor=S.+T.+Cole&title=Tuberculosis+Drug+Discovery+in+the+Post-Post-Genomic+Era&doi=10.1002%2Femmm.201201772"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Tuberculosis drug discovery in the post-post-genomic era</span></div><div class="casAuthors">Lechartier, Benoit; Rybniker, Jan; Zumla, Alimuddin; Cole, Stewart T.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">158-168</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The expectation that genomics would result in new therapeutic interventions for infectious diseases remains unfulfilled.  In the post-genomic era, the decade immediately following the availability of the genome sequence of Mycobacterium tuberculosis, tuberculosis (TB) drug discovery relied heavily on the target-based approach but this proved unsuccessful leading to a return to whole cell screening.  Genomics underpinned screening by providing knowledge and many enabling technologies, most importantly whole genome resequencing to find resistance mutations and targets, and this resulted in a selection of leads and new TB drug candidates that are reviewed here.  Unexpectedly, many new targets were found to be 'promiscuous' as they were inhibited by a variety of different compds.  In the post-post-genomics era, more advanced technologies have been implemented and these include high-content screening, screening for inhibitors of latency, the use of conditional knock-down mutants for validated targets and siRNA screens.  In addn., immunomodulation and pharmacol. manipulation of host functions are being explored in an attempt to widen our therapeutic options.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwFEZdeRp7hLVg90H21EOLACvtfcHk0li6eM_OCWzDXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFWktb4%253D&md5=7db5bd8d9e76b1d69df6966fb75a9712</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Femmm.201201772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Femmm.201201772%26sid%3Dliteratum%253Aachs%26aulast%3DLechartier%26aufirst%3DB.%26aulast%3DRybniker%26aufirst%3DJ.%26aulast%3DZumla%26aufirst%3DA.%26aulast%3DCole%26aufirst%3DS.%2BT.%26atitle%3DTuberculosis%2520Drug%2520Discovery%2520in%2520the%2520Post-Post-Genomic%2520Era%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2014%26volume%3D6%26spage%3D158%26epage%3D168%26doi%3D10.1002%2Femmm.201201772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Hoagland, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, R. E.</span><span> </span><span class="NLM_article-title">New Agents for the Treatment of Drug-Resistant Mycobacterium Tuberculosis</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">55</span><span class="NLM_x">–</span> <span class="NLM_lpage">72</span><span class="refDoi"> DOI: 10.1016/j.addr.2016.04.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=10.1016%2Fj.addr.2016.04.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=27151308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BC28XntlSns7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2016&pages=55-72&author=D.+T.+Hoaglandauthor=J.+Liuauthor=R.+B.+Leeauthor=R.+E.+Lee&title=New+Agents+for+the+Treatment+of+Drug-Resistant+Mycobacterium+Tuberculosis&doi=10.1016%2Fj.addr.2016.04.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">New agents for the treatment of drug-resistant Mycobacterium tuberculosis</span></div><div class="casAuthors">Hoagland, Daniel T.; Liu, Jiuyu; Lee, Robin B.; Lee, Richard E.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">55-72</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Inadequate dosing and incomplete treatment regimens, coupled with the ability of the tuberculosis bacilli to cause latent infections that are tolerant of currently used drugs, have fueled the rise of multidrug-resistant tuberculosis (MDR-TB).  Treatment of MDR-TB infections is a major clin. challenge that has few viable or effective solns.; therefore patients face a poor prognosis and years of treatment.  This review focuses on emerging drug classes that have the potential for treating MDR-TB and highlights their particular strengths as leads including their mode of action, in vivo efficacy, and key medicinal chem. properties.  Examples include the newly approved drugs bedaquiline and delaminid, and other agents in clin. and late preclin. development pipeline for the treatment of MDR-TB.  Herein, we discuss the challenges to developing drugs to treat tuberculosis and how the field has adapted to these difficulties, with an emphasis on drug discovery approaches that might produce more effective agents and treatment regimens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBEswjNcHj27Vg90H21EOLACvtfcHk0lj2GSSKkDLyFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XntlSns7c%253D&md5=7c8ca15b9b493cceaf3d51d93b9afcec</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.addr.2016.04.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.addr.2016.04.026%26sid%3Dliteratum%253Aachs%26aulast%3DHoagland%26aufirst%3DD.%2BT.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DR.%2BB.%26aulast%3DLee%26aufirst%3DR.%2BE.%26atitle%3DNew%2520Agents%2520for%2520the%2520Treatment%2520of%2520Drug-Resistant%2520Mycobacterium%2520Tuberculosis%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2016%26volume%3D102%26spage%3D55%26epage%3D72%26doi%3D10.1016%2Fj.addr.2016.04.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Soares de Melo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, T.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Der Westhuyzen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessner, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Street, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgans, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warner, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moosa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naran, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boshoff, H. I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barry, C. E.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chibale, K.</span><span> </span><span class="NLM_article-title">Aminopyrazolo[1,5-A]pyrimidines as Potential Inhibitors of Mycobacterium Tuberculosis: Structure Activity Relationships and ADME Characterization</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">7240</span><span class="NLM_x">–</span> <span class="NLM_lpage">7250</span><span class="refDoi"> DOI: 10.1016/j.bmc.2015.10.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=10.1016%2Fj.bmc.2015.10.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=26522089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslent7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=7240-7250&author=C.+Soares+de+Meloauthor=T.-S.+Fengauthor=R.+van+Der+Westhuyzenauthor=R.+K.+Gessnerauthor=L.+J.+Streetauthor=G.+L.+Morgansauthor=D.+F.+Warnerauthor=A.+Moosaauthor=K.+Naranauthor=N.+Lawrenceauthor=H.+I.+M.+Boshoffauthor=C.+E.+Barryauthor=C.+J.+Harrisauthor=R.+Gordonauthor=K.+Chibale&title=Aminopyrazolo%5B1%2C5-A%5Dpyrimidines+as+Potential+Inhibitors+of+Mycobacterium+Tuberculosis%3A+Structure+Activity+Relationships+and+ADME+Characterization&doi=10.1016%2Fj.bmc.2015.10.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Aminopyrazolo[1,5-a]pyrimidines as potential inhibitors of Mycobacterium tuberculosis: Structure activity relationships and ADME characterization</span></div><div class="casAuthors">Soares de Melo, Candice; Feng, Tzu-Shean; van der Westhuyzen, Renier; Gessner, Richard K.; Street, Leslie J.; Morgans, Garreth L.; Warner, Digby F.; Moosa, Atica; Naran, Krupa; Lawrence, Nina; Boshoff, Helena I. M.; Barry, Clifton E., III; Harris, C. John; Gordon, Richard; Chibale, Kelly</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7240-7250</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Whole-cell high-throughput screening of a diverse SoftFocus library against Mycobacterium tuberculosis (Mtb) generated a novel aminopyrazolo[1,5-a]pyrimidine hit series.  The synthesis and structure activity relationship studies identified compds. with potent antimycobacterial activity.  The SAR of over 140 compds. shows that the 2-pyridylmethylamine moiety at the C-7 position of the pyrazolopyrimidine scaffold was important for Mtb activity, whereas the C-3 position offered a higher degree of flexibility.  The series was also profiled for in vitro cytotoxicity and microsomal metabolic stability as well as physicochem. properties.  Consequently liabilities to be addressed in a future lead optimization campaign have been identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTbOBTZI7RdrVg90H21EOLACvtfcHk0lj2GSSKkDLyFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslent7zL&md5=29c1f665f7c8e2039e9ae1c9d9aa2d1e</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.10.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.10.021%26sid%3Dliteratum%253Aachs%26aulast%3DSoares%2Bde%2BMelo%26aufirst%3DC.%26aulast%3DFeng%26aufirst%3DT.-S.%26aulast%3Dvan%2BDer%2BWesthuyzen%26aufirst%3DR.%26aulast%3DGessner%26aufirst%3DR.%2BK.%26aulast%3DStreet%26aufirst%3DL.%2BJ.%26aulast%3DMorgans%26aufirst%3DG.%2BL.%26aulast%3DWarner%26aufirst%3DD.%2BF.%26aulast%3DMoosa%26aufirst%3DA.%26aulast%3DNaran%26aufirst%3DK.%26aulast%3DLawrence%26aufirst%3DN.%26aulast%3DBoshoff%26aufirst%3DH.%2BI.%2BM.%26aulast%3DBarry%26aufirst%3DC.%2BE.%26aulast%3DHarris%26aufirst%3DC.%2BJ.%26aulast%3DGordon%26aufirst%3DR.%26aulast%3DChibale%26aufirst%3DK.%26atitle%3DAminopyrazolo%255B1%252C5-A%255Dpyrimidines%2520as%2520Potential%2520Inhibitors%2520of%2520Mycobacterium%2520Tuberculosis%253A%2520Structure%2520Activity%2520Relationships%2520and%2520ADME%2520Characterization%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D7240%26epage%3D7250%26doi%3D10.1016%2Fj.bmc.2015.10.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Arora, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ochoa-Montano, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsang, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blundell, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawes, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizrahi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayliss, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackenzie, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleghorn, L. A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyatt, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uh, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barry, C. E.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boshoff, H. I.</span><span> </span><span class="NLM_article-title">Respiratory Flexibility in Response to Inhibition of Cytochrome C Oxidase in Mycobacterium Tuberculosis</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">6962</span><span class="NLM_x">–</span> <span class="NLM_lpage">6965</span><span class="refDoi"> DOI: 10.1128/AAC.03486-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=10.1128%2FAAC.03486-14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=25155596" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVGjsr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2014&pages=6962-6965&author=K.+Aroraauthor=B.+Ochoa-Montanoauthor=P.+S.+Tsangauthor=T.+L.+Blundellauthor=S.+S.+Dawesauthor=V.+Mizrahiauthor=T.+Baylissauthor=C.+J.+Mackenzieauthor=L.+A.+T.+Cleghornauthor=P.+C.+Rayauthor=P.+G.+Wyattauthor=E.+Uhauthor=J.+Leeauthor=C.+E.+Barryauthor=H.+I.+Boshoff&title=Respiratory+Flexibility+in+Response+to+Inhibition+of+Cytochrome+C+Oxidase+in+Mycobacterium+Tuberculosis&doi=10.1128%2FAAC.03486-14"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Respiratory flexibility in response to inhibition of cytochrome c oxidase in Mycobacterium tuberculosis</span></div><div class="casAuthors">Arora, Kriti; Ochoa-Montano, Bernardo; Tsang, Patricia S.; Blundell, Tom L.; Dawes, Stephanie S.; Mizrahi, Valerie; Bayliss, Tracy; MacKenzie, Claire J.; Cleghorn, Laura A. T.; Ray, Peter C.; Wyatt, Paul G.; Uh, Eugene; Lee, Jinwoo; Barry, Clifton E.; Boshoff, Helena I.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">6962-6965, 5 pp.</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">We report here a series of five chem. diverse scaffolds that have in vitro activities on replicating and hypoxic nonreplicating bacilli by targeting the respiratory bc1 complex in Mycobacterium tuberculosis in a strain-dependent manner.  Deletion of the cytochrome bd oxidase generated a hypersusceptible mutant in which resistance was acquired by a mutation in qcrB.  These results highlight the promiscuity of the bc1 complex and the risk of targeting energy metab. with new drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwNeXOHcpwObVg90H21EOLACvtfcHk0lj2GSSKkDLyFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVGjsr7I&md5=0d9c0195533460bedb0b8e06b66508ef</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1128%2FAAC.03486-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.03486-14%26sid%3Dliteratum%253Aachs%26aulast%3DArora%26aufirst%3DK.%26aulast%3DOchoa-Montano%26aufirst%3DB.%26aulast%3DTsang%26aufirst%3DP.%2BS.%26aulast%3DBlundell%26aufirst%3DT.%2BL.%26aulast%3DDawes%26aufirst%3DS.%2BS.%26aulast%3DMizrahi%26aufirst%3DV.%26aulast%3DBayliss%26aufirst%3DT.%26aulast%3DMackenzie%26aufirst%3DC.%2BJ.%26aulast%3DCleghorn%26aufirst%3DL.%2BA.%2BT.%26aulast%3DRay%26aufirst%3DP.%2BC.%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26aulast%3DUh%26aufirst%3DE.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DBarry%26aufirst%3DC.%2BE.%26aulast%3DBoshoff%26aufirst%3DH.%2BI.%26atitle%3DRespiratory%2520Flexibility%2520in%2520Response%2520to%2520Inhibition%2520of%2520Cytochrome%2520C%2520Oxidase%2520in%2520Mycobacterium%2520Tuberculosis%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2014%26volume%3D58%26spage%3D6962%26epage%3D6965%26doi%3D10.1128%2FAAC.03486-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Moosa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamprecht, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arora, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barry, C. E.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boshoff, H. I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ioerger, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steyn, A. J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizrahi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warner, D. F.</span><span> </span><span class="NLM_article-title">Susceptibility of Mycobacterium Tuberculosis Cytochrome Bd Oxidase Mutants to Compounds Targeting the Terminal Respiratory Oxidase, Cytochrome c</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">e01338-17</span><span class="refDoi"> DOI: 10.1128/AAC.01338-17</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=10.1128%2FAAC.01338-17" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=28760899" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2017&pages=e01338-17&author=A.+Moosaauthor=D.+A.+Lamprechtauthor=K.+Aroraauthor=C.+E.+Barryauthor=H.+I.+M.+Boshoffauthor=T.+R.+Ioergerauthor=A.+J.+C.+Steynauthor=V.+Mizrahiauthor=D.+F.+Warner&title=Susceptibility+of+Mycobacterium+Tuberculosis+Cytochrome+Bd+Oxidase+Mutants+to+Compounds+Targeting+the+Terminal+Respiratory+Oxidase%2C+Cytochrome+c&doi=10.1128%2FAAC.01338-17"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1128%2FAAC.01338-17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01338-17%26sid%3Dliteratum%253Aachs%26aulast%3DMoosa%26aufirst%3DA.%26aulast%3DLamprecht%26aufirst%3DD.%2BA.%26aulast%3DArora%26aufirst%3DK.%26aulast%3DBarry%26aufirst%3DC.%2BE.%26aulast%3DBoshoff%26aufirst%3DH.%2BI.%2BM.%26aulast%3DIoerger%26aufirst%3DT.%2BR.%26aulast%3DSteyn%26aufirst%3DA.%2BJ.%2BC.%26aulast%3DMizrahi%26aufirst%3DV.%26aulast%3DWarner%26aufirst%3DD.%2BF.%26atitle%3DSusceptibility%2520of%2520Mycobacterium%2520Tuberculosis%2520Cytochrome%2520Bd%2520Oxidase%2520Mutants%2520to%2520Compounds%2520Targeting%2520the%2520Terminal%2520Respiratory%2520Oxidase%252C%2520Cytochrome%2520c%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2017%26volume%3D61%26spage%3De01338-17%26doi%3D10.1128%2FAAC.01338-17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Naran, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moosa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barry, C. E.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boshoff, H. I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizrahi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warner, D. F.</span><span> </span><span class="NLM_article-title">Bioluminescent Reporters for Rapid Mechanism of Action Assessment in Tuberculosis Drug Discovery</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">6748</span><span class="NLM_x">–</span> <span class="NLM_lpage">6757</span><span class="refDoi"> DOI: 10.1128/AAC.01178-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=10.1128%2FAAC.01178-16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=27572410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitV2ntbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2016&pages=6748-6757&author=K.+Naranauthor=A.+Moosaauthor=C.+E.+Barryauthor=H.+I.+M.+Boshoffauthor=V.+Mizrahiauthor=D.+F.+Warner&title=Bioluminescent+Reporters+for+Rapid+Mechanism+of+Action+Assessment+in+Tuberculosis+Drug+Discovery&doi=10.1128%2FAAC.01178-16"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Bioluminescent reporters for rapid mechanism of action assessment in tuberculosis drug discovery</span></div><div class="casAuthors">Naran, Krupa; Moosa, Atica; Barry, Clifton E., III; Boshoff, Helena I. M.; Mizrahi, Valerie; Warner, Digby F.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">6748-6757</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The tuberculosis (TB) drug discovery pipeline is fueled by compds.identified in whole-cell screens against the causative agent, Mycobacterium tuberculosis.  Phenotypic screening enables the selection of mols.that inhibit essential cellular functions in live, intact bacilli grown under a chosen in vitro condition.  However, deducing the mechanism of action (MOA), which is important to avoid promiscuous targets, often requires significant biol.resources in a lengthy process that risks decoupling medicinal chem.and biol.efforts.  Therefore, there is a need to develop methods enabling rapid MOA assessment of putative "actives" for triage decisions.  Here, we describe a modified version of a bioluminescence reporter assay that allows nondestructive detection of compds.targeting either of two macromol.processes in M.tuberculosis: cell wall biosynthesis or maintenance of DNA integrity.  Coupling the luxCDABE operon from Photorhabdus luminescens to mycobacterial promoters driving expression of the iniBAC operon (PiniB-LUX) or the DNA damage-inducible genes, recA (PrecA-LUX) or radA (PradA-LUX), provided quant.detection in real time of compds.triggering expression of any of these promoters over an extended 10- to 12-day incubation.  Testing against known anti-TB agents confirmed the specificity of each reporter in registering the MOA of the applied antibiotic in M.tuberculosis, independent of bactericidal or bacteriostatic activity.  Moreover, profiles obtained for exptl.compds.indicated the potential to infer complex MOAs in which multiple cellular processes are disrupted.  These results demonstrate the utility of the reporters for early triage of compds.based on the provisional MOA and suggest their application to investigate polypharmacol.in known and exptl.anti-TB agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1CWtsv8h-h7Vg90H21EOLACvtfcHk0ljg652s75b7nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitV2ntbo%253D&md5=6f08794b0ae28a909e1282adfe642cb5</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1128%2FAAC.01178-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.01178-16%26sid%3Dliteratum%253Aachs%26aulast%3DNaran%26aufirst%3DK.%26aulast%3DMoosa%26aufirst%3DA.%26aulast%3DBarry%26aufirst%3DC.%2BE.%26aulast%3DBoshoff%26aufirst%3DH.%2BI.%2BM.%26aulast%3DMizrahi%26aufirst%3DV.%26aulast%3DWarner%26aufirst%3DD.%2BF.%26atitle%3DBioluminescent%2520Reporters%2520for%2520Rapid%2520Mechanism%2520of%2520Action%2520Assessment%2520in%2520Tuberculosis%2520Drug%2520Discovery%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2016%26volume%3D60%26spage%3D6748%26epage%3D6757%26doi%3D10.1128%2FAAC.01178-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Ren, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamane, M.</span><span> </span><span class="NLM_article-title">Mo(CO)6-Mediated Carbamoylation of Aryl Halides</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">8410</span><span class="NLM_x">–</span> <span class="NLM_lpage">8415</span><span class="refDoi"> DOI: 10.1021/jo101611g</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo101611g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVeru7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2010&pages=8410-8415&author=W.+Renauthor=M.+Yamane&title=Mo%28CO%296-Mediated+Carbamoylation+of+Aryl+Halides&doi=10.1021%2Fjo101611g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Mo(CO)6-Mediated Carbamoylation of Aryl Halides</span></div><div class="casAuthors">Ren, Wei; Yamane, Motoki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8410-8415</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A simple method for the synthesis of amides, e.g., I has been developed by molybdenum-mediated carbamoylation of aryl halides.  Whereas the conventional palladium-catalyzed three-component coupling reaction requires a large excess of gaseous carbon monoxide, the incorporation of carbon monoxide in this Mo-mediated carbamoylation reaction is so efficient that it requires only a slight excess amt. of carbon monoxide in the form of its molybdenum complex, Mo(CO)6.  The reaction is applicable for the synthesis of a wide variety of not only secondary and tertiary amides but also primary amides by using aq. ammonia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdBEDAmViaN7Vg90H21EOLACvtfcHk0ljg652s75b7nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVeru7bL&md5=d4c9de917a2d39248caa5a09769159a3</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjo101611g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo101611g%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DW.%26aulast%3DYamane%26aufirst%3DM.%26atitle%3DMo%2528CO%25296-Mediated%2520Carbamoylation%2520of%2520Aryl%2520Halides%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2010%26volume%3D75%26spage%3D8410%26epage%3D8415%26doi%3D10.1021%2Fjo101611g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Rudzinski, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leadbeater, N. E.</span><span> </span><span class="NLM_article-title">A Weinreb Amide Approach to the Synthesis of Trifluoromethylketones</span> <span class="citation_source-journal">Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">9610</span><span class="NLM_x">–</span> <span class="NLM_lpage">9612</span><span class="refDoi"> DOI: 10.1039/c2cc35037h</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=10.1039%2Fc2cc35037h" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=22911019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht12qsrrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2012&pages=9610-9612&author=D.+M.+Rudzinskiauthor=C.+B.+Kellyauthor=N.+E.+Leadbeater&title=A+Weinreb+Amide+Approach+to+the+Synthesis+of+Trifluoromethylketones&doi=10.1039%2Fc2cc35037h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">A Weinreb amide approach to the synthesis of trifluoromethylketones</span></div><div class="casAuthors">Rudzinski, DiAndra M.; Kelly, Christopher B.; Leadbeater, Nicholas E.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">77</span>),
    <span class="NLM_cas:pages">9610-9612</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A novel route to access trifluoromethylketones (TFMKs) from Weinreb amides is reported.  This represents the first documented case of the Ruppert-Prakash reagent (TMS-CF3) reacting in a constructive manner with an amide and enables synthesis of TFMKs without risk of over-trifluoromethylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsdturpJ_XzrVg90H21EOLACvtfcHk0lj0Vyi7PX0qVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht12qsrrO&md5=b6772eb545451112d3e8df62aa805c24</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1039%2Fc2cc35037h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2cc35037h%26sid%3Dliteratum%253Aachs%26aulast%3DRudzinski%26aufirst%3DD.%2BM.%26aulast%3DKelly%26aufirst%3DC.%2BB.%26aulast%3DLeadbeater%26aufirst%3DN.%2BE.%26atitle%3DA%2520Weinreb%2520Amide%2520Approach%2520to%2520the%2520Synthesis%2520of%2520Trifluoromethylketones%26jtitle%3DChem.%2520Commun.%26date%3D2012%26volume%3D48%26spage%3D9610%26epage%3D9612%26doi%3D10.1039%2Fc2cc35037h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Gauthier, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chauret, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cromlish, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmarais, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duong, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falgueyret, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimmel, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamontagne, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Léger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LeRiche, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massé, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKay, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoll-Griffith, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oballa, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percival, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riendeau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodan, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seto, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thérien, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truong, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venuti, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesolowski, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamboni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Black, W. C.</span><span> </span><span class="NLM_article-title">The Discovery of Odanacatib (MK-0822), a Selective Inhibitor of Cathepsin K</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">923</span><span class="NLM_x">–</span> <span class="NLM_lpage">928</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2007.12.047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=10.1016%2Fj.bmcl.2007.12.047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=18226527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFWktro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=923-928&author=J.+Y.+Gauthierauthor=N.+Chauretauthor=W.+Cromlishauthor=S.+Desmaraisauthor=L.+T.+Duongauthor=J.+P.+Falgueyretauthor=D.+B.+Kimmelauthor=S.+Lamontagneauthor=S.+L%C3%A9gerauthor=T.+LeRicheauthor=C.+S.+Liauthor=F.+Mass%C3%A9author=D.+J.+McKayauthor=D.+A.+Nicoll-Griffithauthor=R.+M.+Oballaauthor=J.+T.+Palmerauthor=M.+D.+Percivalauthor=D.+Riendeauauthor=J.+Robichaudauthor=G.+A.+Rodanauthor=S.+B.+Rodanauthor=C.+Setoauthor=M.+Th%C3%A9rienauthor=V.+L.+Truongauthor=M.+C.+Venutiauthor=G.+Wesolowskiauthor=R.+N.+Youngauthor=R.+Zamboniauthor=W.+C.+Black&title=The+Discovery+of+Odanacatib+%28MK-0822%29%2C+a+Selective+Inhibitor+of+Cathepsin+K&doi=10.1016%2Fj.bmcl.2007.12.047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K</span></div><div class="casAuthors">Gauthier, Jacques Yves; Chauret, Nathalie; Cromlish, Wanda; Desmarais, Sylvie; Duong, Le T.; Falgueyret, Jean-Pierre; Kimmel, Donald B.; Lamontagne, Sonia; Leger, Serge; LeRiche, Tammy; Li, Chun Sing; Masse, Frederic; McKay, Daniel J.; Nicoll-Griffith, Deborah A.; Oballa, Renata M.; Palmer, James T.; Percival, M. David; Riendeau, Denis; Robichaud, Joel; Rodan, Gideon A.; Rodan, Sevgi B.; Seto, Carmai; Therien, Michel; Truong, Vouy-Linh; Venuti, Michael C.; Wesolowski, Gregg; Young, Robert N.; Zamboni, Robert; Black, W. Cameron</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">923-928</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Odanacatib is a potent, selective, and neutral cathepsin K inhibitor which was developed to address the metabolic liabilities of the Cat K inhibitor L-873724.  Substituting P1 and modifying the P2 side chain led to a metabolically robust inhibitor with a long half-life in preclin. species.  Odanacatib was more selective in whole cell assays than the published Cat K inhibitors balicatib and relacatib.  Evaluation in dermal fibroblast culture showed minimal intracellular collagen accumulation relative to less selective Cat K inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7ytNI-SBgarVg90H21EOLACvtfcHk0lj0Vyi7PX0qVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFWktro%253D&md5=e432a420a3ec99c784117750b9bbeda8</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.12.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.12.047%26sid%3Dliteratum%253Aachs%26aulast%3DGauthier%26aufirst%3DJ.%2BY.%26aulast%3DChauret%26aufirst%3DN.%26aulast%3DCromlish%26aufirst%3DW.%26aulast%3DDesmarais%26aufirst%3DS.%26aulast%3DDuong%26aufirst%3DL.%2BT.%26aulast%3DFalgueyret%26aufirst%3DJ.%2BP.%26aulast%3DKimmel%26aufirst%3DD.%2BB.%26aulast%3DLamontagne%26aufirst%3DS.%26aulast%3DL%25C3%25A9ger%26aufirst%3DS.%26aulast%3DLeRiche%26aufirst%3DT.%26aulast%3DLi%26aufirst%3DC.%2BS.%26aulast%3DMass%25C3%25A9%26aufirst%3DF.%26aulast%3DMcKay%26aufirst%3DD.%2BJ.%26aulast%3DNicoll-Griffith%26aufirst%3DD.%2BA.%26aulast%3DOballa%26aufirst%3DR.%2BM.%26aulast%3DPalmer%26aufirst%3DJ.%2BT.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26aulast%3DRiendeau%26aufirst%3DD.%26aulast%3DRobichaud%26aufirst%3DJ.%26aulast%3DRodan%26aufirst%3DG.%2BA.%26aulast%3DRodan%26aufirst%3DS.%2BB.%26aulast%3DSeto%26aufirst%3DC.%26aulast%3DTh%25C3%25A9rien%26aufirst%3DM.%26aulast%3DTruong%26aufirst%3DV.%2BL.%26aulast%3DVenuti%26aufirst%3DM.%2BC.%26aulast%3DWesolowski%26aufirst%3DG.%26aulast%3DYoung%26aufirst%3DR.%2BN.%26aulast%3DZamboni%26aufirst%3DR.%26aulast%3DBlack%26aufirst%3DW.%2BC.%26atitle%3DThe%2520Discovery%2520of%2520Odanacatib%2520%2528MK-0822%2529%252C%2520a%2520Selective%2520Inhibitor%2520of%2520Cathepsin%2520K%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D923%26epage%3D928%26doi%3D10.1016%2Fj.bmcl.2007.12.047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Bock, V. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Speijer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiemstra, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Maarseveen, J. H.</span><span> </span><span class="NLM_article-title">1,2,3-Triazoles as Peptide Bond Isosteres: Synthesis and Biological Evaluation of Cyclotetrapeptide Mimics</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">971</span><span class="NLM_x">–</span> <span class="NLM_lpage">975</span><span class="refDoi"> DOI: 10.1039/b616751a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=10.1039%2Fb616751a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=17340013" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BD2sXisV2gtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2007&pages=971-975&author=V.+D.+Bockauthor=D.+Speijerauthor=H.+Hiemstraauthor=J.+H.+van+Maarseveen&title=1%2C2%2C3-Triazoles+as+Peptide+Bond+Isosteres%3A+Synthesis+and+Biological+Evaluation+of+Cyclotetrapeptide+Mimics&doi=10.1039%2Fb616751a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">1,2,3-Triazoles as peptide bond isosteres: synthesis and biological evaluation of cyclotetrapeptide mimics</span></div><div class="casAuthors">Bock, Victoria D.; Speijer, Dave; Hiemstra, Henk; Van Maarseveen, Jan H.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">971-975</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Since the discovery of CuI-catalyzed click chem., the field of peptidomimetics has expanded to include 1,4-connected 1,2,3-triazoles as useful peptide bond isosteres.  Here, the synthesis of triazole-contg. analogs of the naturally occurring tyrosinase inhibitor cyclo-[Pro-Val-Pro-Tyr] was reported.  It was shown that the analogs, e.g., I, retained enzyme inhibitory activity, which demonstrated the effectiveness of a 1,4-connected 1,2,3-triazole as a trans peptide bond isostere.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPWV4DeB-x67Vg90H21EOLACvtfcHk0lj0Vyi7PX0qVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXisV2gtL8%253D&md5=4af400adf8141cd1ac02d9812fa14477</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1039%2Fb616751a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb616751a%26sid%3Dliteratum%253Aachs%26aulast%3DBock%26aufirst%3DV.%2BD.%26aulast%3DSpeijer%26aufirst%3DD.%26aulast%3DHiemstra%26aufirst%3DH.%26aulast%3Dvan%2BMaarseveen%26aufirst%3DJ.%2BH.%26atitle%3D1%252C2%252C3-Triazoles%2520as%2520Peptide%2520Bond%2520Isosteres%253A%2520Synthesis%2520and%2520Biological%2520Evaluation%2520of%2520Cyclotetrapeptide%2520Mimics%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2007%26volume%3D5%26spage%3D971%26epage%3D975%26doi%3D10.1039%2Fb616751a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Cox, J. A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrahams, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alemparte, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghidelli-Disse, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rullas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angulo-Barturen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurcha, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nataraj, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bethell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remuiñán, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Encinas, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jervis, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cammack, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhatt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruse, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bantscheff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fütterer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barros, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewes, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besra, G. S.</span><span> </span><span class="NLM_article-title">THPP Target Assignment Reveals EchA6 as an Essential Fatty Acid Shuttle in Mycobacteria</span> <span class="citation_source-journal">Nat. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">15006</span><span class="refDoi"> DOI: 10.1038/nmicrobiol.2015.6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=10.1038%2Fnmicrobiol.2015.6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=27571973" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkvFyqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2016&pages=15006&author=J.+A.+G.+Coxauthor=K.+A.+Abrahamsauthor=C.+Alemparteauthor=S.+Ghidelli-Disseauthor=J.+Rullasauthor=I.+Angulo-Barturenauthor=A.+Singhauthor=S.+S.+Gurchaauthor=V.+Natarajauthor=S.+Bethellauthor=M.+J.+Remui%C3%B1%C3%A1nauthor=L.+Encinasauthor=P.+J.+Jervisauthor=N.+C.+Cammackauthor=A.+Bhattauthor=U.+Kruseauthor=M.+Bantscheffauthor=K.+F%C3%BCttererauthor=D.+Barrosauthor=L.+Ballellauthor=G.+Drewesauthor=G.+S.+Besra&title=THPP+Target+Assignment+Reveals+EchA6+as+an+Essential+Fatty+Acid+Shuttle+in+Mycobacteria&doi=10.1038%2Fnmicrobiol.2015.6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">THPP target assignment reveals EchA6 as an essential fatty acid shuttle in Mycobacteria</span></div><div class="casAuthors">Cox, Jonathan A. G.; Abrahams, Katherine A.; Alemparte, Carlos; Ghidelli-Disse, Sonja; Rullas, Joaquin; Angulo-Barturen, Inigo; Singh, Albel; Gurcha, Sudagar S.; Nataraj, Vijayashankar; Bethell, Stephen; Remuinan, Modesto J.; Encinas, Lourdes; Jervis, Peter J.; Cammack, Nicholas C.; Bhatt, Apoorva; Kruse, Ulrich; Bantscheff, Marcus; Futterer, Klaus; Barros, David; Ballell, Lluis; Drewes, Gerard; Besra, Gurdyal S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Microbiology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">15006</span>CODEN:
                <span class="NLM_cas:coden">NMAICH</span>;
        ISSN:<span class="NLM_cas:issn">2058-5276</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Phenotypic screens for bactericidal compds. against drug-resistant tuberculosis are beginning to yield novel inhibitors.  However, reliable target identification remains challenging.  Here, we show that tetrahydropyrazo[1,5-a]pyrimidine-3-carboxamide (THPP) selectively pulls down EchA6 in a stereospecific manner, instead of the previously assigned target Mycobacterium tuberculosis MmpL3.  While homologous to mammalian enoyl-CoA hydratases, EchA6 is non-catalytic yet essential and binds long-chain acyl-CoAs.  THPP inhibitors compete with CoA-binding, suppress mycolic acid synthesis, and are bactericidal in a mouse model of chronic tuberculosis infection.  A point mutation, W133A, abrogated THPP-binding and increased both the in vitro min. inhibitory concn. and the in vivo ED 99 in mice.  Surprisingly, EchA6 interacts with selected enzymes of fatty acid synthase II (FAS-II) in bacterial two-hybrid assays, suggesting essentiality may be linked to feeding long-chain fatty acids to FAS-II.  Finally, our data show that spontaneous resistance-conferring mutations can potentially obscure the actual target or alternative targets of small mol. inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplCDIm9BSu47Vg90H21EOLACvtfcHk0lgru1iGECvkxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkvFyqtbk%253D&md5=d1704f5bc0a939f1213078f71cdcbf49</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fnmicrobiol.2015.6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnmicrobiol.2015.6%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DJ.%2BA.%2BG.%26aulast%3DAbrahams%26aufirst%3DK.%2BA.%26aulast%3DAlemparte%26aufirst%3DC.%26aulast%3DGhidelli-Disse%26aufirst%3DS.%26aulast%3DRullas%26aufirst%3DJ.%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26aulast%3DSingh%26aufirst%3DA.%26aulast%3DGurcha%26aufirst%3DS.%2BS.%26aulast%3DNataraj%26aufirst%3DV.%26aulast%3DBethell%26aufirst%3DS.%26aulast%3DRemui%25C3%25B1%25C3%25A1n%26aufirst%3DM.%2BJ.%26aulast%3DEncinas%26aufirst%3DL.%26aulast%3DJervis%26aufirst%3DP.%2BJ.%26aulast%3DCammack%26aufirst%3DN.%2BC.%26aulast%3DBhatt%26aufirst%3DA.%26aulast%3DKruse%26aufirst%3DU.%26aulast%3DBantscheff%26aufirst%3DM.%26aulast%3DF%25C3%25BCtterer%26aufirst%3DK.%26aulast%3DBarros%26aufirst%3DD.%26aulast%3DBallell%26aufirst%3DL.%26aulast%3DDrewes%26aufirst%3DG.%26aulast%3DBesra%26aufirst%3DG.%2BS.%26atitle%3DTHPP%2520Target%2520Assignment%2520Reveals%2520EchA6%2520as%2520an%2520Essential%2520Fatty%2520Acid%2520Shuttle%2520in%2520Mycobacteria%26jtitle%3DNat.%2520Microbiol.%26date%3D2016%26volume%3D1%26spage%3D15006%26doi%3D10.1038%2Fnmicrobiol.2015.6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Abrahams, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chung, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghidelli-Disse, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rullas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rebollo-López, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurcha, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, J. A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendoza, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiménez-Navarro, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martínez-Martínez, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shillings, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Homes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Argyrou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casanueva, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loman, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moynihan, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lelièvre, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selenski, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Axtman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kremer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bantscheff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angulo-Barturen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Izquierdo, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cammack, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewes, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barros, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Besra, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bates, R. H.</span><span> </span><span class="NLM_article-title">Identification of KasA as the Cellular Target of an Anti-Tubercular Scaffold</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">12581</span><span class="refDoi"> DOI: 10.1038/ncomms12581</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=10.1038%2Fncomms12581" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=27581223" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVOru7%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=12581&author=K.+A.+Abrahamsauthor=C.+Chungauthor=S.+Ghidelli-Disseauthor=J.+Rullasauthor=M.+J.+Rebollo-L%C3%B3pezauthor=S.+S.+Gurchaauthor=J.+A.+G.+Coxauthor=A.+Mendozaauthor=E.+Jim%C3%A9nez-Navarroauthor=M.+S.+Mart%C3%ADnez-Mart%C3%ADnezauthor=M.+Neuauthor=A.+Shillingsauthor=P.+Homesauthor=A.+Argyrouauthor=R.+Casanuevaauthor=N.+J.+Lomanauthor=P.+J.+Moynihanauthor=J.+Leli%C3%A8vreauthor=C.+Selenskiauthor=M.+Axtmanauthor=L.+Kremerauthor=M.+Bantscheffauthor=I.+Angulo-Barturenauthor=M.+C.+Izquierdoauthor=N.+C.+Cammackauthor=G.+Drewesauthor=L.+Ballellauthor=D.+Barrosauthor=G.+S.+Besraauthor=R.+H.+Bates&title=Identification+of+KasA+as+the+Cellular+Target+of+an+Anti-Tubercular+Scaffold&doi=10.1038%2Fncomms12581"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of KasA as the cellular target of an anti-tubercular scaffold</span></div><div class="casAuthors">Abrahams, Katherine A.; Chung, Chun-wa; Ghidelli-Disse, Sonja; Rullas, Joaquin; Rebollo-Lopez, Maria Jose; Gurcha, Sudagar S.; Cox, Jonathan A. G.; Mendoza, Alfonso; Jimenez-Navarro, Elena; Martinez-Martinez, Maria Santos; Neu, Margarete; Shillings, Anthony; Homes, Paul; Argyrou, Argyrides; Casanueva, Ruth; Loman, Nicholas J.; Moynihan, Patrick J.; Lelievre, Joel; Selenski, Carolyn; Axtman, Matthew; Kremer, Laurent; Bantscheff, Marcus; Angulo-Barturen, Inigo; Izquierdo, Monica Cacho; Cammack, Nicholas C.; Drewes, Gerard; Ballell, Lluis; Barros, David; Besra, Gurdyal S.; Bates, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">12581</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Phenotypic screens for bactericidal compds. are starting to yield promising hits against tuberculosis.  In this regard, whole-genome sequencing of spontaneous resistant mutants generated against an indazole sulfonamide (GSK3011724A) identifies several specific single-nucleotide polymorphisms in the essential Mycobacterium tuberculosis β-ketoacyl synthase (kas) A gene.  Here, this genomic-based target assignment is confirmed by biochem. assays, chem. proteomics and structural resoln. of a KasA-GSK3011724A complex by X-ray crystallog.  Finally, M. tuberculosis GSK3011724A-resistant mutants increase the in vitro min. inhibitory concn. and the in vivo 99% ED in mice, establishing in vitro and in vivo target engagement.  Surprisingly, the lack of target engagement of the related β-ketoacyl synthases (FabH and KasB) suggests a different mode of inhibition when compared with other Kas inhibitors of fatty acid biosynthesis in bacteria.  These results clearly identify KasA as the biol. target of GSK3011724A and validate this enzyme for further drug discovery efforts against tuberculosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGockW3Zu8ZMEbVg90H21EOLACvtfcHk0lgru1iGECvkxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVOru7%252FI&md5=a1206008e181383854e026f36ad27489</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1038%2Fncomms12581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms12581%26sid%3Dliteratum%253Aachs%26aulast%3DAbrahams%26aufirst%3DK.%2BA.%26aulast%3DChung%26aufirst%3DC.%26aulast%3DGhidelli-Disse%26aufirst%3DS.%26aulast%3DRullas%26aufirst%3DJ.%26aulast%3DRebollo-L%25C3%25B3pez%26aufirst%3DM.%2BJ.%26aulast%3DGurcha%26aufirst%3DS.%2BS.%26aulast%3DCox%26aufirst%3DJ.%2BA.%2BG.%26aulast%3DMendoza%26aufirst%3DA.%26aulast%3DJim%25C3%25A9nez-Navarro%26aufirst%3DE.%26aulast%3DMart%25C3%25ADnez-Mart%25C3%25ADnez%26aufirst%3DM.%2BS.%26aulast%3DNeu%26aufirst%3DM.%26aulast%3DShillings%26aufirst%3DA.%26aulast%3DHomes%26aufirst%3DP.%26aulast%3DArgyrou%26aufirst%3DA.%26aulast%3DCasanueva%26aufirst%3DR.%26aulast%3DLoman%26aufirst%3DN.%2BJ.%26aulast%3DMoynihan%26aufirst%3DP.%2BJ.%26aulast%3DLeli%25C3%25A8vre%26aufirst%3DJ.%26aulast%3DSelenski%26aufirst%3DC.%26aulast%3DAxtman%26aufirst%3DM.%26aulast%3DKremer%26aufirst%3DL.%26aulast%3DBantscheff%26aufirst%3DM.%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26aulast%3DIzquierdo%26aufirst%3DM.%2BC.%26aulast%3DCammack%26aufirst%3DN.%2BC.%26aulast%3DDrewes%26aufirst%3DG.%26aulast%3DBallell%26aufirst%3DL.%26aulast%3DBarros%26aufirst%3DD.%26aulast%3DBesra%26aufirst%3DG.%2BS.%26aulast%3DBates%26aufirst%3DR.%2BH.%26atitle%3DIdentification%2520of%2520KasA%2520as%2520the%2520Cellular%2520Target%2520of%2520an%2520Anti-Tubercular%2520Scaffold%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D12581%26doi%3D10.1038%2Fncomms12581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Park, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacitto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayliss, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleghorn, L. A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arora, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ioerger, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sacchettini, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blundell, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ascher, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dartois, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonnala, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Via, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizrahi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epemolu, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stojanovski, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simeons, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osuna-Cabello, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacKenzie, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A. R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murugesan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchanan, K. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huggett, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuccotto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rebollo-Lopez, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lafuente-Monasterio, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lelièvre, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selenski, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Axtman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghidelli-Disse, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pflaumer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bosche, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewes, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freiberg, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurnick, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srikumaran, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kempf, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyatt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barry, C. E.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boshoff, H. I.</span><span> </span><span class="NLM_article-title">Essential but Not Vulnerable: Indazole Sulfonamides Targeting Inosine Monophosphate Dehydrogenase as Potential Leads against Mycobacterium Tuberculosis</span> <span class="citation_source-journal">ACS Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">18</span><span class="NLM_x">–</span> <span class="NLM_lpage">33</span><span class="refDoi"> DOI: 10.1021/acsinfecdis.6b00103</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.6b00103" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1amsL3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2017&pages=18-33&author=Y.+Parkauthor=A.+Pacittoauthor=T.+Baylissauthor=L.+A.+T.+Cleghornauthor=Z.+Wangauthor=T.+Hartmanauthor=K.+Aroraauthor=T.+R.+Ioergerauthor=J.+Sacchettiniauthor=M.+Rizziauthor=S.+Doniniauthor=T.+L.+Blundellauthor=D.+B.+Ascherauthor=K.+Rheeauthor=A.+Bredaauthor=N.+Zhouauthor=V.+Dartoisauthor=S.+R.+Jonnalaauthor=L.+E.+Viaauthor=V.+Mizrahiauthor=O.+Epemoluauthor=L.+Stojanovskiauthor=F.+Simeonsauthor=M.+Osuna-Cabelloauthor=L.+Ellisauthor=C.+J.+MacKenzieauthor=A.+R.+C.+Smithauthor=S.+H.+Davisauthor=D.+Murugesanauthor=K.+I.+Buchananauthor=P.+A.+Turnerauthor=M.+Huggettauthor=F.+Zuccottoauthor=M.+J.+Rebollo-Lopezauthor=M.+J.+Lafuente-Monasterioauthor=O.+Sanzauthor=G.+S.+Diazauthor=J.+Leli%C3%A8vreauthor=L.+Ballellauthor=C.+Selenskiauthor=M.+Axtmanauthor=S.+Ghidelli-Disseauthor=H.+Pflaumerauthor=M.+Boscheauthor=G.+Drewesauthor=G.+M.+Freibergauthor=M.+D.+Kurnickauthor=M.+Srikumaranauthor=D.+J.+Kempfauthor=S.+R.+Greenauthor=P.+C.+Rayauthor=K.+Readauthor=P.+Wyattauthor=C.+E.+Barryauthor=H.+I.+Boshoff&title=Essential+but+Not+Vulnerable%3A+Indazole+Sulfonamides+Targeting+Inosine+Monophosphate+Dehydrogenase+as+Potential+Leads+against+Mycobacterium+Tuberculosis&doi=10.1021%2Facsinfecdis.6b00103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Essential but Not Vulnerable: Indazole Sulfonamides Targeting Inosine Monophosphate Dehydrogenase as Potential Leads against Mycobacterium tuberculosis</span></div><div class="casAuthors">Park, Yumi; Pacitto, Angela; Bayliss, Tracy; Cleghorn, Laura A. T.; Wang, Zhe; Hartman, Travis; Arora, Kriti; Ioerger, Thomas R.; Sacchettini, Jim; Rizzi, Menico; Donini, Stefano; Blundell, Tom L.; Ascher, David B.; Rhee, Kyu; Breda, Ardala; Zhou, Nian; Dartois, Veronique; Jonnala, Surendranadha Reddy; Via, Laura E.; Mizrahi, Valerie; Epemolu, Ola; Stojanovski, Laste; Simeons, Fred; Osuna-Cabello, Maria; Ellis, Lucy; MacKenzie, Claire J.; Smith, Alasdair R. C.; Davis, Susan H.; Murugesan, Dinakaran; Buchanan, Kirsteen I.; Turner, Penelope A.; Huggett, Margaret; Zuccotto, Fabio; Rebollo-Lopez, Maria Jose; Lafuente-Monasterio, Maria Jose; Sanz, Olalla; Diaz, Gracia Santos; Lelievre, Joel; Ballell, Lluis; Selenski, Carolyn; Axtman, Matthew; Ghidelli-Disse, Sonja; Pflaumer, Hannah; Bosche, Markus; Drewes, Gerard; Freiberg, Gail M.; Kurnick, Matthew D.; Srikumaran, Myron; Kempf, Dale J.; Green, Simon R.; Ray, Peter C.; Read, Kevin; Wyatt, Paul; Barry, Clifton E.; Boshoff, Helena I.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">18-33</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A potent, noncytotoxic indazole sulfonamide was identified by high-throughput screening of >100,000 synthetic compds. for activity against Mycobacterium tuberculosis (Mtb).  This noncytotoxic compd. did not directly inhibit cell wall biogenesis but triggered a slow lysis of Mtb cells as measured by release of intracellular green fluorescent protein (GFP).  Isolation of resistant mutants followed by whole-genome sequencing showed an unusual gene amplification of a 40 gene region spanning Rv3371 to Rv3411c and in one case a potential promoter mutation upstream of guaB2 (Rv3411c) encoding inosine monophosphate dehydrogenase (IMPDH).  Subsequent biochem. validation confirmed direct inhibition of IMPDH by an uncompetitive mode of inhibition and growth inhibition could be rescued by supplementation with guanine, a bypass mechanism for the IMPDH pathway.  Beads contg. immobilized indazole sulfonamides specifically interacted with IMPDH in cell lysates.  X-ray crystallog. of the IMPDH-IMP-inhibitor complex revealed that the primary interactions of these compds. with IMPDH were direct pi-pi interactions with the IMP substrate.  Advanced lead compds. in this series with acceptable pharmacokinetic properties failed to show efficacy in acute or chronic murine models of tuberculosis (TB).  Time-kill expts. in vitro suggest that sustained exposure to drug concns. above MIC for 24 h were required for a cidal effect, levels that have been difficult to achieve in vivo.  Direct measurement of guanine levels in resected lung tissue from tuberculosis infected animals and patients revealed 0.5-2 mM concns. in caseum and normal lung tissue.  The high lesional levels of guanine and the slow lytic, growth-rate dependent, effect of IMPDH inhibition pose challenges to developing drugs against this target for use in treating TB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGQUg6PXv9hbVg90H21EOLACvtfcHk0lgpDn4MkAdBdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1amsL3P&md5=fe98ee102c3e265f0a4e70ff1f94a063</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.6b00103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.6b00103%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DY.%26aulast%3DPacitto%26aufirst%3DA.%26aulast%3DBayliss%26aufirst%3DT.%26aulast%3DCleghorn%26aufirst%3DL.%2BA.%2BT.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DHartman%26aufirst%3DT.%26aulast%3DArora%26aufirst%3DK.%26aulast%3DIoerger%26aufirst%3DT.%2BR.%26aulast%3DSacchettini%26aufirst%3DJ.%26aulast%3DRizzi%26aufirst%3DM.%26aulast%3DDonini%26aufirst%3DS.%26aulast%3DBlundell%26aufirst%3DT.%2BL.%26aulast%3DAscher%26aufirst%3DD.%2BB.%26aulast%3DRhee%26aufirst%3DK.%26aulast%3DBreda%26aufirst%3DA.%26aulast%3DZhou%26aufirst%3DN.%26aulast%3DDartois%26aufirst%3DV.%26aulast%3DJonnala%26aufirst%3DS.%2BR.%26aulast%3DVia%26aufirst%3DL.%2BE.%26aulast%3DMizrahi%26aufirst%3DV.%26aulast%3DEpemolu%26aufirst%3DO.%26aulast%3DStojanovski%26aufirst%3DL.%26aulast%3DSimeons%26aufirst%3DF.%26aulast%3DOsuna-Cabello%26aufirst%3DM.%26aulast%3DEllis%26aufirst%3DL.%26aulast%3DMacKenzie%26aufirst%3DC.%2BJ.%26aulast%3DSmith%26aufirst%3DA.%2BR.%2BC.%26aulast%3DDavis%26aufirst%3DS.%2BH.%26aulast%3DMurugesan%26aufirst%3DD.%26aulast%3DBuchanan%26aufirst%3DK.%2BI.%26aulast%3DTurner%26aufirst%3DP.%2BA.%26aulast%3DHuggett%26aufirst%3DM.%26aulast%3DZuccotto%26aufirst%3DF.%26aulast%3DRebollo-Lopez%26aufirst%3DM.%2BJ.%26aulast%3DLafuente-Monasterio%26aufirst%3DM.%2BJ.%26aulast%3DSanz%26aufirst%3DO.%26aulast%3DDiaz%26aufirst%3DG.%2BS.%26aulast%3DLeli%25C3%25A8vre%26aufirst%3DJ.%26aulast%3DBallell%26aufirst%3DL.%26aulast%3DSelenski%26aufirst%3DC.%26aulast%3DAxtman%26aufirst%3DM.%26aulast%3DGhidelli-Disse%26aufirst%3DS.%26aulast%3DPflaumer%26aufirst%3DH.%26aulast%3DBosche%26aufirst%3DM.%26aulast%3DDrewes%26aufirst%3DG.%26aulast%3DFreiberg%26aufirst%3DG.%2BM.%26aulast%3DKurnick%26aufirst%3DM.%2BD.%26aulast%3DSrikumaran%26aufirst%3DM.%26aulast%3DKempf%26aufirst%3DD.%2BJ.%26aulast%3DGreen%26aufirst%3DS.%2BR.%26aulast%3DRay%26aufirst%3DP.%2BC.%26aulast%3DRead%26aufirst%3DK.%26aulast%3DWyatt%26aufirst%3DP.%26aulast%3DBarry%26aufirst%3DC.%2BE.%26aulast%3DBoshoff%26aufirst%3DH.%2BI.%26atitle%3DEssential%2520but%2520Not%2520Vulnerable%253A%2520Indazole%2520Sulfonamides%2520Targeting%2520Inosine%2520Monophosphate%2520Dehydrogenase%2520as%2520Potential%2520Leads%2520against%2520Mycobacterium%2520Tuberculosis%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2017%26volume%3D3%26spage%3D18%26epage%3D33%26doi%3D10.1021%2Facsinfecdis.6b00103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Bantscheff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopf, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savitski, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dittmann, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grandi, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michon, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlegl, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abraham, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becher, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergamini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boesche, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delling, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dümpelfeld, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eberhard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huthmacher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poeckel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reader, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strunk, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweetman, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruse, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neubauer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramsden, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drewes, G.</span><span> </span><span class="NLM_article-title">Chemoproteomics Profiling of HDAC Inhibitors Reveals Selective Targeting of HDAC Complexes</span> <span class="citation_source-journal">Nat. Biotechnol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">255</span><span class="NLM_x">–</span> <span class="NLM_lpage">265</span><span class="refDoi"> DOI: 10.1038/nbt.1759</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=10.1038%2Fnbt.1759" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=21258344" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BC3MXps1ahug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=255-265&author=M.+Bantscheffauthor=C.+Hopfauthor=M.+M.+Savitskiauthor=A.+Dittmannauthor=P.+Grandiauthor=A.-M.+Michonauthor=J.+Schleglauthor=Y.+Abrahamauthor=I.+Becherauthor=G.+Bergaminiauthor=M.+Boescheauthor=M.+Dellingauthor=B.+D%C3%BCmpelfeldauthor=D.+Eberhardauthor=C.+Huthmacherauthor=T.+Mathiesonauthor=D.+Poeckelauthor=V.+Readerauthor=K.+Strunkauthor=G.+Sweetmanauthor=U.+Kruseauthor=G.+Neubauerauthor=N.+G.+Ramsdenauthor=G.+Drewes&title=Chemoproteomics+Profiling+of+HDAC+Inhibitors+Reveals+Selective+Targeting+of+HDAC+Complexes&doi=10.1038%2Fnbt.1759"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes</span></div><div class="casAuthors">Bantscheff, Marcus; Hopf, Carsten; Savitski, Mikhail M.; Dittmann, Antje; Grandi, Paola; Michon, Anne-Marie; Schlegl, Judith; Abraham, Yann; Becher, Isabelle; Bergamini, Giovanna; Boesche, Markus; Delling, Manja; Duempelfeld, Birgit; Eberhard, Dirk; Huthmacher, Carola; Mathieson, Toby; Poeckel, Daniel; Reader, Valerie; Strunk, Katja; Sweetman, Gavain; Kruse, Ulrich; Neubauer, Gitte; Ramsden, Nigel G.; Drewes, Gerard</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">255-265</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The development of selective histone deacetylase (HDAC) inhibitors with anti-cancer and anti-inflammatory properties remains challenging in large part owing to the difficulty of probing the interaction of small mols. with megadalton protein complexes.  A combination of affinity capture and quant. mass spectrometry revealed the selectivity with which 16 HDAC inhibitors target multiple HDAC complexes scaffolded by ELM-SANT domain subunits, including a novel mitotic deacetylase complex (MiDAC).  Inhibitors clustered according to their target profiles with stronger binding of aminobenzamides to the HDAC NCoR complex than to the HDAC Sin3 complex.  We identified several non-HDAC targets for hydroxamate inhibitors.  HDAC inhibitors with distinct profiles have correspondingly different effects on downstream targets.  We also identified the anti-inflammatory drug bufexamac as a class IIb (HDAC6, HDAC10) HDAC inhibitor.  Our approach enables the discovery of novel targets and inhibitors and suggests that the selectivity of HDAC inhibitors should be evaluated in the context of HDAC complexes and not purified catalytic subunits.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWdsITjgu14rVg90H21EOLACvtfcHk0lgpDn4MkAdBdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXps1ahug%253D%253D&md5=3a826d143fb793719a56fba3c410d51e</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fnbt.1759&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.1759%26sid%3Dliteratum%253Aachs%26aulast%3DBantscheff%26aufirst%3DM.%26aulast%3DHopf%26aufirst%3DC.%26aulast%3DSavitski%26aufirst%3DM.%2BM.%26aulast%3DDittmann%26aufirst%3DA.%26aulast%3DGrandi%26aufirst%3DP.%26aulast%3DMichon%26aufirst%3DA.-M.%26aulast%3DSchlegl%26aufirst%3DJ.%26aulast%3DAbraham%26aufirst%3DY.%26aulast%3DBecher%26aufirst%3DI.%26aulast%3DBergamini%26aufirst%3DG.%26aulast%3DBoesche%26aufirst%3DM.%26aulast%3DDelling%26aufirst%3DM.%26aulast%3DD%25C3%25BCmpelfeld%26aufirst%3DB.%26aulast%3DEberhard%26aufirst%3DD.%26aulast%3DHuthmacher%26aufirst%3DC.%26aulast%3DMathieson%26aufirst%3DT.%26aulast%3DPoeckel%26aufirst%3DD.%26aulast%3DReader%26aufirst%3DV.%26aulast%3DStrunk%26aufirst%3DK.%26aulast%3DSweetman%26aufirst%3DG.%26aulast%3DKruse%26aufirst%3DU.%26aulast%3DNeubauer%26aufirst%3DG.%26aulast%3DRamsden%26aufirst%3DN.%2BG.%26aulast%3DDrewes%26aufirst%3DG.%26atitle%3DChemoproteomics%2520Profiling%2520of%2520HDAC%2520Inhibitors%2520Reveals%2520Selective%2520Targeting%2520of%2520HDAC%2520Complexes%26jtitle%3DNat.%2520Biotechnol.%26date%3D2011%26volume%3D29%26spage%3D255%26epage%3D265%26doi%3D10.1038%2Fnbt.1759" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Målen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pathak, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Søfteland, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Souza, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiker, H. G.</span><span> </span><span class="NLM_article-title">Definition of Novel Cell Envelope Associated Proteins in Triton X-114 Extracts of Mycobacterium Tuberculosis H37Rv</span> <span class="citation_source-journal">BMC Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">132</span><span class="refDoi"> DOI: 10.1186/1471-2180-10-132</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=10.1186%2F1471-2180-10-132" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=20429878" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A280%3ADC%252BC3czlsVGjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=132&author=H.+M%C3%A5lenauthor=S.+Pathakauthor=T.+S%C3%B8ftelandauthor=G.+A.+de+Souzaauthor=H.+G.+Wiker&title=Definition+of+Novel+Cell+Envelope+Associated+Proteins+in+Triton+X-114+Extracts+of+Mycobacterium+Tuberculosis+H37Rv&doi=10.1186%2F1471-2180-10-132"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Definition of novel cell envelope associated proteins in Triton X-114 extracts of Mycobacterium tuberculosis H37Rv</span></div><div class="casAuthors">Malen Hiwa; Pathak Sharad; Softeland Tina; de Souza Gustavo A; Wiker Harald G</div><div class="citationInfo"><span class="NLM_cas:title">BMC microbiology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">132</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Membrane- and membrane-associated proteins are important for the pathogenicity of bacteria.  We have analysed the content of these proteins in virulent Mycobacterium tuberculosis H37Rv using Triton X-114 detergent-phase separation for extraction of lipophilic proteins, followed by their identification with high resolution mass spectrometry.  RESULTS:  In total, 1417 different proteins were identified.  In silico analysis of the identified proteins revealed that 248 proteins had at least one predicted trans-membrane region.  Also, 64 of the identified proteins were predicted lipoproteins, and 54 proteins were predicted as outer membrane proteins.  Three-hundred-and-ninety-five of the observed proteins, including 91 integral membrane proteins were described for the first time.  Comparison of abundance levels of the identified proteins was performed using the exponentially modified protein abundance index (emPAI) which takes into account the number of the observable peptides to the number of experimentally observed peptide ions for a given protein.  The outcome showed that among the membrane-and membrane-associated proteins several proteins are present with high relative abundance.  Further, a close examination of the lipoprotein LpqG (Rv3623) which is only detected in the membrane fractions of M. tuberculosis but not in M. bovis, revealed that the homologous gene in M. bovis lack the signal peptide and lipobox motif, suggesting impaired export to the membrane.  CONCLUSIONS:  Altogether, we have identified a substantial proportion of membrane- and membrane-associated proteins of M. tuberculosis H37Rv, compared the relative abundance of the identified proteins and also revealed subtle differences between the different members of the M. tuberculosis complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTlM3gu7QTAcO2mnZh2OgS0fW6udTcc2eYna13ktFEVprntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3czlsVGjsA%253D%253D&md5=de3193520f418826f094e3cb6d1b0f88</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1186%2F1471-2180-10-132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2180-10-132%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25A5len%26aufirst%3DH.%26aulast%3DPathak%26aufirst%3DS.%26aulast%3DS%25C3%25B8fteland%26aufirst%3DT.%26aulast%3Dde%2BSouza%26aufirst%3DG.%2BA.%26aulast%3DWiker%26aufirst%3DH.%2BG.%26atitle%3DDefinition%2520of%2520Novel%2520Cell%2520Envelope%2520Associated%2520Proteins%2520in%2520Triton%2520X-114%2520Extracts%2520of%2520Mycobacterium%2520Tuberculosis%2520H37Rv%26jtitle%3DBMC%2520Microbiol.%26date%3D2010%26volume%3D10%26spage%3D132%26doi%3D10.1186%2F1471-2180-10-132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Augustijns, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wuyts, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hens, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Annaert, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brouwers, J.</span><span> </span><span class="NLM_article-title">A Review of Drug Solubility in Human Intestinal Fluids: Implications for the Prediction of Oral Absorption</span> <span class="citation_source-journal">Eur. J. Pharm. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">322</span><span class="NLM_x">–</span> <span class="NLM_lpage">332</span><span class="refDoi"> DOI: 10.1016/j.ejps.2013.08.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=10.1016%2Fj.ejps.2013.08.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=23994640" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVyltL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=322-332&author=P.+Augustijnsauthor=B.+Wuytsauthor=B.+Hensauthor=P.+Annaertauthor=J.+Butlerauthor=J.+Brouwers&title=A+Review+of+Drug+Solubility+in+Human+Intestinal+Fluids%3A+Implications+for+the+Prediction+of+Oral+Absorption&doi=10.1016%2Fj.ejps.2013.08.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">A review of drug solubility in human intestinal fluids: Implications for the prediction of oral absorption</span></div><div class="casAuthors">Augustijns, Patrick; Wuyts, Benjamin; Hens, Bart; Annaert, Pieter; Butler, James; Brouwers, Joachim</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">322-332</span>CODEN:
                <span class="NLM_cas:coden">EPSCED</span>;
        ISSN:<span class="NLM_cas:issn">0928-0987</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The purpose of this paper is to collate all recently published soly. data of orally administered drugs in human intestinal fluids (HIF) that were aspirated from the upper small intestine (duodenum and jejunum).  The data set comprises in total 102 soly. values in fasted state HIF and 37 soly. values in fed state HIF, covering 59 different drugs.  Despite differences in the protocol for HIF sampling and subsequent handling, this summary of HIF solubilities provides a crit. ref. data set to judge the value of simulated media for intestinal soly. estn.  In this regard, the review includes correlations between the reported solubilizing capacity of HIF and fasted or fed state simulated intestinal fluid (FaSSIF/FeSSIF).  Correlating with HIF solubilities enables the optimal use of soly. measurements in simulated biorelevant media to obtain accurate ests. of intestinal soly. during drug development.  Considering the fraction of poorly sol. new mol. entities in contemporary drug discovery, adequate prediction of intestinal soly. is crit. for efficient lead optimization, early candidate profiling, and further development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8IijZQJ8SKrVg90H21EOLACvtfcHk0lhQ3yegwYYbqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVyltL3L&md5=4e7a43d3d0cfe514577f6b10a1ba0c97</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.ejps.2013.08.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejps.2013.08.027%26sid%3Dliteratum%253Aachs%26aulast%3DAugustijns%26aufirst%3DP.%26aulast%3DWuyts%26aufirst%3DB.%26aulast%3DHens%26aufirst%3DB.%26aulast%3DAnnaert%26aufirst%3DP.%26aulast%3DButler%26aufirst%3DJ.%26aulast%3DBrouwers%26aufirst%3DJ.%26atitle%3DA%2520Review%2520of%2520Drug%2520Solubility%2520in%2520Human%2520Intestinal%2520Fluids%253A%2520Implications%2520for%2520the%2520Prediction%2520of%2520Oral%2520Absorption%26jtitle%3DEur.%2520J.%2520Pharm.%2520Sci.%26date%3D2014%26volume%3D57%26spage%3D322%26epage%3D332%26doi%3D10.1016%2Fj.ejps.2013.08.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Kansy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gubernator, K.</span><span> </span><span class="NLM_article-title">Physicochemical High Throughput Screening: Parallel Artificial Membrane Permeation Assay in the Description of Passive Absorption Processes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1007</span><span class="NLM_x">–</span> <span class="NLM_lpage">1010</span><span class="refDoi"> DOI: 10.1021/jm970530e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm970530e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADyaK1cXhs12kt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=1007-1010&author=M.+Kansyauthor=F.+Sennerauthor=K.+Gubernator&title=Physicochemical+High+Throughput+Screening%3A+Parallel+Artificial+Membrane+Permeation+Assay+in+the+Description+of+Passive+Absorption+Processes&doi=10.1021%2Fjm970530e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Physicochemical High Throughput Screening: Parallel Artificial Membrane Permeation Assay in the Description of Passive Absorption Processes</span></div><div class="casAuthors">Kansy, Manfred; Senner, Frank; Gubernator, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1007-1010</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The majority of pharmaceutical discovery projects aim for an orally available form of a new therapeutic principle.  One obstacle for per oral treatment is intestinal absorption.  A simple predictive exptl. method to assess the potential of intestinal absorption is therefore highly welcome.  The authors describe here the PAMPA (Parallel Artificial Membrane Permeation Assay) method, a simple, robust, high throughput screen (HTS) which has been shown to be predictive for passive diffusion through membranes and thus for oral absorption.  In addn. PAMPA can deliver information in parallel on the lipophilicity, the ionization state and the soly. of a compd.  Therefore PAMPA complements HTS, combinatorial chem. and parallel synthesis efforts in preclin. pharmaceutical research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqcwCGodCr1rVg90H21EOLACvtfcHk0lhQ3yegwYYbqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhs12kt70%253D&md5=85d8ab409313b583de52348eb4d895da</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm970530e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970530e%26sid%3Dliteratum%253Aachs%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DSenner%26aufirst%3DF.%26aulast%3DGubernator%26aufirst%3DK.%26atitle%3DPhysicochemical%2520High%2520Throughput%2520Screening%253A%2520Parallel%2520Artificial%2520Membrane%2520Permeation%2520Assay%2520in%2520the%2520Description%2520of%2520Passive%2520Absorption%2520Processes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D1007%26epage%3D1010%26doi%3D10.1021%2Fjm970530e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Sarathy, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuccotto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsinpin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandberg, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Via, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marriner, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masquelin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyatt, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dartois, V.</span><span> </span><span class="NLM_article-title">Prediction of Drug Penetration in Tuberculosis Lesions</span> <span class="citation_source-journal">ACS Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">552</span><span class="NLM_x">–</span> <span class="NLM_lpage">563</span><span class="refDoi"> DOI: 10.1021/acsinfecdis.6b00051</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.6b00051" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVCjtr%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2016&pages=552-563&author=J.+P.+Sarathyauthor=F.+Zuccottoauthor=H.+Hsinpinauthor=L.+Sandbergauthor=L.+E.+Viaauthor=G.+A.+Marrinerauthor=T.+Masquelinauthor=P.+G.+Wyattauthor=P.+C.+Rayauthor=V.+Dartois&title=Prediction+of+Drug+Penetration+in+Tuberculosis+Lesions&doi=10.1021%2Facsinfecdis.6b00051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of Drug Penetration in Tuberculosis Lesions</span></div><div class="casAuthors">Sarathy, Jansy P.; Zuccotto, Fabio; Hsinpin, Ho; Sandberg, Lars; Via, Laura E.; Marriner, Gwendolyn A.; Masquelin, Thierry; Wyatt, Paul; Ray, Peter; Dartois, Veronique</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">552-563</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The penetration of antibiotics in necrotic tuberculosis lesions is heterogeneous and drug-specific, but the factors underlying such differential partitioning are unknown.  We hypothesized that drug binding to macromols. in necrotic foci (or caseum) prevents passive drug diffusion through avascular caseum, a crit. site of infection.  Using a caseum binding assay and MALDI mass spectrometry imaging of tuberculosis drugs, we showed that binding to caseum inversely correlates with passive diffusion into the necrotic core.  We developed a high-throughput assay relying on rapid equil. dialysis and a caseum surrogate designed to mimic the compn. of native caseum.  A set of 279 compds. was profiled in this assay to generate a large data set and explore the physicochem. drivers of free diffusion into caseum.  Principle component anal. and modeling of the data set delivered an in silico signature predictive of caseum binding, combining 69 mol. descriptors.  Among the major pos. drivers of binding were high lipophilicity and poor soly.  Determinants of mol. shape such as the no. of rings, particularly arom. rings, no. of sp2 carbon counts, and vol.-to-surface ratio neg. correlated with the free fraction, indicating that low-mol.-wt. nonflat compds. are more likely to exhibit low caseum binding properties and diffuse effectively through caseum.  To provide simple guidance in the property-based design of new compds., a rule of thumb was derived whereby the sum of the hydrophobicity (clogP) and arom. ring count is proportional to caseum binding.  These tools can be used to ensure desirable lesion partitioning and guide the selection of optimal regimens against tuberculosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosriLLKTq-DLVg90H21EOLACvtfcHk0li74CfBCVPtDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVCjtr%252FJ&md5=53cd208be87cb190dc64b2f24fc008ab</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.6b00051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.6b00051%26sid%3Dliteratum%253Aachs%26aulast%3DSarathy%26aufirst%3DJ.%2BP.%26aulast%3DZuccotto%26aufirst%3DF.%26aulast%3DHsinpin%26aufirst%3DH.%26aulast%3DSandberg%26aufirst%3DL.%26aulast%3DVia%26aufirst%3DL.%2BE.%26aulast%3DMarriner%26aufirst%3DG.%2BA.%26aulast%3DMasquelin%26aufirst%3DT.%26aulast%3DWyatt%26aufirst%3DP.%2BG.%26aulast%3DRay%26aufirst%3DP.%2BC.%26aulast%3DDartois%26aufirst%3DV.%26atitle%3DPrediction%2520of%2520Drug%2520Penetration%2520in%2520Tuberculosis%2520Lesions%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2016%26volume%3D2%26spage%3D552%26epage%3D563%26doi%3D10.1021%2Facsinfecdis.6b00051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Haverkamp, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breithardt, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camm, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janse, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antzelevitch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Escande, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malik, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, R.</span><span> </span><span class="NLM_article-title">The Potential for QT Prolongation and Proarrhythmia by Non-Antiarrhythmic Drugs: Clinical and Regulatory Implications. Report on a Policy Conference of the European Society of Cardiology</span> <span class="citation_source-journal">Eur. Heart J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">1216</span><span class="NLM_x">–</span> <span class="NLM_lpage">1231</span><span class="refDoi"> DOI: 10.1053/euhj.2000.2249</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=10.1053%2Feuhj.2000.2249" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=10924311" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A280%3ADC%252BD3cvjs1aiuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2000&pages=1216-1231&author=W.+Haverkampauthor=G.+Breithardtauthor=A.+J.+Cammauthor=M.+J.+Janseauthor=M.+R.+Rosenauthor=C.+Antzelevitchauthor=D.+Escandeauthor=M.+Franzauthor=M.+Malikauthor=A.+Mossauthor=R.+Shah&title=The+Potential+for+QT+Prolongation+and+Proarrhythmia+by+Non-Antiarrhythmic+Drugs%3A+Clinical+and+Regulatory+Implications.+Report+on+a+Policy+Conference+of+the+European+Society+of+Cardiology&doi=10.1053%2Feuhj.2000.2249"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a policy conference of the European Society of Cardiology</span></div><div class="casAuthors">Haverkamp W; Breithardt G; Camm A J; Janse M J; Rosen M R; Antzelevitch C; Escande D; Franz M; Malik M; Moss A; Shah R</div><div class="citationInfo"><span class="NLM_cas:title">European heart journal</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1216-31</span>
        ISSN:<span class="NLM_cas:issn">0195-668X</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTimf7TsooszfSAs_PE1QvifW6udTcc2eZ6p6wqrlrAxrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3cvjs1aiuw%253D%253D&md5=f2b59d1e8806c5d389f5435ec78925bb</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1053%2Feuhj.2000.2249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Feuhj.2000.2249%26sid%3Dliteratum%253Aachs%26aulast%3DHaverkamp%26aufirst%3DW.%26aulast%3DBreithardt%26aufirst%3DG.%26aulast%3DCamm%26aufirst%3DA.%2BJ.%26aulast%3DJanse%26aufirst%3DM.%2BJ.%26aulast%3DRosen%26aufirst%3DM.%2BR.%26aulast%3DAntzelevitch%26aufirst%3DC.%26aulast%3DEscande%26aufirst%3DD.%26aulast%3DFranz%26aufirst%3DM.%26aulast%3DMalik%26aufirst%3DM.%26aulast%3DMoss%26aufirst%3DA.%26aulast%3DShah%26aufirst%3DR.%26atitle%3DThe%2520Potential%2520for%2520QT%2520Prolongation%2520and%2520Proarrhythmia%2520by%2520Non-Antiarrhythmic%2520Drugs%253A%2520Clinical%2520and%2520Regulatory%2520Implications.%2520Report%2520on%2520a%2520Policy%2520Conference%2520of%2520the%2520European%2520Society%2520of%2520Cardiology%26jtitle%3DEur.%2520Heart%2520J.%26date%3D2000%26volume%3D21%26spage%3D1216%26epage%3D1231%26doi%3D10.1053%2Feuhj.2000.2249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Werner, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweetman, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savitski, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bantscheff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savitski, M. M.</span><span> </span><span class="NLM_article-title">Ion Coalescence of Neutron Encoded TMT 10-Plex Reporter Ions</span> <span class="citation_source-journal">Anal. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x">, </span> <span class="NLM_fpage">3594</span><span class="NLM_x">–</span> <span class="NLM_lpage">3601</span><span class="refDoi"> DOI: 10.1021/ac500140s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ac500140s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjsVSlsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2014&pages=3594-3601&author=T.+Wernerauthor=G.+Sweetmanauthor=M.+F.+Savitskiauthor=T.+Mathiesonauthor=M.+Bantscheffauthor=M.+M.+Savitski&title=Ion+Coalescence+of+Neutron+Encoded+TMT+10-Plex+Reporter+Ions&doi=10.1021%2Fac500140s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Ion Coalescence of Neutron Encoded TMT 10-Plex Reporter Ions</span></div><div class="casAuthors">Werner, Thilo; Sweetman, Gavain; Savitski, Maria Faelth; Mathieson, Toby; Bantscheff, Marcus; Savitski, Mikhail M.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Chemistry (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3594-3601</span>CODEN:
                <span class="NLM_cas:coden">ANCHAM</span>;
        ISSN:<span class="NLM_cas:issn">0003-2700</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Isobaric mass tag-based quant. proteomics strategies such as iTRAQ and TMT utilize reporter ions in the low mass range of tandem MS spectra for relative quantification.  The recent extension of TMT multiplexing to 10 conditions has been enabled by utilizing neutron encoded tags with reporter ion m/z differences of 6 mDa.  The baseline resoln. of these closely spaced tags is possible due to the high resolving power of current day mass spectrometers.  In this work we evaluated the performance of the TMT10 isobaric mass tags on the Q Exactive Orbitrap mass spectrometers for the first time and demonstrated comparable quantification accuracy and precision to what can be achieved on the Orbitrap Elite mass spectrometers.  However, we discovered, upon anal. of complex proteomics samples on the Q Exactive Orbitrap mass spectrometers, that the proximate TMT10 reporter ion pairs become prone to coalescence.  The fusion of the different reporter ion signals into a single measurable entity has a detrimental effect on peptide and protein quantification.  We established that the main reason for coalescence is the commonly accepted max. ion target for MS2 spectra of 1e6 on the Q Exactive instruments.  The coalescence artifact was completely removed by lowering the max. ion target for MS2 spectra from 1e6 to 2e5 without any losses in identification depth or quantification quality of proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWEX7QZakgM7Vg90H21EOLACvtfcHk0lhmC8yBEPGEYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjsVSlsrc%253D&md5=da3546478628dff1b4a1775491a621d5</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fac500140s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fac500140s%26sid%3Dliteratum%253Aachs%26aulast%3DWerner%26aufirst%3DT.%26aulast%3DSweetman%26aufirst%3DG.%26aulast%3DSavitski%26aufirst%3DM.%2BF.%26aulast%3DMathieson%26aufirst%3DT.%26aulast%3DBantscheff%26aufirst%3DM.%26aulast%3DSavitski%26aufirst%3DM.%2BM.%26atitle%3DIon%2520Coalescence%2520of%2520Neutron%2520Encoded%2520TMT%252010-Plex%2520Reporter%2520Ions%26jtitle%3DAnal.%2520Chem.%26date%3D2014%26volume%3D86%26spage%3D3594%26epage%3D3601%26doi%3D10.1021%2Fac500140s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i90"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01347">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_08153"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b01347">10.1021/acs.jmedchem.7b01347</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Synthesis and analytical data of intermediates, chemoproteomics materials and methods, microbiology assays, in vitro ADMET assays, metabolite identification studies, and mouse pharmacokinetic studies (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01347/suppl_file/jm7b01347_si_001.pdf">PDF</a>)</p></li><li><p class="inline">MS/MM data for profiling of <b>25</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01347/suppl_file/jm7b01347_si_002.xls">XLS</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01347/suppl_file/jm7b01347_si_003.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01347/suppl_file/jm7b01347_si_001.pdf">jm7b01347_si_001.pdf (947.52 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01347/suppl_file/jm7b01347_si_002.xls">jm7b01347_si_002.xls (588.5 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01347/suppl_file/jm7b01347_si_003.csv">jm7b01347_si_003.csv (3.96 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b01347&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-24%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b01347%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b01347" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799a1128d5732a9","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
